,,,,,,,,,,,
,,,,, : ubat yang baru ditambah selepas jkut bil 1/2025,,,,,,
,,,,,,,,,,,
ATC,"NAMA GENERIK UBAT 
& KEKUATAN",INDIKASI,DOS,KATEGORI PRESKRIBER,JABATAN,CATATAN,BRAND NAME*,PRICE/UNIT (RM),,,
"1.0 ALIMENTARY SYSTEM
1.1 ANTACIDS, GASTRIC ULCER REMEDIES",,,,,,,,,,,
A02,"Dexlansoprazole 30 mg, 60mg Delayed Release Capsule","i) Treatment of erosive esophagitis (EE)
ii) Maintenance of healed erosive esophagitis (EE)
iii) Symptomatic treatment of non-erosive gastroesophageal reflux disease. 
Restrictions: 
As a second-line therapy for: 
i) Patients with refractory EE
ii) Geriatrics
iii) Patients with polypharmacy. ","i) Treatment of EE – 60 mg once daily for 8 weeks
ii) Maintenance of healed EE – 30 mg once daily for 6 months
iii) Symptomatic non-erosive gastroesophageal reflux disease – 30 mg once daily for 4 weeks.
",A*,Pembedahan,Kuota,Dexilant ,1.49,/,tab,A*
A02,Esomeprazole 40 mg Injection,i) Acute erosive/ ulcerative oesophagitis,i) 20- 40 mg once daily for 2-5 days,A*,"Perubatan, 
Pembedahan",,Nexium,24.60,/,vial,A*
,,"ii) Non -variceal upper gastrointestinal 
bleed",ii) 80 mg by IV bolus followed by 8mg/hour infusion for 72 hours,,,,,,,,
A02,Esomeprazole 40 mg Tablet,i) Gastro-oesophageal reflux disease ,i) 20mg daily for 4-8 weeks ,A,"Perubatan, 
Pembedahan",,Emanera,0.48,/,tab,A*
,,"ii) H. pylori eradication

Restrictions:
- First-line therapy for patients on Ryle’s tube or unable to tolerate oral therapy
- Second-line therapy for patients who are not suitable to take or did not respond well to pantoprazole despite optimal duration of treatment",ii) 40mg daily for 10 days. in combination with amoxicillin 1g twice daily or clarithromycin 500mg twice daily,,,,,,,,
A03,Itopride HCl 50 mg Tablet,"Treatment of gastrointestinal symptoms of functional, non-ulcer dyspepsia (chronic gastritis)
 i.e sensation of bloating, early satiety, upper abdominal pain or discomfort, anorexia, heartburn, nausea and vomiting",50 mg 3 times daily before meal,A*,Pembedahan,,Progit,0.52,/,tab,A*
A02,Magnesium Trisilicate Mixture(200ml),"Heartburn, dyspepsia",10-20 ml 3-4 times daily before meals,C,Product discont due to chloroform,KIV,Hovid,1.87,/,bot,C
A02,Magnesium Trisilicate Tablet,"Heartburn, dyspepsia","ADULT  :  1-2 tablet to be chewed up to 6 times a day 
before meals. ",C,,,Idaman Pharma MMT Compound,0.15,/,tab,C
,,,CHILD (over 6 years):one tablet to be taken 3-4 times a day,,,,,,,,
A03,Mebeverine HCl 135 mg Tablet,"i) Irritable bowel syndrome
ii) Treatment of gastro-intestinal spasm secondary to organic diseases.",135 mg 3 times daily,B,"Perubatan, 
Pembedahan",,Dusphatalin,0.85,/,tab,B
A02,Omeprazole 20 mg Capsule,i)Reflux oesophagitis   ,i)20 - 80 mg 1 - 2 times daily up to 8 - 12 weeks,A/KK,"Pembedahan, 
Perubatan, 
Pediatrik",,Ometac 20,0.51,/,cap,A/KK
,,ii)For eradication of Helicobacter pylori infection,"ii)20 mg twice daily in combination with any of the 2 antibiotics
(clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily or metronidazole 400 mg twice daily)for 1 - 2 weeks",,,,,,,,
,,iii)Benign peptic ulcer not responding to conventional therapy,iii) 20 mg once daily for 4 - 6 weeks,,,,,,,,
,,iv)Zollinger-Ellison Syndrome,"iv) ADULT: 20 - 120 mg once daily adjusted according 
to the patient's response. ",,,,,,,,
,,,     CHILD :  0.4 - 0.8 mg/kg/day,,,,,,,,
A02,Pantoprazole 40 mg Injection,"Bleeding peptic ulcer and acute stress 
ulceration","40 mg twice daily until oral administration can be resumed. 
CHILD not recommended",A/KK,,,Vaxcel,3.71,/,vial,A*
A02,Pantoprazole 40 mg Tablet,i) Helicobacter pylori eradication  ,"i) 40 mg twice daily in combination with any of the 2 antibiotics
(Clarithromycin 500 mg twice daily, Amoxicillin 1 g twice daily or Metronidazole 400 mg twice daily) for 1-2 weeks",A/KK,,,Vencid ,0.19,/,tab,A/KK
,,ii) Peptic ulcer disease,ii) 40 mg daily for 2 - 4 weeks,,,,,,,,
,,iii) Erosive and non-erosive reflux oesophagitis (GERD and NERD),iii) 20 - 40 mg daily on morning for 4 weeks,,,,,,,,
,,iv) Zollinger-Ellison Syndrome,"iv) Initially 80 mg daily, dose can be titrated up or down as 
needed",,,,,,,,
,,v) Prevention of NSAID induced gastropathy,v) 20 mg daily. CHILD not recommended,,,,,,,,
A02,Ranitidine 150 mg Tablet,i) Benign gastric and duodenal ulcer  ,"i) 150 mg twice daily (at morning and night) or 300 mg on night for 4-8 weeks. 
Maintenance: 150-300 mg on night",B,,,Ranitidine,0.18,/,tab,B
,,ii) Reflux oesophagitis, ii) 150 mg twice daily or 300 mg on night for 8-12 weeks ,,,,,,,,
,, iii) Non-ulcer dyspepsia, iii) 150 mg daily or twice daily,,,,,,,,
,,iv) Zollinger-Ellison Syndrome,iv) 150 mg and may be increased as necessary to 6 g/day,,,,,,,,
A02,Ranitidine 50 mg/2 ml Injection,"i) Benign gastric/ duodenal ulceration, reflux oesophagitis, 
Zollinger Ellison Syndrome ","i) ADULT: Slow IV injection of 50 mg diluted to 20 ml and given over at least 2 minutes. 
May be repeated every 6-8 hours or IV infusion at rate of 25 mg/hour for 2 hours, may be repeated at 6-8 hours intervals or IM. 
CHILD: 1 mg/kg/dose 6-8 hourly",B,,,Rantac,0.67,/,amp,B
,,"ii) Stress ulcer prophylaxis in 
post-operative and high risk patients","ii) Initial slow IV injection of 50 mg, then continuous infusion 
of 125-250 mcg/kg/hour",,,,,,,,
A02,Sodium Alginate 1000mg/10ml & Potassium Bicarbonate 200mg/10ml Suspension (150ml),"Treatment of symptoms of gastro-oesophageal reflux eg. acid regurgitation, heartburn,
indigestion due to the reflux of stomach contents not responding to conventional antacids or as an addition to PPI when PPI alone fails to control the symptoms","Adult, elderly & children ≥12 year: 5-10 mL.",A*,"Perubatan, 
Pembedahan",,Gaviscon Advance,15.40,/,bot,A*
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.2 ANTIDIARRHOEALS",,,,,,,,,,,
A07,Diphenoxylate HCL 2.5mg with Atropine Sulphate 0.025mg Tablet,"Symptomatic treatment of acute and 
chronic diarrhoea","ADULT: 2 tablets 4 times daily, later reduced when diarrhoea is controlled.
Maintenance: 2 tablets once daily as needed (Max: 8 tablets daily)",B,,,Pharmaniaga Diphenoxylate ,0.10,/,tab,B
A07,Loperamide 2 mg Capsule,"i. Adjunct to rehydration in:
a. acute diarrhea in adult; and
b. chronic diarrhea in adult

ii. In patients with an ileostomy, it can be used to reduce the number and volume of stools and to harden their consistency","6 – 8 mg per day up to max. of 16mg per day

Dosing is individualised and according to product insert / protocol",B,Pembedahan,,Lomide,0.07,/,cap,B
,,,,,,,,,,,
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.3 ANTIHAEMORRHOIDAL",,,,,,,,,,,
C05,Diosmin 450 mg and Hesperidin 50 mg Tablet,i) Haemorrhoids,"Acute attack: 6 tablets daily for the first 4 days,
then 4 tablets daily in 2 divided doses for 3 days and 2 tablets thereafter. ",B,,,Hemo Rid,0.33,/, tab,A/KK
,,,Chronic attack : 2 tablets daily,,,,,,,,
,, ii) Chronic venous insufficiency,ii) 2 tab daily with meals,,,,,,,,
C05,"Zinc Oxide 300 mg, Balsam Peru 50 mg & Benzyl Benzoate 33 mg Suppository","For relief of pruritus, burning and soreness in patients 
with haemorrhoids and perianal conditions","Insert 1 suppository night and morning after bowel movements; 
do not use for longer than 7 days OR please refer to the product insert.",C,,,Anucare,0.87,/,supp,C
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.4 ANTISPASMODICS",,,,,,,,,,,
A03,Atropine Sulphate 1mg/ml Injection,"i) Reduce vagal inhibition,salivary
 and bronchiol secretion in anaesthesia","i) Adult: 300-600 mcg IM/SC 30-60 minutes before anaesthesia. 
Alternatively, 300-600 mcg IV immediately before induction of anaesthesia. ",B,,,Pharmaniaga Atropine Sulphate ,1.46,/,amp,B
,,,"Child: >20 kg: 300-600 mcg; 12-16 kg: 300 mcg; 7-9 kg: 200 mcg; >3 kg: 100 mcg. 
Doses to be given via IM/SC admin 30-60 minutes before anaesthesia.",,,,,,,,
,,ii) Reversal of excessive bradycardia,"ii) Adult: 500 mcg every 3-5 minutes. Total: 3 mg. 
Max Dosage: 0.04 mg/kg body weight.",,,,,,,,
,,"iii) Reversal of effect of 
competitive muscle relaxants",iii) Adult 0.6-1.2 mg before or with anticholinesterase ,,,,,,,,
,,"iv) Overdosage with other 
compounds having muscarinic action","iv) Adult: 0.6-1 mg IV/IM/SC, repeated every 2 hr.",,,,,,,,
,,v) Organophosphate poisoning,"v) Adult: 2 mg IV/IM, every 10-30 minutes until muscarinic effects disappear or atropine toxicity appears. 
In severe cases, dose can be given as often as every 5 minutes. 
In moderate to severe poisoning, a state of atropinisation is maintained for at least 2 days and continued for as long as symptoms are present. ",,,,,,,,
,,,Child: 20 mcg/kg given every 5-10 minutes.,,,,,,,,
A03,Domperidone 10 mg Tablet,"Nausea, vomiting, dyspepsia, 
gastro-esophageal reflux","Chronic dyspepsia ADULT 10 mg 3 times daily. 
Acute and subacute conditions (particularly nausea and vomiting)
ADULT :  20 mg 3-4 times daily",B,,,Molax-M,0.06,/,tab,B
,,,,,,,,,,,
A03,Domperidone 1mg/ml suspension (60ml),"Nausea, vomiting, dyspepsia, 
gastro-esophageal reflux",Adults and adolescents ≥ 12 years of age and weighing ≥ 35kg & children < 12 years of age and weighing ≥ 35kg: 10ml three to four times per day. Maximum dose: 40mg/day. Adults and adolescents (≥ 12 years of age) weighing < 35kg: 0.25mg/kg three to four times per day. Maximum dose: 35mg/day.,B,,,Motidom,3.84,/,bottle,
A03,Hyoscine N-Butylbromide 20 mg/ml Injection,"Gastrointestinal tract and genito-urinary tract spasm, dyskinesia of the biliary system","20 mg IM/IV repeated after 30 min if needed. 
Max: 100 mg daily.",B,,,Copan,1.82,/,amp,B
A03,Hyoscine N-Butylbromide 10 mg Tablet,"Gastrointestinal tract and genito-urinary tract spasm, dyskinesia of the biliary system.","ADULT 10-20mg, 3-4 times a day. 
CHILD 6-12 years old: 10mg 3 times a day.",B,,,Spasmoliv,0.19,/,tab,B
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.5 LAXATIVES, PURGATIVES (CATHARTICS)",,,,,,,,,,,
A06,Bisacodyl 5 mg Tablet,i) Constipation,i) ADULT and CHILD over 10 years : 5-10 mg. To be taken at night for effect on the following morning,C,,,Laxodyl,0.07,/,tab,C
,,,CHILD 4-10 years :  5 mg. To be taken at night for effect on the following morning,,,,,,,,
,,ii) Bowel preparation for radiological procedures and surgery, ii) ADULT :  10-20 mg the night before procedures,,,,,,,,
,,, CHILD over 4 years: 5 mg the night before procedures,,,,,,,,
A06,Bisacodyl 10mg Suppository,i) Constipation ,i) ADULT and CHILD over 10 years: 10 mg insert rectally,C,,,YSP,0.45,/,supp,C
,,,CHILD less than 10 years :  5 mg insert rectally ,,,,,,,,
,,ii) Bowel preparation for radiological procedures and surgery,ii) ADULT : 10-20 mg the following morning before procedures insert rectally,,,,,,,,
,,,CHILD over 4 years :  5 mg the following morning before procedures insert rectally ,,,,,,,,
A06,Glycerin 25% and Sodium Chloride 15% Enema,Constipation,1 enema as required,C+,,,Royce,1.00,/,tube,C+
A06,Lactulose 3.35 g/5 ml Liquid,i) Constipation ,i) ADULT : 15 ml twice daily adjusted to patient's need. ,C+,,,Unilac,2.70,/,bot of 100ml,C+
,,,CHILD : 0.5 ml/kg/dose once or twice daily,,,,,,,,
,,ii) Hepatic encephalopathy,"ii) ADULT : 30-50 ml 3-4 times daily, dose adjusted to
 produce 2-3 soft stools daily. ",,,,,,,,
,,,CHILD : 1 ml/kg/dose 3-4 times daily,,,,,,,,
A06,Liquid Paraffin 5kg,Constipation,"ADULT :  10-30 ml daily at night but should not 
be taken immediately before going to bed. 
CHILD : not recommended",C,,,-,69.00,/,unit (5kg),C
A06,"Macrogol 64g, Anhydrous Sodium Sulfate 5.7g, Sodium Bicarbonate 1.68g, NaCl 1.46g & KCl 0.75g","Bowel cleansing prior to colonoscopy, radiological examination or colonic surgery. 
Suitable for patients with heart failure or renal failure","1 sachet dissolved in 1 L of water. 2-3 L of oral solution are required. 
When morning surgery is planned, the oral solution is given in the late afternoon the day prior. 
If surgery is scheduled in afternoon, the oral solution should be given on the same day for ingestion to be completed three hours before surgery",A,Pembedahan,Kuota,Fortrans,13.13,/,sac,A
A06,"Sodium Biphosphate 16%, Sodium Phosphate 6% Rectal Solution","Bowel cleansing before colonic surgery, 
colonoscopy or radiological examination to ensure the bowel is free of solid contents. It is not to be used for treatment of constipation",ADULT 133 ml (1 bottle) administered rectally. CHILD more than 2 years half the adult dose (66.6ml),A,Pembedahan,,Fleet enema,9.54,/,"bot 
133ml",
A06,"Monobasic Sodium Phosphate 48%, Dibasic Sodium Phosphate 18%","Bowel cleansing prior to colonoscopy, 
radiological examination or bowel surgery","45 ml diluted with half a glass (120 ml) of water, followed by one full glass (240 ml) of water to be taken depending on the time of the procedure.
-  For morning procedure, 45 ml dilute with half glass of water should be taken at 7 am and the second 45 ml at 7 pm on the day before the procedure. 
-  For afternoon procedure, the first dose should be taken at 7 pm on the day before and the second dose at 7 am on the day of the procedure. 
-  Solid food must not be taken during the preparation period; clear fluids or water can be taken liberally. 
-  Not recommended for use in children",A,Pembedahan,,Fleet Phospho - Soda,11.16,/,bot 45ml,A
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.6 MOUTH AND THROAT PREPARATION",,,,,,,,,,,
A01,Benzydamine HCl 0.15% Solution,"For relief of painful condition of the oral 
cavity","Used as a 30 seconds gargle or rinse, undiluted. 
ADULT : 15 ml. 
CHILD less 12 years :  5-15 ml. 
Uninterrupted treatment should not be more than 7 days",B,,,Difflam,5.95,/,100ml,B
A01,"Choline Salicylate 8.7%, Cetylkonium Chloride 0.01% Dental Gel","For relief of the pain and discomfort in
mouth ulcers and sores, infant teething 
and denture irritation",Apply to area 4 times daily,B,,,Oracue,6.40,/,10 g tube,B
A01,Glycerin Oral Gel,As a lubricant and osmotic dehydrating agent ,"Apply to area when required
",C+,,,Glycerin,80.34,/,5kg,C+
A01,Thymol Compound Gargle,"For sore throat and minor mouth 
inflammation",To be gargled 3-4 times daily,C,,,Thymol ,1.20,/,60ml,C
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.7 ANTIEMETICS",,,,,,,,,,,
A04,Aprepitant 125mg AND 80mg Capsule,"In combination with other antiemetic 
agents for prevention of delayed nausea 
and vomiting associated with 
initial and repeat 
course of highly emetogenic chemotherapy","125 mg 1 hour prior to chemotherapy on Day 1. 
To be given as part of a 3-day regimen that includes a corticosteroid and a 5-HT3 antagonist",A*,,,Emend,222.6,/,pack of 3 capsules,A*
,,,"80 mg once daily in the morning on Days 2 and Day 3. 
To be given as part of a 3-day regimen that includes a corticosteroid & a 5-HT3 antagonist",,,,,,,,
A04,Granisetron HCl 3 mg/3 ml Injection,i) Prevention and treatment of nausea and vomiting associated with chemotherapy and radiotherapy ,i) ADULT : 1-3 mg as an IV bolus not not less than 30 seconds; maximum 9 mg/day. ,A,Pembedahan,,Kytron,3.98,/,amp,A
,,,CHILD over 2 years ; single dose of 10-40 mcg/kg as an IV infusion; maximum 3 mg/day,,,,,,,,
,,ii) Post-operative nausea and vomiting,ii) ADULT : 1 mg by slow IV injection over 30 seconds prior to induction of anaesthesia,,,,,,,,
A04,Granisetron HCl 1 mg Tablet,Prevention and treatment of nausea and vomiting associated with chemotherapy and radiotherapy,"ADULT : 1 mg twice daily or 2 mg once daily with the first dose to be administered 
within 1 hour prior to cytostatic therapy and can be given for up to 1 week following radiotherapy. 
Maximum 9 mg/day",A,,,Kytron,11.80,/,tab,A
R06,Meclozine HCl 25 mg and Pyridoxine 50 mg Tablet,Nausea and vomiting in pregnancy,Optimum dosing: 1 to 2 tablets OD. Maximum dosing: 4 tablets/day.,B,Obstetrik ,,Veloxin,0.67,/,tab,B
A03,Metoclopramide HCl 10 mg/2 ml Injection,Use in adults for: i) Prevention of post-operative nausea and vomiting ,"All indications (adult): A single 10mg dose is recommended for the prevention of post-operative nausea and vomiting. 
The recommended dose for the symptomatic treatment of nausea and vomiting, including nausea and vomiting induced by migraine attacks and for the prevention of radiotherapy-induced nausea and vomiting is 10mg per dose, 1 to 3 times daily. 
The maximum recommended daily dose is 30mg or 0.5mg/kg. Treatment duration when administering by injection should be as short as possible and a switch to administration via oral or rectal route should be instituted as quickly as possible. ",B,,,Malon,0.63,/,amp,B
,,"ii) Symptomatic treatment of nausea and vomiting, including nausea and vomiting induced by migraine attacks iii) Prevention of radiotherapy-induced nausea and vomiting ",,,,,,,,,
,,"Use in children aged 1 to 18 years for: 
i) Prevention of delayed chemotherapy- induced nausea and vomiting as a second-line option ","All indications (children aged 1 to 18 years of age) The recommended dosage is 0.1 to 0.15mg/kg, 1 to 3 times daily, by intravenous route. 
The maximum daily dose is 0.5mg/kg. 
Dosing table: CHILD age 1-3 years old (body weight 10-14kg): 1mg TDS, 
3-5 years old (body weight 15-19kg): 2mg TDS, 
5-9 years old (body weight 20-29kg): 2.5mg TDS, 
9-18 years old (body weight 30-60kg): 5mg TDS, 
15-18 years old (body weight > 60kg): 10mg TDS. 
For the prevention of delayed CINV, the maximum treatment duration is 5 days. 
For the prevention of post-operative nausea and vomiting, the maximum treatment duration is 48 hours.",,,,,,,,
,,ii) Prevention of post-operative nausea and vomiting as a second-line option,,,,,,,,,
A03,Metoclopramide HCl 10 mg Tablet,Use in adults for: i) Prevention of delayed chemotherapy induced nausea and vomiting (CINV)  ,"Adult: The recommended single dose is 10mg, repeated up to three times daily. The maximum recommended daily dose is 30mg or 0.5mg/kg body weight. The maximum recommended treatment duration is 5 days. Prevention of delayed CINV (children aged 1-18 years): The recommended dose is 0.1-0.5mg/kg body weight, repeated up to three times daily by oral route. The maximum dose in 24 hours is 0.5mg/kg body weight.",B,,,Sunward,0.03,/,tab,B
,,ii) Prevention of radiotherapy induced nausea and vomiting (RINV),,,,,,,,,
,,"iii) Symptomatic treatment of nausea and vomiting, including acute migraine induced nausea and vomiting",,,,,,,,,
,,Use in children aged 1-18 years for: i) Prevention of delayed chemotherapy induced nausea and vomiting (CINV) as a second line option,"CHILD age 1-3 years old (body weight 10-14kg): 1mg TDS, 3-5 years old (body weight 15-19kg): 2mg TDS, 5-9 years old (body weight 20-29kg): 2.5mg TDS, 9-18 years old (body weight 30-60kg): 5mg TDS, 15-18 years old (body weight > 60kg): 10mg TDS. Tablets are not suitable for use in children weighing less than 30kg. Other pharmaceutical forms may be more appropriate for administration to this population.",,,,,,,,
A05,Prochlorperazine Maleate 5mg Tablet,i) Severe nausea and vomiting ,"Nausea and vomiting Adult: As maleate or mesilate: 20 mg, further doses are given if needed. Recommended buccal dose: As maleate: 3-6 mg bid. ",B,,,Prochlor Tablet 5,0.17,/,tab,B
,,ii) Vertigo/labyrinthine disorders,"Vertigo Adult: As maleate or mesilate: 15-30 mg daily, given in divided doses. May reduce gradually to 5-10 mg daily. Recommended buccal dose: 3-6 mg bid. May be taken with or without food.",,,,,,,,
A04,Prochlorperazine Mesylate 12.5 mg/ml Injection,i) Severe nausea and vomiting ,"Deep IM injection, 12.5 mg repeated if necessary after 6 hours and then followed by an oral dose. Not recommended in children",B,,,Lartil,2.25,/,amp,B
,,ii) Vertigo/labyrinthine disorders,,,,,,,,,
,,,,,,,,,,,
"1.0 ALIMENTARY SYSTEM
1.8 ANTICHOLINERGIC / ANESTHETIC PREMEDICATION AGENTS",,,,,,,,,,,
A03,Glycopyrrolate 200 mcg/ml Injection,"i) To reduce secretions (respiratory tract) 
for certain types of surgery ","i) Pre-op: 4 mcg/kg via IM administration 30-60 mins before procedure. 
Intraoperative: 0.1 mg via IV administration, repeat at 2-3 min intervals when needed. 
Max: 400 mcg/dose",A*,,,Pyronium,3.34,/,vial,A*
,,"ii) Reversal of neuromuscular block in 
patients where atropine is contraindicated","ii) 0.2 mg by IV for each 1 mg of neostigmine or 
5 mg pyridostigmine",,,,,,,,
R03,Glycopyrrolate 1mg tablet,Excessive airway secretion,"Child: ≥3 years Initially, 20 mcg/kg tid. Titrate dose in increments of 20 mcg/kg every 5-7 days according to response. Max: 100 mcg/kg tid not to exceed 1,500-3,000 mcg/dose.

HSM Practice: 1mg TDS",Not in FUKKM,Pediatrik,import permit required for purchase (UKK),Glycorate,0.67,/,tab,
,,,,,,,,,,,
"2.0 RESPIRATORY SYSTEM
2.1 ANTIASTHMATIC",,,,,,,,,,,
R03,Aminophylline 25 mg/ml Injection (250mg/10ml),"Reversible airways obstruction, acute severe brochospasm","Adult: Loading dose: 5 mg/kg (ideal body weight) or 250-500 mg (25 mg/ml) by slow inj or infusion over 20-30 min. 
Maintenance infusion dose: 0.5 mg/kg/hr. 
Max rate: 25 mg/min. ",B,,,Fresenius Aminophylline,3.36,/,amp,B
,,,"Child: Loading dose: same as adult dose. 
Maintenance dose: 
6 mth-9 yr: 1 mg/kg/hr 
10-16 yr: 0.8 mg/kg/hr.",,,,,,,,
R03,"Beclomethasone Dipropionate (100 mcg/dose, 200 doses MDI )",Prophylaxis of asthma especially if not fully controlled by bronchodilators,"Adults: The usual maintenance dose is one to two inhalations (200-400 mcg) twice daily.
If needed,the dose can be increased up to 1600 mcg/day divided in two to four doses ",B,,,Biosone,12.3,/,unit,B
,,,Children 6-12 years old: One inhalation (100 mcg) two times daily and dose may be increased up to 800 mcg/day in divided two to four doses if necessary.,,,,,,,,
R03   ,Beclomethasone dipropionate 100mcg and formoterol fumarate dihydrate 6mcg pressurized inhalation solution,"Prescriber category A/KK:
i) Regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2 agonist) is appropriate in:
a) Patients not adequately controlled with inhaled corticosteroids and ""as needed"" inhaled short-acting beta2 agonist, or
b) Patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

Prescriber category A*:
ii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more
iii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","For asthma, the dosage is based on treatment approach:
i) Maintenance therapy (taken as regular maintenance treatment with a separate as needed rapid-acting bronchodilator):
Dose recommendations for adults 18 years and above: One or two inhalations twice daily. The maximum daily dose is 4 inhalations.
ii) Maintenance and reliever therapy (taken as regular maintenance treatment and as needed in response to asthma symptoms):
Dose recommendations for adults 18 years and above: The recommended maintenance dose is 1 inhalation twice daily (one inhalation in the morning and one inhalation in the evening). Patients should take 1 additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. The maximum daily dose is 8 inhalations.

For COPD:
2 puffs two times a day.","A*, A/KK",Perubatan,To start by Respi Consultant (visiting) only,Foster,66.73,/,unit,
R03   ,Benralizumab 30mg/ml injection,"As add-on maintenance treatment in adult patients from 18 years with severe eosinophilic asthma characterised by the following criteria:
a) At least two exacerbations in the past 12 months on the current standard therapy (high-dose inhaled corticosteroids plus long-acting bronchodilators) and/or need for treatment with systemic corticosteroids.
b) Eosinophil count in the blood of ≥0.3 G/L (corresponding to ≥300 cells/μL)

Prescribing restriction:
To be prescribed by Respiratory Physician (Pulmonologist) only","30 mg every 4 weeks for the first 3 doses, and then every 8 weeks thereafter administered as subcutaneous injection",A*,Perubatan,Kuota,Fasenra,3713,/,PFS,
R03   ,"Budesonide (200 mcg/dose,300 doses MDI )",Maintenance treatment of asthma as prophylactic therapy especially if not fully controlled by bronchodilators,ADULT:200 - 1600 mcg daily in 2-4 divided doses. Maintenance with twice daily dosing. ,B,,,Budesonide Aerosol for inhalation,21.46,/,unit,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,B
,,,"CHILD more than 7 years: 200-800 mcg, 2 - 7 years: 200-400 mcg. To be inhaled in 2 - 4 divided doses.

",,,,,,,,
R03,Budesonide 1 mg/2 ml Nebulising Solution,"Treatment of asthma in patients where use of a pressurized inhaler or dry
powder formulation is unsatisfactory or inappropriate. ",ADULT : Initially 1 - 2 mg twice daily. CHILD 3 months - 12 years of age : 500 mcg - 1 mg. Maintenance dose : half of the above doses,B,,,Talgan,3.44,/,respule,B
R03,"Budesonide 160 mcg and Formoterol 4.5 mcg Inhalation Turbuhaler (120 doses, 30 doses)","Category of prescriber A/KK: 
i) Regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and ""as needed"" inhaled short-acting beta2-agonists. or 
- Patients already adequately controlled on both inhaled corticosteroids and long- acting beta2-agonists.
ii) As a reliever treatment for mild asthma patients who do not adhere to regular inhaled corticosteroid","i) Asthma Maintenance therapy:  
Adult ≥18 yr : 160 mcg to 320 mcg bd. Some patients may require up to a max of 640 mcg bd. 
Adolescent 12-17 yr :  160 mcg to 320 mcg bd.
Children 6-11 yr :  160 mcg bd.
<6 yr Not recommended. 
Maintenance & relief : Adult and adolescent ≥12 yr : 320 mcg/day either as 160 mcg bd or 320 mcg od either morning or evening. 

For some patients a maintenance dose of 320 mcg bd may be appropriate. Patients should take 160 mcg additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. 
Not more than 960 mcg should be taken on any single occasion. A total daily dose of more than 1280 mcg is not normally needed, however a total daily dose of up to 1920 mcg could be used for a limited period. Patients using more than 1280 mcg daily should seek medical advice, should be reassessed & their maintenance therapy reconsidered. 

ii) Asthma reliever-only therapy: 160mcg as needed, but no more than 960mcg in a single occasion.
Children <12 yr: Not recommended. 

iii) & iv) COPD: Adult ≥18 yr : 320 mcg bd.",A/KK & A*,"Perubatan (120 & 30 doses)

Jabatan Pesakit Luar (30 doses)
",,"Symbicort Turbuhaler
(120 doses)

Symbicort Turbuhaler (30 doses)","70.17


20.00",/,unit,A/KK
,,"Category of prescriber A*
iii) Treatment of COPD patients with a blood eosinophil count of 300 cells/ microliter and more",,,,,,,,,
,,iv) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.,,,,,,,,,
R03,"Budesonide 320 mcg and Formoterol 9 mcg Inhalation Turbuhaler, 60 doses","
i) Category of prescriber A/KK: Regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- - Patients not adequately controlled with inhaled corticosteroids and ""as needed"" inhaled short-acting beta2-agonists. or - Patients already adequately controlled on both inhaled corticosteroids and long- acting beta2-agonists. 

Category of prescriber A*: ii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more 
iii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators. ","
Asthma Maintenance therapy Adult ≥18 yr 160 mcg to 320 mcg bd. Some patients may require up to a max of 640 mcg bd. 
Adolescent 12-17 yr 160 mcg to 320 mcg bd. 
Childn 6-11 yr 160 mcg bd, <6 yr Not recommended. 
Maintenance & relief Adult and adolescent ≥12 yr 320 mcg/day either as 160 mcg bd or 320 mcg od either morning or evening. For some patients a maintenance dose of 320 mcg bd may be appropriate. Patients should take 160 mcg additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. Not more than 960 mcg should be taken on any single occasion. A total daily dose of more than 1280 mcg is not normally needed, however a total daily dose of up to 1920 mcg could be used for a limited period. Patients using more than 1280 mcg daily should seek medical advice, should be reassessed & their maintenance therapy reconsidered. Children & adolescent <12 yr: Not recommended. COPD: Adult ≥18 yr 320 mcg bd.
",A/KK,,,Symbicort Turbuhaler,88.30,/,unit,A/KK
R03,"Fluticasone Propionate 125 mcg/dose Inhalation MDI, 120 doses",Prophylactic treatment for asthma,"ADULT and CHILD more than 16 years
i) Mild asthma : 100 mcg - 250 mcg twice daily 
ii) Moderate asthma : 250 - 500 mcg twice daily 
iii) Severe asthma : 500 mcg - 1000 mcg twice daily. 
Alternatively, the starting dose of fluticasone dipropionate may be gauged at half the total daily dose of beclomethasone dipropionate or equivalent administered by inhalation.",B,,,"Flixotide 
Evohaler",10.50,/,unit,B
R03,Glycopyrronium 50mcg Inhalation Powder Hard Capsules,For maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). COPD diagnosis is confirmed by spirometry.,"One capsule daily. The recommended dose is the inhalation of the content of one capsule once daily using inhaler. It is recommended to be administered, at the same time of the day each day. 
No relevant use of glycopyrronium in pediatric population (<18 years) for COPD.",A/KK,Perubatan,,Seebri,80.60,/,set with 30 caps,A/KK
R03,Indacaterol Maleate 110mcg and Glycopyrronium Bromide 50mcg inhalation powder capsules,As a once-daily maintenance bronchodilator treatment to relieve symptoms and reduce exacerbations in adult patients with chronic obstructive pulmonary disease (COPD).,One capsule inhalation daily.,A/KK,Perubatan,,"Ultibro 
Breezhaler",80.83,/,set with 30 caps,A*
R03,Indacaterol Maleate 150 mcg Inhalation Capsule,"
Maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD). 
Prescribing restriction: Initiation of LABA, LAMA and LABA/LAMA for COPD: 
i) The diagnosis of COPD should be confirmed by spirometry 
ii) For Pulmonologist: COPD patient must be assessed for suitability for lung volume reduction (surgical or bronchoscopic approach) and lung transplant before they are discharged to Klinik Kesihatan. 
iii) For Family Medicines Specialist: COPD patients must be referred to Pulmonologist for assessment of suitability for lung volume reduction (surgical or bronchoscopic approach) and lung transplant prior initiation of LABA, LAMA and LABA/LAMA in Klinik Kesihatan.
",Once-daily inhalation of the content of one 150/300 microgram capsule. Maximum dose is 300 microgram once-daily.,A/KK,Perubatan,Kuota,Onbrez,3.13,/,cap,A/KK
R03,Ipratropium Bromide 0.025% Nebulising Solution (UDV 500mcg/2ml) and 0.0125% Nebulising Solution (UDV 250mcg/2ml),"Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. Used concomitantly with inhaled beta-agonists in the treatment of acute bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and asthma.","Maintenance treatment: 
i) Adult and adolescents over 12 years old: 500mcg per dose, 3 to 4 times daily. 
ii) Children 6 - 12 years old: 250mcg per dose, 3 to 4 times daily. 
iii) Children less than 6 years old: 100 - 250mcg per dose, 3 to 4 times daily. ",B,,,"Ipraneb 500, Ipraneb 250","1.00,
0.79",/,UDV,B
,,,"Acute attacks (in combination with beta-agonist): 
i) Adult and adolescents over 12 years old: 500mcg per dose, time interval between doses may be determined by the physician.
 ii) Children 6 - 12 years old: 250mcg per dose, time interval between doses may be determined by the physician. 
iii) Children less than 6 years old: 100 - 250mcg per dose, time interval between doses may be determined by the physician.",,,,,,,,
R03,"Ipratropium Bromide 20 mcg and Fenoterol 50 mcg/dose Inhalation MDI, 200 doses",Management of symptoms in chronic obstructive airway disorders with reversible bronchospasm such as bronchial asthma and chronic bronchitis with or without emphysema,"ADULT & CHILD more than 6 years; Acute asthma 2 puffs. Severe cases: if breathing has not noticeably improved after 5 mins, 2 further puffs may be taken. Intermittent and long-term treatment : 1-2 puffs for each administration, up to max 8 puffs/day (average: 1-2 puffs three times daily)",B,,,Berodual,16.59,/,unit,B
R03,Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg per UDV,Management of reversible bronchospasm associated with obstructive airway diseases,"Acute attacks : 1 unit dose vial. In severe cases not relieved by 1 unit dose vial, 2 unit dose vials may require, patient should consult a doctor immediately. 
Maintenance : 1 unit dose vial 3 - 4 times daily",B,,,Combineb,0.62,/,UDV,B
R03,Montelukast Sodium 4 mg Oral Granules,"Asthmatics, not controlled on high dose inhaled corticosteroids more than 1600 mcg/day and with co-morbid allergic disorders. Chronic treatment of asthma",12 months - 5 years: 1 packet of 4mg oral granules daily at bedtime,A*,Pediatrik,,"4mg Aspira

5mg Montelair Hovid

10mg Montular","0.72/4mg,

 0.20/5mg,
 0.18/10mg",/,tab,"A*, A*, A/KK"
,Montelukast Sodium 5 mg Tablet,"Asthmatics, not controlled on high dose inhaled corticosteroids more than 1600 mcg/day and with co-morbid allergic disorders. Chronic treatment of asthma",CHILD 6 - 14 years: One 5 mg chewable tablet daily at bedtime, A*,"Perubatan, Pediatrik ",,,,,,
,Montelukast Sodium 10 mg Tablet,Chronic treatment of asthma and relief of symptoms of seasonal allergic rhinitis for children more than 15 years and adults,CHILD more than 15 years and ADULT: 10 mg daily at bedtime, A/KK,Perubatan,,,,,,
R03,"Salbutamol 100 mcg/dose, 200 doses MDI",Asthma and other conditions associated with reversible airways obstruction,"ADULT : 100 - 200 mcg up to 3 - 4 times daily. 
CHILD : 100 mcg increased to 200 mcg if necessary",B,,,Biomol,5.97,/,unit,B
,"(200 mcg/dose, 200 doses Easyhaler)",Asthma and other conditions associated with reversible airways obstruction,"CHILD : 100 - 200 mcg. Maintenance : 100 - 200 mcg 2 - 4 times daily. 
ADULT : 100 - 400 mcg. Maitenance : 100 - 400 mcg 2 - 4 times daily",B,,,Buventol Easyhaler,91.50,/,unit,B
R03,Salbutamol 0.5 % Inhalation Solution,"Indicated for the relief of bronchospasm in patients with reversible
obstructive airway disease and acute bronchospasm.
","2.5 to 5mg (0.5ml – 1ml), repeat according to response and tolerability.
Dosing is individualised and according to product insert/protocol",B,,,Pharmaniaga Salbutamol,5.10,/,bot,B
R03,Salbutamol 0.5 mg/ml Injection,Asthma and other conditions associated with reversible airways obstruction,"500 mcg by SC/IM injection 4 hourly or 250 mcg by slow IV. If required, by IV infusion, initially 5 mcg/min adjusted according to response and heart rate, usually in the range 3 - 20 mcg/min",A,,,YSP Salbutamol,1.83,/,amp,A
R03,Salbutamol 2 mg/5 ml Syrup,Asthma and other conditions associated with reversible airways obstruction,"CHILD 2 - 6 years : 1 - 2 mg 3 - 4 times daily, 
6 - 12 years : 2 mg 3 -4 times daily",B,,,KCK Salbutamol,1.03,/,60ml bot,B
R03,"Salmeterol 50 mcg and Fluticasone Propionate 250 mcg Inhalation Accuhaler, 60 doses","Category of prescriber A/KK:
i) Regular treatment of reversible obstructive airways diseases including asthma. 
Category of prescriber A*: 
ii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more
iii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","i) ADULT and CHILD more than 12 years : 1 puff twice daily.  
ii) For COPD: Dose is one inhalation 50/250mcg to 50/500mcg twice daily.",A/KK,Perubatan,,Seretide Accuhaler,77.40,/,unit,A/KK
R03,"Salmeterol 50 mcg and Fluticasone Propionate 500 mcg Inhalation Accuhaler, 60 doses","Category of prescriber A/KK is only approved for indication (i):
 i) Regular treatment of reversible obstructive airways diseases including asthma. 
The following indication is still under category of prescriber A*: 
ii) Treatment of COPD patients with a blood eosinophil count of 300 cells/microliter and more 
iii) Treatment of COPD patients with blood eosinophil count of 100 cells/microliter and more with history of repeated exacerbation despite regular treatment with long-acting bronchodilators.","i) ADULT and CHILD more than 12 years : 1 puff twice daily.   
ii) ADULT :  1 puff twice daily",A/KK,Perubatan,,Seretide Accuhaler,40.20,/,unit,A/KK
R03,"Salmeterol 25 mcg and Fluticasone Propionate 125 mcg Inhalation MDI, 120 doses",Regular treatment of reversible obstructive airway diseases including asthma.,"ADULT and CHILD more than 12 years : 1 - 2 puff twice daily.   
CHILD over 4 years : 1 puff twice daily",A*,"Perubatan, Pediatrik ",,Seretide Evohaler,12.13,/,unit,A*
R03,"Salmeterol 25 mcg and Fluticasone Propionate 50 mcg Inhalation MDI, 120 doses ","Regular treatment of reversible obstructive airway diseases including asthma in children, where use of lower dose of a combination (bronchodilator and inhaled corticosteroids) is appropriate. Prescribing is limited to pediatric population for the purpose of dose tapering. ","CHILD more than 12 years : 2 puff twice daily. CHILD over 4 years : 2 puff twice daily No data on use for children aged under 4 years.
",A*,"Perubatan, Pediatrik ",Kuota,Seretide Evohaler,55.20,/,can,A*
R03,Terbutaline Sulphate 10 mg/ml Inhalation Solution,Asthma and other conditions associated with reversible airways obstruction,"ADULT : 5 - 10 mg 2 -4 times daily, additional doses may be necessary in severe acute asthma. 
CHILD up to 3 years : 2 mg, 3 - 6 years : 3 mg, 6 - 8 years : 4 mg, over 8 years : 5 mg ,  2 - 4 times daily",B,,,Terbutaline,28.80,/,bot,B
R03,Terbutaline Sulphate 0.5 mg/ml Injection,"Bronchial asthma, chronic bronchitis, emphysema and other lung diseases where broncoconstriction is a complicating factor","SC, IM or slow IV : 250-500 mcg up to 4 times daily. 
CHILD 2 - 15 years :  10mcg/kg to a maximum of 300 mcg. 
Continuous IV infusion, as a solution containing 3 - 5 mcg/ml, 1.5 - 5 mcg/minute for 8 - 10 hours; reduce dose for children",B,,,Baltic,5.65,/,amp,B
R03,Tezepelumab 210 mg Solution for Injection in Pre-Filled Pen/Syringe,As add-on maintenance treatment for severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment,"SC
Adult: 210 mg once every 4 weeks.
Child: ≥12 years Same as adult dose.",Not in FUKKM,Perubatan,"Kuota

Special drugs approval (UKK) required",Tezspire,4272.28,/,PFS,
R03,Theophylline 125 mg Tablet,"Reversible airways obstruction, acute severe asthma","ADULT: 125 mg 3 - 4 times daily after food, increased to 250 mg if required. 
CHILD: 1 - 15 years : 5 mg/kg/dose (up to 600 mg/ day) every 3 - 4 times daily",B,,,Pharmaniaga Theophylline,0.06,/,tab,B
R03,Theophylline 250 mg Long Acting Tablet,Reversible airways obstruction and acute severe asthma,"ADULT: 250 mg 2 times daily. 
CHILD under 12 years : Up to 10 mg/kg body weight 2 times daily",B,,,Neulin SR,0.16,/,tab,B
R03,Tiotropium 2.5mcg and Olodaterol 2.5mcg inhalation,As a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD),"2 puffs once daily, at the same time of the day",A/KK,Perubatan,,Spiolto,82.00,/,can ,A*
R03,Umeclidinium 62.5mcg & Vilanterol 25mcg Inhalation,Indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).,One inhalation daily,A*,Perubatan,Kuota,Anoro,89.27,/,cap,A*
,,,,,,,,,,,
"2.0 RESPIRATORY SYSTEM
2.2 COUGH AND COLD REMEDIES, ANTIALLERGICS",,,,,,,,,,,
R05,Bromhexine HCl 8 mg Tablet,Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucous secretion and impaired mucous transport. Prescribing restriction(s): Medical Assistant in health settings without Medical Officer is allowed to prescribe this medicine for adult use only.,"Adult: 8-16 mg three times daily. 
Children: 
By body weight: 0.3 mg/kg/day 8 hourly for 7 days, then 0.15 mg/kg/day 8 hourly; or 
Based on age: 6-12 years : 4 mg three times daily;  2-6 years :  2 mg three times daily",B,,,Rexom,0.02,/,tab,B
R06,Cetirizine HCl 10 mg Tablet,"Urticaria, allergic dermatoses (insect bites, atopic eczema), perennial rhinitis, allergic rhinitis","ADULT and CHILD over 6 years : 10 mg daily or 5 mg twice daily. 
Child 2-6 years : 5 mg once daily or 2.5 mg twice daily",B,,,Sunizine ,0.05,/,tab,A/KK
R06,Chlorpheniramine Maleate 10 mg/ml Injection,Allergic conditions,"10 - 20 mg IM or SC, repeated if required. Not to exceed 40 mg in 24 hours. 
10 - 20 mg over 1 minute by slow IV",B,,,Imach,0.48,/,amp,B
R06,Chlorpheniramine Maleate 2 mg/5 ml Syrup,Symptomatic treatment of allergic conditions responsive to antihistamine,"CHILD 2 - 5 years : 1 mg every 4 - 6 hours (maximum 6 mg daily) ;  
6 - 12 years : 2 mg every 4 - 6 hours (maximum 12 mg daily)",C,,,Alleryl,3.70,/,bot,C
R06,Chlorpheniramine Maleate 4 mg Tablet,Symptomatic treatment of allergic conditions responsive to antihistamines,"ADULT : 4 mg every 4 - 6 hours. Maximum 24 mg daily. 
CHILD : 2 - 5 years : 1 mg every 4 - 6 hours (maximum 6 mg daily) 
6 - 12 years : 2 mg every 4 - 6 hours (maximum 12 mg daily)",C,,,Antamin,0.03,/,tab,C
R06,Diphenhydramine HCl 7 mg/5 ml and Ammonium Chloride 67.5 mg/5 ml Expectorant,Cough,"ADULT : 5 - 10 ml 2 - 3 times daily. 
CHILD : 2.5 - 5 ml 2 - 3 times daily (not to be used in children less than 2 years of age)",C,,,Uphadyl,1.48,/,bot,C
R06,Diphenhydramine HCl 14 mg/5 ml and Ammonium Chloride 135 mg/5 ml Expectorant,Cough,"ADULT : 5 - 10 ml 2 - 3 times daily. 
CHILD : 2.5 - 5 ml 2 - 3 times daily (not to be used in children less than 2 years of age)",C,,,Nilco,3.36,/,bot,C
R06,Loratadine 1 mg/1 ml Syrup,"Allergic rhinitis, chronic urticaria and other allergic dermatological disorders","ADULT and CHILD over 6 years : 10 mg once daily. 
CHILD 2 - 6 years : 5 mg once daily",B,,,Rhinitin Syrup,2.10,/,bot,A
R06,Loratadine 10 mg Tablet,Allergic rhinitis and allergic dermatoses,"ADULT and CHILD over 6 years : 10 mg once daily.
CHILD 2 - 6 years: 5 mg once daily",B,,,Rhinitin,0.14,/,tab,B
R01,Loratadine 5 mg and Pseudoephedrine Sulphate 120 mg Tablet,For treatment of allergic rhinitis and allergic dermatoses,ADULT and CHILD over 12 years :  1 tablet twice daily,A/KK,"Perubatan, ENT",,Carinox,0.96,/,tab,A/KK
R03,Omalizumab 150mg/ml Solution for Injection in Pre-filled Syringe,HSM Off-label indication: Chronic Spontaneous / Idiopathic Urticaria ,ADULT: 300mg S/C every 4 weeks,Pre-filled Syringe Not in FUKKM,"Perubatan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru jika ingin menggunakan peruntukan ubat farmasi","UBAT PESARA

Special Drugs Approval (UKK) required ",Xolair,1164.95,/,/,
R06,Promethazine HCl 25 mg/ml Injection,"i) Allergic conditions
ii) Treatment and prevention of vomiting including:
- motion sickness
- drug induced nausea
- prevention and control of nausea and vomiting associated with
certain types of anaesthesia and surgery","i) Allergic Conditions
Adult and adolescent dose: 25mg intramuscular or intravenous. May be
repeated within 2 hours if required.
Children 2 years and older: intramuscularly-0.125mg/kg body weight every 4
to 6 hours OR 0,5mg/kg bodyweight at bedtime as needed OR 6.25-12.5mg
three times a day as needed OR 25mg at bedtime as needed.
",B,,,Promethazine HCl - Fresenius,2.15,/,amp,B
,,,"ii. Treatment and prevention of vomiting:
- Motion Sickness
Adult and adolescent dose: 25mg twice a day as needed. 
Children: 0.5mg/kg every 12 hours as needed OR 10 - 25mg twice a day as needed.

- Anti Emetic Therapy
Adult and adolescent dose: 25mg initially and then 10 -25mg every 4 - 6 hours as needed.
Children: 0.25-0.5mg/kg every 4 to 6 hours as needed OR 10 - 25mg every 4 to 6 hours as needed.
Dosing is individualised and according to product insert/protocol",,,,,,,,
R01,Triprolidine HCl 1.25 mg and Pseudoephedrine HCl 30 mg per 5 ml Syrup,"Decongestion of the upper respiratory tract in common cold, hay fever, allergic and vasomotor rhinitis and sinusitis. Doses to be taken twice daily or three times daily","ADULT and CHILD more than 12 year : 10 ml.  
CHILD 6 - 12 years : 5 ml 
2 - 5 years : 2.5 ml",B,To remove from formulary,,Tridin - P,2.57,/,bot,B
R01,Triprolidine HCl 2.5 mg and Pseudoephedrine HCl 60 mg Tablet,"Decongestion of the upper respiratory tract in common cold, hay fever, allergic and vasomotor rhinitis and aerotitis","ADULT :  2.5 mg every 4 - 6 hours; maximum dose 10 mg/day. 
CHILD (syrup) 6 - 12 years : 1.25 mg every 4 - 6 hours; maximum dose 5 mg/day ; 
4 - 6 years : 0.938 mg every 4 - 6 hours; maximum dose 3.744 mg/day ; 
2 - 4 years : 0.625 mg every 4 - 6 hours; maximum dose 2.5 mg/day",B,,,Decondine,0.14,/,tab,B
,,,,,,,,,,,
"3.0 CARDIOVASCULAR SYSTEM
3.1 ANTIANGINAL DRUGS",,,,,,,,,,,
C08,Diltiazem HCl 30 mg Tablet,"Treatment of angina pectoris in the following cases: 
i) inadequate response or intolerance to beta-blockers and Isosorbide Dinitrate 
ii) contraindication to beta-blockers
iii) coronary artery spasm","Initially 30mg tds, may increase to 60mg tds (elderly initially twice daily; increased if necessary to 360 mg daily.",B,,,Herbesser,0.20,/,tab,B
C01,Glyceryl Trinitrate 0.5 mg Tablet,Prophylaxis and treatment of angina and left ventricular failure,"0.5-1 mg sublingually may be repeated every 5 minutes until relief is obtained. 
Seek physician if the pain persists after a total of 3 tablets in a 15 minutes period.",C,,,Myonit Insta,31.05,/,bot,C
C01,Glyceryl Trinitrate 5mg/ml Injection,"Prescriber Category A:
i) Angina pectoris.
ii) Congestive heart failure.
iii) Production of controlled hypotension during surgery.

Prescriber Category A/KK:
iv) Control of hypertensive episodes.","Initial:
5-25mcg/min

Dosing is individualised and according to product insert or protocol.","A, A/KK",,,Gitrinil,18.15,/,amp,
C01,Isosorbide Dinitrate 1 mg/ml Injection,Treatment for angina pectoris and left ventricular failure,"2-10 mg/hour IV infusion after dilution, higher doses up to 20 mg/hour may be required",A,,,Isoket,19.23,/,amp,A
C01,Isosorbide Dinitrate 10 mg Tablet,Prophylaxis and treatment for: i) Angina ,i) 30 - 120 mg daily in divided doses ,B,,,Solbid,0.01,/,tab,B
,,ii) Left ventricular failure,"ii) 40 - 160 mg, up to 240 mg if required",,,,,,,,
C01,"Isosorbide-5-Mononitrate 
60 mg SR Tablet","Prophylaxis and treatment of angina
pectoris","60mg once daily, increase to 120 mg daily",A/KK,Perubatan,,Imdex,0.32,/,tab,A
C01,Ranolazine 375mg Prolonged Release Tablet,"Indicated in adults as add-on therapy for the symptomatic treatment of
patients with stable angina pectoris who are inadequately controlled or intolerant
to first-line antianginal therapies (such as beta-blockers and/or calcium
antagonists)","Initial dose: 375mg BD
After 2-4 weeks, the dose can titrate up to 500mg BD, according to patient's response, further titrated to a maximum dose of 750mg BD",Not in FUKKM,Perubatan," Special Drugs Approval (UKK) required
",Ranexa,2.87,/,tab,
C01,Trimetazidine 20 mg Tablet,Prophylactic treatment of episodes of angina pectoris,20 mg 3 times daily,B,,,Metazine,0.06,/,tab,B
C01,Trimetazidine 35mg MR Tablet,Prophylactic treatment of episodes of angina pectoris,35 mg twice daily in the morning and evening with meals,B,Perubatan,,Vastarel MR,0.18,/,tab,
,,,,,,,,,,,
"3.0 CARDIOVASCULAR SYSTEM
3.2 ANTICOAGULANTS AND HAEMOSTATICS",,,,,,,,,,,
B01,"Acetylsalicylic Acid 100 mg, Glycine 45 mg Tablet","Prevention of myocardial infarct, stroke, vascular occlusion and deep vein thrombosis. Transient ischaemic attacks",1 tablet daily,B,,,Wincardia,0.07,/,tab,B
B01,Alteplase 50mg/50ml Powder for Injection ,Thrombolytic treatment of acute ischaemic stroke.,0.9 mg/kg (maximum of 90 mg) infused over 60 minutes with 10% of the total dose administered as an initial intravenous bolus. Treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging technique.,A*,,,Actilyse,2325.82,/,inj,A
B01,Clopidogrel 75 mg Tablet,"Secondary prevention of atherothrombotic events in: 
i) Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. Prescribing restriction: as second/third line treatment in patients who are sensitive or intolerant to acetylsalicylic acid and/or ticlopidine). 
ii) Adult patients suffering from acute coronary syndrome: 
• Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention. 
• ST segment elevation acute myocardial infarction, in combination with acetylsalicylate acid (ASA) in medically treated patients eligible for thrombolytic therapy.",75 mg once daily,A/KK,Perubatan,,Vitraq,0.24,/,tab,A*
B01,Dabigatran Etexilate 110 mg Capsule,i) Prevention of venous thromboembolic events in patients who have undergone total knee replacement or total hip replacement surgery. ,"i) Following total knee replacement: Initially ADULT 110mg (ELDERLY, 75 mg) within 1- 4 hours after surgery, then 220 mg (ELDERLY, 150 mg) once daily thereafter for 6-10 days. 
Following total hip replacement: Initially ADULT 110 mg (ELDERLY, 75 mg) within 1- 4 hours after surgery, then 220 mg (ELDERLY, 150 mg) once daily thereafter for 28-35 days",A*,Perubatan,Kuota,Pradaxa,3.42,/,cap,A*
,,ii) Reduction of the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF).,"ii) Recommended daily dose is 300mg taken orally as 150mg hard capsule twice daily. 
Therapy should be continued lifelong.",,,,,,,,
,, iii) Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults.," iii) Recommended daily dose is 300mg taken as one 150mg capsule BD following treatment with a parenteral anticoagulant for at least 5 days. 
The duration of therapy should be individualized after careful assessment of the treatment benefit against the risk for bleeding.",,,,,,,,
,,,"ii) & iii) For the following groups, the recommended daily dose is 220 mg taken as one 110mg capsule twice daily: 
- Patients aged 80 years or above 
-Patients who receive concomitant verapamil 
Special patient population for renal impairment : Renal function should be assessed by calculating the creatinine clearance (CrCl) prior to initiation of treatment with Dabigatran to exclude patients for treatment with severe renal impairment (i.e. CrCl < 30 ml/min).",,,,,,,,
,"Dabigatran Etexilate150 mg 
Capsule",i) Reduction of the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF).,"i) Recommended daily dose is 300mg taken orally as 150mg hard capsule twice daily. 
Therapy should be continued lifelong.",,,,,,,,
,,ii) Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults.,"ii) Recommended daily dose is 300mg taken as one 150mg capsule BD following treatment with a parenteral anticoagulant for at least 5 days. 
The duration of therapy should be individualized after careful assessment of the treatment benefit against the risk for bleeding. 
For the following groups, the recommended daily dose is 220 mg taken as one 110mg capsule twice daily: 
- Patients aged 80 years or above
 -Patients who receive concomitant verapamil Special patient population for renal impairment : Renal function should be assessed by calculating the creatinine clearance (CrCl) prior to initiation of treatment with Dabigatran to exclude patients for treatment with severe renal impairment (i.e. CrCl < 30 ml/min).",,,,,,,,
B01,Edoxaban 60mg Film Coated Tablets,"Indicated in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, and age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA).","The recommended dose is 60 mg edoxaban once daily.
Therapy with edoxaban in NVAF patients should be continued long term.

The recommended dose is 30 mg once daily in patients with one or more of the following clinical factors:
• Moderate or severe renal impairment (creatinine clearance (CrCL) 15 - 50 mL/min)
• Low body weight ≤ 60 kg
• Concomitant use of the following P-glycoprotein (P-gp) inhibitors: ciclosporin, dronedarone, erythromycin, or ketoconazole.",A*,Perubatan,Kuota,Lixiana,6.37,/,tab,
B01,"Enoxaparin Sodium 40 mg, 60 mg Injection","
KATEGORI PRESKRIBER A*:
i. Prophylaxis of venous thromboembolic diseases (DVT and PE) especially in perioperative, high risk surgical cases and medical patients with acute illness at increased risk of VTE

ii. Treatment of venous thromboembolic diseases (DVT and PE).
","KATEGORI PRESKRIBER A*
i. Moderate risk: 20mg SC 2 hours before surgery then 20mg SC once daily
High risk: 40mg SC 12 hours before surgery then 40mg SC once daily
Medical patients: 40mg once daily

ii. 1.5mg/kg once daily or 1mg/kg twice daily

iii. 1 mg/kg every 12 hours","A*, A/KK","Perubatan, Obstetrik",,Clexane,"19.00, 23.50",/,PFS,A*
,,"iii. Acute coronary syndrome:
a. Treatment of unstable angina and Non-ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid.
b. Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).",,,,,,,,,
,,"KATEGORI PRESKRIBER A/KK:
Prevention of DVT in antenatal and/or postnatal women with VTE risk scoring of 3 or more. A written consent form by the patient is necessary prior treatment initiation. Healthcare facilities are advised to refer to “Panduan Penggunaan Ubat- Ubatan yang Mengandungi Unsur Tidak Halal”.","KATEGORI PRESKRIBER A/KK:
<50 kg: 20mg OD
50-90 kg: 40mg OD
91-130 kg: 60mg OD
131-170 kg: 80mg OD
>170 kg: 0.6mg/kg/day",,,,,,,,
,,,,,,,,,,,
B02 ,"Factor VIII 250 IU Injection (Biostate), 

Factor VIII 250 IU with Von Willebrand factor 500 IUInjection (Biostate)

Factor VIII 250 IU with Von Willebrand factor 250 IU Injection  (Alphanate)

Factor VIII 250 IU with Von Willebrand factor 500 IU Injection  (Alphanate)","i)The treatment and prophylaxis of haemorrhage or surgical bleeding in Von Willebrand Disease (VWD) when 1-deamino-8-D-arginine vasopressin (desmopressin, DDAVP) treatment alone is ineffective or contraindicated. ","i. Von Willebrand Disease: Spontaneous Bleeding Episodes: Initially, factor VIII 12.5-25 IU/kg and ristocetin cofactor 25-50 IU/kg followed by factor VIII 12.5 IU/kg and ristocetin cofactor 25 IU/kg subsequently every 12-24 hrs. 
Minor Surgery: Factor VIII 30 IU/kg and ristocetin cofactor 60 IU/kg daily. 
Major Surgery: Initially, factor VIII 30-40 IU/kg and ristocetin cofactor 60-80 IU/kg followed by factor VIII 15-30 IU/kg and ristocetin cofactor 30-60 IU/kg subsequently every 12-24 hrs. Prophylaxis: Factor VIII 12.5-20 IU/kg and ristocetin cofactor 25-40 IU/kg 3 times weekly.",A*,,Biostate with & without VWF obtained FOC from PDN,"
Biostate

Alphanate 250

Alphanate 500","0

95.70


191.40",/,vial,A*
,,ii)The treatment and prophylaxis of bleeding associated with factor VIII deficiency due to haemophilia A.,"ii. Hemophilia A therapy: Minor haemorrage: 10-15 IU/kg every 12-24 hours. 
Moderate to severe haemorrhage: 15-40 IU/kg every 8 to 24 hours. 
Minor surgery: Loading dose 20-30 IU/kg, maintenance dose 15-30 IU/kg. 
Major surgery: Loading dose 40-50 IU/kg, maintenance dose 10-40 IU/kg. 
Prophylaxis: 25-40 IU/kg three times weekly As product may differ from one to another, it is strongly advised to refer to the manufacturer (product insert) in regards to dosing calculation.",,,,,,,,
B02 ,"Human Prothrombin Complex, Factor IX,II, X in combination 500 IU/vial injection ","i) Treatment and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors caused by Vit.K antagonists

ii) Treatment and prophylaxis of bleeding in patients with single/multiple congenital deficiencies of factor IX,II or X","25-50 IU/kg
Note: INR <4.5 may have sufficient factor VII present to permit efficacy with 3 factor PCC",A*,Pathologi,kuota, (prothrombinex-VF),0 (FOC from PDN),/,vial,
B02 ,"Human Prothrombin Complex, Factor IX,II, VII, X in combination 500 IU/vial injection ","i) Treatment and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex factors caused by Vit.K antagonists

ii) Treatment and prophylaxis of bleeding in patients with single/multiple congenital deficiencies of factor IX,II,VII Ior X","INR<5, 15IU/kg              
INR>5, 30IU/kg                  
Max 6 vials per dose (usually 4-5 vials/patient)
Note: INR >4.5 do not have meaningful factor VII levels, and thus require 4 factor PCC (Octaplex) ",A*,Blood Bank,"Kuota
 (80 vials a year)", Octaplex,715.00,/,vial,
B02 ,Factor IX 500 iu Injection,"Prevention and control of bleeding 
in patients with factor IX deficiency due to haemophilia B","Number of factor IX units required =
body weight (kg) x desired factor IX increase (%) x 1.0 IU/kg
Dosing is individualised and according to product insert/protocol.",A,Pediatrik,Kuota,AlphaNine,464.00,/,vial,A
,Ferric Subsulphate Solution (Monsel's),Cervical cautherisation after cervical biopsy post colposcopy,Thickened formulation apply directly to biopsy site to stop bleeding,Not in FUKKM,Obstetrik,"Import Permit Required for purchase
(UKK)",Monsel solution,302.80,/,botol,
B01,Fondaparinux Sodium 12.5 mg/ml Injection in Prefilled Syringe (7.5MG/0.6ML),"i)Treatment of acute Deep Vein Thrombosis (DVT)
ii) Treatment of acute Pulmonary Embolism (PE)","The recommended dose to be administered by SC injection once daily is: 5mg for body weight less than 50kg, 7.5mg for body weight 50 to 100kg, 10mg for body weight greater than 100kg. Treatment should be continued for at least 5 days and until adequate oral anticoagulation is established (INR 2 to 3). Concomitant treatment with vitamin K antagonists should be initiated as soon as possible, usually within 72 hours. The usual duration of treatment is 5 to 9 days",A*,Perubatan,restriction: For patient weighing >80kg only,Arixtra,50.90,/,PFS,
B01,Fondaparinux Sodium 2.5 mg/0.5 ml Injection,"Prescribing Category A*:
i) Prevention of venous thromboembolic events (VTE) in orthopedic surgery (e.g. hip fracture, major knee or hip replacement surgery), abdominal surgery in patients at risk of thromboembolic complication.","i) 2.5 mg once daily given by SC, administered 6 hr following surgical closure provided homeostasis has been established. 
Usual duration of therapy is 5 to 9 days; for hip fracture patients, an extended course of up to 24 days is recommended.","A*, A",Perubatan,,Arixtra,22.60,/,PFS,A*
,,"Precribing Category A:
ii)) Treatment of unstable angina or non-ST segment elevation myocardial infarction [UA/NSTEMI] in patients for whom urgent invasive management (PCI) is not indicated.","ii) ADULT more than 18 years: 2.5 mg once daily given by SC, initiated as soon as possible after diagnosis and continued for up to 8 days or until hospital discharge.
If patient needs to undergo PCI, unfractionated heparin to be admin as per local practice protocol, taking into account the patient's bleeding risk and time of last dose of fondaparinux. Fondaparinux may be restarted no earlier than 2 hr after sheath removal. ",,,,,,,,
,,iii) Treatment of ST segment elevation myocardial infarction (STEMI) in patients managed with thrombolytics or are not receiving other forms of reperfusion therapy," iii) ADULT more than 18 years: 2.5 mg once daily; first dose to be given IV (directly through an existing IV line or as infusion in 25 or 50 ml of 0.9% saline over 1-2 min), subsequent doses to be given SC.
Treatment to be initiated as soon as diagnosis is made and continued up to a max of 8 days or until hospital discharge, whichever comes earlier. If patient needs to undergo non-primary PCI, unfractionated heparin to be admin as per local practice protocol, taking into account the patient's bleeding risk and time of last dose of fondaparinux. Fondaparinux may be restarted no earlier than 3 hr after sheath removal",,,,,,,,
B01,"Heparin 1000 units/ml, 5000 units/ml Injection",i) Prophylaxis and treatment of venous thrombosis and pulmonary embolism. ,"i) By IV injection, loading dose of 5000 units (10,000 units in severe pulmonary embolism) followed by continuous infusion of 15-25 units/kg/hr. By SC injection (for DVT) of 15,000 units every 12 hours (laboratory monitoring on daily basis essential to adjust dose). 
Small adult or child, lower loading dose then, 15-25 units/kg/hr by IV infusion, or 250 units/kg every 12 hours by SC injection.",B,,,"Heparinol 1000

Heparinol 5000

Unihepa 5000","11.37


10.79


 10.79",/,vial,B
,,ii) Treatment of myocardial infarction and arterial embolism. ,"ii) As i), for unstable angina and acute peripheral arterial 
occlusion.",,,,,,,,
,,iii) Prevention of clotting in arterial and heart surgery and for prevention of cerebral thrombosis," iii) Prophylaxis in general surgery, by SC injection, 5000 units 2 hour before surgery, then every 8-12 hours for 7 days or until patient is ambulant, during pregnancy (with monitoring), 5000-10000 units every 12 hours. 
An adjusted dose regimen may be used for major orthopaedic surgery or low molecular weight heparin may be selected",,,,,,,,
B01,Heparin Sodium 50 units in Sodium Chloride Injection,"To maintain patency of peripheral venous 
catheters",Flush with 5 ml (50 units) every 4 hours or as required,B,,,Heparinol,0.51,/,amp,B
B01,Rivaroxaban 10 mg Tablet,"i. Prevention of venous thromboembolism in patients undergoing elective hip or knee replacement surgery
ii. Treatment of deep vein thrombosis (DVT), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute DVT in adults
iii. Treatment of Pulmonary Embolism (PE), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute PE in adults

HSM off label use: 
Treatment and prevention of thrombosis and coronary aneurysm in peadiatric patient","Indication i:
10 mg once daily. Initial dose should be taken 6 to 10 hour post-surgery provided that haemostasis has been established. Duration of treatment: Major hip surgery 5 weeks. Major knee surgery 2 weeks

Indication ii & iii
15mg BD for 21 days, followed by 20mg OD
Dose reduction to 15mg OD for renal impairment (CrCl 15 to 49 ml/min)

HSM Off label: 
12kg -29.9kg 5mg BD",A*,Pediatrik,"Kuota

Special Drugs Approval (UKK) required for off-label indication",Xarelto,6.74,/,tab,
B01,"Rivaroxaban 15 mg, 20 mg Tablet                                                               ","i)Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as Congestive heart failure (CHF), hypertension, age ≥ 75 yrs, diabetes mellitus, prior stroke or transient ischaemic attack. ","i)20mg once daily or 15mg once daily 
(for patients with moderate renal impairment 
(creatinine clearance 30-49 ml/min) )",A*,Perubatan,Kuota,Xarelto,"6.8, 6.8",/,tab,A*
,,"ii)Treatment of deep vein thrombosis (DVT), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute DVT in adults.","Dosage (ii) & (iii)15mg BD for 21 days, followed by 20mg OD",,,,,,,,
,," iii) Treatment of Pulmonary Embolism (PE), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute PE in adults.",,,,,,,,,
B01,"Streptokinase 1,500,000 IU Injection","Acute myocardial infarction, acute pulmonary embolism","Myocardial infarction: 1,500,000 units over 30 - 60 minutes. 
Pulmonary embolism: 250,000 units by IV infusion over 30 minutes, then 100,000 units every hour for up to 12-72 hours with monitoring of clotting factors",A*,,,Idaman Streptokinase Karma,1055.60,/,vial,A*
B01,"Tenecteplase 10,000 unit (50 mg) Injection",Acute myocardial reinfarction where streptokinase is contraindicated due to previous streptokinase induced antibodies. [antibodies were given more than 5 days and less than 12 months],"Less than 60 kg: 30 mg, 
60 - 69 kg: 35 mg, 
70 - 79 kg: 40 mg; 
80 -90 kg: 45 mg, 
90 kg or above: 50 mg. 
Administer single IV bolus over 5-10 seconds",A*,,,Metalyse,3548.90,/,vial,A*
B01,Ticagrelor 90 mg Tablet ,"a)Patient who failed clopidogrel readmitted to hospital with recurrent atherothrombotic event while patients are on clopidogrel. 
b) ACS patients with:
i) STEMI - going for invasive (PCI), 
ii) NSTEMI/UA - intermediate to high risk (based on TIMI score). 
iii) Other complicated ACS cases treated either medically or invasively via PCI or CABG (risk of Stent thrombosis, 3VD etc.)","Initially, 180mg as single dose followed by 90mg bd with maintenance dose of ASA 75-150 mg daily.",A*,,"Ticagrelor 90 mg Tablet IS
NOT KEPT AT OPD pharm. INITIATION ONLY BY CARDIOLOGIST AT HRPB. STOCK FROM KWKK HRPB",Brilinta,2.77,/,tab,A*
B01,Ticlopidine HCl 250 mg Tablet,"i) Prevention of thrombotic stroke for patients who are sensitive /intolerant to Acetysalicylic Acid ii) Maintenance of coronary bypass surgery or angioplasty 
iii) Maintenance of patency of access in patients on chronic haemodialysis",250 mg twice daily taken with food,A/KK,,,Dynapharm Ticlopidine,0.14,/,tab,A/KK
B01,"Tinzaparin 3500, 4500, 14000 anti-Factor Xa IU Injection","i)Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), not amounting to hemodynamic instability. ","i)Treatment of DVT and PE, in conjunction with warfarin: 
175 anti-Factor Xa IU/kg SC once daily for at least 6 days. ",A*,"Perubatan, Obstetrik",,Innohep,"13.61, 18.85, 50.58",/,inj,A*
,,ii)Prevention of post-operative DVT in patients undergoing general and orthopaedic surgery.,"ii)Thromboprophylaxis in patients with:
Moderate risk of thrombosis (general surgery):3,500 anti-Factor Xa IU SC 2 hrs before surgery and postoperatively, 3,500 anti-Factor Xa IU once daily for 7-10 days. 
High risk of thrombosis (eg. total hip replacement):4,500 anti-Factor Xa IU SC or 50 anti-Factor Xa IU/kg body weight SC 2 hrs before surgery and then once daily until the patients has been mobilized.",,,,,,,,
B02,Tranexamic Acid 250 mg Capsule,Haemorrhage associated with excessive fibrinolysis,ADULT: 1-1.5 g (15-25 mg/kg) 2-4 times daily. ,B,,,Transamin,0.37,/,cap,B
,,,"CHILD: 25 mg/kg/day 2-3 times daily. Menorrhagia (initiated when menstruation has started), 
1 g 3 times daily for up to 4 days; maximum 4 g daily",,,,,,,,
B02,Tranexamic Acid 100 mg/ml Injection,Haemorrhage associated with excessive fibrinolysis,"ADULT: Slow IV 0.5-1 g (10 - 15 mg/kg) 3 times daily. 
Continuous infusion at a rate of 25 - 50 mg/kg daily. ",B,,,Bioindustrial IM,2.60,/,amp,B
,,,CHILD: slow IV 10 mg/kg/day 2-3 times daily,,,,,,,,
B01,"Urokinase 60,000 IU Injection","Treatment of thromboembolic disease such as mycocardial infarction, peripheral artery occlusion, pulmonary embolism, retinal artery thrombosis and other ophthalmologic use","ADULT: Acute pulmonary embolism: IV loading dose 4400 iu/kg over 10 mins, maintenance 4400 iu/kg/hour for 12 hours. 
Peripheral vascular occlusion: infuse 2500 iu/ml into clot at a rate of 4000 iu/min for 2 hours. This may be repeated up to 4 times. 
Hyphaema: 5000 IU in 2 ml saline solution is injected and withdrawn repeatedly over the iris. If residual clot remains, leave 0.3ml in the anterior chambers for 24-48 hours to facilitate futher dissolution",A,,"Import Permit Required for purchase
(UKK)",Urokinase,407.65,/,vial,A
B02,Vitamin K1 1 mg/ml Injection,Vitamin K deficiency in neonates,"Prophylaxis of vitamin K deficiency bleeding in neonates Child: Neonate: 0.5-1 mg, given as a single dose via IM inj. Alternatively, 2 mg may be given orally, followed by a 2nd dose of 2 mg after 4-7 days. 
Intravenous Vitamin K deficiency bleeding in neonates Child: Infant: 1 mg by IV/IM/SC inj, further doses may be given if necessary",C+,,,Kisan,"3.39, ",/,amp,C+
,Vitamin K1 10 mg/ml Injection,Haemorrhage associated with hypoprothrombinaemia caused by overdose of anticoagulants,0.5 - 20 mg by very slow IV at a rate not exceeding 1 mg per minute,B,,,,3.35,,,B
B01,Warfarin Sodium 1 mg Tablet,Treatment and prophylaxis of thromboembolic disorders,"Initially 2 to 5mg per day.
Maintenance dose 2-10mg daily according to the INR

Dosing is individualised based on patient’s INR and according product insert/protocol/ guideline.",B,,,Apotex,0.29,/,tab,B
B01,Warfarin Sodium 2 mg Tablet,,,,,,Apotex,0.30,/,tab,B
B01,Warfarin Sodium 5 mg Tablet,,,,,,Apotex,0.31,/,tab,B
,,,,,,,,,,,
"3.0 CARDIOVASCULAR SYSTEM
3.3 ANTIHYPERTENSIVES",,,,,,,,,,,
C08,"Amlodipine 5 mg, 10 mg Tablet",Hypertension,5 mg once daily. Max: 10 mg once daily,B,,,Hovasc,"0.02, 0.03",/,tab,B
C09,Amlodipine 10 mg and Valsartan 160 mg Tablet,Essential hypertension in patients whose blood pressure is not adequately controlled by monotherapy,"Doses range from amlodipine besylate 5 mg/valsartan 160 mg to amlodipine besylate 10 mg/valsartan 320 mg ORALLY once daily, with dose titration occurring every 1 to 2 weeks if necessary. 
MAX :  amlodipine besylate 10 mg/valsartan 320 mg",A/KK,Perubatan,,Exforge,0.84,/,tab,A/KK
C07,Atenolol 100 mg Tablet,"Hypertension, angina pectoris, myocardial infarction and arrhythmias","Hypertension and arrythmias; 50 - 100 mg daily, 
Angina; 100 mg daily, 
Myocardial infarction; individualised",B,,,Pharmaniaga Atenolol,0.17,/,tab,B
C07,"Bisoprolol Fumarate 2.5 mg, 5 mg Tablet",Treatment of stable moderate to severe congestive cardiac failure in addition to ACEI's and diuretics,1.25 mg once daily to 5 - 10 mg daily,B,,,Bisocor,"0.07, 0.10",/,tab,B
C09,Captopril 25 mg Tablet,i) Hypertension ,"i) Initially 12.5 mg twice daily. Maintenance: 25-50 mg 2 - 3 times daily, 
may be increased to maximum 450 mg/day in divided doses  ",B,,,APUZIN,0.06,/,tab,B
,, ii) Congestive heart failure,"ii) Initially 6.25 - 12.5 mg 3 times daily, increase after 
several days to 25 - 50 mg 3 times daily",,,,,,,,
,,iii) Post-myocardial infarction,"iii) Start 3 days after MI Initially 6.25 mg daily, gradually increased to 37.5 mg daily in divided doses. 
May increase after several week to 150 mg/day in divided doses if needed and tolerated",,,,,,,,
,, iv) Diabetic nephropathy, iv) 75 - 100 mg daily in divided dose.,,,,,,,,
C07,"Carvedilol 6.25 mg, 25 mg Tablet",Treatment of stable moderate to severe congestive cardiac failure in addition to ACEI's and diuretics,"3.125 mg twice daily for 2 weeks, then 6.25 mg twice daily for 2 weeks, then 12.5 mg twice daily for 2 weeks then 25 mg twice daily (titrated up to the highest tolerated level). 
Max: <85 kg: 25 mg bid; >85 kg: 50 mg bid.",A/KK,,,Vacodil,"0.13, 0.15",/,tab,A/KK
C02,Clonidine HCL 0.025mg Tablet,"HSM Off-label indication: Status dystonicus

Rapid opiod detoxification combination use with naltrexone","Status dystonicus: 0.1mcg/kg/dose OD up to 2mcg/kg/dose TDS

Rapid detoxification in 4-5 days (use with naltrexone): 6 mcg/kg ORALLY divided in 3 doses 6 to 8 hours apart the first day, increasing to 11 mcg/kg divided in 3 doses given day two, tapering to 0.6 mcg/kg the third day. Rapid opioid detoxification for 7 days (use with naltrexone): 0.1 to 0.2 mg every 4 hours as needed",A,Pediatrik,Special Drugs Approval (UKK) required for off-label indication,Sandoz Clonidine,1.10,/,tab,
C02,Diazoxide 50mg Tablet,Hypoglycemia,"Adult: Initially, 3-5 mg/kg daily in 2 or 3 divided doses. Maintenance: 3-8 mg/kg daily up to 10-15 mg/kg daily in patients w/ refractory hypoglycaemia or insulinoma.
Child: Neonates: Initially, 5 mg/kg bid. Maintenance: 1.5-3 mg/kg bid or tid up to 7 mg/kg tid may be required in some cases. ≥1 mth Initially, 1.7 mg/kg tid. Maintenance: 1.5-3 mg/kg bid or tid up to 5 mg/kg tid may be required in some cases.",Not in FUKKM,Perubatan,Import permit required for purchase (UKK),Eudemine,9.16,/,tab,
C09,"Enalapril 5 mg, 20 mg Tablet",i) Hypertension ,"i) Initially 5 mg daily, (ELDERLY 2.5 mg once daily), usual maintenance dose 10 - 20 mg daily. 
Maximum: 40 mg/day in 1 - 2 divided doses ",B,,,"Pharmaniaga Enalapril

Invoril","0.18, 


0.05",/,tab,B
,,ii) Congestive heart failure,"ii) Initially 2.5 mg daily, usual maintenance dose 20 mg daily in 1 - 2 divided doses; 
maximum: 40 mg/day",,,,,,,,
C07,Esmolol HCl 10 mg/ml Injection,"i) Supraventricular tachycardia
ii) Intraoperative and postoperative tachycardia and/or hypertension","i) & ii) 50-200 mcg/kg/min

Dosing is invidualised and according to product insert/protocol.",A*,Kecemasan,Kuota,Esocard,117.50,/,vial,A*
C08,"Felodipine 5 mg, 10 mg Tablet",Hypertension,"Initiate at 5 mg once daily. Usual dose, 5 - 10 mg once daily in the morning",A/KK,,,Plendil,"0.24, 0.28",/,tab,A/KK
C02,Hydralazine HCl 20 mg Injection,Hypertensive crisis in pregnancy,"i) Slow IV injection, ADULT: 5-10 mg diluted with 10ml sodium chloride 0.9%. May be repeated after 20-30 minutes if necessary. 
ii) IV infusion :  200-300 mcg/minutes. Maintenance dose 50-150 mcg/minutes",B,,,Ciron Hydralazine,17.64,/, amp,B
C07,Labetalol HCl 25 mg/5 ml Injection,Hypertension crisis,"ADULT: 20mg injected slowly for at least 2 min, followed by 40-80mg dose every 10 min, if necessary upto 300 mg. 
Patient should remain supine during and 3 hr after the procedure.",B,,,Pharmaniaga Labetalol,8.60,/,amp,B
C07,Labetalol HCl 100 mg Tablet,Hypertension (including in pregnancy),"ADULT: 100 mg daily with food, increased at intervals of 14 days to usual dose of 200 mg twice daily, up to 800 mg twice daily (3 - 4 divided doses if higher dose). 
Max: 2.4 g daily",B,,,Trandate,0.80,/,tab,B
C09,"Losartan Potassium 50 mg, 100 mg Tablet","Patients intolerant of ACE inhibitors, only in the treatment of i) Hypertensive patient with left ventricular hypertrophy ii) Hypertension in diabetics with proteinuria or nephropathy","Hypertension: Usual starting and maintenance dose: 50 mg once daily. Maximum increasing the dose to 100 mg once daily. Patients with intravascular volume-depletion starting dose of 25 mg once daily. 
Renal protection in Type 2 diabetic patients with proteinuria and hypertension, starting dose: 50 mg once daily, may be increased to 100 mg once daily based on blood pressure response",B,,,Zylovaa,"0.03, 0.1",/,tab,B
C09,Losartan Potassium 50 mg and Hydrochlorothiazide 12.5 mg Tablet,"Hypertension in patients who cannot tolerate ACE inhibitors because of cough, hypertensive patient with left ventricular hypertrophy","Fixed dose combination is not indicated for initial therapy. 
i. Usual starting & maintenance dose: 1 tab of losartan & HCTZ 50/12.5 mg once daily. May be increased to 2 tab of losartan & HCTZ 50/12.5 mg or 1 tab of losartan & HCTZ 100/25mg once daily if blood pressure remain uncontrolled after about 3 weeks of combination therapy with losartan & HCTZ 50/12.5mg. Max: 1 tab of losartan & HCTZ 100/25mg once daily or 2 tab of Losartan & HCTZ 50/12.5 mg once daily. 
ii. Usual starting dose: 50 mg losartan once daily, may be titrated with a combination of losartan 50mg & HCTZ 12.5 mg, maybe substituted with losartan 100mg & HCTZ 12.5mg, followed by losartan 100 mg & HCTZ 25 mg once daily.", A/KK,,,Lorista,0.17,/,tab, A/KK
C02,Minoxidil 5 mg Tablet,Severe hypertension,"ADULTS and CHILD above 12 years old: 
Initially 5 mg daily in single or divided doses (elderly 2.5 mg). May increase by 5 - 10 mg daily at intervals of 3 or more days until optimum control is achieved. 
Maximum 50 mg daily",A*,Pediatrik,,Hirsutin,1.22,/,tab,
C02,Methyldopa 250 mg Tablet,Hypertension,"Adult: 250 mg 2 - 3 times daily, gradually increased at intervals of 2 or more days, maximum; 3 g/day. 
Elderly: initially 125 mg twice daily, increased gradually, maximum; 2 g daily. 
Child: Initially, 10 mg/kg or 300 mg/m2 daily in 2-4 divided doses; increase as necessary. Max: 65 mg/kg, 2 g/m2 or 3 g daily, whichever is least.",B,,,Pharmaniaga Methyldopa,0.25,/,tab,B
C07,Metoprolol Tartrate 100 mg Tablet,"Hypertension, angina, myocardial infarction, arrhythmias","Hypertension: Initially 100 mg to maximum 400 mg daily, 
Angina: 50 mg - 100 mg in 2 - 3 times daily. 
Myocardial infarction: 200 mg daily in divided doses. 
Arrythmias: 50 mg - 300 mg in 2 - 3 times daily",B,,,Betawin,0.18,/,tab,B
C07,Nebivolol 5 mg Tablet,Acute Myocardial Infarction,2.5mg OM (every morning),-,Perubatan,Luar FUKKM (KPK),Nebilet,1.10,/,tab,-
C08,Nicardipine 10mg/10ml Injection,Treatment of hypertensive crisis,"i) Adult Dose

Initial dose
Treatment should start with the continuous administration of nicardipine at a rate of 3-5 mg/h for 15 minutes. Rates can be increased by increments of 0.5 or 1 mg every 15 minutes. The infusion rate should not exceed 15 mg/h.

Maintenance dose 
When the target pressure is reached, the dose should be reduced progressively, usually to between 2 and 4 mg/h, to maintain the therapeutic efficacy.

ii) Paediatric Dose
Nicardipine should only be used for life-threatening hypertension in paediatric intensive care settings or postoperative contexts.

Initial dose:
In case of emergency, a starting dose of 0.5 to 5 mcg/kg/min is recommended.

Maintenance dose:
The maintenance dosage of 1 to 4mcg/kg/min is recommended",A,,,Nicardin,48.05,/,PFS,
C08,Nifedipine 10 mg Tablet,Hypertension,"Initial dose of 10 mg twice daily. Usual range :  10 - 30 mg 3 times daily. Maximum: 120 - 180 mg per day. 
Elderly: Dose reduction may be necessary.",B,,,Nudipin,0.06,/,tab,B
C09,"Perindopril 4 mg, 8 mg Tablet",i) Hypertension ,"Initial: 2mg - 4mg once daily
Max. 8mg daily",B,,,"Provinace, Covinace","0.06,
 0.13",/,tab,B
,,ii) Stable coronary artery disease ,,,,,,,,,
,,iii) Congestive heart failure (4mg strength only),"iii) Initial: 2mg once daily
Maintenance: 4mg once daily

Dosing is individualised and according to product insert/protocol",,,,,,,,
C09,Perindopril 10 mg and Indapamide 2.5 mg Tablet,"As substitution therapy for treatment of essential hypertension, in patients already controlled with perindopril and indapamide given concurrently at the same dose level.",One tablet daily.,A/KK,Perubatan,,Coversyl Plus,0.66,/,tab,
C09,Perindopril 4 mg and Indapamide 1.25 mg Tablet,"Essential hypertension, for patients whose blood pressure is insufficiently controlled by perindopril alone.","One tablet daily, preferably taken in the morning and before a meal.",B,,,Coversyl Plus,0.36,/,tab,A/KK
C09,"Perindopril Arginine 10mg, Indapamide 2.5mg & Amlodipine 10mg tablet","As substitution therapy for treatment of essential hypertension, in patients already controlled with perindopril/indapamide fixed dose combination and amlodipine, taken at the same dose level.",1 tablet a day,A/KK,Perubatan,Kuota,Triplixam ,0.64,/,tab,
C02,"Prazosin HCl 1 mg, 2 mg Tablet",Hypertension,"Initially 0.5 mg 2 - 3 times daily, the initial dose on retiring to bed at night; increased to 1 mg 2 - 3 times daily after 3 - 7 days: further increased if necessary to maximum 20 mg daily",B,,,Lopresin,"0.14, 0.18",/,tab,B
C07,Propranolol HCl 40 mg Tablet,i) Hypertension   ,"i) Initially : 80 mg twice daily increased as required to a usual range of 160 - 320 mg daily. 
CHILD: Initial doses of 1 mg/kg in divided doses, can be increased to 2 - 4 mg/kg/day in divided doses  ",B,,,Corbeta,0.01,/,tab,B
,,ii) Angina,"ii) Initial dose :  40 mg 2 - 3 times daily. 
Maintenance:  120 - 240 mg daily ",,,,,,,,
,,iii) Myocardial infarct,"iii) 40mg 4 times daily for 2 - 3 days then 80 mg twice daily, beginning 5 - 21 days after infarction",,,,,,,,
,,iv) Cardiac arrhythmia, iv) 10 - 40 mg 3 - 4 times daily,,,,,,,,
,,v) Portal hypertension, v) Initially 40 mg twice daily. The dose may be increased as required up to 160 mg twice daily ,,,,,,,,
,,vi) Migraine,"vi) Initial prophylaxis dose: 40 mg 2 - 3 times daily. 
The dose may be increased at weekly intervals up to 160 mg daily",,,,,,,,
,, vii) Thyrotoxicosis,"vii) Adjunct: 10 - 40 mg 3 - 4 times daily. 
CHILD: Arrythmias, thyrotoxicosis: 0.25 - 0.5 mg/kg 3 - 4 times daily as required",,,,,,,,
C09,Ramipril 5 mg Tablet,i) Hypertension and congestive heart failure ,"i) Hypertension: Initially 2.5 mg once daily, increased at intervals of 1 - 2 weeks to maximum 10 mg once daily; 
Congestive heart failure:Initially 1.25 mg once daily. Max: 10 mg/day",A,Perubatan,,"Ramtace, Apo - Ramipril",0.50,/,tab,A
,,ii) Post-myocardial infarction,"ii) Initially 2.5 mg twice daily for 2 days then 
increased to maximum 5 mg twice daily",,,,,,,,
,,"iii) Reducing risk of myocardial infarction, stroke or cardiovascular death in diabetics or patients with increased cardiovascular risks","iii) Initially 1.25 - 2.5 mg once daily, increased to 5 mg once daily after 1 week, 
maximum dose: 10 mg once daily after 3 weeks",,,,,,,,
C09,"Sacubitril/ Valsartan 200 mg tablet

Sacubitril/ Valsartan 100 mg tablet 

Sacubitril/ Valsartan 50 mg Tablet 

(Entresto) ","To reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure.

Prescribing restriction(s): 
i. For heart failure patients with reduced ejection fraction
ii. NYHA class II-IV
iii. Second line for patients intolerant of or not responding to ACEi or ARB.","The recommended starting dose of sacubitril/valsartan is one tablet of 100 mg twice daily.
The dose should be doubled at 2-4 weeks to the target dose of one tablet of 200 mg twice daily, as tolerated by the patient.

For the following patients, initiate with sacubitril/valsartan 50 mg twice daily.
- Not currently on ACEI/ ARB
- Switching from low dose of ACEI/ ARB
- In patients with systolic BP ≥100 to 110 mmHg.
- In patients with moderate renal impairment (eGFR 30-60 ml/min/1.73 m2)
- In patients with moderate hepatic impairment (Child-Pugh B classification)

For patients ""Not currently on ACEI/ ARB"" and ""switching from low dose of ACEI/ ARB"", double the dose every 3-4 weeks to achieve the target dose of 200 mg twice daily as tolerated by the patient.",A*,Perubatan,Kuota,"Entresto: 200mg

Savagen: 50mg & 100mg","200mg: 3.80


100mg: 3.23


50mg: 3.13",/,tab,A*
C09,Telmisartan 40 mg Tablet,Hypertension in patients who cannot tolerate ACE inhibitors because of cough,40mg - 80mg once daily,A/KK,Perubatan,,Teleact,0.20,/,tab,A/KK
C09,Telmisartan 80 mg Tablet,i)Hypertension in patients who cannot tolerate ACE inhibitors because of cough ,i) 40mg - 80mg once daily,A/KK,Perubatan,,Teleact,0.25,/,tab,A/KK
,,"ii)Reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years or older at high risk of developing major cardiovascular events who are unable to take ACE inhibitors", ii) 80mg once daily,,,,,,,,
C09,Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablet,Hypertension in patients who cannot tolerate ACE inhibitors because of cough,1 tablet daily,A/KK,,,Micardis Plus,1.22,/,tab,A/KK
C09,Valsartan 160 mg Tablet,"Patients who cannot tolerate ACE inhibitors because of cough, in i) Heart failure ii) Post myocardial infarction",i) 40 mg twice daily. Uptitration to 80 mg and 160mg twice daily. Max: 320 mg in divided doses.,A/KK,Perubatan,,Diovan,0.54,/,tab,A/KK
,, ii) Post myocardial infarction, ii) 20 mg twice daily increased over several weeks to 160mg twice daily if tolerated.,,,,,,,,
,,,,,,,,,,,
"3.0 CARDIOVASCULAR SYSTEM
3.4 CARDIAC DRUGS",,,,,,,,,,,
C01,Adenosine 3 mg/ml Injection,Rapid conversion of paroxysmal supraventricular tachycardia to sinus rhythm,"ADULT: Initially: 3 mg given as a rapid IV bolus (over 2 seconds). Second dose: If the first dose does not result in elimination of the supraventricular tachycardia with in 1 or 2 minutes, 6 mg should be given also as a rapid IV bolus. Third dose: If the second dose does not result in elimination of the supraventicular tachycardia with in 1-2 minutes, 12 mg should be given also as a rapid IV bolus",B,,,Adenorhythm ,14.36,/,vial,B
C01,Adrenaline Acid (Epinephrine) Tartrate 1 mg/ml Injection,Cardiopulmonary resuscitation,1 mg by intravenous injection repeated every 3-5 minutes according to response,B,,,Tacarline,1.73,/,amp,B
C01,Alprostadil 500 mcg/ml Injection,For treatment of congenital heart diseases which are ductus arteriosus dependent,"0.05 - 0.1 mcg/kg/min by continuous IV infusion, then decreased to lowest effective dose",A*,,,Prostin VR,1795.00,/,amp,A*
C01,Amiodarone 150 mg/3 ml Injection,"Category A*:
i) Arrhythmias
ii) Cardiopulmonary resuscitation of shock-resistant ventricular fibrillation in cardiac arrest

Category A/KK:
Ventricular arrythmia (ventricular tachycardia and ventricular fibrillation)
Restriction:
Use only for emergency cases in health clinic with Medical Officers (MO) upon consultation with Family Medicine Specialist (FMS)","i) Initial: 5mg/kg over 20-120minutes
Maintenance: 10-20mg/kg/24hr
Max. dose: 1.2g/24hr.

ii) Initial: 300mg or 5mg/kg rapid
Additional 150mg if condition persists.

Dosing is according to product insert / protocol.","A*, A/KK",Perubatan,,Bioindustrial Amiodarone ,6.10,/,amp,A*
C01,Amiodarone 200 mg Tablet,Arrhythmias,"200 mg 3 times daily for 1 week, then reduced to 200 mg twice daily for another week. Maintenance dose, usually 200 mg daily or the minimum required to control the arrhythmia",A*,,,Eurythmic,0.79,/,tab,A*
C01,Digoxin 500 mcg/2 ml Injection,"Heart failure with atrial fibrillation, supraventricular arrhythmias (particularly atrial fibrillation)","Rapid digitilisation: ADULT & CHILD over 10 years, initially 0.75 - 1.5 mg, followed by 250 mcg 6 hourly until digitilisation is complete",A,,,Lanoxin,13.75,/,amp,A
C01,Digoxin 0.25 mg Tablet,"Heart failure , with atrial fibrillation, supraventricular arrhythmias (particularly, atrial fibrillation)","Rapid digitalisation: 0.75 -1.5 mg in divided doses over 24 hours; 
less urgent digitalisation, 250 mcg-500 mcg daily (higher dose may be divided). 
Maintenance : 62.5mg -500 mcg daily (higher dose may be divided) according to renal function and , in atrial fibrillation, on heart rate response; usual range, 125-250 mcg daily (lower dose may be appropriate in elderly)",B,,,Lanoxin,0.14,/,tab,B
C01,Dobutamine HCl 250 mg/20 ml Injection,Hypotension and heart failure,"Initial : 0.5-1 mcg/kg/min by IV, maintenance : 2.5-10mcg/kg/min. 
Frequently,doses up to 20mcg/kg/min are required for adequate hemodynamic improvement. On rare occasions,infusion rates up to 40mcg/kg/min",A,,,Mobitil,11.59,/,vial,A
C01,Dopamine HCl 40 mg/ml Injection,Non-hypovolemic hypotension,"Initial dose 2-5  mcg/kg/min with incremental changes of 5-10 mcg/kg/min at 10-15 minutes intervals until adequate response is noted. Most patients are maintained at less than 20 mcg/kg/min. If dosage exceeds 50 mcg/kg/min, assess renal function frequently",B,,,Loxin,3.48,/,amp,B
C01,Epinephrine Auto-Injector 0.3 mg Injection,Anaphylactic shock ,0.3mg PRN,Not in FUKKM,Perubatan,Import permit required for purchase (UKK),Epinephrine,318.65,/,pen,-
C01,Ephedrine HCl 30 mg/ml Injection,"Treatment of bronchial spasm in asthma, adjunct to correct haemodynamic imbalances and treat hypotension in epidural and spinal anaesthesia","By IM, SC or IV. Severe, acute bronchospasm : 12.5-25 mg. Further dosage should be determine by patient response. 
When used as a pressor agent : ADULT 25 - 50 mg SC/IM. If necessary, a second IM dose of 50 mg or an IV dose of 25 mg may be given. Direct IV injection, 10 - 25 mg may be given slowly. 
Maximum parenteral ADULT dose : 150 mg in 24 hours. 
CHILD : 3 mg/kg or 100 mg/m2 SC or IV daily, in 4 - 6 divided doses",B,,,Ephedrine,0.99,/,amp,B
C01,Ibuprofen 100 mg/5 ml Syrup,Pain and inflammation in rheumatic disease,"Dosage: ADULT : 200 - 400 mg 3 times daily after food, maximum 3.2 g daily. 
CHILD : 30-50 mg/kg body weight daily in divided doses, maximum 2.4g daily. 
Lowest effective dose for the shortest possible duration.",-,Pediatrik,"Import Permit required for purchase
(KPK)",Ibupen,1.50,/,bot,-
C01,Isoprenaline HCl 0.2mg/ml Injection,"Complete heart block (third-degree artrioventricular block) not responding to atropine, while waiting for cardiac pacing","If given as IM: Initially 0.2 mg (1 ml of 1:5000 solution), followed by 0.02-1 mg depending on clinical response. 
If given as SC: 0.2 mg (1 ml of 1:5000 solution), followed by 0.15-0.2 mg depending on clinical response. 
If given as IV : 1-2 mg in 500 ml of dextrose 5%, infused at a rate of 0.5-2 ml/min while the patient's EKG is being monitored. The dose should be titrated to produce the desired clinical response",B,,"Import Permit required for purchase
(UKK)",ISOLIN,11.29,/,amp,B
C01,"Ivabradine 5 mg, 7.5 mg Tablet","i) Symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. Ivabradine is indicated: - in adults unable to tolerate or with a contraindication to the use of beta-blockers - or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose. 
ii) Treatment of chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.","Initial dose 5 mg twice daily. May increase dose after 3-4 weeks to 7.5 mg twice daily depending on response. 
ELDERLY : initial dose 2.5 mg twice daily and titrate to a maximum of 7.5 mg twice daily",A*,Perubatan,Kuota,Coralan,"2.39, 2.39",/,tab,A*
C01,"Lignocaine HCl (Lidocaine) 100 mg/5 ml, 500 mg/5 ml Injection",Ventricular tachycardia and ventricullar fibrillation. To be diluted before use,"50-100 mg IV as a bolus, repeated after 5 minutes if necessary. 
Maintenance : 1-4 mg/min by IV infusion under ECG monitoring",B,,,INJECSOL,"1.50, 1.40",/,amp,B
C01,Noradrenaline Acid Tartrate (Norepinephrine Bitartrate) 4 mg/4 ml Injection,"Category A:
i) For blood pressure control in certain acute hypotensive states (e.g.pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions).
ii) As an adjunct in the treatment of cardiac arrest and profound hypotension

Category A/KK:
Septic shock and shock where peripheral vascular resistance is low
Restrictions
Use only for emergency cases in health clinic with Medical Officers (MO) upon consultation with Family Medicine Specialist (FMS)","Infuse and titrate to desired pressure response. 
Range: 0.05 - 0.5 mcg/kg/minute","A, A/KK",,,Cardiamed,5.50,/,amp,A
C01,Phenylephrine 10 mg/ml Injection,"Treatment of hypotensive episode post 
spinal anaesthesia"," Initial dose: 100-180 mcg/min 
when BP stabilized, Maintenance dose: 40-60 mcg/min ",Not in FUKKM,Bius,UKK by bulk,ZYPHRIN,6.00,/,amp,-
C08,Verapamil HCl 5 mg/2 ml Injection,Supraventricular tachycardia,"Initially 5-10mg given by slow IV over at least 2 minutes. 
The dose can be repeated 10mg 30 minutes after the first dose if the initial response is not adequate.",A/KK,,Import Permit Required for purchase (UKK),Ratiopharm,10.46,/,amp,A/KK
C08,Verapamil HCl 40 mg Tablet,i) Supraventricular tachyarrhythmias (SVT) prophylaxis ii) angina,"ADULT: 40 - 80 mg 3-4 times daily. In oral long term therapy, max: 480 mg daily",B,,,Akilen 4,0.26,/,tab,B
,,,,,,,,,,,
"3.0 CARDIOVASCULAR SYSTEM
3.5 VASODILATORS AND CEREBRAL ACTIVATORS",,,,,,,,,,,
N07,Betahistine Dihydrochloride 24 mg Tablet,"i) Meniere's Syndrome as defined by the following core symptoms:
- Vertigo (with nausea/vomiting).
- Hearing loss (Hardness of hearing).
- Tinnitus (ringing in the ears)

ii) Symptomatic treatment of vestibular vertigo","24-48mg in divided doses daily

Prescribing Restriction
(Hanya terpakai untuk fasiliti kesihatan primer)
Short term (max. 2 months) treatment with Betahistine can be initiated by Family Medicine Specialist (FMS) for patients with Menieres syndrome and vestibular vertigo, pending referral/ evaluation by the Otorhinolaryngology team.",A/KK,"Perubatan,
ENT",,Betanor,0.18,/,tab,A*
N07,Cinnarizine 25 mg Tablet,Vestibular disorders,Adult: One tablet 3 times daily,B,,,Cinnarizine,0.06,/,tab,B
C04,Pentoxifylline 400 mg Tablet,Peripheral vascular disease,400 mg 2 - 3 times daily,A/KK,,,Trenlin SR,0.89,/,tab,A/KK
N06,Piracetam 1.2 gm Tablet,"Mild cognitive impairment, post concussional head syndrome, head injury disorder, chronic vertigo and myoclonus","Initially 7.2 g daily in 2 - 3 divided doses, increased according to response by 4.8 g daily every 3 - 4 days to maximum of 20 g daily. 
CHILD under 16 years not recommended",A*,Perubatan,,"Nootropil, Ceretam","1.00, 0.65",/,tab,A*
N06,Piracetam 20% Solution  (1gm / 5ml)                                              ,"Children with learning disability, progressive myoclonic epilepsy and hypoxia",30 - 160 mg/kg/day orally. To be given 2 times daily or 3 - 4 times daily. Maximum 24 g/day,A*,,Kuota,Ceretam,34.18,/,bot,A*
N07,Riluzole 50mg tablet,Motor Neuron Disease / Amyotrophic lateral sclerosis,50 mg bid. Discontinue if ALT levels increase to 5 times the upper limit of normal (ULN).,Not in FUKKM,Perubatan," Special Drugs Approval (UKK) required
",Rilutek,28.86,/,tab,
G04,Sildenafil Citrate 50mg tablet,"Off-label indication: 
i) Adjunct treatment of pulmonary hypertension of newborn (UKK bulk basis)

ii) Raynaud's phenomenon (UKK patient basis)","i) 0.5 -2 mg/kg QID

ii) Raynaud's phenomenon: 50mg BD","50mg
 Not in FUKKM",Perubatan, Special Drugs Approval (UKK) required,Iqnyde,1.25,/,tab,A*
,,,,,,,,,,,
"3.0 CARDIOVASCULAR SYSTEM
3.6 VASOCONSTRICTORS AND ANTIMIGRAINE DRUGS",,,,,,,,,,,
N07,Flunarizine HCl 5 mg Capsule,i) Migraine prophylaxis,i) ADULT: 5 - 10 mg daily preferably at night. ELDERLY more than 65 years: 5 mg at night. Maintenance 5-day treatment at the same daily dose ,B,Perubatan,,Fluden,0.51,/,cap,B
,, ii) Maintenance treatment of vestibular disturbances and of cerebral and peripheral disorders,"ii) 5 - 10 mg at night. If no improvement after 1 month, discontinue treatment",,,,,,,,
N02,Pizotifen 0.5 mg Tablet,Prophylactic treatment of vascular headache,"Starting with 0.5mg daily, the dosage should be progressively increased. The average maintenance dosage is 1.5mg daily in divided doses or as a single dose at night. Max dose: 4.5 mg/day and 3 mg/dose. Child: >2 yr: Up to 1.5 mg daily in divided doses. Max dose: 1 mg/dose.",B,,,Pizogran,0.88,/,tab,B
N02,Sumatriptan 50 mg Tablet,Treatment of acute migraine attacks,50 mg per attack and not more than 300 mg daily,A/KK,Perubatan,,Striptan,2.33,/,tab.,A/KK
,,,,,,,,,,,
"4.0 DIURETICS AND ANTIDIURETICS
4.1 DIURETICS",,,,,,,,,,,
C03,Amiloride HCl 5 mg & Hydrochlorothiazide 50 mg Tablet,i) Diuretic as an adjunct to the management of oedematous states ,i) Initially 1 - 2 tab daily adjusted according to response. Max : 4 tabs daily. ,B,,,Moduride,0.11,/,tab,B
,,ii) Hypertension,ii) 1 -2 tabs daily as a single or divided dose,,,,,,,,
C03,Bumetanide 0.5mg/ml Injection ,Oedema used in furosemide allergic patient,"IV injection: 1 - 2 mg repeated after 20 mins. 
IV infusion: 2 - 5 mg over 30 - 60 mins",A*,Perubatan,,Burinex,20.45,/,amp,A*
C03,Bumetanide 1mg Tablet,Oedema used in furosemide allergic patient,"1 mg in the early evening.
Max: 10mg daily",A*,Perubatan,,Burinex,7.98,/,tab,A*
C03,Eplerenone 50mg tablet,"
Reduce risk of CV mortality & morbidity 
in stable patients w/ left ventricular 
dysfunction & clinical evidence of heart failure after recent MI.",Initially 25 mg once daily & titrate to target dose of 50 mg once daily preferably w/in 4 wk.,Not in FUKKM,Perubatan,Special drugs approval (UKK) required,Inspra,4.93,/,tab,
C03,Finerenone 10mg & 20mg Tablet,"To reduce the risk of sustained eGFR decline, end-stage kidney disease,
cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in
adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D)","Recommended target dose is 20 mg once daily

Measure estimated glomerular filtration rate (eGFR) to determine the starting dose:
- 20 mg once daily if eGFR ≥ 60 mL/min/1.73 m2
- 10 mg once daily if eGFR ≥ 25 to < 60 mL/min/1.73 m2",Not in FUKKM,Perubatan,Special drugs approval (UKK) required,Firialta,"10mg: 5.70

20mg: 6.81",/,tab,
C03,Furosemide 20 mg/2 ml Injection,Pulmonary oedema,Initially 20 -40 mg IM or slow IV (rate not exceeding 4 mg/min). CHILD: 0.5 - 1.5 mg/kg. Max: 20 mg daily,B,,,Furosemide,0.81,/,amp,B
C03,Furosemide 40 mg Tablet,Pulmonary oedema,"ADULT: Initial 40 - 80 mg on morning if required, can be increased to a max of 1 g/day in certain cases especially in chronic renal failure. CHILD : 1 - 3 mg/kg daily",B,,,Frusemide,0.05,/,tab,B
C03,Furosemide 10mg/ml oral solution,Pulmonary oedema,"ADULT: The usual initial oral dose is 40mg once daily, adjusted as necessary according to response. 
Mild cases may respond to 20mg daily or 40mg on alternate days. Some patients may need doses of 80mg or more daily given as one or two doses daily; or intermittently. 
Severe cases may require gradual titration of the frusemide dosage up to 600mg daily. 
Children: The usual dose is 1 to 3mg/kg daily up to a maximum dose of 40mg daily.",B,,,Vusimide,69.05,/,120ml,B
C03,"Hydrochlorothiazide 25 mg, 50 mg Tablet","Diuretic, hypertension","ADULT: Diuretics; 25-200 mg daily. Hypertension ; 12.5-25 mg daily. 
CHILD: Oedema and hypertension; Adjunct; 1 to 2 mg/kg ORALLY daily in single or two divided doses; 
Children 2-12 years old MAX dose, not to exceed 100 mg ORALLY daily; 
Infants less than 6 months old, may require doses up to 3 mg/kg ORALLY daily in two divided doses, 
Infants up to 2 yrs old: MAX dose, not to exceed 37.5 mg ORALLY daily",B,,Only 50mg available,Apo - hydrochlorothiazide,"0.13, 0.15",/,tab,B
C03,Metolazone 5mg tablet,"i) Oedema associated with heart failure or renal disease

ii) Hypertension","i) Adult: For cases associated with heart failure or renal diseases (e.g. nephrotic syndrome): Slow and incompletely bioavailable formulation: 5-10 mg daily. Doses may be increased to 20 mg daily if necessary. Max: 80 mg daily. Dosage must be individualised according to the severity of condition and patient response.

ii) Adult: Alone or in combination with other antihypertensives: Slow and incompletely bioavailable formulation: 2.5-5 mg daily; alternatively, initial dose of 1.25 mg daily may be given. Dosage must be individualised and may be adjusted after 3-4 weeks according to response. Maintenance: 5 mg on alternate days. Rapidly absorbed and completely bioavailable formulation: Initially, 0.5 mg once daily, may be increased to 1 mg once daily if necessary.",5mg Not in FUKKM,Perubatan,Import permit required for purchase (UKK),Zaroxolyn,1.12,/,tab,
C03,Spironolactone 25 mg Tablet,"Oedema and ascites in cirrhosis of the liver, congestive heart failure","ADULT: 100 - 200 mg daily in divided doses. Increase to 400 mg if required. 
CHILD: initially 3 mg/kg daily in divided doses",B,,,Spiro,0.16,/,tab,B
,,,,,,,,,,,
"4.0 DIURETICS AND ANTIDIURETICS
4.2 ANTIDIURETICS",,,,,,,,,,,
H01,Desmopressin Acetate 4 mcg/ml Injection,Diabetes insipidus,"ADULT : 1 - 4 mcg IV daily. 
CHILD :0.4 mcg daily",A,,,Minirin,50.80,/,amp,A
H01,Desmopressin 100 mcg/ml Nasal Spray,i) Diabetes Insipidus ,"i) ADULT : 10 - 20 mcg 1-2 times daily. 
CHILD: 5 - 10mcg 1-2 times daily ",A,,,Minirin,114.84,/,2.5ml,A
,,ii) Primary nocturnal enuresis,ii) 10-40 mcg nocte,,,,,,,,
H01,Desmopressin 120mcg Sublingual Tablet ,"i)Central diabetes insipidus 
ii)Primary nocturnal enuresis 
iii)Treatment of nocturia associated with nocturnal polyuria in adult","i) 60mcg 3 times daily sublingually (daily dose range from 120mcg to 720mcg)
ii) 120mcg once daily at bedtime, sublingually (maximum dose 240mcg)
iii) 60mcg once daily at bedtime (dose range from 120mcg to 240mcg)",A,"Perubatan, pembedahan",,Minirin,7.05,/,tab,A
H01,Vasopressin 20 units/ml Injection,"i) Pituitary diabetes insipidus 
ii) Oesophageal variceal bleeding","i) 5 - 20 units SC or IM every 4 hours 
ii) 20 units in 100 - 200 ml 5% dextrose saline over 15 minutes as infusion which may be repeated after at intervals of 1 - 2 hours. Maximum: 4 doses",A,Perubatan,Kuota,Hanlim Vasopressin ,17.70,/,amp,A
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.1 ANTIINFLAMMATORY ENZYMES",,,,,,,,,,,
M09,Prolase Tablet,Oedema and inflammation in conjunction with other physical or chemotherapeutic measures,"2 tablet 4 times daily for the first day, then 1 tablet 4 times daily for at least 5 days.",B,,,Prozyme,0.04,/,tab,B
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.2 ANTIPYRETICS & ANALGESICS",,,,,,,,,,,
N02,"Acetylsalicylic Acid 150mg, 300 mg Soluble Tablet",Initial treatment of cardiovascular disorders such as angina pectoris and myocardial infection and for the prevention of cardiovascular events in patients at risk. Other such uses include the treatment and prevention of cerebrovascular disorders such as stroke.,"150mg to be taken daily. 
Use in children under 16 years old is not recommended",C,,Jul 2025: Switching to 150mg after finishing 300mg stock,"Winsiprin
150mg

300mg","
0.14

0.30",/,tab,
M01,Ibuprofen 200 mg Tablet,Pain and inflammation in rheumatic disease,"Dosage: ADULT : 200 - 400 mg 3 times daily after food, maximum 3.2 g daily. 
CHILD : 30-50 mg/kg body weight daily in divided doses, maximum 2.4g daily. 
Lowest effective dose for the shortest possible duration.",B,,,Royce Ibuprofen,0.09,/,tab,
N02,Paracetamol 10 mg/ml in 100 mL solution for IV infusion,Mild to moderate pain and pyrexia,"Body Weight (BW) = 10kg: 7.5mg/kg, max: 30mg/kg 
BW >10kg to = 33kg: 15mg/kg, max 60mg/kg not exceeding 2g 
BW >33kg to = 50kg: 15mg/kg, max 60mg/kg not exceeding 3g 
BW >50kg (with risk of hepatotoxicity): 1g, max 3g 
BW >50kg (without risk of hepatotoxicity): 1g, max 4g OR as in the product leaflet",A,,,Paracetamol Kabi,3.44,/,bot,
N02,"Paracetamol 125 mg, 250 mg Suppository",Symptomatic relief of fever and post operative pain whom cannot tolerate oral preparations.,"ADULT & CHILDREN more than 12 years old: 500mg - 1g every 4-6 hours. 
CHILD 6 - 12 years : 250 - 500 mg; 
1 - 5 years : 125 - 250 mg; 
3 - 11 months : 80 mg inserted every 4 - 6 hours if necessary, maximum 4 doses in 24 hours. 
INFANTS under 3 months should not be given Paracetamol unless advised by doctor; a dose of 10 mg/kg (5 mg/kg if jaundiced) is suitable.","C+,B",,,Poro,"0.28,0.36",/,supp,
N02,"Paracetamol 250 mg/5 ml 
Syrup ",Mild to moderate pain and pyrexia,"CHILD: up to 1 year: 60 - 120 mg. 
1 - 5 years: 120 - 240 mg. 
6 - 12 years: 240 - 480 mg per dose. 
Repeat every 4 - 6 hours when necessary. 
Maximum of 4 doses in 24 hours",C+,,,Fepril,3.48,/,60ml,
N02,Paracetamol 500 mg Tablet,Mild to moderate pain and pyrexia,"ADULT: 500 - 1000 mg every 4 - 6 hours, maximum of 4 g daily",C+,,,"Uphamol, Paracil",0.05,/,tab,
-,Sucrose 24 % Oral Liquid in 2ml single use amp/vial,Use as pain relief for painful procedure in neonatal age group (<28 days of life),,Not in FUKKM,Pediatrik ,"Import Permit required for purchase
(UKK)",Phebra,6.00,/,amp,
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.3 ANTIRHEUMATIC, ANTIINFLAMMATORY AND ANALGESICS",,,,,,,,,,,
M01,Celecoxib 200 mg Capsule,"i) Osteoarthritis 
ii) Rheumatoid Arthritis 
iii) Acute pain 
iv) Ankylosing Spondylitis","i) ADULTS: 200 mg once daily. May increase to 200 mg bid, if necessary. CHILD not recommended 
ii) 100mg twice daily, increased if necessary to 200 mg 2 times daily; CHILD not recommended 
iii) 400mg as a single dose on first day followed by 200mg once daily on subsequent days 
iv) Initial, 200 mg once daily or 100 mg twice daily; if no effect after 6 weeks, may increase to max. 400 mg daily in 1-2 divided doses. If no response following 2 weeks of treatment with 400 mg/day, consider discontinuation and alternative treatment",A,,,Hovid ,0.55,/,cap,
M02,Diclofenac 1% Emulgel,"Post-traumatic inflammation of the tendons,ligaments & joints. Localised forms of soft tissue rheumatism and degenerative rheumatism",Apply 3 - 4 times daily and gently rubbed in,A,,,Dicloran,0.10,/,"20g 
tube",
M01,Diclofenac Sodium 75 mg/3 ml Injection,"Pain and inflammation in rheumatic disease and of non-rheumatic origin
","IM 75 mg once daily (2 times daily in severe cases) for not more than 2 days. Max : 150mg/day. 
Not suitable for children.",A/KK,,,Dicloran ,0.42,/,amp,
M01,"Diclofenac Sodium 12.5mg,
25 mg Suppository",Pain and inflammation in rheumatic disease and juvenile arthritis,"ADULTS: 75 - 150 mg daily in divided doses. Maximum 150mg/day. 
CHILD 1-12 years : 12.5- 25 mg daily
PAEDS more than 6 months : 1 - 3 mg/kg body weight daily in divided doses. Maximum 3mg/kg/day (Max 150mg/day).",A,,,Voren,0.66,/,supp,
M01,Diclofenac Sodium 50 mg Tablet,"Pain and inflammation in rheumatic disease and of non-rheumatic origin
","ADULTS: Initial dose of 150 mg daily. Mild or long term: 75 - 150 mg daily in 2 to 3 divided doses after food. Maximum : 200mg/day. 
PAEDS more than 6 months : 1 - 3 mg/kg body weight daily in divided doses. Maximum : 3mg/kg/day (Max 150mg/day).",B,,,Dicloran,0.03,/,tab,
N02,Dihydrocodeine Tartrate 30 mg Tablet,For the control of moderate to severe chronic pain,"ADULT: 30 - 60 mg every 4 - 6 hours. 
PAED, over 4 yrs: 0.5 - 1 mg/kg body weight every 4-6 hours",B,,,"P.P. Dihydrocodeine, Dicodine ",0.29,/,tab,
M01,Etoricoxib 90 mg Tablet,"i)Acute and chronic treatment of signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) 

ii)Acute gouty arthritis iii)Acute pain","i) OA: 60 mg once daily. RA: 60mg once daily and may be increased to 90mg once daily if needed.Once the patient is stabilized, down-titration to 60mg once daily may be appropriate. 

ii & iii) Acute gouty arthritis and acute pain: 120 mg once daily (Given the exposure to COX-2 inhibitors, doctors are advised to use the lowest effective dose for the shortest possible duration of treatment)",A/KK,"Perubatan, Ortopedik",,Arcoxia,1.81,/,tab,
M01,Glucosamine Sulfate 500mg Capsule,"Adjuvant treatment of osteoarthritis
","1500 mg once daily, as a single dose or in 2-3 divided doses.

*For 3-6 months duration only, for patient to self purchase after that  [Pekeliling Pengawalan Penggunaan Glucosamine di fasiliti KKM]",Not in FUKKM,"Ortopedik, Rheumatologi",PESARA ONLY,AVM-Artrisa,0.32,/,cap,
P01,Hydroxychloroquine Sulphate 200 mg Tablet,"i) SLE and mixed connective tissue disease for skin, joint and serosa 

ii) Second line therapy for acute rheumatoid arthritis","i) Initially 400 mg daily in divided dose. Maintenance : 200 - 400 mg daily 

ii) ADULT : 400 - 600 mg daily. Maintenance: 200 - 400 mg daily. 
CHILD : up to 6.5 mg/kg daily (maximum 400mg daily)",A,,,"Plaquenil , Uniquin","0.47, 0.43",/,tab,
M02,Ketoprofen 2.5% Gel,"Local treatment of osteoarticular & muscular painful disorders of rheumatic or
traumatic origin: Contusions, distortions, muscle strains, stiff neck, lumbago.",Apply onto affected areas 2-4 times daily up to 10 days.,A/KK,Ortopedik,,Ketofen gel ,0.12,/,tube,
M02,Ketoprofen 30 mg Transdermal Plaster,"Treatment of signs & symptoms of arthritis deformans, periarthritis humero-scapularis, tendinitis, peritendinitis, sore muscle, swelling, pain resulting from trauma (eg. contusion, distorsion, sprain).",Apply 1 plaster to the affected area twice daily,A,Ortopedik,,Ketotop,0.84,/,plaster,
M01,Ketorolac Tromethamine 30 mg/ml Injection,Short term management of moderate to severe postoperative pain,"ADULT : 60mg as a single dose via IM inj or 30mg as a single IV dose. 
Alternatively, 30mg every 6 hr via IM or IV admin up to a max of 120mg daily.",A*,Bius,Kuota,Keto,10.99,/,vial,
L04,"Leflunomide 10mg, 20 mg Tablet","i) Persistent active rheumatoid arthritis 
ii) Active psoriatic arthritis","Loading dose: 100 mg once daily for 3 days. 
Maintenance: 10-20 mg once daily.",A*,"Perubatan
Rheumatology ",Kuota:10mg,"Arava 10
Arava 20","8.67
12.63",/,tab,
M01,Mefenamic Acid 250 mg Capsule,Mild to moderate pain,"ADULT: 250 - 500 mg 3 times daily after meals. 
CHILD over 6 months: 6.5 - 25 mg/kg daily 3 - 4 times daily for not longer than 7 days except in juvenile arthritis",B,,,"Pontacid, Pharmaniaga Mefenamic, Mefa ",0.15,/,tab,
M01,Meloxicam 7.5 mg Tablet,Only for patients not responding to other NSAIDs in the treatment of i) painful osteoarthritis ii) rheumatoid arthritis,"i) initially 7.5 mg daily. May be increased to 15 mg daily 
ii) initially 15 mg daily. May be reduced to 7.5 mg daily. Maximum 15 mg daily. 
Child under 12 years not recommended",A/KK,,,Aroxicam,0.11,/,tab,
A07,"Mesalazine MR 500 mg Tablet (Pentasa),
Mesalazine 500mg Tablet (Salofalk)",Inflammatory bowel disease of ulcerative colitis and Crohn's disease.,"Active
ADULT: up to 4g given once daily or in divided doses
CHILD: starting with 30-50 mg/kg/day in divided doses. Maximum
dose: 75 mg/kg/day in divided doses. Total daily dose 4g/day
Maintenance
ADULT: 1.5g to 2g mesalazine once daily or divided doses
CHILD: starting with 30-50 mg/kg/day in divided doses. Maximum
dose: 75 mg/kg/day in divided doses. Total daily dose 2g/day
Dose is according to product insert and dependent on the
product/brand used.",A,Pembedahan,Kuota: BRAND SALOFALK ,"Pentasa, 
Salofalk ","1.06
1.42",/,tab,
A07,Mesalazine 1g Suppository,Inflammatory bowel disease of ulcerative colitis and Crohn's disease.,"Ulcerative colitis: 1 g suppository insert rectally once daily at bedtime. To achieve maximum benefit, it is recommended that the suppository be retained in the rectum for a minimum of 1 to 3 hours or longer. The usual course of therapy, depending upon response, may last from 3 to 6 weeks. CHILD not recommended",A,Perubatan,,Pentasa,9.76,/,supp,
M02,Methyl Salicylate 25% Ointment,"Relief of minor aches and pains of muscles and joints associated with simple backache, arthritis and rheumatic conditions.","To be massage well to the affected area, 3 - 4 times daily.",C+,,,i-Salic,4.06,/,30g tube,
M01,Parecoxib Sodium 40mg Injection,Management of post operative pain in the immediate post operative setting only,"40 mg followed by 20 or 40 mg every 6 to 12 hours, as required, not exceeding daily dosage of 80 mg. There is limited clinical experience with parecoxib treatment beyond three days. Reduce the initial dose by 50% in elderly less than 50 kg, with a maximum daily dosage of 40 mg.",A*,,,Dynastat,27.70,/,amp,
M01,Penicillamine 250mg Capsule,"i) Treatment of severe lead poisoning, it is used as adjunctive treatment following initial treatment with another chelating agent. May also be used as sole therapy in the treatment of asymptomatic patients with moderately elevated blood concentrations 
ii) Wilson's Disease: to aid in elimination of copper ions","i) Heavy metal poisoning: 900mg-1800mg daily. Duration of treatment is dictated by the urinary heavy metal excretion. Simultaneous oral vitamin B6 replacement with at least 40mg daily is essential 
ii) Wilson's disease: 0.25g - 1.5g daily on an incremental basis. Maximal daily dose: 2g. Maintenance dose: 0.75g - 1g daily",A,Perubatan,KPK,2. iSALIC Ointment,3.15,/,cap,
A07,Salicylazosulphapyridine (Sulfasalazine) 500 mg Tablet,"i) Treatment of inflammatory bowel disease of ulcerative colitis and Crohn's disease 
ii) Rheumatoid arthritis","i) ADULT: acute attack 1-2 g 4 times daily until remission occurs (if necessary corticosteroids may also be given), reducing to a maintenance dose of 500 mg 4 times daily, 
CHILD over 2 years: acute attack 40-60 mg/kg daily, maintenance dose 20-30 mg/kg daily 
ii) ADULT: initially; 0.5-1 g/day, increase weekly to maintenance dose of 2 g/day in 2 divided doses, maximun 3 g/day. 
CHILD over 6 years, juvenile rheumatoid arthritis: 30-50 mg/kg/day in 2 divided doses up to a maximum of 2 g/day",A/KK,Perubatan,,"Salazopyrin 
EN",0.43,/,tab,
N02,Tramadol HCl 50 mg Capsule,"Moderate to severe acute or chronic pain (eg. Post-operative pain, chronic cancer pain and analgesia/pain relief for patients with impaired renal function)","ADULT: 50mg initially, can take another 50mg after 30 - 60 min if pain not relieved. Max 400 mg daily. 
CHILD: 1mg/kg/dose repeated every 6 hours (Max: 2mg/kg/dose and 100mg/dose)",A/KK,,,Acugesic,0.06,/,cap,
N02,Tramadol HCl 50 mg/ml Injection,"Moderate to severe acute or chronic pain (eg. Post-operative pain, chronic cancer pain and analgesia/pain relief for patients with impaired renal function)","ADULT: IV/IM/SC 50 - 100mg. (IV inj over 2-3 min or IV infusion). Initially 100 mg then 50 - 100 mg every 4 - 6 hours. . Max: 400 mg daily. 
CHILD (1 year and above): 1 - 2mg/kg/dose",A,,,Acugesic,1.00,/,amp,
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.4 ANALGESICS (NARCOTICS)",,,,,,,,,,,
N01,Fentanyl Citrate 50 mcg/ml Injection,"Short duration analgesia during pre-medication induction and maintenance of anaesthesia, and in the immediate post-operative period.","Dose should be individualized according to age, body weight, physical status, underlying pathological conditions and type of surgery and anaesthesia. ADULT: Premedication: IM 50 - 100 mcg, 30 - 60 mins prior to surgery. Adjunct to general anaesthesia: Induction IV 50 - 100mcg, repeat 2 - 3 mins intervals until desired effect is achieved. IV/IM 25 - 50mcg in elderly and poor risk patients. Maintenance: IV/IM 25 - 50mcg. Adjunct to regional anaesthesia: IM/slow IV 50 - 100mcg when additinal analgesia is required. Post-operatively (recovery room): IM 50 - 100mcg for pain control, tachypnoea and emergency delirium. May be repeated in 1- 2 hours as needed. CHILD (2 - 12 years): Induction & maintenance: 2 - 3 mcg/kg.",A,,,Talgesil,2.19,/,amp,A
N02,Fentanyl 25 mcg/ hr Transdermal Patch,"Category Prescriber A*:
i) As a second line drug in the management of opioid responsive, moderate chronic cancer pain

Category Prescriber A/KK:
ii) As a second line drug in the management of opioid responsive, severe chronic cancer pain
To be prescribed by Family Medicine Specialists trained in pain management","Patients who have not previously received a strong opioid analgesic, initial dose , one 25 mcg/hour patch to be replaced after 72 hours. 

Patients who have received a strong opioid analgesic, initial dose based on previous 24 hours opioid requirement (oral morphine sulphate 90 mg over 24 hours = one 25 mcg/hour patch). 

Not recommended in children.","A*, A/KK",Perubatan,,Fentanyl Hexal,29.43,/,patch,A*
N02,Morphine HCl 10 mg/5 ml  1L Solution (made from morphine HCL powder BP),For use in management of moderate to severe pain especially that associated with neoplastic disease,5-20 mg or more regularly every 4 hours as needed in terminal pain,B,"Perubatan, Pembedahan",galenical,Morphine HCL powder BP,129.92,/,pack of 10g,B
N02,Morphine Sulphate 10 mg/ml Injection,For moderate to severe pain especially that associated with neoplastic disease,"ADULT: 5-20mg SC or IM every 4 hours in terminal pain. 
CHILD: Up to 1 month: 0.15 mg/kg body weight; 
1 - 12 months: 0.2 mg/kg body weight; 
1 - 5 years: 2.5 - 5 mg ; 
6 - 12 years: 5 - 10 mg",B,,,Morpheas Inj,0.95,/,amp,B
N02,Morphine Sulphate 10 mg Controlled Release Tablet  ,"Category Prescriber A/KK:
i) Prolonged relief of severe pain associated with neoplastic disease
To be prescribed by Family Medicine Specialists trained in pain management

Category Prescriber A:
ii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non- pharmacological approach failed
Initiated by Pain or Palliative Specialists only","10 - 60 mg 12 hourly intervals, depend upon the severity of the pain. 
Children (more than 1 year of age) with severe cancer pain: 0.2 - 0.8mg/kg 12 hourly.","A, A/KK",Perubatan,,MST Continus,2.72,/,tab,A
N02,Morphine Sulphate 30 mg Controlled Release Tablet  ,"i) Prolonged relief of severe pain associated with neoplastic disease

ii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non- pharmacological approach failed
Initiated by Pain or Palliative Specialists only","10 - 60 mg 12 hourly intervals, depend upon the severity of the pain",A,Perubatan,,MST Continus,7.21,/,tab,
N02,Nalbuphine HCl 10 mg/ml Injection,"Perioperative analgesia, for relief of moderate to severe pain","10 - 20 mg SC, IM or IV every 3 - 6 hours",B,,,Intapan,6.01,/,vial,B
N02,Oxycodone HCl 10 mg/ml Injection,"For the treatment of moderate to severe pain in patients with cancer and post-operative pain. For the treatment of severe pain requiring the use of a strong opioid.

PRECAUTIONS
Geriatric patients: Caution and proper monitoring is warranted.
Opioid related adverse effects may be more prominent in this population therefore should be monitored
regularly and addressed if occurred.
","Adults over 18 years: The following starting doses are recommended. A gradual increase in dose may be required if analgesia is inadequate or if pain severity increases. 
IV Bolus: Dilute to 1 mg/ml in 0.9% saline, 5% dextrose or water for injections. Administer a bolus dose of 1 to 10 mg slowly over 1-2 minutes. Doses should not be administered more frequently than every 4 hours. 
IV Infusion: Dilute to 1 mg/ml in 0.9% saline, 5% dextrose or water for injections. A starting dose of 2 mg/hour is recommended. 
IV PCA: Dilute to 1 mg/ml in 0.9% saline, 5% dextrose or water for injections. 
Bolus doses of 0.03 mg/kg should be administered with a minimum lock-out time of 5 minutes. 
","A*

Consultant/specialists for specific indications only, including Geriatricians",,,Oxynorm,9.51,/,amp,A*
,,,"SC Bolus: Use as 10 mg/ml concentration. A starting dose of 5 mg is recommended, repeated at 4-hourly intervals as required. 
SC Infusion: Dilute in 0.9% saline, 5% dextrose or water for injections if required. A starting dose of 7.5 mg/day is recommended in opioid naÔve patients, titrating gradually according to symptom control. 
Cancer patients transferring from oral oxycodone may require much higher doses (see below). Transferring patients between oral and parenteral oxycodone: The dose should be based on the following ratio: 2 mg of oral oxycodone is equivalent to 1 mg of parenteral oxycodone. It must be emphasised that this is a guide to the dose required.Inter-patient variability requires that each patient is carefully titrated to the appropriate dose.",,,,,,,,
N02,Oxycodone HCl 5 mg Immediate Release Capsule,"i) Management of moderate to severe chronic cancer pain non-responsive to morphine in accordance with WHO step-wise ladder of chronic pain management 

ii) As a step-down analgesic drug in post-operative procedures iii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non-pharmacological approach failed (Initiated by Pain, Palliative Specialists and geriatricians only)


","Initially 5 mg every 4 to 6 hours, increased if necessary according to severity of pain, usual max. 400 mg daily, but some patients may require higher doses

PRECAUTIONS
Geriatric patients: Caution and proper monitoring is
warranted.",A*,"
",,Oxynorm,1.53,/,cap,A*
N02,Oxycodone HCl 10 mg Prolonged Release Tablet,"i) Management of moderate to severe chronic cancer pain non-responsive to morphine in accordance with WHO step-wise ladder of chronic pain management.

ii) As a second line treatment of chronic non-cancer pain when treatments with adjuvant analgesics and non-pharmacological approach failed (Initiated by Pain, Palliative Specialists or Geriatricians only)
PRECAUTIONS
Geriatric patients: Caution and proper monitoring is
warranted.","Adults, elderly and children over 12 years: Usual starting dose for opioid-naive patients or patients presenting with moderate to severe pain uncontrolled by weaker opioids (especially if they are receiving concurrent sedatives, muscle relaxants or other CNS medicines) is 10mg 12 hourly. 
The dose should then be carefully titrated with longitudinal patient monitoring, assessing whether the pain is opioid responsive and providing the patient significant pain relief. 
Patients with renal or hepatic impairment: The recommended adult starting dose should be reduced by 1/3 to 1/2, and each patient should be titrated to adequate pain control according to their clinical situation.",A*,"

",,Oxycontin,4.47,/,cap,A*
N02,Oxycodone HCl 10mg and Naloxone HCl Dihydrate 5 mg Tablet,"The management of moderate to severe chronic pain unresponsive to non-narcotic analgesics. The opioid antagonist naloxone in the fixed combination is added to counteract and/or prevent opioid-induced constipation.

PRECAUTIONS
Geriatric patients: Caution and proper monitoring is warranted.","Adults and paediatric patients from 18 years of age: The usual starting dose for opioid-naive patients or patients presenting with moderate to severe chronic pain uncontrolled by weaker opioids is one tablet 10mg/5mg at 12 hourly intervals, or one tablet 5mg/2.5mg 12-hourly for patients with mild hepatic impairment and patients with renal impairment. The dose should then be cautiously titrated, as frequently as every 1-2 days if necessary, to achieve pain relief.","A*
Consultant/ specialists for specific indications only, including Geriatricians",,,Targin 10/5,4.80,/,cap,
N02,"Pethidine HCl 50 mg/ ml, 100 mg/2 ml Injection","For relief of moderate to severe pain (medical and surgical), pre-anaesthetic medication and obstetrical analgesia","ADULT: 0.5 - 2 mg/kg SC or IM every 3 - 4 hours if necessary. 
CHILD: by IM 0.5 - 2 mg/kg. Up to 1 year : 1- 2 mg/kg weight IM, 1 - 5 years : 12.5 - 25 mg IM, 6 - 12 years: 25 - 50 mg IM",B,,,"Pharmaniaga Pethidine HCL

Demothine","
0.8

0.93",/,amp,B
N01,Remifentanil 5 mg Injection ,"i) As an analgesic agent for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery. 
ii)Continuation of analgesia into the immediate post-operative period under close supervision, during transition to longer acting analgesia. 
iii)Provision of analgesia and sedation in mechanically ventilated intensive care patients.","For IV use only. ADULT: Induction:Bolus infusion: 1µg/kg over 30-60 seconds; Continuous infusion: 0.5-1µg/kg/min; Maintenance: Continuous infusion: 0.025 to 2 µg/kg/min. 
CHILD (1-12 years of age): Induction: Insufficient data; 
Neonates: IV infusion 0.4-1.0 mcg/kg/minute depending on the anaesthetic method and adjust according to patient response, supplemental IV inj of 1 mcg/kg dose may be given. ",A*,,,Ultiva      ,153.57,/,vial,
,,,"1-12 yr: initially 0.1-1 mcg/kg by IV inj over at least 30 seconds (excluded if not needed), followed by IV infusion 0.05-1.3 mcg/kg/minute depending on the anaesthetic method and adjust according to patient response, supplemental IV bolus inj may be admin during infusion. 

12-18 yr: 0.1-1 mcg/kg IV inj over at least 30 seconds (excluded if not needed), followed by IV infusion of 0.05-2 mcg/kg/minute depending on anaesthetic method and adjust according to patient response, supplemental IV bolus inj may be admin during infusion.",,,,,,,,A*
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.5 ANTIGOUT PREPARATIONS",,,,,,,,,,,
M04,Allopurinol 100 mg Tablet,"i) Frequent and disabling attacks of gouty arthritis (2 or more flares/year)
ii) Clinical or radiographic signs of erosive gouty arthritis.
iii) The presence of tophaceous deposits
iv) Urate nephropathy
v) Urate nephrolithiasis
vi) Impending cytotoxic chemotherapy or radiotherapy for lymphoma or
leukaemia
","Initial dose: 50-100 mg daily. 
Maintenance: 300-900mg daily (depending on renal function).",A/KK,Perubatan,,"Allopurinol
100mg

300mg",0.07,/,tab,
M04,"Allopurinol 100mg, 300 mg Tablet",,,,,,,"
0.07

0.29",/,tab,A/KK
M04,Colchicine 0.5 mg Tablet,"i) Acute gout and prophylaxis of recurrent gout. 

ii) Leucocytoclastic Vasculitis either cutaneous or systemic involvement, Behcet's syndrome, Urticarial vasculitis, Systemic sclerosis, Sweet's syndrome and severe recalcitrant aphthous stomatitis","i) Initial dose, 1 mg, then 0.5 mg every 2-3 hour until relief of pain is obtained or vomiting or diarrhoea occurs (Maximum : 6 mg). The course should not be repeated within 3 days. Prevention of attacks during initial treatment with allopurinol or uricosuric drugs: 0.5 mg 2-3 times daily. 

ii) 0.5 mg 1-3 times daily depends on disease and severity, up to a maximum of 3 mg/day",B,,,Colchicine,0.09,/,tab,B
M04,Febuxostat 80 mg Tablet,"Treatment of chronic hyperuricaemia in adult patients, in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).
Prescribing restriction(s): 
i) As second line for patients who are allergic or intolerant to allopurinol, or
ii) Fail to achieve serum uric acid target despite dose escalation and good compliance to allopurinol","The recommended starting dose is 40 mg once daily.
The recommended oral dose is 40 mg or 80 mg once daily.
If serum uric acid is > 6.0 mg/dL (357 µmol/L) after 2-4 weeks, 80 mg once daily may be considered.

The 80 mg tablet can be divided into equal halves. In order to provide a 40 mg dose, the tablet should be split just before use. Prescribers should advise patients on how to break the tablets in half and to keep the other half for the next dose.",A/KK,Perubatan,,Febuton,2.81,/,tab,A*
M04,Probenecid 500 mg Tablet  ,"Hyperuricemia associated with gout and gouty arthritis 
(for cases allergic to allopurinol or serum uric acid not controlled by allopurinol alone)",500 mg to 1000 mg twice daily,A,Perubatan,Kuota,Sunward,0.35,/,tab,A
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.6 ANTIPSYCHOTICS",,,,,,,,,,,
N05,Alprazolam 0.5 mg Tablet,Anxiety disorders,"0.25 - 0.5 mg 3 times daily (elderly or delibitated 0.25 mg 2-3 times daily), increased if necessary to a total dose of 3 mg/day. Not recommended for children",A,,,Alpraline,0.45,/,tab,A
N05,"Amisulpride 100 mg, 400 mg Tablet","Treatment of psychoses, particularly acute or chronic schizophrenia disorders characterized by positive symptoms(e.g. delusion, hallucinations, thought disorders) and/or negative symptoms(e.g. blunted emotions, emotional and social withdrawal) including when the negative symptoms predominate","Predominantly negative episodes: 50-300 mg once daily adjusted according to the patient?s response. 
Mixed episodes with positive and negative symptoms: 400-800 mg/day in 2 divided doses adjusted according to the patient?s response. 
Should be taken on an empty stomach (Preferably taken before meals)",A*,Psikiatrik,Kuota,Solian,"1.40, 5.22",/,tab,A*
N05,Aripiprazole 10 mg Tablet,"i) Treatment of acute episodes of schizophrenia and for maintenance of clinical improvement during continuation therapy. 
ii) Treatment of acute manic episodes associated with bipolar I disorder","Schizophrenia: 10 or 15 mg/day. Maintenance dose: 15 mg/day. 
Bipolar mania: Starting dose: 15 or 30 mg/day. Dose adjustment should occur at intervals of not less than 24 hour",A*,Psikiatrik,,Apalife,1.26,/,tab,A*
N05,Aripiprazole 400mg Injection,Maintenance treatment of schizophrenia & maintenance monotherapy treatment of bipolar I disorder in adult patients.,400 mg once mthly as single IM inj (no sooner than 26 days after previous inj).,A*,Psikiatrik,"
Kuota
","Abilify 
Otsuka",680.03,/,PFS,
N05,Asenapine  10 mg Sublingual Tablet,"For second or third line treatment in adult for: 
i) Schizophrenia 
ii) Bipolar Disorder
 - Monotherapy: Acute treatment of manic or mixed episodes associated with Bipolar I disorder. 
- Adjunctive therapy: As adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with Bipolar I Disorder.","i) Schizophrenia: 
- Acute treatment in adults: Recommended starting and target dose of asenapine is 5mg given twice daily.
 - Maintenance dose: 5mg twice daily. 
ii) Bipolar Disorder:
 - Monotherapy: 10mg twice daily. 
Adjunctive therapy: 5mg twice daily with lithium or valproate. 
Dose can be increased to 10mg twice daily based on clinical response.",A*,Psikiatrik,Kuota,Saphris,8.85,/,tab,A*
N05,Brexpiprazole 2mg Tablet ,"Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)

Prescribing Restriction:
To be prescribed by Psychiatrists only",The recommended starting dose as adjunctive treatment is 0.5 mg or 1 mg once daily. Dose titration to 1 mg/day and up to the target dose of 2 mg/day should occur at intervals of up to 1 week based on the patient’s clinical response and tolerability. Doses up to 3 mg/day have been studied in clinical trials.,A*,Psikiatrik,Kuota,Rexulti,16.17,/,tab,
N05,Chlorpromazine HCl 100 mg Tablet,Psychosis mania and agitation,"ADULT : Initial dose - 25 mg 3 times daily according to response up to 1 g daily. 
PAEDIATRIC: Up to 5 years: 0.5 mg/kg body weight every 4 - 6 hours (Maximum 40 mg daily). 
CHILD 6 - 12 years: A third to half adult dose (Maximum 75 mg daily)",B,,,"Idaman
Chlorpromazine",0.17,/,tab,B
N05,"Clozapine 25 mg, 100 mg Tablet",Treatment of resistant schizophrenia,"Initial dose : 12.5 mg ( once or twice ) daily, increase slowly in steps of 25 - 50 mg up to 300 mg daily within 2 - 3 weeks. Maximum : 900 mg/day",A,Psikiatrik,,Clozaril,"0.41, 0.91",/,tab,A
N05,Diazepam 10 mg/2 ml Injection,"i) Status epilepticus 

ii) Skeletal muscle spasm 

iii) Anxiety disorders","i) ADULT: initial dose 10-20mg IV, in the following hours 20mg IM or by intravenous drip infusion as necessary. 
CHILD 2 to 5 years of age: slow IV 0.2 - 0.5mg every two to five minutes up to a maximum of 5mg. If necessary, dose can be repeated in two to four hours. 
CHILD 5 years and older: slow IV 1mg every two to five minutes up to a maximum of 10mg. If necessary, dose can be repeated in two to four hours.

 ii) ADULT: 10mg once or twice IV. 
CHILD 2 to 5 years of age: IM or IV, 1 to 2mg the dosage being repeated every three to four hours as needed. 
CHILD 5 years and older: IM or IV, 5 to 10mg, the the dosage being repeated every three to four hours as needed. 

iii) ADULT: 10-20mg three times daily IM or IV until acute symptoms subside.",B,,,Zopam ,4.52,/,amp,B
N05,Diazepam 5 mg Tablet,"i) Muscle spasm of varied aetiology, including tetanus 

ii) Anxiety disorders","i) ADULT: 2-10 mg 3-4 times daily. 
CHILD 6 months and older: 0.12 - 0.8 mg/kg daily in divided doses, every 6-8 hours 

ii) ADULT : 2 mg 3 times daily, increased in severe anxiety to 15 - 30 mg daily in divided doses. ELDERLY (or delibitated) : half adult dose. 
CHILD (night terrors) : 1 - 5 mg at bedtime",B,,,Diapo,0.40,/,tab,B
N05,Flupenthixol Decanoate Depot 20 mg/ml lnjection,Chronic psychoses,"By deep IM, initial test dose of 5-20 mg, then after at least 7 days. 20 - 40 mg repeated at intervals of 2 - 4 weeks. Maximum 400 mg weekly. 
- Usual maintenance dose 50 mg every 4 weeks to 300 mg every 2 weeks. 
- ELDERLY, initially quarter to half adult dose. 
 - CHILD not recommended. 
 - Deep IM recommended. Not for IV use",B,,,Fluanxol,20.88,/,amp,B
N05,Fluphenazine Decanoate 25 mg/ml Injection,Long term management of psychotic disorders,"By deep IM : Test dose 12.5 mg (6.25 mg in ELDERLY), then after 4-7 days 12.5 mg-100 mg repeated at intervals of 14-35 days, adjusted according to response. 
CHILD not recommended",B,,,Shrizine,0.92,/,amp,B
N05,Haloperidol 5 mg/ml Injection,Acute psychoses and mania,"ADULT: IM or IV , 2 mg - 10 mg then every 4 - 8 hours according to response to total maximum 18 mg daily. Use in child is not recommended",B,,,MENACE,3.85,/,amp,B
N05,"Haloperidol 1.5 mg, 5 mg Tablet",Schizophrenia and other psychoses,"Adult:0.5-5 mg bid/tid, may increase up to 100 mg daily in severe or resistant cases. 
Usual maintenance: 3-10 mg daily.
Child: >3 yr: Initially, 25-50 mcg/kg daily in 2 divided doses, increased gradually if necessary. 
Max: 10 mg/day.",B,,,"Haloperidol, HADOL-5","0.16, 0.14",/,tab,B
N05,"Lithium Carbonate 
300 mg Tablet","i) Prophylaxis and treatment of acute mania and hypomania episodes 
ii)Prophylaxis of manic depression in bipolar illness or bipolar depression and recurrent depression","Dose depends on the preparation used. 
Doses should be adjusted to produce a serum-lithium concentration of 0.4-1 mmol/l.",A,Psikiatrik,,Liconate,0.57,/,tab,A
N05,Lorazepam 1 mg Tablet,"i) Severe anxiety 
ii) Insomnia","i) 1 - 4 mg increase to 10 mg daily in divided doses. ELDERLY (or delibitated): half adult dose 
ii) 1 - 2 mg at bedtime Not recommended in children",A/KK,,,Tranpam,0.44,/,tab,A/KK
N06,Methylphenidate HCl 10 mg Tablet,Attention deficit hyperactivity disorder (ADHD),"CHILD over 6 years, initially 5 mg 1 - 2 times daily, increased if necessary at weekly intervals by 5 - 10 mg daily to maximum of 60 mg daily in divided doses; discontinue if no response after 1 month, also suspend periodically to assess child's condition (usually finally discontinued during or after puberty)",A,Pediatrik,,Ritalin,1.62,/,tab,A
N06,"Methylphenidate HCl 18 mg, 36 mg Extended-release Tablet",Attention deficit hyperactivity disorder (ADHD),"CHILD over 6 years: Individualize dosage, to be taken once daily in the morning. Dose may be adjusted in increments to a maximum of 54 mg/day, at weekly interval. 
Patient new to methylphenidate: starting dose 18 mg once daily; adults 18mg or 36mg once daily. 
Patient currently using methylphenidate: 18 - 36 mg. Maximum 54 mg/day. 
Discontinue if no response after 1 month",A*,Pediatrik,,Concerta,"7.45, 11.60",/,tab,A*
N05,"Olanzapine 5 mg, 10 mg Tablet","i) Acute and maintenance treatment of schizophrenia and other psychoses where positive and or negative symptoms are prominent 
ii) Short-term use for acute mania episodes associated with Bipolar 1 disorder","i) 5 - 10 mg once daily, increase to 10 mg once daily within 5 - 7 days, adjust by 5 - 10 mg/day at 1 week intervals, maximum 20 mg/day 
ii) 10 - 15 mg once daily, increase by 5 mg/day at intervals of not less than 24 hours. Maintenance : 5 - 20 mg/day; maximum 20 mg/day",B,Psikiatrik,,Olenza,"0.21, 0.66",/,tab,A*
N05,"Olanzapine 5 mg, 10 mg Disintegrating Tablet","i) Acute and maintenance treatment of schizophrenia and other psychoses where positive and or negative symptoms are prominent 
ii) Short-term use for acute mania episodes associated with Bipolar 1 disorder

","i) 5 - 10 mg once daily, increase to 10 mg once daily within 5 - 7 days, adjust by 5 - 10 mg/day at 1 week intervals, maximum 20 mg/day 
ii) 10 - 15 mg once daily, increase by 5 mg/day at intervals of not less than 24 hours. Maintenance : 5 - 20 mg/day; maximum 20 mg/day","A*

Consultant/ specialists for specific indications only, including Geriatricians",Psikiatrik,,"Hovid, Jubrexa","0.94, 1.53",/,tab,A*
N05,"Paliperidone 6 mg, 9mg Extended Released Tablet                 ",Second or third line treatment of schizophrenia,"ADULT : 6 mg once daily in the morning, adjusted if necessary; usual range 3 -12 mg daily. 
Renal impairment (creatinine clearance between 10-50 mL/min) : 3 mg once daily. 
Avoid if creatinine clearance less than 10mL/min",A*,Psikiatrik,Kuota,Invega ,"13.5, 16.2",/,tab,A*
N05,"Paliperidone 100 mg, 150 mg Prolonged Release Injection                         ",Second or third line treatment of acute and maintenance treatment of schizophrenia in adults,"Initiation: Deltoid IM 150 mg eq on Day1, followed by deltoid IM 100 mg eq on one week later. Maintenance: Monthly dose of 75 mg eq ( this can be increased or decreased based on individual patient's tolerability and/or efficacy). 
These monthly maintenace dose can be administered in either the deltoid or gluteal muscle",A*,,,Invega Sustenna       ,"904.51, 919.00",/,vial,A*
N05,Perphenazine 4 mg Tablet,Schizophrenia and other psychoses,"ADULT: Initially 4 mg 3 times daily adjusted according to response, maximum 24 mg daily. 
ELDERLY: 1/4 to 1/2 adult dose. CHILD not recommended",B,Psikiatrik,,Apo-Perphenazine,0.26,/,tab,B
N05,"Paliperidone 350mg/1.750ml , 525mg/ 2.625ml Prolonged Release for IM Injection",For the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.,"Apply 3.5 as a dose multiplier to the previous 1-month injection dose, and administer every 3 months",A*,Psikiatrik,Kuota,Invega Trinza,2512.90,/,inj,
N05,"Quetiapine Fumarate 200mg, 300mg Extended Release Tablet"," i)Schizophrenia
ii) Moderate to severe manic episodes in bipolar disorder
iii) Major depressive episodes in bipolar disorder
Prescribing Restriction:
Consultant/specialists for specific indications only, including Geriatricians and Neurologists","i) & ii) 300 mg once daily on Day 1 then 600 mg on Day 2. Maintenance dose: 400 to 800 mg once daily. Maximum dose: 800 mg daily

iii) 50 mg on Day 1, 100 mg on Day 2, 200 mg on Day 3 and 300 mg on Day 4. Recommended daily dose is 300 mg. May be titrated up to 600 mg daily. In elderly or hepatic impairment:Start with 50mg/ day, may be increased in increments of 50mg /day to an effective dose.",A*,Psikiatrik,Kuota,Seroquel XR,"7.70, 11.27",/,tab,
N05,"Quetiapine Fumarate 100 mg, 200 mg Immediate Release Tablet","i) Schizophrenia 

ii) Short term treatment of acute manic episodes associated with bipolar I disorder, either monotherapy or adjunct to lithium or divalproex 

iii) Treatment of depressive episodes associated with bipolar disorder","i) Initial titration schedule over 4 days: 25 mg twice daily on Day 1, increase in steps of 25 - 50 mg 2 to 3 times daily on Days 2 and 3 to reach target dose of 300 - 400 mg daily by Day 4, given in 2 - 3 divided doses. 
Institute further dose adjustments, if indicated, at intervals of 2 days or more, in steps of 25 - 50 mg twice daily 

ii) 100 mg (Day 1), 200 mg (Day 2), 300 mg (Day 3) & 400 mg (Day 4). ",A*,"Psikiatrik, Geriatrik",,Seroquel ,"1.13, 1.62",/,tab,
,,,"Further dosage adjustments up to 800 mg/day by Day 6 should be in increments of not more than 200 mg/day. Adjust dose within the range of 200 - 800 mg/day depending on clinical response and tolerability of the patient. Usual effective dose range: 400 - 800 mg/day 

iii) 50 mg ORALLY once a day on Day 1, then 100 mg once daily on Day 2, then 200 mg once daily on Day 3, then 300 mg once daily on Day 4 (all doses given at bedtime); patients requiring higher doses should receive 400 mg on Day 5, increased to 600 mg on Day 8 (week 1)",,,,,,,,A*
N05,"Risperidone 1 mg, 2 mg Tablet",Psychoses and schizophrenia,"ADULT : 2 mg in 1 - 2 divided doses on first day
 then 4 mg in 1 - 2 divided doses on 2nd day
 then 6 mg in 1 - 2 divided doses on 3rd day 
(slower titration appropriate in some patients); usual range 4 - 8 mg daily;
dose above 10 mg daily only if benefit outweigh risk (maximum 16 mg daily). 
Elderly (or in hepatic or renal impairment): initially 0.5 mg twice daily increased in steps of 0.5 mg twice daily to 1 - 2 mg twice daily. Not recommended in children under 15 years",B,"Psikiatrik, Geriatrik",,Rozidal,"0.06, 0.08",/,tab,B
N05,Sulpiride 200 mg Tablet,"Acute and chronic schizophrenia, chronic delusional psychoses","200-400 mg twice daily; 800 mg daily in predominantly negative symptoms and 2.4 g daily in mainly positive symptoms. 
Elderly, lower initial dose; increased gradually according to response. 
Child under 14 years not recommended",B,,,Negatil,0.13,/,tab,B
N05,Trifluoperazine HCI 5 mg Tablet,Psychotic disorder,"ADULT: Initially 5 mg twice daily, increase by 5 mg after 1 week, then at 3-day intervals. Maximum 40 mg/day. 
CHILD up to 12 years: Initially up to 5 mg daily in divided doses adjusted to response, age and body weight",B,,,APO-Trifluoperazine,0.33,/,tab,B
N05,Zuclopenthixol 20 mg/ml Drops,Only for psychoses with insight or compliance,"Acute Schizophrenia and Other Acute Psychoses; Severe Acute States of Agitation; Mania: Oral treatment: Usually 10-50 mg/day. 
In moderate to severe cases initially 20 mg/day increased, if necessary, by 10-20 mg/day every 2-3 days to =75 mg daily.",A*,Psikiatrik,,Clopixol Drops,48.48,/,bot,A*
N05,Zuclopenthixol Acetate 50 mg/ml Injection                         ,Only for treatment of agitated and violent patients suffering from schizophrenia who are not responding to the available standard drugs,"Clopixol-Acuphase: Clopixol-Acuphase is administered by IM injection. The dosage range should normally be 50-150 mg (1-3 mL) IM repeated if necessary, preferably with a time interval of 2-3 days. In a few patients, an additional injection may be needed 24-48 hrs following the 1st injection. 
In the maintenance therapy, treatment should be continued with oral Clopixol or Clopixol Depot IM after the following guidelines: Change to Oral Clopixol: 2-3 days after the last injection of Clopixol-Acuphase, a patient who has been treated with 100 mg Clopixol-Acuphase, oral treatment should be started at a dosage of about 40 mg daily, possibly in divided dosages. If necessary, the dose can be further increased by 10-20 mg every 2-3 days up to 75 mg or more.",A*,,,Clopixol Accuphase,20.31,/,vial,A*
N05,Zuclopenthixol Decanoate 200 mg/ml Injection,Only for treatment of agitated and violent patients suffering from schizophrenia who are not responding to the available standard drugs,By deep IM injection test dose 100 mg followed after 7 - 28 days by 100 - 200 mg or more followed by 200 - 400 mg at intervals of 2 - 4 weeks adjusted according to response. Maximum 600 mg weekly. Child not recommended,B,,,Clopixol Depot,23.83,/,vial,B
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.7 HYPNOTICS AND SEDATIVES",,,,,,,,,,,
N05,Chloral Hydrate 200 mg/5 ml Mixture,Preoperative sedation,"ADULT : 0.5 - 1 g (max 2 g) with plenty of water at bedtime. 
CHILD : Neonate: 30-50 mg/kg; up to 100 mg/kg may be used with respiratory monitoring. 
1 mth-12 yr: 30-50 mg/kg (max: 1 g); up to 100 mg/kg (max: 2 g) may be used; 
12-18 yr: 1-2 g. Doses to be taken 45-60 minutes before procedure. 
May be given rectally if oral route is not available.",B,,,  -,-,/,bot,B
N05,Dexmedetomidine HCl 100mcg/ml Injection,"i) Sedation of intubated and mechanically ventilated ICU patients.

ii) For use only by specialist anaesthetist:
For sedation of non-intubated patients prior to and/or during surgical and other procedures","i) Not to be infused for more than 24 hours, 1 mcg/kg over 10 minutes as loading dose. Maintenance dose: 0.2 - 0.7 mcg/kg/hr

ii) Not to be infused for more than 24 hours, 1 mcg/kg over 10 minutes as loading dose. Maintenance dose: 0.2 - 0.7 mcg/kg/hr",A*,,,Hydex,10.81,/,vial,
N05,Melatonin 3 mg Tablet,sleep cycle disorder,3mg ON (every night),Not in FUKKM,Pediatrik ,"Import Permit required for purchase
(UKK)",Melatonin,0.60,/,tab,-
N05,"Midazolam 5 mg/ml, 15 mg/3 ml Injection","Prescriber Category A:
i) Pre-operative sedation, induction of general anaesthesia, premedication and sedation in ICU and sedation for minor procedures

Prescriber Category A/KK:
ii) For induction of intubation and sedation post-intubation","Indication (i)
Usual sedative range : 2.5 - 7.5 mg (about 70 mcg/kg by IV injection over 30 seconds). 
Premedication by IM injection : 70 - 100 mcg/kg 30-60 minutes before surgery; ELDERLY: 1 - 1.5 mg/kg.
Induction: Induction by slow IV infusion 200 - 300 mcg/kg (ELDERLY 100 - 200 mcg/kg. 
CHILD over 7 years : 150-200 mcg/kg); Max: 0.35mg/kg. 
Sedation in ICU : 0.03 - 0.2 mg/kg/hour

Indication (ii)
Induction: Induction by slow IV infusion 200 - 300 mcg/kg (ELDERLY 100 - 200 mcg/kg. 
CHILD over 7 years 150 - 200 mcg/kg); Max: 0.35mg/kg.
Sedation: 0.03 - 0.2 mg/kg/hour","A, A/KK",,,"Domi, Domi","1.4, 1.9",/,amp,A
N05,Midazolam 7.5 mg Tablet,Pre and post-operative sedation,"ADULT: Usually 7.5 - 15 mg at bedtime; or for premedication, 30 - 60 minutes before the procedure. 
For ELDERLY, debilitated or impaired liver/kidney function: 7.5 mg",A/KK,,,Dormicum,1.20,/,tab,A/KK
N05,Zolpidem Tartrate 10 mg Tablet,For treatment of insomnia,"10-mg tablet daily. Stilnox should always be taken just before going to bed. 
In elderly patients or patients with hepatic insufficiency: Dosage should be halved ie, 5 mg. Dosage must never exceed 10 mg/day.",A,,,Zopim,1.01,/,tab,A
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.8 ANTIPARKINSON PREPARATION",,,,,,,,,,,
N04,Amantadine HCl 100mg Capsule ,Parkinson's disease,"Initial dose: 100 mg daily and is increased to 100 mg twice daily (not later than 4 p.m.) after a week. 
Elderly over 65 years: less than 100 mg or 100 mg at intervals of more than 1 day",B,Perubatan,,PK-MERZ,1.05,/,cap,B
N04,Benzhexol 2 mg Tablet,"i) Parkinson's disease 
ii) Drug induced parkinsonism 
iii) Dystonias","ADULT: Initially 1 mg daily, increase gradually. 
Maintenance: 5 - 15 mg daily in 3 - 4 divided doses. (Max 15mg/day)",B,,,Pharmaniaga Benzhexol,0.04,/,tab,B
N04,Entacapone 200 mg Tablet,"Parkinson's Disease. An adjunct to standard levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson's disease and end of dose motor fluctuations, who cannot be stabilised on those combinations",200 mg to be taken with each daily dose of levodopa/dopa-decarboxylase inhibitor. Max 2g daily. May be taken with or without food,A,Perubatan,,Entacapone HTC,1.70,/,tab,A
N04,"Levodopa 100 mg, Benserazide 25 mg HBS capsule",Parkinson's Disease,"Initial: 100/25 mg 1-2 times/day, increase every 3-4 days until therapeutic effect, optimal dosage: 400/100 mg to 800/200 mg/day divided into 4-6 doses. 
Dose: 200/50 mg used only when maintenance therapy is reached and not to exceed levodopa 1000-1200 mg/benserazide 250-300 mg per day",B,Perubatan,Kuota,Madopar HBS,1.05,/,cap,B
N04,"Levodopa 200 mg, Benserazide 50 mg Tablet",Parkinson's Disease,Dose: 200/50 mg used only when maintenance therapy is reached and not to exceed levodopa 1000-1200 mg/benserazide 250-300 mg per day,B,Perubatan,,Madopar-Roche,0.80,/,cap,B
N04,Levodopa 100 mg and Carbidopa 25 mg Tablet,Parkinson's disease,"Patients not receiving Levodopa before, initially 100 - 125 mg 3 - 4 times daily adjusted according to response. Maintenance: 0.75 - 2 g in divided doses. 
In patients previously treated with Levodopa the dose should be about 20 - 25% of the dose previously being taken.",B,Perubatan,,Apo - levocarb,0.46,/,tab,B
N04,Levodopa 250 mg and Carbidopa 25 mg Tablet,Parkinson's disease,"Patients not receiving Levodopa before, initially 100 - 125 mg 3 - 4 times daily adjusted according to response. 
Maintenance: 0.75 - 2 g in divided doses. In patients previously treated with Levodopa the dose should be about 20 - 25% of the dose previous being taken.",B,Perubatan,,Sinedopa,0.93,/,tab,B
N04,"Levodopa 150mg, Carbidopa 37.5mg and Entacapone 200mg Tablet

Levodopa 100mg, Carbidopa 25mg, Entacapone 200mg",Idiopathic Parkinson's disease,"The optimum daily dosage must be determined by careful titration of levodopa in each patient. The daily dose should preferably be optimised using 1 of the 4 available tablet strengths (50/12.5/200mg, 100/25/200mg, 150/37.5/200mg or 200/50/200mg levodopa/carbidopa/entacapone). 
Patients should be instructed to take only 1 tablet/dose administration. While the experience with total daily dosage >200 mg carbidopa is limited, the maximum recommended daily dose of entacapone is 2000 mg and therefore the maximum dose, for the strengths of 50/12.5/200 mg, 100/25/200 mg and 150/37.5/200 mg, is 10 tablets/day. Ten (10) tablets of the strength 150/37.5/200 mg equals carbidopa 375 mg/day. Therefore, using a maximum recommended daily dose of carbidopa 375 mg, the maximum daily dose of 200/50/200 mg is 7 tablets per day. The maximum total daily levodopa dose administered should not exceed 1500 mg.",A*,Perubatan,Kuota,"Stalevo 150
Stalevo 100","3.84
3.80",/,tab,A*
N06,Memantine HCl 10 mg tablet,As monotherapy or as adjunctive therapy with cholinesterase inhibitors for the symptomatic treatment of patients with moderate to severe Alzheimer's disease.,"Adult Initially 5 mg/day on the 1st week, 5mg twice a day on the 2nd week, then 15 mg/day (10mg in the morning and 5mg in the evening) on the 3rd week. From the 4th week on, continue treatment with maintenance dose of 20 mg/day (10mg twice a day). Max: 20 mg/day.",A*,"Psikiatrik, Geriatrik",,Marixino,0.52,/,tab,A*
N04,Piribedil 50 mg Tablet,Parkinson disease,"As monotherapy: 150 - 250 mg as 3 - 5 divided doses daily. 
As combination with L-dopa therapy: 50 - 150 mg daily (50 mg per 250 mg of L-dopa)",A*,Perubatan,,Triva,1.79,/,tab,A*
N04,"Pramipexole Dihydrochloride 0.375 mg, 1.5mg ER Tablet",Treatment for signs and symptoms of advanced idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa,"Dose escalation: 0.375 mg/day on week 1, 0.75 mg/day on week 2, 1.5 mg/day on week 3. Increase by 0.75 mg at weekly intervals if needed up to a max of 4.5 mg/day. 
Patient on l-dopa: reduce dose. 
Renal Impairment: CrCl 30-50 mL/min Initially 0.375 mg every other day. 
May be increased by 0.375 mg at weekly intervals to max 2.25 mg/day",A*,Perubatan,,Sifrol,"3.00, 12.10",/,tab,A*
N04,Procyclidine HCl 10 mg/2 ml Injection,"i) All forms of Parkinson's disease (idiopathic paralysis agitants), post-encephalitis and arteriosclerosis 
ii) To control troublesome extrapyramidal symptoms induced by neuroleptic drugs including pseudo-parkinsonism, acute dystonic reactions and akathisia","i) Initial dose 2.5mg TDS, increasing by 2.5-5mg/day at intervals of 2 or 3 days until the optimum clinical response is achieved. Usual maintenance dose: 15-30mg/day. Max: 60mg/day 
ii) Initial dose 2.5mg TDS, increasing by 2.5mg daily until symptoms are relieved. Usual maintenance dose: 10-30mg/day. IV Emergency: 5-10 mg. IM Emergency: 5-10 mg as a single dose, may repeat after 20 mins if needed. Max: 20 mg/day.",B,,,Cyclid,45.00,/,amp,B
N04,Selegiline HCl 5 mg Tablet,Only for treatment of late stage Parkinsonism with on and off phenomenon,"5 mg twice daily at breakfast and lunch. 
Maximum 10 mg/day",A*,Perubatan,,Selegos,1.14,/,tab,A*
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.9 ANTICONVULSANTS",,,,,,,,,,,
N03,Carbamazepine 100 mg/5 ml (2% w/v) Syrup,Epilepsy,"ADULT: Initially, 100-200 mg once or twice daily gradually increased by increments of 100-200 mg every 2 week. Maintenance: 0.8-1.2 g daily in divided doses. 
CHILD: 10-15 years: 0.6-1 g daily; 5-10 years: 400-600 mg daily; 1-5 years: 200-400 mg daily; less than or equal to 1 year: 100-200 mg daily. 
Alternatively, 10-20 mg/kg body weight daily in divided doses. Max: Adult: 1.6 g daily",A,"Perubatan, Pediatrik",,Tegretol,50.50,/,bot,A
N03,Carbamazepine 200 mg Tablet,"i) Epilepsy 
ii) Trigeminal neuralgia","i) ADULT: 100 - 200 mg 1 - 3 times daily increased gradually to usual dose of 0.8 - 1.2 g daily in divided doses. 
CHILD: Up to 1 year: 100 - 200 mg daily; 1 - 5 yrs: 200 - 400 mg daily; 5 - 10 years: 400 - 600 mg daily; 10 - 15 years: 0.6 - 1 g daily 
ii) The initial dosage of 200 to 400mg should be slowly raised daily until freedom from pain is achieved (normally at 200mg 3 to 4 times daily). The dosage should then be gradually reduced to the lowest possible maintenance level. In elderly patients, an initial dose of 100mg twice daily is recommended.",B,,,Carzepin,0.13,/,tab,B
N03,Carbamazepine CR 400mg,Epilepsy,"ADULT: Initial, 200 mg twice daily for the first week, may increase dosage by 200 mg/day at weekly intervals until optimal response is obtained. Maximum 1.6 g/day. 
CHILD: usual maximum dosage 1000 mg/day in children 12-15 years of age, 1200 mg/day in patients above 15 years of age",A,Perubatan,,Tegretol CR,1.09,/,tab,A
N05,Clobazam 10 mg Tablet,As adjunctive therapy in patients with epilepsy not adequately stabilised with their basic medication.,"The initial dose in adults and adolescents >15 yr should be low (5 to15mg daily), if necessary, increased gradually to a maximum daily dose of about 80mg. Doses of up to 30mg may be taken as a single dose in the evening. 
The initial dose in children from 3 to15 yr is normally 5mg. A maintenance dose of 0.3 to 1.0mg/kg body weight daily is usually sufficient.",A*,Pediatrik,,Frisium,0.66,/,tab,A*
N03,"Clonazepam 0.5 mg, 2 mg Tablet","i) Epilepsy 
ii) Non-epileptic myoclonus","i) & ii) ADULT: Initial dose should not exceed 1.5mg/day divided into 3 doses, may be increased in increments of 0.5mg every 3 days until seizures are controlled. Maintenance dose: 3-6mg/day. Maximum: 20mg/day. 
CHILD up to 10 years: initial dose 0.01-0.03 mg/kg/day in 2-3 divided doses, increased by no more than 0.25-0.5mg every third day, maximum 0.2mg/kg/day. 
CHILD 10-16 years: initial dose 1-1.5mg/day in 2-3 divided dose, may be increased by 0.25-0.5mg every third day until individual maintenance dose of 3-6mg/day is reached.",B,,,"Rivotril, Rivopam","0.30, 
0.26",/,tab,B
N05,Diazepam 5 mg Rectal Solution Tube,"Status epilepticus, skeletal muscle spasm","Status epilepticus - ADULT: 0.5 mg/kg repeated after 12 hours if necessary. 
CHILD (febrile convulsions, prolonged or recurrent): 0.5 mg/kg (maximum 10 mg), repeated if necessary. Not recommended for children below 2 years",C,,,Stesolid,65.00,/,tube,C
N03,"Gabapentin 300 mg, 600 mg Capsule","PRESCRIBER CATEGORY A*: Add-on therapy for intractable partial epilepsy, refractory to standard anti-epileptic drugs
. 
PRESCRIBER CATEGORY A/KK: Treatment of various types of neuropathic pain, both peripheral (which includes diabetic neuropathy, post-herpetic neuralgia, trigeminal neuralgia) in adult more than 18 years.","ADULT & CHILD > 12 yrs: 900-3600mg/day. 
Therapy may be initiated by administered 300mg TDS on day 1, or by titrating the dose as: 300mg once on day 1, 
300mg BD on day 2, 
300mg TDS on day 3. 
Thereafter, may be increased in 3 equally divided doses up to max 3600mg/day.
CHILD 3-12 yr: Initially 10-15 mg/kg/day in 3 divided dose. Effective dose: 
CHILD 3 to less than 5 yrs: 40mg/kg/day in 3 divided doses, 
CHILD 5-12 yrs: 25-35mg/kg/day in 3 divided doses 

ii) ADULT: 900mg/day in 3 equally divided doses. Max 3600mg/day",A*,"Ortopedik, Perubatan",,Neurontin,"0.09, 0.40",/,cap,A*
N03,Lacosamide 100 mg Tablet,Epilepsy with severe learning disability,100mg ON (every night),-,"Perubatan, Pediatrik",,Vimpat,5.32,/,tab,-
N03,Lamotrigine 5 mg Dispersible Tablet,Management of seizures in children aged 2 - 12 years,"a) Add-on therapy in patients not taking Valproate: week 1 and 2: 2 mg/kg/day twice daily, week 3 and 4: 5 mg/kg/day twice daily. Maintenance: 5 - 15 mg/kg/day twice daily 
b) Add-on therapy in patients taking Valproate or other anti-epileptic drugs, 
week 1 and 2: 0.2 mg/kg/day as a single dose 
(children less than 25 kg may take 5 mg on alternate days), 
week 3 and 4: 0.5 mg/kg/day as a single dose. 
Maintenance dose: 1 -5 mg/kg/day once daily or twice daily",A,"Perubatan, Pediatrik",,Lamictal,1.26,/,tab,A
N03,Lamotrigine 25 mg Dispersible Tablet,Add-on therapy in intractable partial seizures,25 mg daily - 50 mg twice daily,A,,,,1.59,/,tab,
N03,Lamotrigine 100 mg Non-Dispersible tab.,"i) Adjunctive or monotherapy for partial seizures and generalised tonic-clonic seizures not satisfactorily controlled with other antiepileptic drugs 
ii) Prevention of mood episodes in adult 18 years and above with bipolar disorder, predominately by preventing depressive episodes","i) Up to 200 mg daily in single or divided dosage 
ii) 25- 200 mg daily",A,"Perubatan, Pediatrik",,Lamotaxyl,0.20,/,tab,A
N03,Levetiracetam 100 mg/ml Injection,"i) Monotherapy therapy in the treatment of partial onset seizures with or without secondary generalization in patients from age 16 years of age with newly diagnosed epilepsy 
ii) Adjunctive treatment in partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy; juvenile myoclonic epilepsy and idiopathic generalized tonic clonic epilepsy from 12 years of age. To be initiated when conventional IV antiepileptic drugs failed to achieve control, or oral form is temporarily not feasible in seizure emergencies","i) ADULTS and ADOLESCENT (from 16 years): Starting dose: 250 mg twice daily, Increase dose to 500 mg twice daily after 2 week. Dose can be further increased by 250 mg twice daily every 2 weeks depending upon the clinical response. Max: 1500 mg twice daily. 
ii) ADULT more than 18 years and ADOLESCENT (12 to 17 years) more than or equal to 50 kg: Initially 500 mg twice daily may be increased up to 1500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2 to 4 weekly. 
CHILD (4 to 11 years) and ADOLESCENT (12 to 17 years) less than 50 kg : Initially 10 mg/kg twice daily, may be increased up to 30 mg/kg twice daily. 
Dose changes should not exceed increments or decrements of 10 mg/kg twice daily every 2 weeks. CHILD more than or equal to 50 kg: Adult dose",A*,"Perubatan, Pediatrik, Pembedahan",Kuota,Keppra,103.85,/,vial,A*
N03,"Levetiracetam 100 mg/ml
 Oral Solution",As adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy,"CHILD: 4-11 years and adolescent (12-17 years) less than 50 kg: Initially 10 mg/kg twice daily, may be increased up to 30 mg/kg twice daily. 
Dose changes should not exceed increments or decrements of 10 mg/kg two times daily twice weekly",A*,"Perubatan, Pediatrik",,Keppra,86.65,/,bot,A*
N03,Levetiracetam 500 mg Tablet,"
i) Monotherapy therapy in the treatment of partial onset seizures with or without secondary generalization in patients from age 16 years of age with newly diagnosed epilepsy 
ii) Adjunctive treatment in partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy; juvenile myoclonic epilepsy and idiopathic generalized tonic clonic epilepsy from 12 years of age","i) Monotherapy ADULTS and ADOLESCENT (from 16 years) : Starting dose: 250 mg twice daily, Increase dose to 500 mg twice daily after 2 week. Dose can be further increased by 250 mg twice daily every 2 week depending upon the clinical response. Max: 1500 mg twice daily. 
ii) ADULT more than 18 years and ADOLESCENT (12-17 years) more than or equal to 50 kg: Initially 500 mg twice daily may be increased up to 1500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements 2-4 weekly. 
CHILD (4-11 years) and ADOLESCENT (12-17 years) less than 50 kg : Initially 10 mg/kg twice daily, may be increased up to 30 mg/kg twice daily. Dose changes should not exceed increments or decrements of 10 mg/kg twice daily every 2 weeks. 
CHILD more than or equal to 50 kg: Adult dose",A*,"Perubatan, Pediatrik ",, Torleva,0.47,/,tab,A*
N05,Nitrazepam 5 mg Tablet,Epilepsy (infantile spasms),"5 - 10 mg at bedtime. ELDERLY or debilitated 2.5 - 5 mg. 
CHILD not recommended. Increasing slowly according to response",B,,,Nitrapam,0.62,/,tab,B
N03,Perampanel 2 mg Film-coated Tablet,Refractory Epilepsy,2mg ON ,Not in FUKKM,"Pediatrik, Perubatan",Special Drugs Approval (UKK) required,Fycompa,3.58,/,tab,A*
N03,Phenobarbitone Sodium 200 mg/ml Injection,Status Epilepticus,"ADULT: 10 mg/kg IV at a rate of not faster than 100 mg/minute. Initial maximum dose does not exceeding 1 gm. Daily maintenance :  1 - 4 mg/kg/day. 
CHILD: 10 - 20 mg/kg/dose loading dose, followed by repeated doses at 10 mg/kg/dose (strictly in ICU setting). Maintenance: 5 - 8 mg/kg/day",B,,Registered brand currently not available (UKK),Martindale,52.92,/,amp,B
N03,Phenobarbitone 30 mg Tablet,Epilepsy,"ADULT: 60 - 180 mg daily on. 
CHILD: Up to 8 mg/kg daily",B,,,idaman Phenobarbitone,0.17,/,tab,B
N03,Phenytoin Sodium 250 mg/5ml Injection,Status epilepticus,"i) Status epilepticus: ADULT : 10 - 15 mg/kg by slow IV. Maximum : 50 mg/minute. 
Maintenance: 100 mg orally/IV every 6 - 8 hours.
 CHILD : 15 - 20 mg/kg by slow IV. Maximum: 1 - 3 mg/kg/minute 
ii) Neurosurgery :  100 - 200 mg IM approximately at 4 hourly interval",B,,,"Pharmaniaga
Phenytoin ",15.31,/,amp,B
N03,"Phenytoin Sodium 30 mg, 100 mg Capsule",Epilepsy,"ADULT and CHILD more than 6 years: 300-400 mg/day in 3 - 4 divided doses before meals. Maximum: 600 mg/day. 
CHILD: Initially 5 mg/kg/day in 2 - 3 divided doses. Maintenance: 4 - 8 mg/kg/day. 
Maximum: 300 mg/day",B,,,Dilantin,"0.37, 0.28",/,cap,B
N03,Pregabalin 75 mg Capsule,"Kategori preskriber A*:
i. Fibromyalgia
ii. Epilepsy
Restriction: Consultant/specialists for specific indications only, including Geriatricians

Kategori preskriber A/KK:
iii. Neuropathic pain
Restriction: In primary care setting, for patients who cannot tolerate gabapentin at high doses.","The dose range is 150 to 600 mg per day given in either two or three divided doses.

Dosing is according to Product Insert","A*, A/KK

Consultant/ specialists for specific indications only, including Geriatricians","Perubatan, Ortopedik",,Prelica,1.08,/,tab,A*
N03,Pregabalin 150 mg Capsules,,,,,,Prelica,1.46,/,56,A*
N03,Sodium Valproate 400 mg Injection,Status epilepticus,"ADULT and CHILD above 10 years: 10 to 15 mg/kg/day IV, may increase 5 to 10 mg/kg/week to achieve optimal clinical response 
(Maximum 60 mg/kg/day or less with a therapeutic range of 50 to 100 mcg/mL)",B,Perubatan,Kuota,Epilim,85.59,/,vial,B
N03,Sodium Valproate 200 mg/5 ml Syrup,Epilepsy,"ADULT: Initially 600 mg/day; dose may be increased by 200 mg at 3-day intervals to max 2500 mg/day. Usual maintenance dose: 1000-2000 mg/day (20-30 mg/kg/day). 
CHILD: More than 20 kg: Initially 400 mg/day with spaced increases until control is achieved (usually 20-30 mg/kg/day), dose may be increased to 35 mg/kg/day. 
Less than 20 kg: 20 mg/kg/day. 
Severe cases: 50 mg/kg daily",B,,,Epilim,55.20,/,bot,B
N03,Sodium Valproate 200 mg Tablet,"i. Epilepsy 
ii. Treatment and prevention of mania associated with bipolar disorders","i. Epilepsy: ADULT: Initially 600 mg/day in 2 - 3 divided doses, dose may be increased by 200 mg at 3-day intervals to max 2.5 g/day. 
Usual maintenance dose: 1-2 g/day (20-30 mg/kg/day). 
CHILD: More than 20 kg : Initially 400 mg/day with spaced increases until control is achieved (usually 20-30 mg/kg/day), dose may be increased to 35 mg/kg/day. Less than 20 kg : 20 mg/kg/day, in severe cases the dose may be increased provided plasma concentration can be monitored. ",B,,,Epilim,0.23,/,tab,
,,,"ii. Treatment and prevention of mania associated with bipolar disorders: 
Adults: The recommended initial dose is 1000mg/day. The dose should be increased as rapidly as possible to achieve the lowest therapeutic dose, which produces the desired clinical effects. The recommended maintenance dosage for the treatment of bipolar disorder is between 1000mg and 2000mg daily. In exceptional cases, the dose may be increased to not more than 3000mg daily.",,,,,,,,B
N03,"Topiramate 25 mg, 100 mg Tablet",Add-on therapy for intractable partial epilepsy,"ADULT: Initially 25-50mg nightly for 1 week. Subsequently at wkly or bi-wkly intervals, increase dose by 25-50 to 100mg/day in 2 divided doses. 
CHILD aged 2 and above: Approx 5-9 mg/kg/day in 2 divided doses. Titrate at 25mg (or less, based on a range of 1-3mg/kg/day) nightly for the 1st week. Subsequently at 1 or 2 wkly intervals, with increments of 1-3 mg/kg/day in 2 divided dose.",A*,Perubatan,,"Topamax, Epimate","2.76,4.08",/,tab,A*
N03,Valproic Acid & Sodium Valproate (ER) 500mg Tablet,"i) In the treatment of generalized or partial epilepsy, particularly with the following patterns of seizures:absence, myoclonic, tonic-clonic, atonic-mixed as well as, for partial epilepsy:simple or complex seizures, secondary generalized seizures, specific syndrome (West, Lennox-Gastatut). 
ii) Treatment and prevention of mania associated with bipolar disorders.","i) Adults: Dosage should start at 500mg daily increasing by 200mg at three-day intervals until control is achieved. This is generally within the dosage range 1000mg to 2000mg per day. 
Children: >20KG: 500mg/day (irrespective of weight) with spaced increases until control is achieved. 
ii) Initial dose of 1000mg/day, to be increase rapidly as possible to achieve lowest therapeutic dose, which produce desired clinical effects. Recommend initial dose is 1000mg & 2000mg daily. Max dose 3000mg daily.",B,Psikiatrik,Kuota,Valparin,0.62,/,tab,B
N03,Vigabatrin 500mg Tablet ,"i) early infantile epileptic encephalopathy with infantile spasm
ii) Epileptic encephalopathy","i) 250mg BD (twice daily)
ii) 500 mg BD",Not in FUKKM,Pediatrik,"special drugs approval
(UKK) (secara pukal) required once a year for infantile spasm",Sabril,3.35,/,tab,-
N03,Zonisamide 100mg tablet,"As adjunctive therapy in the treatment of partial seizures in adults with epilepsy.

Off-label use in HSM: Adjunctive treatment for Parkinson disease","For adults, usually 100 to 200mg of zonisomide is to be administered orally 1 to 3 times a day initially. The dose is gradually increased at every one to two weeks up to 200-400mg daily, in 1 to 3 divided dose. The maximum daily dose should not exceed 600mg per day.
Prescribing restriction:
As adjunctive therapy in the treatment of partial seizures in adults with epilepsy when 1st line and 2nd line therapy failed.

Parkinson disease: 100mg OD
",A*,Perubatan,Special Drugs Approval (UKK) required for off-label indication,Zonergan,1.22,/,tab,
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.10 ANTIDEPRESSANTS",,,,,,,,,,,
N06,Agomelatine 25mg Tablet,Major depression,"The recommended dose is 25mg once daily at bedtime, maybe increased to 50mg once daily at bedtime.",A*,Psikiatrik,Kuota,Valdoxan  ,3.90,/,tab,A*
N06,Amitriptyline HCl 25 mg Tablet,Depression,"Initially 25mg 3 times a day. Maintenance: 25-100mg daily in divided doses. 
Hospitalized patient: 100mg/day &gradually increase to 200-300mg/day. 
ADOLESCENT and ELDERLY: initially 20-30mg/day in divided doses w/ gradual increments. 
CHILD under 16 years are not recommended.",B,,,Apo-Amitryptyline,0.29,/,tab,B
N06,Clomipramine HCI 25 mg Tablet,"Depression, obsessive-compulsive disorder.","Initially 10 mg daily, increased gradually as necessary to 30 - 150 mg daily in divided doses or as a single dose at bedtime; max 250 mg daily. 
ELDERLY: initially 10 mg daily increased carefully over approximately 10 days to 30 - 75 mg daily
Child: ≥10 yr: Initially, 25 mg daily, increased gradually over 2 wk. Max: 3 mg/kg/day or 100 mg daily, whichever is smaller. 
Give in divided doses. Once titrated, dose may be given as a single dose at bedtime.",A,Psikiatrik,,"Apo-
Clomipramine",0.77,/,tab,A
N06,Desvenlafaxine Succinate 50 mg Extended Release Tablet                                      ,Major depression,"Recommended dose is 50mg once daily, with or without food.",A*,Psikiatrik,Kuota,Pristiq,4.44,/,tab,A*
N06,"Dothiepin HCl 25 mg, 75 mg Capsule",Depression of any aetiology,"Initially 75 mg (ELDERLY 50-75 mg) daily in divided doses or single dose at bedtime, increased gradually as necessary to 150 mg daily (ELDERLY 75 mg may be sufficient), up to 225 mg daily in some circumstances. CHILD is not recommended",A,Psikiatrik,,"Depropin, Dothep","0.37, 1.52",/,cap,A
N06,"Duloxetine 30 mg, 60 mg Capsule","Major depression, diabetic peripheral neuropathic pain","ADULT: 60 mg once daily up to a maximum dose of 120mg/day (in divided doses) 
CHILD and ADOLESCENT under 18 years not recommended",A*,Psikiatrik,Kuota,"Cymbalta, Dulox","4.31, 4.31",/,cap,A*
N06,Escitalopram 10 mg Tablet,"i) Major depression 
ii) Treatment of panic disorder with or without agoraphobia","i) 10 mg once daily; may be increased to max 20 mg daily. 
ii) Panic disorder with or without agoraphobia :Initially 5 mg for the first week, thereafter increased to 10 mg daily. Max 20 mg daily, 
ELDERLY: initially half the adult dose, lower maintenance dose may be sufficient. 
CHILD and ADOLESCENT under 18 years not recommended",B,"Psikiatrik, Geriatrik",,ESLO,0.12,/,tab,A*
N06,Fluoxetine HCl 20 mg Capsule,"i) Depression 
ii) Obsessive-compulsive disorder","i) 20 mg once daily increased after 3 weeks if necessary, usual dose 20 - 60 mg (ELDERLY: 20 - 40 mg) once daily. Max : 80 mg once daily (ELDERLY: Max: 60 mg once daily). 
ii) Initially 20 mg once daily increased after 2 weeks if necessary, usual dose 20 - 60 mg (ELDERLY 20 - 40 mg) once daily. Max: 80 mg (ELDERLY max 60 mg) once daily, discontinue if no improvement within 10 weeks. 
CHILD and ADOLESCENT under 18 years are not recommended",A/KK,Psikiatrik,,Fluovex,0.49,/,cap,A
N06,"Fluvoxamine 50 mg, 100 mg Tablet",Depression,"For depression, initially 50 - 100 mg daily in the evening, increased if necessary to 300 mg daily (over 150 mg in divided doses); usual maintenance dose : 100 mg daily. 
CHILD and ADOLESCENT under 18 years not recommended",B,Psikiatrik,,Luvox,"0.31, 
0.83",/,tab,B
N06,"Mirtazapine 15 mg, 30 mg Orodispersible Tablet",Major depression,"Initially 15 mg daily at bedtime increased according to response up to 45 mg daily as a single dose at bedtime or in 2 divided doses. 
CHILD and ADOLESCENT under 18 years not recommended",A*,"Psikiatrik, Geriatrik",,Remeron,"2.35, 
4.52",/,tab,A*
N06,Moclobemide 150 mg Tablet,Treatment of depressive syndrome,Initially 300 mg daily in divided doses. Gradually to increase up to 600 mg daily in divided doses depending on response. Usual range 150 - 600 mg daily. Not recommended in children,A*,Psikiatrik,,Aurorix,2.40,/,tab,A*
N06,Sertraline HCI 50 mg Tablet,"Major depression, obsessive-compulsive disorder (OCD), panic disorder","Depression, obsessive-compulsive disorder: 50 mg/day, may increase in steps of 50mg at weekly interval, max:200mg/day. 
Panic disorder: Initially 25 mg/day. After 1 week, increase dose to 50 mg/day. All dose changes should be made at intervals of more than 1 week, max: 200 mg/day",B,"Psikiatrik, Perubatan, Geriatrik",,Serlift,0.13,/,tab,B
N06,Venlafaxine HCl 75 mg Extended Release Capsule,"i) Depression 
ii) Generalized anxiety disorder 
iii) Social anxiety disorder (social phobia) 
iv) Panic disorder","i), ii) & iii) ADULT: 75 mg once daily. May increase dose by 75 mg/day every 4 days to a maximum dose of 225 mg/day, (severe depression: max: 375mg/day) i
v) 37.5 mg/day for the first 4-7 days after which the dose should be increased to 75 mg once daily. CHILD and ADOLESCENT under 18 years not recommended",A*,Psikiatrik,,EFEXOR,2.89,/,tab,A*
N06,Vortioxetine 10 mg Tablet,"Treatment of major depressive episodes in adults.

Restriction:
Consultant/specialists for specific indications only, including Geriatricians and Neurologists","ADULT
Initially 10 mg once daily, may be increased to max: 20 mg once daily or decreased to min: 5 mg once daily.

ELDERLY
Initially 5 mg once daily.",A*,Psikiatrik,Kuota,Brintellix,4.60,/,tab ,A*
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.11 MUSCLE RELAXANTS",,,,,,,,,,,
M03,Atracurium Besylate 25mg/2.5 ml Injection,"Muscle relaxant in general anaesthesia, Endotracheal intubation, Aid controlled ventilation.","Adult & childn >2 mth: 0.3-0.6 mg/kg IV. 
Endotracheal intubation dose: 0.5-0.6 mg/kg. 
Supplementary dose: 0.1-0.2 mg/kg as required. 
Continuous infusion rates : of 0.3-0.6 mg/kg/hr to maintain neuromuscular block during long surgical procedure.",A*,,,Atracurium - Hameln,4.52,/,vial,A*
M03,Baclofen 10 mg Tablet,Spasticity of the skeletal muscle,"ADULT: 5 mg 3 times daily. Max: 80 mg daily. 
CHILD: 0.75 - 2 mg/kg daily 
(more than 10 years, maximum: 2.5 mg/kg daily)",B,,,Musafen,0.88,/,tab,B
M03,Cisatracurium Besylate 2 mg/ml Injection,"As an adjunct to general anaesthesia to facilitate endotracheal intubation, to provide skeletal muscle relaxation during surgery and to facilitate mechanical ventilation. Restricted to patients with lung problem such as asthma.","Administered as bolus intravenous injection. May be administered as infusion in ICU patients at a rate of 3mcg/kg/min. 
Adult dose: a) Induction: 0.15mg/kg over 5-10 secs, b) Maintenance: 0.03 mg/kg. 
Children 2-12 years: a) Induction: 0.1 mg/kg over 5-10 secs, b) Maintenance: 0.02 mg/kg",A*,,,Fresenius,17.70,/,vial,A*
M03,Clostridium Botulinum Toxin Type A Powder for Injection 100 units,"i) Focal dystonias
ii) Hemifacial spasm
iii) Spasticity including cerebral palsy
iv) Neurogenic bladder","20 - 200 units 3 months once

HSM Practice: average 300 units every 4 months",A*,Perubatan,Kuota,"Allergan 
Botox",1048.50,/,vial,
M03,Eperisone HCl 50 mg Tablet,"Myotonic symptoms associated with cervical syndrome, periarthritis of shoulder and lumbago spastic paralysis",50 mg 3 times daily,A,,,Myonal,0.72,/,tab,A
M03,Orphenadrine Citrate 60mg/2ml Injection ,"Painful muscle spasm, extrapyramidal side effects associated with antipsychotics",Adult: 60mg IM/IV. May be repeated in 12 hours.,Not in FUKKM,Psikiatrik,Import Permit required for purchase (UKK),Norflex,27.90,/,vial ,-
M03,Rocuronium Bromide 10 mg/ml Injection,"As an adjunct to general anaesthesia to facilitate endotracheal intubation, to provide skeletal muscle relaxation during surgery and to facilitate mechanical ventilation in adults, children and infants from one month of age.","Adult: Initially, 600 mcg/kg by inj. Higher doses of 1 mg/kg may be used for intubation during rapid sequence induction of anaesthesia. Maintenance: 150 mcg/kg by inj (may reduce to 75-100 mcg/kg if inhalational anaesthesia is used) or by infusion at a rate of 300-600 mcg/kg/hr. Doses should be based on lean body weight for obese patients weighing >30% above the ideal body weight. 
Child: Infants and children >1 mth: Initially, 600 mcg/kg by inj. Maintenance: 150 mcg/kg by inj or by infusion at a rate of 300-600 mcg/kg/hr, maintenance doses may be required more frequently than in adult patients. 
Elderly: Reduced maintenance doses: 75-100 mcg/kg. 
Renal impairment: Initially, 600 mcg/kg by inj. Maintenance: 75-100 mcg/kg. 
Hepatic impairment: or biliary tract disease: Initially, 600 mcg/kg by inj. Maintenance: 75-100 mcg/kg.",A*,,,Rocuronium Kabi ,5.47,/,amp,A*
M03,Suxamethonium Chloride 50 mg/ml lnj,Muscle relaxant as an adjunct to anaesthesia,"Intravenous: Muscle relaxant in general anaesthesia 
Adult: As chloride: single dose of 0.3-1.1 mg/kg injected; supplementary doses of 50-100% of the initial dose may be given at 5-10 min intervals. Max dose (repeated IV injection or continuous infusion): 500 mg/hr 
Child: As chloride: <1 yr: 2 mg/kg; 1-12 yr: 1 mg/kg. 
Intramuscular: Muscle relaxant in general anaesthesia 
Adult: As chloride: 3-4 mg/kg. Max total dose: 150 mg 
Child: As chloride: <1 yr: Up to 4-5 mg/kg; =1 yr: Up to 4 mg/kg. Max dose: 150 mg.",B,,,Suxamethonium,3.42,/,amp,B
M03,Vecuronium Bromide 4 mg/ml Injection,As an adjunct in anaesthesia to produce skeletal muscle relaxation,"ADULT & NEONATES > 5 MONTHS Initial: 80-100 mcg/kg as inj. Maintenance: 20-30 mcg/kg, adjust according to response. Alternatively, as continuous infusion at 0.8-1.4 mcg/kg/min after initial IV dose of 40-100 mcg/kg. 
NEONATE and INFANT up to 4 months: Initially 10 - 20 mcg/kg, then incremental dose to achieve response.",A*,,,Norcuron,5.80,/,amp,A*
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.12 CHOLINERGICS",,,,,,,,,,,
N07,Neostigmine Methylsulphate 2.5 mg/ml Injection,"i) Myasthenia gravis 
ii) Reversal of non-depolarising neuromuscular blockade","i) ADULT: 1 - 2.5 mg at suitable intervals by SC, IM or IV. Usual total daily dose 5 - 20 mg. 
CHILD: 200 - 500 mcg at suitable intervals throughout the day. 
NEONATE: 50 - 250 mcg every 4 hours 
ii) By IV injection over 1 minute, 50 - 70 mcg/kg (maximum 5 mg) after or with atropine sulphate 0.6 - 1.2 mg",B,,,Setisin,1.02,/,amp,B
N07,Pyridostigmine Bromide 60 mg Tablet,Myasthenia gravis,"ADULT: 30 - 120 mg at suitable intervals throughout the day, total daily dose 0.3 - 1.2 g. 
CHILD up to 6 years: Initially 30 mg
6 - 12 years: Initially 60mg, usual total daily dose 30-360 mg",B,,,Mestinon,0.36,/,tab,B
,,,,,,,,,,,
"5.0 NEUROMUSCULAR SYSTEM
5.13 ANTIDEMENTIA",,,,,,,,,,,
N06,"Donepezil HCl 5 mg,10 mg Tablet","Treatment of mild, moderate and severe dementia in Alzheimer's disease. 
Restriction:
Psychiatrists, Neurologists, Geriatricians, Family Medicine Specialists trained in Mental Health Disorders",5 - 10 mg once daily at bedtime. Maximum: 10 mg daily,A/KK,"Psikiatrik, Geriatrik",,Alzer,"0.16, 
0.26",/,tab,A
N06,"Donepezil Orodispersible 5 mg, 10 mg Tablet","Treatment of mild to moderate dementia in Alzheimer's disease, as well as in patients with severe Alzheimer's disease. [psychiatrists and neurologists only]","Initiated at 5mg/day (one a day dosing), should be maintained for at least 1 month in order to allow the earliest clinical responses and to allow steady state concentration to be achieved. The maximum recommended daily dose is 10 mg.",A*,,,"Torpezil, Aricept Evess","3.93, 
5.75",/,tab,A*
N06,Rivastigmine 3 mg Capsule,For psychiatrists and neurologists only. Mild to moderately severe dementia associated with Alzheimer's or Parkinson's disease,"Initial dose : 1.5 mg 2 times daily, may increase by 1.5 mg 2 times daily every 2 weeks to maximum of 6 mg 2 times daily. 
If treatment is interrupted for several days, should be reinitiated at the lowest daily dose",A*,"Perubatan, Psikiatrik, Geriatrik",,Rivadem,1.25,/,tab,A*
N06,"Rivastigmine 4.6 mg/24 hr, 9.5 mg/24 hr  Transdermal Patch                                                                                 ",Mild to moderately severe dementia associated with Alzheimer's or Parkinson's disease,"Initial, 4.6 mg/24 hr patch TOPICALLY once daily; after a minimum of 4 weeks and good tolerability, increase the dose to 9.5 mg/24 hr patch once daily",A*,"Psikiatrik, Geriatrik",Kuota,Rivamensa,6.56,/,patch,A*
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.1 AMINOGLYCOSIDES",,,,,,,,,,,
J01,Amikacin 250 mg/2 ml Injection,Infections due to susceptible organisms,"ADULT: (IM or IV): 15 mg/kg/day 8 - 12 hourly for 7 - 10 days. Maximum: 1.5 g/day. 
CHILD: 15 mg/kg/day 8 - 12 hourly. Maximum: 1.5 g/day. 
Neonates: Initial loading dose of 10 mg/kg followed by 7.5 mg/kg/day 12 hourly. 
Maximum 15mg/kg/day",A,,,Apalin ,4.64,/,vial,A
J01,Gentamicin 7.5 mg Beads,"Treatment of chronic osteomyelitis of post-traumatic, post-operative or hematogenous origin",7.5 - 22.5 mg chains to fill affected cavity,A,,,Septopal,1253.00,/,30 beads,A
J01,Gentamicin Sulphate 80 mg/2 ml Injection,Infections due to susceptible organisms,"ADULT: 3 - 5 mg/kg/day 8 hourly IM or IV. 
CHILD up to 2 weeks: 3mg/kg every 12 hours; 
2 weeks - 12 years: 2 mg/kg 8 hourly",B,,,Garasent,0.80,/,vial,B
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.2 CEPHALOSPORINS",,,,,,,,,,,
J01,Cefazolin Sodium 1 g Injection,"Infection caused by cefazolin-sensitive microorganism, infection of the respiratory tract, urogenital tract, skin and soft tissue, bile duct, bones and joint, endocarditis, systemic septic infection, peri-operative/ surgical prophylaxis","ADULT: Uncomplicated infections: 500 - 1000 mg 2 - 3 times daily. 
Moderately severe and severe infections: 500 - 1000 mg 3 - 4 times daily. 
Severe life-threatening infections: 1 - 1.5 g 4 times daily. 
Rarely, dose up to 12 g daily. 
CHILDREN >1 month: 25-50mg/kg/day in 3-4 divided dose",A,,,AFT,6.90,/,vial,A
J01,Cefepime 1 g Injection,"Febrile neutropenia, septicaemia, lower respiratory tract infection, urinary tract infection, skin and skin structure infections, gynaecologic and intra-abdominal infections","ADULT: 1 - 2 g twice daily for most infections. 
For severe infections including febrile neutropenia: 2 g 3 times daily. 
CHILD:2 mth - 16 yr:  ≤40 kg: 50 mg/kg every 8-12 hr for 7-10 days",A*,,,Vaxcel,6.20,/,vial,A*
J01,Cefoperazone Sodium 1 g Injection,Infections due to gram-negative bacteria,"ADULT: 1 - 2 g twice daily IM or IV. By IV, adult dose may be doubled. Maximum: 16 g daily in divided doses. 
CHILD & INFANT: 50 - 200 mg/kg/day in 2 - 4 divided doses. 
NEONATE less than 8 days: 50 - 200 mg/kg/day 12 hourly",A,,,"Cefobid , Bicafar ",5.48,/,vial,A
J01,Cefoperazone Sodium 500 mg & Sulbactam Sodium 500 mg Injection,"i) Treatment of infections due to multi-drug resistance pathogens producing B-lactamase 
ii) Treatment of infections caused by Acinetobacter species","ADULT: 1 - 2 g twice daily. In severe or refractory infections the daily dosage of sulbactam/cefoperazone may be increased up to 8g (4g cefopreazone activity) 
CHILD: 40 - 80 mg/kg/day in 2 to 4 equally divided doses; in serious or refractory infections, may increase to 160mg/kg/d in 2 - 4 equally divided doses.",A,,,CEFOBACTAM,5.52,/,vial,A
J01,"Cefotaxime 0.5 g, 1 g Injection",Infections due to gram-negative bacteria,"ADULT: 1 g 12 hourly (up to 12 g/day in severe cases). 
CHILD: 50 - 180 mg/kg/day in 4 - 6 divided doses",A,,,Rekaxime,"7.66, 8.47",/,vial,A
J01,Ceftazidime 2 g Injection,Severe gram negative bacterial infections,ADULT: 1 g 8 hourly or 2 g 12 hourly. In severe infections: 2 g 8 hourly. CHILD: 25 - 150 mg/kg/day in 2 - 3 divided doses,A,,,"Fortum, Cefatum ",12.06,/,vial,A
J01,Ceftazidime 2g & Avibactam 0.5g Injection,"i. Complicated intra-abdominal infection, in combination with metronidazole;
ii. Complicated urinary tract infection, including pyelonephritis;
iii. Hospital-acquired pneumonia, including ventilator-associated pneumonia.

Prescribing Restrictions:
i. To be restricted to carbapenem-resistant Enterobacteriaceae (CRE) as an alternative to polymyxin.
ii. Treatment initiated after proven susceptibility to ceftazidime/avibactam via C&S testing.
iii. To be prescribed by Infectious Disease Specialist only",Ceftazidime 2g / Avibactam 0.5g vial three times daily by intravenous infusion over 2 hours in patients 18 years or older for 5 to 14 days,A,,,Zavicefta,215.50,/,vial,
J01,Ceftriaxone 1g Injection,Infections caused by susceptible organisms,"ADULT: 1 - 2 g once daily. Severe infection: 4 g daily at 12 hour intervals. 
INFANT & CHILD, 3 weeks - 12 years: 20 - 80 mg/kg body weight daily. 
CHILD with body weight 50 kg or more: adult dose. 
NEONATE up to 2 weeks: 20 - 50 mg/kg body weight daily, not to exceed 50 mg/kg",A,,,UNOCEF,10.90,/,vial,A
J01,"Cefuroxime Axetil 
125 mg/5 ml Suspension",Infections caused by susceptible organisms,"30 mg/kg/day in 2 divided doses, up to 500 mg daily.",A,,,Zinnat,15.19,/,bot,A
J01,Cefuroxime Axetil 125 mg Tablet,"Upper and lower respiratory tract, genito-urinary tract, skin & soft tissue and urinary tract infections (UTI)","ADULT:
Most infections: 250 mg twice daily
Severe infections: 500mg twice daily

CHILD:
Most infections: 125mg twice daily or 30 mg/kg/day in 2 divided doses, up to 500 mg daily
Severe infections: 250mg twice daily

Dosing is individualised and according to package insert",A/KK,,,Auroxetil,0.50,/,tab,A/KK
J01,Cefuroxime Sodium 750 mg Injection,"Infections caused by susceptible organisms, surgical prophylaxis","ADULT: 750 mg every 6 - 8 hours as IM or IV. Severe infections: 1.5 g every 6 - 8 hours as IV. 
CHILD: 30 - 100 mg/kg/day in 3 - 4 divided doses or 2-3 divided doses in neonates. 
Surgical prophylaxis: 1.5 g IV",A,,,Anikef,7.42,/,amp,A
J01,Cephalexin Monohydrate 250 mg Capsule,"i) Respiratory tract infection, urinary tract infection 
ii) Complicated, recurrent or chronic infections, bronchitis 
iii) Pneumonia","i) 250 mg 6 hourly 
ii) 250 - 500 mg 6 hourly 
iii) 1 - 1.5 g 3 times daily or 4 times daily. Maximum: 6 g/day 
Child: 25-100 mg/kg daily in divided doses. Max: 4 g daily.",B,,,Cephalexin,0.19,/,cap,B
J01,Cephalexin Monohydrate 125 mg/5 ml Syrup,"Respiratory tract infections, ear, nose and throat infections, urinary tract infections, obstetric and gynaecologic infections",CHILD: 25 - 100 mg/kg/day every 6 hourly. Maximum: 4 g daily,B,,,Dynalexin,2.07,/,bot,B
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.3 MACROLIDES",,,,,,,,,,,
J01,Azithromycin 200 mg/5 ml Granules,"PRESCRIBER CATEGORY A*: Treatment of complicated respiratory tract infections. 
PRESCRIBER CATEGORY A/K: Treatment of pertussis","CHILD: 36 - 45 kg: 400 mg, 
26 - 35 kg: 300mg, 
15 - 25 kg: 200 mg,
 less than 15 kg: 10 mg/kg. 
To be taken daily for 3 days or to be taken as a single dose on day 1, then half the daily dose on days 2 - 5",A*,Pediatrik,,"Binozyt, Imexa","6.80, 15.7",/,bot,A*
J01,Azithromycin 500 mg Injection,Only for treatment of severe atypical pneumonia,500 mg IV as a single daily dose for a minimum of two days followed by 500 mg oral dose as a single daily dose to complete a 7 - 10 days course,A*,,,Vaxcel,18.24,/,vial,A*
J01,Azithromycin 250 mg Tablet,"Category of prescriber A/KK is only approved for indications: 
(i) Adult treatment of uncomplicated genital infections due to Chlamydia trichomatis or susceptible Neisseria gonorrhoea. 
(ii) Treatment of pertussis 
The following indications are still under the category of prescriber A*: 
(iii) Treatment of complicated respiratory tract infections; 
(iv) Prophylaxis against Mycobacterium avium complex in patients with advanced HIV.","i) 1 g as a single dose; 
ii) 500mg in a single dose on day 1 then 250mg per day on days 2-5 
iii) 500 mg daily for 3 days
iv) 1 g weekly",A*,Perubatan,,Ziomycin,0.48,/,tab,A*
J01,Clarithromycin 250 mg Tablet,"Only for i) treatment of complicated respiratory tract infection not responding to standard macrolides 
ii) eradication of Helicobacter pylori infection","i) 250 - 500 mg twice daily. Up to 6 - 14 days 
ii) 500 mg twice daily with omeprazole & amoxicillin. Up to 2 weeks",A*,"Perubatan, Pembedahan, Endoskopi",,Claritrox - 250 ,0.67,/,tab,A*
J01,Clindamycin HCl 300 mg Capsule,"i) Skin and soft tissue infections, bone& joint infections 
ii) Cerebral toxoplasmosis 
iii) Children less than 8 years old:Treatment and prophylaxis of malaria in combination with quinine, as an alternative to doxycline","i) ADULT: 150 - 300 mg every 6 hours; up to 450 mg every 6 hours in severe infections; Max: 1.8g/day 
CHILD: 3 - 6 mg/kg every 6 hours. Children weighing <10 kg should receive at least 37.5 mg every 8 hr. 
ii) 600 mg 6 hourly for 6 weeks 
iii) 10mg/kg twice a day, in combination with quinine. The combination to be given for 7 days",A*,"Perubatan, pembedahan, ortopedik",,Tidact,0.78,/,cap,A*
J01,Clindamycin Phosphate 150mg/ml Injection,"i) Skin and soft tissue infections, bone & joint infections
ii) Cerebral toxoplasmosis","i) ADULT: 0.6 - 2.7 g daily (in 2 - 4 divided doses); up to 4.8 g daily; CHILD over 1 month, 20 - 40 mg/kg/day or 350 mg/m2/day in 3 - 4 divided doses
ii) 1200 mg every 6 hours for 3 weeks followed by 300 mg orally every 6 hours for another 3 weeks",A*,,,Tidact,15.96,/,amp,
J01,Erythromycin Ethylsuccinate 200 mg/5 ml Suspension,Treatment of susceptible bacterial infections,"Child: 30-50 mg/kg daily, increased to twice the usual dose in severe cases. 
2-8 yr: 1 g daily in divided doses; 
<2 yr: 500 mg daily in divided doses.",B,,,"Ericin, Ettrocin",6.96,/,bot,B
J01,Erythromycin Ethylsuccinate 400 mg Tablet,Treatment of susceptible bacterial infections,"Adult: 400 mg 6 hrly or 800 mg 12 hrly. Max: 4 g/day. 
Childn : 30-50 mg/kg in divided doses. 
Childn 2-8 yr: 1 g/day in divided doses in severe cases. 
Infant & childn ≤2 yr : 500 mg/day in divided doses.",B,,,Axcel,0.38,/,tab,B
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.4 PENICILLINS",,,,,,,,,,,
J01,Amoxicillin 250 mg Capsule,Infections caused by susceptible strains of gram positive and gram negative organisms,"ADULT: 250 - 500 mg 3 times daily. 
CHILD: 20 - 40 mg/kg/day in divided doses 8 hourly",B,,,Betamox,0.24,/,cap,B
J01,Amoxicillin Trihydrate 125 mg/5 ml Syrup,Infections caused by susceptible strains of gram positive and gram negative organisms,"CHILD less than 10 years: 125 - 250 mg 8 hourly. 
CHILD less than 20 kg: 20 - 40 mg/kg/day in 3 - 4 divided doses",B,,,Dyna,1.55,/,bot,B
J01,Amoxicillin 1 g & Clavulanate 200 mg Injection,"Infections caused by susceptible organisms. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection & osteomyelitis","CHILD less than 3 months: 30mg/kg 12 hourly. 
3 months - 12 years: 30mg/kg 6 - 8 hourly. 
ADULT: 1.2 g by IV or intermittent infusion 6 - 8 hourly",A,,,Clavixin ,5.66,/,vial,A
J01,Amoxicillin & Clavulanate 228 mg/5 ml Syrup,Infections caused by susceptible organisms,"Mild to Moderate infection: 25mg/kg/day (based on Amoxicillin dose) in 2 divided dose. 
Severe infection: 45mg/kg/day (based on Amoxicillin dose) in 2 divided dose",A/KK,,,Fleming,8.00,/,bot,A/KK
J01,Amoxicillin 500 mg & Clavulanate 125 mg Tablet,"Infections due to beta-lactamase producing strain where amoxicillin alone is not appropriate. Respiratory tract, skin, soft tissue, GUT infection, septicaemia, peritonitis, post-operative infection & osteomyelitis","ADULT & CHILD more than 12 years: 
Mild to moderate infections: 625 mg twice daily.",A/KK,,,CO-AMOXICLAV,3.75,/,tab,A/KK
J01,Ampicillin Sodium 500 mg Injection,Treatment of susceptible bacterial infections (non beta-lactamase-producing organisms); meningitis,"250 - 500 mg IM/IV every 4 - 6 hours. Maximum: 400 mg/kg/day. 
Meningitis: 2 g 6 hourly. 
CHILD: 150 mg/kg/daily IV in divided doses. 
Usual children dose less than 10 years, half adult dose",B,,,Kampibiotic 500,2.03,/,vial,B
J01,Ampicillin Sodium 1g & Sulbactam Sodium 500mg Injection,Treatment of susceptible bacterial infections,"ADULT: 1.5 - 12 g/day in divided doses 6 - 8 hourly. Maximum: 4 g Sulbactam. 
CHILD: 150-300 mg/kg/day 6 - 8 hourly. Prophylaxis of surgical infections: 1.5 - 3 g at induction of anaesthesia. May be repeated 6 - 8 hourly. 
NEONATES: First week of life, 75mg/kg/day in divided doses every 12 hour",A,,,Amsubac,3.78,/,vial,A
J01,Ampicillin Sodium & Sulbactam Sodium 375 mg Tablet,Treatment of susceptible bacterial infections,"ADULT: 375-750mg twice daily 
CHILDREN AND INFANTS: 25-50mg/kg/day in 2 divided doses, 
if ≥ 30kg use an adult dose",A/KK,,,Unasyn,1.84,/,tab,A/KK
J01,Benzathine Penicillin 2.4 mega units Injection,"i) Treatment of mild to moderately severe infections due to Penicillin G-sensitive organisms 
ii) Treatment of syphillis","i) ADULT: 1.2 mega units IM 
ii) For syphillis: 2.4 mega units weekly for 1 - 3 weeks",B,,,Benzapen,8.70,/,vial,B
J01,Benzylpenicillin 1 mega unit (600 mg)  Injection,"i) Infections caused by susceptible organisms 
ii) Infective endocarditis","i) Adult: 600mg - 3600mg (1 - 6 mega units) daily, divided into 4 to 6 doses. 
Higher doses (24 mega units) in divided doses may be given in serious infections such as meningitis. 
Child 1 month to 12 years old: 100mg/kg/day in 4 divided doses, 
not exceeding 4g/day; 
Infants 1 -4 weeks: 75mg/kg/day in 3 divided doses
Newborn Infants: 50mg/kg/day in 2 divided doses 
ii)7.2 to 12g (12 - 20 mega units) maybe given daily in divided doses",B,,,Bepen ,"3.25, 4.87",/,vial,B
,Benzylpenicillin 5 mega unit (3 g) Injection,"i) Infections caused by susceptible organisms 
ii) Infective endocarditis","i) ADULT: 600 - 1200 mg IM 4 times daily, increased if necessary in more serious infections. 
CHILD: 50 - 100 mg/kg body weight daily IV in 2 - 4 divided doses 
ii) ADULT: 7.2 g daily by slow IV infusion in 6 divided doses",,,,,,,,
J01,Cloxacillin Sodium 250 mg Capsule,"Treatment of susceptible bacterial infections, notably penicillinase-producing staphylococci","ADULT: 250 - 500 mg every 6 hours. 
Child: 50-100 mg/kg in divided doses every 6 hr.",B,,,Cloxacilla,0.37,/,cap,B
J01,"Cloxacillin Sodium 250mg, 500 mg Injection","Treatment of susceptible bacterial infections, notably penicillinase-producing staphylococci infections",ADULT: 250 to 500 mg every 6 hours depending on type and severity of infection. CHILD less than 20 kg: 25 to 50 mg/kg/day in equally divided doses every 6 hours,B,,,"Monoclox 250mg
Cloxabiotic 500mg","2.93

1.56",/,vial,B
J01,Cloxacillin Sodium 125 mg/5 ml Suspension,"Treatment of susceptible bacterial infections, notably penicillinase-producing staphylococci",Child: 50-100 mg/kg in divided doses every 6 hr,B,,,Cloxacilla ,11.95,/,bot,B
J01,Phenoxymethyl Penicillin 125 mg/5 ml Syrup,Treatment or prophylaxis of infections caused by susceptible organisms,"CHILD: Up to 1 year: 62.5 mg 6 hourly; 
1 - 5 years: 125 mg 6 hourly; 
6 - 12 years: 250 mg 6 hourly",C,,,Beapen VK,3.00,/,bot,C
J01,Phenoxymethyl Penicillin 125 mg Tablet,"i) Treatment or prophylaxis of infections caused by susceptible organisms 
ii) Prophylactic, rheumatic fever","i) ADULT: 500 - 750 mg 6 hourly.
CHILD; up to 1 year: 62.5 mg, 
1 - 5 years: 125 mg, 
6 - 12 years: 250 mg 6 hourly 
ii) ADULT: 125 - 250 mg twice daily. 
CHILD: 25 - 50 mg/kg in divided doses every 6 - 8 hours. Maximum: 3 g/day",C,,,Penicillin V,0.53,/,tab,C
J01,Piperacillin 4 g & Tazobactam 500 mg Injection,"Febrile neutropenia, lower respiratory tract infection and severe sepsis","Adult and children more than 12 years: 4.5g 6 hourly, 
for neutropenia adult and children more than 50kg: 4.5g 6 hourly. 
Children less than 50kg: 90mg/kg 6 hourly",A*,,,AUROTAZ-P,8.50,/,vial,A*
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.5 TETRACYCLINE",,,,,,,,,,,
J01,Doxycycline 100 mg Capsule,Prophylaxis and treatment for infections due to susceptible organisms.,"Prophylaxis
100-200mg daily or weekly

Treatment
100-300mg daily

Dosing is individualised based on type of infections and according to product insert/protocol",B,,,Pharmaniaga Doxycycline,0.25,/,cap,B
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.6 SULPHONAMIDES",,,,,,,,,,,
J01,Sulphamethoxazole 400 mg & Trimethoprim 80 mg Injection,"i) Severe or complicated infections when oral therapy is not feasible 
ii) Treatment and prophylaxis of pneumocystis carinii pneumonia (PCP) in immunocompromised patients","i) ADULT: 960 mg twice daily increased to 1.44 g twice daily in severe infections. CHILD: 36 mg/kg daily in 2 divided doses increased to 54 mg/kg/day in severe infections 
ii) Treatment: ADULT & CHILD over 4 weeks: 120 mg/kg/day PO/IV infusion in 2 - 4 divided doses for 14 days. 
Prophylaxis: ADULT: 960 mg once daily or 960 mg on alternate days (3 times a week) or 960 mg twice daily on alternate days (3 times a week). 
CHILD 6 weeks - 5 months: 120 mg twice daily on 3 consecutive days or 7 days per week; 6 months - 5 years: 240 mg; 6 - 12 years: 480 mg",A,Perubatan,,Bactrim,5.73,/,amp,
J01,Sulphamethoxazole 200 mg & Trimethoprim 40 mg/5ml Suspension,Infections caused by susceptible pathogens,"Mild to moderate infections: more than 2months: 8 - 12mg Trimethoprim/kg/day divided every 12hours. 
Serious Infections: 15-20mg Trimethoprim/kg/day divided every 6hours.",B,,,Dynaprim,2.40,/,bot,
J01,Sulphamethoxazole 400 mg & Trimethoprim 80 mg Tablet,"i) Severe or complicated infections due to susceptible infection 
ii) Treatment and prophylaxis of pneumocystis carinii pneumonia (PCP) in immunocompromised patients","i) ADULT: 1 - 3 tablets twice daily 
ii) Treatment: ADULT & CHILD over 4 weeks: 120 mg/kg/day in 2 - 4 divided doses for 14 days. 
Prophylaxis: ADULT: 960 mg once daily or 960 mg on alternate days (3 times a week) or 960 mg twice daily on alternate days (3 times a week). 
CHILD; 6 weeks - 5 months: 120 mg twice daily on 3 consecutive days or 7 days per week; 6 months - 5 years: 240 mg; 6 - 12 years: 480 mg",B,,,Co-trimoxazole,0.12,/,tab,
,,,,,,,,,,,
"6.0 ANTIBIOTICS
6.7 OTHERS",,,,,,,,,,,
J01,Ciprofloxacin 200 mg/100 ml Injection,Treatment of infections due to susceptible bacterial strains,"Suggest to rephrase ADULT: the dosage range is 100mg-400mg twice daily Gonorrhoea: 100mg single dose 
Upper and Lower Urinary Tract Infection: 100mg BD 
Upper and Lower Respiratory Tract Infection: 200mg-400mg twice daily 
Cystic Fibrosis with psuedomonal Lower RTI: 400mg BD 
Others: 200-400mg BD
Inhalation Anthrax: 400mg BD",A,,,Ciproxol,5.50,/,vial,A
J01,Ciprofloxacin 250 mg Tablet,Treatment of infections due to susceptible bacterial strains,"ADULT: 125-750 mg twice daily. 
Acute gonorrhoea: a single dose of 250 mg",A,,,C-FLOX,0.13,/,tab,A
J01,Colistimethate 1 Million IU Injection (Polymyxin E),"Intravenous administration for the treatment of serious infections caused by Gram negative bacteria, when more commonly used systemic antibacterial agents may be contraindicated or may be ineffective because of bacterial resistance.","A minimum of 5 days treatment is generally recommended. 
For the treatment of respiratory exacerbations in cystic fibrosis patients, treatment should be continued up to 12 days. 
Children and adults (including elderly): Up to 60kg: 50,000 units/kg/day to a maximum of 75,000 units/kg/day. The total daily dose should be divided into three doses given at approximately 8-hour intervals. 
Over 60kg: 1-2 million units three times a day. The maximum dose is 6 million units in 24 hours. ",A*,,,Colomycin ,38.40,/,vial,
,,,"Renal impairment: In moderate to severe renal impairment, excretion of colistimethate sodium is delayed. Therefore, the dose and dose interval should be adjusted in order to prevent accumulation. 
Suggested Dosage Adjustment in Renal Impairment 
(for over 60 kg body weight): 
- Mild (CrCl 20-50 ml/min): 1-2 million units every 8 hr. 
- Moderate (CrCl 10-20 ml/min): 1 million units every 12-18 hr. 
- Severe (CrCl <10 ml/min): 1 million units every 18-24 hr.",,,,,,,,A*
J01,Ertapenem 1 g Injection,"i) Patient with confirm ESBL producing gram-negative infection. 
ii) Empiric treatment for severe community acquired pneumonia or other infections when Pseudomonas aeruginosa is not suspected.","ADULT: 1 g once daily. 
CHILD 3 month to 12 years: 15 mg/kg twice daily. 
Not to exceed 1 g/ day",A*,,,Invanz,113.05,/,vial,A*
J01,"Fusidate, Sodium 250 mg Tablet",Treatment of infections caused by susceptible organisms especially Staphylococcal infections including Methicillin Resistant Staphylococcus aureus (MRSA),"ADULT: 500 mg 3 times daily, 
skin and soft tissue infection: 250 - 500 mg twice daily",A*,Ortopedik,,Fucidin,0.94,/,tab,A*
J01,Imipenem 500 mg and Cilastatin 500 mg Injection,Severe infections caused by susceptible pathogens especially useful in infections involving ESBL organisms. Not to be used for prophylaxis.,"Based on type or severity of infection, susceptibility of pathogen(s) and patient condition including body weight and renal function. 

ADULT: 1 - 2 g/day in 3 - 4 divided doses. Maximum: 4 g/day or 50 mg/kg/day. Infusion rate: less than 500 mg dose: over 20 - 30 minutes, more than 500 mg: dose over 40 - 60 minutes. 
CHILDREN: ≥ 40kg body weight should receive adult doses. 
CHILDREN AND INFANTS: <40kg body weight should receive 15mg/kg at six hour intervals. The total daily dose should not exceed 2g.",A*,,,Imipenem / Cilastin Kabi,16.24,/,vial,A*
J01,Levofloxacin 500mg tablet,Community acquired pneumonia,500 mg daily for 7 - 14 days,A*,Perubatan,,Glevo,1.05,/,tab,A*
J01,Linezolid 2 mg/ml Injection,MRSA patient with severe sepsis requiring intensive care and not clinically responding to vancomycin,"ADULT: 600 mg twice daily for 10 - 14 days. 
CHILD: 10 mg/kg 3 times daily. 
PREMATURE NEONATES less than 7 days: 10 mg/kg twice daily",A*,,,Zyvox,150.00,/,bag,A*
J01,Linezolid 600 mg Tablet,MRSA patient with severe sepsis requiring intensive care and not clinically responding to vancomycin.,"ADULT: Above 12 years : 600 mg every 12 hours for 10-14 days. 
CHILD :10 mg/kg 3 times daily. 
PREMATURE NEONATES less than 7 days: 10 mg/kg twice daily",A*,,,Zyvox,130.15,/,tab,A*
J01,Linezolid 600mg tablet,MRSA patient with severe sepsis requiring intensive care and not clinically responding to vancomycin.,ADULT: Above 12 years 600 mg every 12 hours for 10-14 days. CHILD :10 mg/kg 3 times daily. PREMATURE NEONATES less than 7 days: 10 mg/kg twice daily,A*,Perubatan,,Zyvox,28.98,/,tab,
J01,Meropenem 1 g Injection,"i. Emperical treatment for presume infections in patients (adult and children) with febrile neutropenia, used as monotherapy or in combination with anti-virals or antifungal agent 
ii. Septicaemia 
iii. Serious infections in renal impaired patients","ADULT: 0.5g - 1g 8 hourly 
CHILD: (aged 3 months and over): 10-40mg/kg 8 hourly, 
if body weight over 50kg, adult dosage should be used",A*,,,KABI,12.80,/,tab,A*
J01,Metronidazole 500 mg/100 ml Injection,Anaerobic infections,"ADULT: 500 mg IV infusion 8 hourly. 
CHILD: 7.5 mg/kg body weight every 8 hours. 
Neonates: 15mg/kg LD, followed by 7.5mg/kg every 12 hourly. 
1 month to 18 years: 7.5mg/kg (maximum 500mg) every 8 hours.",A,,,Metronol,2.31,/,bot,A
J01,Metronidazole 200 mg Tablet,Anaerobic infection,"Anaerobic bacterial infections 
Adult: Initially, 800 mg followed by 400 mg 8 hly for about 7 days. 
Other recommended doses: 500 mg 8 hrly or 7.5 mg/kg 6 hrly (max: 4 g in 24 hr). 
Child: 7.5 mg/kg 8 hrly. 
Elderly: Use lower end of adult dose recommendations. Do not admin as a single dose. 
Prophylaxis of postoperative anaerobic bacterial infections 
Adult: 400 mg by mouth 8 hrly in the 24 hr prior to surgery followed postoperatively by IV or rectal admin until oral therapy is possible. Other sources recommend that oral doses be initiated only 2 hr prior to surgery and that number of doses for all admin routes be limited to a total of 4. 
Elderly: Dose reduction may be necessary. 
Tab: Should be taken with food.",B,,,"Metronidazole, Metrogyl",0.10,/,tab,B
J01,Ofloxacin 100 mg Tablet,"i) As second-line treatment of leprosy 
ii) As second-line treatment for tuberculosis and multidrug resistant tuberculosis (MDR-TB) 
iii) Sequential therapy for UTI and pyelonephritis","i) 400 mg/day 
ii) 400 mg twice daily 
iii) 200 mg twice daily",A,"Perubatan, ENT",,Oflicin ,0.30,/,tab,A
J01,"Polymyxin B Sulphate 500,000 units Injection","i. Acute infections caused by susceptible strains of Pseudomonas Aeruginosa.
• Treatment of infections of the meninges and blood stream, caused by susceptible strains of Pseudomonas Aeruginosa.

ii. Indicated in serious infections caused by susceptible strains of the following organisms, when less potentially toxic drugs are ineffective or contraindicated:
• H. influenzae, specifically meningeal infections.
• Aerobacter aerogenes, specifically bacteremia.
• Klebsiella pneumoniae, specifically bacteremia.

Prescribing Restrictions:
• Use as targeted therapy. As 2nd line for empirical therapy.
• To be prescribed by Infectious Disease, General Medicine & ICU specialist only","Loading dose: 25,000 units/kg/dose.
(Maximum dose: 2,000,000 units / 2MU).

Maintenance dose: 15,000 units/kg every 12 hours.
(Maximum dose per day: 2,000,000 units / 2MU).",A*,,,Poly-Mxb,59.75,/,vial,
J01,Vancomycin HCl 500 mg Injection,Only for the treatment of MRSA and CAPD peritonitis,"Slow IV infusion, ADULT: 500 mg over at least 60 minutes every 6 hours or 1 g over at least 100 minutes every 12 hours. 
NEONATE up to 1 week: 15 mg/kg initially, then 10 mg/kg every 12 hours. INFANT 1 - 4 weeks: 15 mg/kg initially then 10 mg/kg every 8 hours. 
CHILD over 1 month: 10 mg/kg every 6 hours",A*,,,Celovan,12.84,/,vial,A*
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.1 ANTIHELMINTICS",,,,,,,,,,,
P02,Albendazole 200 mg/5 ml Suspension,"i) Single or mixed infestations of intestinal parasites 
ii) Strongyloides infection","i)Child 12-24months: 200mg as a single dose 
ii) Adult & Child above 2 years: 400mg as a single dose for 3 consecutive days; Child 12 - 24months: 200mg as a single dose for 3 consecutive days",C+,,,Albendazole,5.45,/,bot,C+
P02,Albendazole 200 mg Tablet,"i) Single or mixed infestations of intestinal parasites 
ii) Strongyloides infection","i) Child 12-24months: 200mg as a single dose 
ii) Adult & Child above 2 years: 400mg as a single dose for 3 consecutive days; Child 12 - 24months: 200mg as a single dose for 3 consecutive days",C+,,,Champs D-Worms,0.58,/,tab,C+
P02,Levamisole 50mg Tablet,Steroid -sensitive Idiopathic Nephrotic Syndrome,Tablet Levamisole 50mg EOD,Not in FUKKM,Pediatrik,"Import Permit Required for purchase
(UKK)",Vitilex,1.49,/,tab ,-
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.2 ANTIFILARIALS",,,,,,,,,,,
ATC,NAMA GENERIK UBAT & KEKUATAN,INDIKASI,DOS,KATEGORI PRESKRIBER,JABATAN,CATATAN,BRAND NAME*,PRICE/UNIT (RM),,,CAT.
P02,Diethylcarbamazine Citrate 50 mg Tablet,"i) Bancrofti filariasis, onchocerciasis, loasis, creeping eruption 
ii) Ascariasis 
iii) Tropical eosinophilia","i) 1 mg/kg on the first day and increased gradually over 3 days to 6 mg/kg daily in divided doses. This dosage is maintained for 21 days. 
ii) 13 mg/kg once daily for 7 days. 
CHILD : 6 - 10 mg/kg 3 times daily for 7 days 
iii) 6 mg/kg/day in 3 divided doses for 21 days",B,,,DCMC-100,2.83,/,tab,B
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.3 ANTIFUNGALS (SYSTEMIC)",,,,,,,,,,,
J02,Amphotericin B 50 mg Injection,Systemic fungal infections,"ADULT: 0.25 mg/kg/day by IV infusion, gradually increase if tolerated to 1 mg/kg/day. 
Maximum in severe cases: 1.5 mg/kg daily or on alternate days. 
For neonates, lower doses are recommended",A,,,Amphotret,39.21,/,vial,A
J02,Anidulafungin 100mg Injection,"Treatment of invasive candidiasis, including candidemia in adults when intolerance or resistance to Amphotericin B or Fluconazole","Loading dose of 200 mg on day 1, then 100 mg once daily thereafter for at least 14 days after the last positive culture.",A*,Perubatan,,Eraxis,340.50,/,vial,
J02,Caspofungin Acetate 50mg injection,"i) Confirmed systemic fungal infection in patients who are refractory or intolerant to other fungal therapies

ii) For pediatric patient (12 month and older) for the following indications : 
a) Empirical therapy for presumed fungal infections in febrile, neutropenic patients b) Treatment of invasive candidiasis, including candidemia and the following Candida infections ; intra-abdominal abscesses, peritonitis and pleural space infections c) Treatment of esophageal candidiasis d) Treatment of invasive Aspergillosis in patients who are refractory to or intolerant of others therapy (eg : Amphotericin B)","70mg over 1 hour, then 50mg per day for 2 weeks",A*,Perubatan,,CANCIDAS,566.00,/,vial,
J02,Fluconazole 100 mg Capsule,"i) Oropharyngeal candidiasis, atrophic oral candidiasis associated with dentures, other candidal infections of mucosa 
ii) Tinea pedis, corporis, cruris, versicolor and dermal candidiasis 
iii) Invasive candidal & cryptococcal infections (including meningitis) 
iv) Prevention of relapse of cryptococcal meningitis in AIDS patients after completion of primary therapy 
v) Prevention of fungal infections in immunocompromised patients considered at risk as a consequence of HIV infections or neutropenia following cytotoxic chemotherapy, radiotherapy or bone marrow transplant","i) Oropharyngeal candidiasis: 50 - 100 mg daily for 7 - 14 days (Maximum 14 days) except in severely immunocompromised patients, treatment can be continued for longer periods. 
Atrophic oral candidiasis associated with dentures: 50 mg daily for 14 days. 
Other candidal infections of mucosa: 50 - 100 mg daily for 14 - 30 days. ",A,,,Pharmaniaga Fluconazole,4.76,/,cap,
,,,"CHILD: 3 - 6 mg/kg on first day then 3 mg/kg daily 
(every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 - 4 weeks old) 
ii) 50 mg daily for 2 - 4 weeks, maximum 6 weeks 
iii) 400 mg initially then 200 - 400 mg daily for 6 - 8 weeks. 
CHILD: 6 - 12 mg/kg daily (every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 -4 weeks old) 
iv) 100 - 200 mg daily
v) 50 - 400 mg daily. CHILD: 3 - 12 mg/kg daily (every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 - 4 weeks old)",,,,,,,,A
J02,Fluconazole 2 mg/ml Injection,"i) Oropharyngeal candidiasis, atrophic oral candidiasis associated with dentures, other candidal infections of mucosa ii) Tinea pedis, corporis, cruris, versicolor and dermal candidiasis iii) Invasive candidal& cryptococcal infections (including meningitis) iv) Prevention of relapse of cryptococcal meningitis in AIDS patients after completion of primary therapy v) Prevention of fungal infections in immunocompromised patients considered at risk as a consequence of HIV infections or neutropenia following cytotoxic chemotherapy, radiotherapy or bone marrow transplant","i) 50 - 100 mg daily for 7 - 14 days (Maximum 14 days) except in severely immunocompromised patients, treatment can be continued for longer periods. Atrophic oral candidiasis associated with dentures: 50 mg daily for 14 days. Other candidal infections of mucosa: 50 - 100 mg daily for 14 - 30 days. 
CHILD: 3 - 6 mg/kg on first day then 3 mg/kg daily (every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 - 4 weeks old) 
ii) 50 mg daily for 2 - 4 weeks, maximum 6 weeks 
iii) 400 mg initially then 200 - 400 mg daily for 6 - 8 weeks. ",A,,,Fluconol,6.84,/,vial,
,,,"CHILD: 6-12 mg/kg daily (every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 - 4 weeks old) 
iv) 100 - 200 mg daily 
v) 50 - 400 mg daily. CHILD: 3 - 12 mg/kg daily (every 72 hours in NEONATE up to 2 weeks old, every 48 hours in NEONATE 2 - 4 weeks old)",,,,,,,,A
J02,Flucytosine 500 mg Tablet,Only for the treatment of fungal meningitis,ADULT: 50 - 150 mg/kg/day in 4 divided doses,A*,Perubatan,"Import Permit required for purchase
(UKK)",Flusine,4.04,/,tab,
D01,Griseofulvin 125 mg Tablet,"Dermatophyte infections of the skin, scalp, hair and nails, where topical therapy has failed or inappropriate","(Ultramicrosize 125 mg = 250 mg Microsize) 
Adults: 500mg-1000mg daily, taken as a single dose or in divided;
Children: 10mg-20mg/kg daily in divided doses.

The dosing is individualized according to product insert / protocol",B,,,Medofulvin,0.12,/,tab,B
J02,Itraconazole 100 mg Capsule,"i) Dermatomycosis including pityriasis versicolor 
ii) Oral candidiasis 
iii) Palmar tinea manus and plantar tinea pedis 
iv) Fingernail onychomycosis 
v) Toenail onychomycosis 
vi) Vulvovaginal candidiasis","i) 200 mg once daily for 7 days 
ii) 100 mg daily for 15 days 
iii) 200 mg twice daily for 7 days 
iv) 200mg twice daily for 1 week per month for 2 months 
v) 200 mg twice daily for 1 week per month for 3 months 
vi)200 mg morning and evening for 1 day or 200 mg once daily for 3 days",A/KK,Perubatan,,Inox,0.65,/,cap,A/KK
A07,"Nystatin 100,000 units/ml Suspension","Prevention and treatment of candidiasis of the skin and mucous membranes, protection against candidas overgrowth during antimicrobial /corticosteroid therapy and as selective decontamination regimens","NEWBORN: 50,000-100,000 units daily. 
CHILD up to 5 years: 100,000 -500,000 units 6 hourly. 
CHILD up to 6-12 years and ADULT: 500,000-1,000,000 units 3 to 4 times daily",B,,,Tystatin,10.82,/,bot,B
D01,Terbinafine HCl 250 mg Tablet,Fungal infections especially onchomycosis caused by dermatophytes,"250 mg once daily for 6 weeks for fingernails: 
12 weeks for toenails",A/KK,Perubatan,,Onchofin,1.13,/,tab,A/KK
J02,Voriconazole 200mg Tablet,"i) Treatment of immunocompromised patients with progressive, possibly life-threatening infections such as invasive aspergillosis, fluconazole-resistant serious invasive candidiasis, candidiasis of the oesophagus, serious fungal infections caused by Scedosporium species and Fusarium species ii) Prevention of breakthrough fungal infections in febrile high-risk neutropenic patients",Adult and Children 12 years and greater and over 40 kg: Loading dose: 400 mg 12 hourly for first 24 hours. Maintenance: 200 - 300 mg 12 hourly. Less than 40 kg: Loading dose: 200 mg 12 hourly for first 24 hours. Maintenance: 100 - 150 mg 12 hourly. Children aged 2years to <12years with normal hepatic and renal function: No loading dose needed; 200mg 12hourly,A*,Oftalmologi,,Voritrop,51.77,/,tab,
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.4 ANTILEPROTICS, ANTITUBERCOLISIS AGENTS",,,,,,,,,,,
J04,Bedaquiline 100mg Tablet,"Indicated for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

PRESCRIBING RESTRICTIONS
To be prescribed by Respiratory Physicians only.","Week 1 to 2: 400mg once daily,
Week 3 to 24: 200mg three times per week",A*,Perubatan,,Sirturo,"3.65

658.58","/

/","tab

course of 188 tab",
J04,Clofazimine 100 mg Capsule,"i) Previously untreated leprosy patients 
ii) Leprosy patients resistant to sulphones 
iii) Suppression of lepra reactions","i) ADULT: 100 mg each other day or 50 mg daily with 100mg Dapsone & 300mg once a month with 600mg rifampicin under supervision. Maximum: 200 mg/day.

CHILD: 10-14 yr: 50mg clofazimine on alternate days with 50mg dapsone & 150 mg clofazimine with 450 mg rifampicin once a month.Maximum: 100 mg/day. 

ii) 100 mg daily 

iii) 200-300mg usually effective. Treatment with minimum suppression dose continued for at least 6 months",B,Perubatan,,Fazim,0.37,/,cap,B
J04,Cycloserine 250 mg Capsule,Multi-Drug Resistance Tuberculosis treatment failure. (For respiratory physicians),"ADULT: Initial: 250 mg every 12 hours for 14 days, then administer 0.5 - 1 g daily in 2 divided doses for 18 - 24 months (maximum daily dose: 1 g). 
CHILD: 2-12 yr: 5 mg/kg bid; 
12-18 yr: 250 mg bid for 2 wk then adjusted to a max dose of 1 g daily",A*,Perubatan,,Coxerin,7.20,/,cap,A*
J04,Dapsone 100 mg Tablet,"i)Leprosy 
ii) Dermatitis herpetiformis","i) ADULT: 6 - 10 mg/kg weekly/ 1.4mg/kg daily (around 50 - 100 mg daily). 
CHILD: 1 - 2 mg/kg/day. Maximum: 100 mg/day 
ii) ADULT: 50 - 300 mg daily",B,Perubatan,"Import Permit required for purchase
(UKK)",Dapsone,0.06,/,tab,B
J04,Ethambutol HCl 400 mg Tablet,Tuberculosis,Adult: 15-25mg/kg daily (max : 1200mg) or 50mg/kg biweekly (max : 2000mg). Children: 15-25mg/kg daily or 50 mg/kg twice weekly.,B,Perubatan,,ECOX,0.46,/,tab,B
J04,Ethionamide 250 mg Tablet,"As second-line therapy in the treatment of Multi Drug Resistant Tuberculosis only in combination with other efficacious agents and only when therapy with isoniazid, rifampicin, or other first-line agents has failed.","ADULT: 15-20mg/kg daily, in divided doses if necessary; maximum dose 1g/day. 
CHILD: 10-20mg/kg in 2-3 divided doses or 15mg/kg/24hrs as a single daily dose.",A*,Perubatan,,Ethomid,2.30,/,tab,A*
J04,Isoniazid 100 mg Tablet,"i) Tuberculosis 
ii)Tuberculous meningitis",i) & ii) ADULT: 5-8mg/kg daily (Max 300mg) or 15-20mg/kg biweekly (max 1200mg),B,,,Isoniazid,0.24,/,tab,B
J01,Kanamycin 1 g Injection,"i) Treatment of gonorrhoea and neonatal meningitis 

ii) Treatment of TB patients who require reserved second line drugs but have no pre-existing renal complications","i) ADULT: 1 - 2 g daily IM in 1 - 2 equally divided doses. 
CHILD: 30 - 50 mg/kg/day in 1 - 2 divided doses 

ii) ADULT: 2 g daily IM in 2 equally divided doses twice a week or 1 g once daily 3 days a week",A*,perubatan,,Kanamycin,6.75,/,amp,A*
J04,Para Amino Salicylic Acid 1 g Tablet,"Multi-Drug Resistance Tuberculosis treatment failure. 
(For respiratory physicians)",4 gram BD,-,Perubatan,KPK,,1.50,/,tab,-
J01,Minocycline 100 mg Capsule,"i) As second-line treatment for leprosy only
ii) Treatment of infections due to susceptible strains of the designated organism e.g. Carbapenem-resistant acinetobacter baumannii","i) 100 mg daily 6 - 18 months
ii) Initially, 200 mg followed by 100-200mg every 12 hours",A*,Perubatan,,Minocin,2.14,/,cap,
J04,Pyrazinamide 500 mg Tablet,Tuberculosis,Adult: 20-40mg/kg daily (max 1500mg) or 50mg/kg biweekly (max 2000mg). Children: 20-30mg/kg daily or 30-40mg/kg thrice weekly.,B,,,Pyrazinamide,0.18,/,tab,B
J04,"Rifampicin 150 mg, 300 mg Capsule","i) Tuberculosis
ii) Leprosy
iii) Prophylaxis for meningococcal meningitis
iv)Staphylococcus biofilm related prosthetic joint infection or any biofilm
sensitive to rifampicin in combination therapy with another antibiotic","i) ADULT: 450 - 600 mg as a single morning dose.
CHILD: 10 - 20 mg/kg body weight daily in 1 - 2 doses. Directly observed
therapy (DOT): 10 mg/kg twice weekly or 3 times/week. Maximum: 600 mg
ii) ADULT: 600 mg/day
CHILD: 10mg/kg
iii) ADULT: 600 mg twice daily for 2 days
CHILD: 10mg/kg twice daily for 2 days
INFANT: 5mg/kg twice daily for 2 days
iv) ADULT: 600mg OD
CHILD: 10-20mg/kg/day in 1-2 divided doses
Dosing is individualised and according to product insert/protocol.",B,,,Rifampicin,"0.20, 
0.33",/,cap,B
J04,"Rifampicin 150 mg, Isoniazid 75 mg, Pyrazinamide 400 mg & Ethambutol HCl 275 mg Tablet","Treatment of both pulmonary and extrapulmonary tuberculosis, in the intensive treatment phase","ADULT: 30 - 37 kg: 2 tablets daily, 
38 - 54 kg: 3 tablets daily, 
55 - 70 kg: 4 tablets daily, 
more than 70 kg: 5 tablets daily",B,,,FORECOX-TRAC,0.43,/,tab,B
J01,Streptomycin Sulphate 1 g Injection,Tuberculosis,"ADULT: 15 mg/kg daily; max: 1 g daily. 
Reduce max daily dose to 500-750 mg in patients >40 yr. 
As part of an intermittent therapy: 25-30 mg/kg/day 2-3 times/wk; max: 1.5 g/dose. Not >120 g over the course of treatment should be given unless there are no other treatment options. 
Child: 20-40 mg/kg (max: 1 g) daily or 25-30 mg/kg (max: 1.5 g) 2-3 times wkly.",B,,,Streptin,2.49,/,vial,B
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.5 ANTIPROTOZOAL, ANTIMALARIALS",,,,,,,,,,,
P01,Artemether 20 mg + Lumefantrine 120 mg Tablet,Acute uncomplicated falciparum malaria,"ADULT and CHILD over 12 years weighing over 35 kg : 4 tablets as a single dose at the time of initial diagnosis, again 4 tablets after 8 hours and then 4 tablets twice daily (morning and evening) on each of the following two days (total course comprises 24 tablets). 
INFANT and CHILD weighing 5 kg to less than 35 kg : A 6 dose regimen with 1 to 3 tablets per dose, depending on bodyweight",B,,,Riamet,3.52,/,tab,B
P01,Artesunate 60 mg Injection,"Treatment of severe malaria in adults and 
children","2.4mg of artesunate/kg body weight, by intravenous (IV) or intramuscular (IM) injection, at 0, 12 and 24 hours,  then once daily until oral treatment can be substituted. 
For adults and children with severe malaria or who are unable to tolerate oral medicines, artesunate 2.4 mg/kg body weight IV or IM given on admission (time = 0), then at 12 hrs and 24 hrs, then once a day for 5-7 days is the recommended treatment.",B,,,Artesun,32.00,/,vial,B
P01,Chloroquine Phosphate 250 mg Tablet (150 mg Chloroquine base),Treatment of malaria - acute attack,"ADULT: 600 mg base stat, 300 mg 6 - 8 hours later and a further 300 mg on each of 2 following days. 
CHILD 3 - 4 years : 150 mg base stat, 75 mg 6 hours later, then 75 mg daily for 2 days. 
CHILD 5 - 8 years : 300 mg stat, 150 mg 6 hours later, then 150 mg daily for 2 days",C,,,Chloroquine,0.11,/,tab,C
P01,Pentamidine Isethionate 300 mg Injection / nebulizing solution,"Only for the treatment of pneumonia due to Pneumocytosis carinii

off-label indication: PCP Prophylaxis in CD4 count less than 200 via inhalation route","4 mg/kg once daily by slow IV infusion for at least 14 days

Inhalation route for PCP Prophylaxis: 300mg monthly until CD4 count more than 200
",A*,Perubatan,Import Permit required (UKK) to purchase Pentacarinat brand to use via inhalation route,Pentacarinat,141.78,/,vial,A*
P01,Primaquine 7.5 mg base Tablet,"i) Treatment of malaria 
ii) Prophylaxis together with a schizonticide such as chloroquine","i) 15 mg daily for 14 days, increased to higher doses or longer course if resistance in P.vivax occurs. 
ii) ADULT: 30 mg once weekly. 
CHILD: 0.5 mg once weekly
Child: 250 mcg/kg daily for 14 days. Should be taken with food. 
Take with meals to avoid GI discomfort.",B,,,Primaquine,1.16,/,tab,B
P01,Pyrimethamine 25mg Tablet,cerebral toxoplasmosis,25mg OD (once daily),Not in FUKKM,Perubatan,Import Permit Required for purchase (UKK),Daraprim ,2.13,/,tab,-
P01,Quinine Dihydrochloride 600 mg/2 ml Injection,Severe and complicated malaria,"By slow intravenous infusion (over 4 hours). 
ADULT : 20 mg/kg followed by 10 mg/kg every 8 hours. 
CHILD : 20 mg/kg followed by 10 mg/kg every 12 hours, initial dose should be half in patients who have received quinine, quinidine or mefloquine during the previous 12 or 24 hours",B,,"Import Permit 
(KPK)",Malakin,19.32,/,vial,B
P01,Sulfadoxine 500 mg & Pyrimethamine 25 mg Tablet,Treatment of Plasmodium falciparum malaria in patients in whom chloroquine resistance is suspected and malaria prophylaxis for travellers to areas where chloroquine-resistant malaria is endemic,"Chloroquine resistant falciparum malaria acute attack. Adult: (Per tab contains pyrimethamine 25 mg and sulfadoxine 500 mg): 2-3 tabs as a single dose. Do not repeat for at least 7 days. 
Child: Pyrimethamine 25mg + Sulfadoxine 500mg (Tablet): 
<2 yr (5-10 kg): 1/2 (half) tab as a single dose; 
2-5 yr (>10-20 kg): 1 tab as a single dose; 
5-10 yr (< 20-30 kg): 1 1/2 (one and half) tab as a single dose; 
10-14 yr (> 30-45 kg): 2 tab as a single dose. Do not repeat for at least 7 days. 
Renal impairment: Dose reduction may be needed. Severe: contra-indicated.
Hepatic impairment: Dose reduction may be needed. Severe: contra-indicated.",B,,,FANSIDAR,0.23,/,tab,B
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.6 ANTIVIRALS",,,,,,,,,,,
J05,Abacavir 300 mg Tablet                                           ,HIV Infection,"Adult: Combined w/ other antiretrovirals: 300 mg bid or 600 mg once daily.
Child: ≥3 mth 14 to <20 kg: 150 mg bid or 300 mg once daily; ≥20 kg to <25 kg: 150 mg in the morning and 300 mg in the evening or 450 mg once daily; ≥25 kg: Same as adult dose.",A*,Perubatan,,ABACAVEX,2.02,/,tab,-
J05,Abacavir Sulphate 600 mg & Lamivudine 300 mg Tablet                                           ,"Antiretroviral combination therapy of HIV infection in adults and adolescents from 12 years of age with the following criteria: i)Patients unsuitable or failed other HAART treatment 
ii)Patients who are at high risk of renal impairment 
iii)Patients with osteoporosis or at high risk of bone loss","ADULTS & ADOLESCENT (> 12 years of age): Recommended dose is one tablet once daily. Not to be used in adults or adolescents weigh less than 40kg. 

CHILDREN : Not recommended",A*,Perubatan,Kuota,Kivexa,5.23,/,tab,A*
J05,Acyclovir 250 mg Injection,"Treatment and prophylaxis of herpes simplex in immunocompromised, severe initial genital herpes and Varicella -Zoster","ADULT: 5 mg/kg by IV infusion 8 hourly for 5 days, doubled to 10mg/kg every 8 hourly in varicella-zoster in the immunocompromised and in simplex encephalitis (usually given for at least 10 days in encephalitis; possibly for 14 - 21 days). NEONATE & INFANT up to 3 months with disseminated herpes simplex: 20mg/kg every 8 hourly for 14 days (21 days in CNS involvement),
:varicella-zoster 10-20mg/kg every 8 hourly usually for 7 days. 
CHILD, 3 months - 12 years: Herpes simplex or Varicella Zoster: 250 mg/m2 8 hourly for 5 days, doubled to 500 mg/m2 8 hourly for varicella-zoster in the immunocompromised and in simplex encephalitis (usually given for 10 days in encephalitis)",A*,,,Vaxcel,6.96,/,vial,A*
J05,"Acyclovir 200 mg, 800 mg Tablet","i) Mucocutaneous Herpes Simplex infection in immunocompromised and AIDS patients 
ii) Primary and recurrent Varicella Zoster infection in immunocompromised and AIDS patients 
iii) Severe Kaposi Varicella Eruption (Eczema herpeticum) iv) Severe primary HSV infections (eg. Neonatal herpes, encephalitis, eczema herpeticum, genital herpes, gingival stomatitis, vaginal delivery with maternal vulva herpes) v) Severe and complicated varicella infection (eg. Encephalitis, purpura fulminans) 
vi) Severe zoster infection in paediatrics (eg. Encephalitis, purpura fulminans, immunocompromised patients and facial, sacral and motor zoster)","i) ADULT: initially 400 mg 5 times daily for 7 - 14 days. 
CHILD less than 2 years: 200 mg 4 times daily, 
CHILD more than 2 years: 400 mg 4 times daily 

ii), iii) and iv) ADULT: 200 - 400 mg 4 times daily. 
CHILD: less than 2 years, half adult dose; more than 2 years, adult dose 

v) ADULT: 800 mg 5 times daily for 7 days 

vi) ADULT: 20 mg/kg (maximum: 800 mg) four times daily for 5 days, 
CHILD 6 years: 800 mg four times daily. 
CHILD less than 2 years; 400mg 4 times daily, more than 2 years; 800mg 4 times daily",A/KK,,,"Aciclovir, Lovir","0.70, 0.56",/,tab,A/KK
J05,Didanosine 250 mg Enteric Coated Capsule,"HIV infection, in combination with other antiretrovirals",ADULT less than 60 kg: 250 mg once daily; 60 kg or greater: 400 mg once daily. Dose may varies if taken in combination with tenofovir,A*,"Pediatrik, Perubatan",Kuota,Didanosine Delayed-Release Capsules,3.73,/,cap,A*
J05,Atazanavir 300 mg capsule,"Treatment of HIV-1 infected, antiretroviral treatment experienced adults, in combination with other antiretroviral medicinal products. 
Restriction: For Infectious Disease Consultant use, in patients with treatment failure on NNRTI regime.","The recommended dose is 300mg once daily taken with ritonavir 100mg once daily and with food. Ritonavir is used as a booster of atazanavir pharmacokinetics. If atazanavir with ritonavir is co- administrated with didanosine, it is recommended that didanosine be taken 2 hours after atazanavir with ritonavir taken with food.",A*,Perubatan,,Atazor 300,4.96,/,cap,
J05,Daclatasvir 60mg tablet,To be used in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults.,"60 mg once daily, to be taken orally with or without meals.

Dose recommendation when taking concomitant medicines:
i. Strong inhibitors of cytochrome P450 enzyme 3A4 (CYP3A4):
Reduce dose to 30 mg once daily when co-administered with strong inhibitors of CYP3A4.

ii. Moderate inducers of CYP3A4:
Increase dose to 90 mg once daily when co-administered with moderate inducers of CYP3A4.

Daclatasvir must be administered in combination with other medicinal products for the treatment of hepatitis C infection.

Dose modification of daclatasvir to manage adverse reactions is not recommended.",A*,Perubatan,,Dasvir,1.71,/,tab,
J05,Dolutegravir 50 mg Tablet,"Dolutegravir is indicated in combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age.
Restriction: For patients who are not able to tolerate or failing treatment or resistance to the first line therapy (efavirenz and nevirapine).","i) HIV-1 patients without documented or clinically suspected resistance to the integrase class: 50 mg (one tablet), once daily, orally. 
ii) HIV-1 patients with resistance to the integrase class: 50 mg (one tablet), twice daily, orally.",A/KK,Perubatan,Kuota,Myltega,6.20,/,tab,A*
J05,"Dolutegravir 50mg, Lamivudine 300mg, Tenofovir Disoproxil Fumarate 300mg Film-Coated Tablets",Indicated for use alone as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing 40 kg or greater,One tablet once daily,A/KK,Perubatan,Kuota,Teldy,6.17,/,tab,
J05,Efavirenz 200 mg Capsule,Combination therapy for HIV infections with a protease inhibitor and or Nucleoside Reverse Transcriptase Inhibitors (NRTIs),"ADULT: 600 mg once daily. 
ADOLESCENT & CHILD less than 17 years, 
more than 40 kg: 600 mg once daily, 
32.5 - less than 40 kg: 400 mg once daily, 
25 - less than 32.5 kg: 350 mg once daily, 
20 - less than 25 kg: 300 mg once daily, 
15 - less than 20 kg: 250 mg once daily, 
13 - less than 15 kg: 200 mg once daily. 
No studies in children less than 3 years or less than 13 kg. 
Formulation unsuitable for children less than 40 kg",A/KK,Perubatan,,Efamat 200,1.31,/,cap,A*
J05,Efavirenz 600mg Tablet,,,A/KK,Perubatan,,Efamat 600,0.38,/,tab,A/KK
J05,Entecavir 0.5 mg Tablet,First line treatment of Chronic Hepatitis B in patients who satisfy the criteria for treatment and require long-term therapy or have a very high baseline viral load,"0.5-1mg once daily. 
Renal Dose Adjustment: 
0.5-1mg every 48hours (30-49ml/min); 
0.5-1mg every 72hours (10-29ml/min); 
0.5mg-1mg every 5-7 days (<10ml/min; HD or CAPD).",A*,Perubatan,Kuota,Hebecavir,2.82,/,tab,A*
J05,Ganciclovir Sodium 500 mg/10 ml Injection,"Treatment of cytomegalovirus (CMV) disease in immunocompromised patients, prevention of CMV disease during immunosuppressive therapy following organ transplantation","Initial: 5 mg/kg infused over 1 hour 12 hourly for 14 - 21 days (CMV retinitis treatment) or 7 - 14 days (CMV disease prevention). 
Long term maintenance: 6 mg/kg daily for 5 days/week or 5 mg/kg daily for 7 days/week (a min duration of 3 months has been practiced)",A*,,,Cymevene,140.50,/,vial,A*
J06,Lamivudine 10 mg/ml Oral Solution,HIV infection in combination with other antiretroviral agents,"ADULT: 150 mg twice daily or 300 mg once daily. 
INFANT under 1 month: 2 mg/kg twice daily. 
CHILD 3 month or over: 4 mg/kg twice daily. Maximum 300 mg daily",A*,"Perubatan, Pediatrik",,3TC Oral Solution,231.85,/,bot,A*
J05,Lamivudine 100 mg Tablet,Management of chronic hepatitis B infection associated with evidence of hepatitis B viral replication and active liver inflammation,"Adult:100 mg once daily. 
For patients with concomitant HIV infection: 300 mg once daily or in 2 divided doses.
Child: >2 yr: 3 mg/kg once daily. Max: 100 mg/day.",A*,Perubatan ,,Axcel,3.21,/,tab,A*
J05,Lamivudine 150 mg Tablet,HIV infection in combination with other antiretroviral agents,"ADULT: 150 mg twice daily or 300 mg once daily. 
INFANT under 1 month: 2 mg/kg twice daily. 
CHILD 3 month or over: 4 mg/kg twice daily. Maximum 300 mg daily",A/KK,Perubatan,,Valfix,2.22,/,tab,A/KK
J05,"Lopinavir 200 mg and 
Ritonavir 50 mg Tablet","As second line protease inhibitor if intolerant to indinavir/ ritonavir 
as part of HAART regimen","Adult: (Therapy-naive patients) 400/100 mg bd or 800/200 
mg once daily; (Therapy-experienced patients): 400/100 mg bd. Concomitant therapy (efavirenz, nevirapine, amprenavir, fosamprenavir or nelfinavir) 400/100 mg bd. Children >40 kg or w/ BSA >1.4 m2 as adult dose.",A,Perubatan,,Kaletra 200/50,2.90,/,tab,A
J05,"Lopinavir 100 mg and
Ritonavir 25 mg Tablet",As second line protease inhibitor if intolerant to indinavir/ ritonavir as part of HAART regimen.,"Adult: (Therapy-naive patients) 400/100 mg bd or 800/200 mg once daily; 
(Therapy-experienced patients): 400/100 mg bd. 
Concomitant therapy (efavirenz, nevirapine, amprenavir, fosamprenavir or nelfinavir) 400/100 mg bd. 
Children >40 kg or w/ BSA >1.4 m2 as adult dose.",A,Perubatan,,Kaletra 100/25,6.60,/,tab,A
J05,Nevirapine 200 mg Tablet,Treatment of HIV-1 infection in combination with other antiretroviral agents,"Combined with other antiretrovirals: 200 mg once daily for the 1st 14 days; up to 200 mg twice daily if rash does not develop. 
Re-introduce at a lower dose for the 1st 14 days if treatment is interrupted for >7 days,necessitate reintroduction at a lower dose for the first 14 days.",A/KK,Perubatan,,Herapine,0.40,/,tab,A/KK
J05,Oseltamivir 60mg/5ml oral suspension (100ml),i) For treatment of patients with suspected or confirmed influenza and severe disease (requiring hospitalization or evidence of lower respiratory tract infection). ii) For treatment of patients with suspected or confirmed influenza and with co-morbidity and associated with increased risk of influenza complications. Not to be used as prophylaxis,Children ≥ 1 year (for 5 days): a) ≤15 kg: 30mg twice daily b) >15kg to 23kg:45mg twice daily c) >23kg to 40kg: 60mg twice daily Children with body weight more than 40kg who are able to swallow capsule is recommended to be dosed as adults.,A/KK,Pediatrik,,Ranbaxy Fluhart,98.60,/,bot,
J05,Oseltamivir 75 mg Capsule,"i) For treatment of patients with suspected or confirmed influenza and severe disease (requiring hospitalization or evidence of lower respiratory tract infection). 
ii) For treatment of patients with suspected or confirmed influenza and with co-morbidity and associated with increased risk of influenza complications. Not to be used as prophylaxis.","Recommended dose in adults and adolescents = 13 years of age and body weight >40kg is 75mg twice daily for 5 days. 
Dosing adjustment for renal impaired patient, follow manufacturer's recommendations in product insert.",A/KK,,,Osmivir,5.93,/,cap,A/KK
J05,Raltegravir 400mg Tablet     ,Raltgeravir combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection in patients who are contraindicated to boosted Protease Inhibitor or who are intolerant to boosted Protease Inhibitor.,"400mg administered orally, twice daily with or without food, to be given combination with other antiretroviral agent.",A*,Perubatan,"Kuota

Discontinue by company, not available",Isentress ,7.54,/,tab,A*
J05,Remdesivir 100mg/20ml Injection,Coronavirus disease 2019 (COVID-19),"Adult: In hospitalised patients with severe case: 200 mg as a single dose on day 1, followed by 100 mg once daily starting on day 2. Treatment duration: Patients not requiring mechanical ventilation/extracorporeal membrane oxygenation (ECMO): 5 days; may extend for up to 5 additional days (total of 10 days) in patients who do not demonstrate clinical improvement. Patients requiring invasive mechanical ventilation/ECMO: 10 days. Doses are given via infusion over 30-120 minutes. Dosage recommendation is based on currently available data from clinical studies and may vary among local guidelines or countries.",,Perubatan,,Veklury,966.00,/,vial,
,,,"Child: In hospitalised patients with severe disease (for compassionate use): As lyophilised powder: 3.5-<40 kg: 5 mg/kg on day 1, followed by 2.5 mg/kg once daily starting on day 2; ≥40 kg: As concentrated solution or lyophilised powder: Same as adult dose. Treatment duration: Patients not requiring mechanical ventilation/ECMO: 5 days; may extend for up to 5 additional days (total of 10 days) in patients who do not demonstrate clinical improvement. Patients requiring invasive mechanical ventilation/ECMO: 10 days. Doses are given via infusion over 30-120 minutes. Dosage recommendations may vary among countries based on currently available data. Dosage recommendation is based on currently available data from clinical studies and may vary among local guidelines or countries.",,,,,,,,
J05,Ribavirin 200 mg Capsule,For the treatment of chronic hepatitis C (in combination with interferon alfa-2a/2b),"ADULT (more than 18 years old): 50mg/kg/day 
Recommended: 
Body weight: = 75kg should receive 1000mg daily as two 200mg capsules in the morning and three 200mg capsules in the evening 
Body weight: >75kg should receive 1200mg as three 200mg capsules in the morning and three 200mg capsules in the evening 
Genotype 1,4: 48 weeks Genotype: 24 weeks duration should be individualized in accordance with the baseline characteristics of the disease.",A*,,,Rebetol,-,/,cap,A*
J05,Ravidasvir 200mg tablet,"To be used in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults

Prescribing restriction:
In non-cirrhotic patients or compensated cirrhosis patients who are treatment naïve to NS5A inhibitor","200 mg once daily, to be taken orally with or without food.
Patients without cirrhosis: Ravidasvir plus sofosbuvir for 12 weeks.
Patients with compensated cirrhosis: Ravidasvir plus sofosbuvir for 24 weeks",A*,Perubatan,,Ravida,15.60,/,tab,
J05,Ritonavir 100mg capsule,"Progressive or advanced HIV infection in combination with other antiretroviral agents.

Criteria of use: 
a) Clinical AIDS
b) CD4 less than 350 cells or
c) Viral load more than 10,000 copies/ml","ADULT: (Single PI) initially 300 mg twice daily, increase by 100 mg twice daily increments to 600 mg twice daily. (Dual PI) Initially 200mg BD, then increase by 100mg BD & reaching 400mg BD within 2 wk.",A*,Perubatan,,Norvir,4.92,/,cap,
J05,Sofosbuvir 400mg tablet,To be used in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults.,"One 400 mg tablet, taken orally, once daily with food.
Sofosbuvir should be used in combination with other medicinal products. Monotherapy of sofosbuvir is not recommended.",A*,Perubatan,,Sofovir,2.45,/,tab,
J05,Tenofovir Disoproxil Fumarate 300 mg Tablet                 ,"Prescriber Category A*:
i. Treatment of HIV-1 infected adults in combination with other antiretroviral agents.

ii. Use as first line monotherapy for chronic hepatitis B or as a rescue therapy for patients with drug resistance hepatitis B virus (according to resistant profile or treatment guidelines).

Prescriber Category A/KK:
iii. For antenatal patients only with chronic Hepatitis B with HBeAg reactive or HBV DNA more than 200,000 or deranged LFT.

iv. For adult patients with chronic Hepatitis B (CHB) eAg positive or eAg negative chronic hepatitis. (For non-cirrhotic liver disease only)","Indication i, ii & iv:
300mg once daily.

Renal Dose Adjustment: 
300mg every 48hours (30-49ml/min); 
300mg every 72hours (10-29ml/min); 
300mg every 7 days after dialysis (Hemodialysis)

Indication iii:
300mg once daily from 28 weeks of gestation and continue till 4 weeks postpartum","A*, A/KK",Perubatan,,Ricovir,0.52,/,tab,A*
J05,Tenofovir Disoproxil Fumarate 300 mg & Emtricitabine 200 mg Tablet,Treatment of HIV-1 infection in adults in combination with other antiretroviral agents (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors).,1 tablet once daily.,A/KK,Perubatan,,Tenvir-EM,0.86,/,tab,A/KK
J05,Valganciclovir 450 mg Tablet,"i) For the prevention of cytomegalovirus (CMV) disease in CMV-negative patients who have received a solid organ transplant from a CMV-positive donor

ii) Treatment of Cytomegalovirus (CMV) disease (e.g CMV retinitis) in immunocompromised patients
","i) For adult patients who have received other than kidney transplant, 
the recommended dose is 900 mg (two 450 mg tablets) once a day starting within 10 days of transplantation until 100 days post-transplantation. 
For adult patients who have received a kidney transplant, the recommended dose is 900 mg (two 450 mg tablets) once a day starting within 10 days of transplantation until 200 days post-transplantation.

ii) induction adults: 900mg BD x 3 weeks
   maintenance adults: 900 mg OD (a min of 3 months has  been practiced)",A*,Oftalmologi,,Valcyte,84.67,/,tab,A*
J05,Zidovudine 100 mg Capsule,"i) Management of patients with asymptomatic and symptomatic (early or advanced) HIV infections with CD4 cell counts less than 500 cu. mm 
ii) Neonatal prophylaxis","i) HIV infection 
Adult: 600 mg daily in divided doses, in combination with other antiretroviral agents. 
Child: 6 wk - 12 yr: 160 mg/m2 every 8 hr. Max: 200 mg every 8 hr. May be used in combination with other anti-retrovirals. 
Renal and Hepatic impairment: Dose reduction may be needed. 

ii) Prophylaxis of HIV infection in neonates 
Child: Neonates: 2 mg/kg every 6 hr for 1st 6 wk of life, starting within 12 hr after birth. 
Renal and hepatic impairment: Dose adjustment may be needed.",A/KK,Perubatan,,Zidovudine,1.10,/,cap,A/KK
J05,Zidovudine 1% Injection,"To reduce the rate of maternal-foetal transmission of HIV in: 
i) HIV-positive pregnant women over 14 weeks of gestation 
ii) Their newborn infants","i) Prophylaxis of maternal-foetal HIV transmission during labour and delivery.
Adult: Loading dose: 2 mg/kg, followed by continuous infusion of 1 mg/kg/hr until umbilical cord is clamped. If caesarean section is planned, start the IV infusion 4 hr before the operation. 
Renal and Hepatic impairment: Dose reduction may be needed. 
HIV infection (to be discuss: not in indication) 
Adult: 1-2 mg/kg every 4 hr, given as 2-4 mg/ml infusion over 1 hr. 
Child: As continuous infusion: 20 mg/m2/hr. Alternatively, as intermittent infusion: 120 mg/m2 every 6 hr. 
Renal impairment: Haemodialysis or peritoneal dialysis: 1 mg/kg every 6-8 hr. 

ii) Prophylaxis of HIV infection in neonates Child: Neonates: 1.5 mg/kg every 6 hr. Start treatment within 12 hr after birth and continue for 1st 6 wk of life. Dose to be given via IV infusion over 30 minutes. Renal impairment: Dose adjustment may be needed.",A,,,Retrovir,146.50,/,vial,A
J05,Zidovudine 10 mg/ml Syrup,"i) Management of patients with asymptomatic and symptomatic (early or advanced) HIV infections with CD4 cell counts less than 500 cu. mm.
 ii) Neonatal prophylaxis","i) HIV infection 
Adult: 600 mg daily in divided doses, in combination with other antiretroviral agents. 
Child: 6 wk - 12 yr: 160 mg/m2 every 8 hr. Max: 200 mg every 8 hr. May be used in combination with other anti-retrovirals. 
Renal and Hepatic impairment: Dose reduction may be needed. 
ii) Prophylaxis of HIV infection in neonates 
Child: Neonates: 2 mg/kg every 6 hr for 1st 6 wk of life, starting within 12 hr after birth. 
Renal and hepatic impairment: Dose adjustment may be needed.",A*,Pediatrik,,Retrovir,94.20,/,bot,A*
J05,Zidovudine 300 mg & Lamivudine 150 mg Tablet,HIV infection in combination with at least one other antiretroviral drug,ADULT and CHILD over 12 years: 1 tablet twice daily,A/KK,Perubatan,,Zovilam,0.57,/,tab,A/KK
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.7 ANTINEOPLASTICS/IMMUNOSUPPRESSANTS",,,,,,,,,,,
L02,Abiraterone acetate 250mg tablet,"With prednisone or prednisolone, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men. 

Restriction:
i. Those who have progressed on OR failed prior docetaxel
chemotherapy
ii. Those who are contraindicated or unsuitable for
chemotherapy",1000mg once daily,A*,Pembedahan,Kuota,Arabitro,6.23,/,tab,
L01,"All-Trans Retinoic Acid (tretinoin) 10mg
Capsule",Acute promyelocytic leukaemia,"Induction: 45 mg/m2 daily for 30 - 90 days. 
Maintenance: 45 mg/m2 daily for 2 weeks every 
3 months. 
Renal/or hepatic insufficiency: 25mg/m2 daily for 
30-90 days. 

Refer to protocols",A*,"Perubatan, Pediatrik",,Vesanoid,13.58,/,cap,
L01,Abemaciclib 150mg Film Coated Tablet,"Abemaciclib, in combination with endocrine therapy, is indicated for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive early breast cancer at high risk of recurrence.

In pre- or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (LHRH) agonist.

Prescribing restrictions:
i. For high-risk stage II and III early breast cancer. High risk defined by clinical and pathological features: either ≥pALN (positive axillary lymph nodes) or 1 – 3 pALN and at least one of the following criteria: tumour size ≥5cm or histological grade 3.
ii. To be prescribed by Oncologist only","The recommended dosing is 150mg twice daily, taken orally with or without food for 2 years, or until disease recurrence or unacceptable toxicity occurs",A*,"Pembedahan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi",UBAT PESARA,Yulareb,1021.9,/,pack of 14 tabs,
L04,Adalimumab 40mg Injection ,"i) Third line treatment of:
 - Severe rheumatoid arthritis 
- Psoriatic arthritis 
- For reducing signs and symptoms in patients with active ankylosing spondylitis, after failure of conventional DMARDs or other biologics.

ii)Treatment of adults with moderate to severe chronic plaque psoriasis who have not responded to, have contraindication or are unable to tolerate phototherapy and/or systemic therapies including acitretin, methotreaxate and cyclosporine 

","i) Severe rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis
 : Subcutaneous 40 mg every other week 

ii) Chronic plaque psoriasis
 : Initial, 80 mg SC, followed by 40 mg SC every other week starting one week after the initial dose

iii) & iv) Crohn's disease & Ulcerative colitis: 160mg at week 0 (dose can be administered as four injections in one day or as two injections per day for two consecutive days) and 80mg at week 2. After induction treatment, the recommended maintenance dose is 40mg every other week via subcutaneous injection.",A*,Perubatan,Kuota,Humira,500.00,/,pen,A*
,,"iii) Crohn's Disease 
a) For treatment of moderately to severely active Crohn?s Disease in adult patients who have inadequate response to conventional therapy 
b) For treatment of moderately to severely active Crohn?s Disease in adult patients who have lost response to or are intolerant to infliximab 

iv) Ulcerative Colitis
 - For treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies",,,,,,,,,
L01,Afatinib  30mg Film Coated Tablet,First line monotherapy for the treatment of epidermal growth factor receptor (EGFR) TKI-naïve patients with locally advanced or metastatic non-small cell lung cancer with EGFR mutation,30-40mg OD,A*,Perubatan,Kuota,Giotrif,49.00,/,tab,
L02,Anastrozole 1 mg Tablet,Hormonal therapy in breast cancer in post-menopausal women if failed /contraindicated with Tamoxifen,1 mg daily,A*,"Pembedahan, Obstetrik",,Aremed,1.58,/,tab,A*
L04,Azathioprine 50 mg Tablet,"i) Prophylaxis of rejection in organ and tissue transplant
ii) Auto-immune diseases 
iii) Rheumatoid arthritis","i) Adult: 1-5 mg/kg/day. Adjust dose according to clinical response and haematological tolerance. Dose may also be given via IV administration. 
ii) Adult: 1-3 mg/kg/day. Discontinue treatment if there is no improvement after 12 week. 
iii) Adult: Initially, 1 mg/kg/day given in 1-2 divided doses for 6-8 week, may increase by 0.5 mg/kg every 4 week until response or up to 2.5 mg/kg/day. 
Maintenance: Reduce dose gradually to achieve the lowest effective dose.",A,Perubatan,,Imuran,0.87,/,tab,A
L04,Baricitinib 4mg Tablet,"1. Treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. May be
used as monotherapy or in combination with methotrexate.
Restriction: Severe active rheumatoid arthritis: To be prescribed by Rheumatologist only

","1. Severe active rheumatoid arthritis: 4mg once daily

",A*,Perubatan,"Kuota

Special Drugs Approval (UKK) not needed for Covid as exemption has been given",Olumiant,6.19,/,tab,
,,"2. Indicated for the treatment of severe atopic dermatitis in adult patients who are candidates for systemic therapy.
Restriction:
i. As fourth line of treatment in patients who have failed / have contraindications / experienced adverse events to: 
• Intensive and optimized topical treatment 
• Phototherapy 
• At least two immunosuppressants 
ii. To be prescribed by Dermatologists only.

Off-label indication: 1) Treatment of severe Covid-19 infection","2. Severe atopic dermatitis: The recommended dose of baricitinib is 4 mg once daily with or without food and may be taken at any time of the day. A dose of 2 mg once daily is appropriate for patients such as those aged ≥ 75 years and may be appropriate for patients with a history of chronic or recurrent infections. A dose of 2 mg once daily should be considered for patients who have achieved sustained control of disease activity with 4 mg once daily and are eligible for dose tapering. Baricitinib can be used with or without concomitant topical therapies (Refer package insert)

Treatment of severe Covid-19 infection: 4mg OD for 2 weeks",,,,,,,,
L04,Belimumab 120mg Powder for Injection,Reducing disease activity in adult patients w/ active autoantibody +ve SLE receiving standard therapy,"Adult 10 mg/kg IV infusion over 1 hr on days 0, 14 & 28 & at 4-wk intervals thereafter. Patient w/ allergies Premed w/ oral antihistamine w/ or w/o antipyretic before infusion.",Not in FUKKM,Perubatan,Special Drugs Approval (UKK) required,Benlysta,428.00,/,vial,
L01,Bevacizumab 100mg/4ml,"Bevacizumab, in combination with atezolizumab, is indicated for the treatment of patients with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received prior systemic therapy.

Note:
Currently, innovator bevacizumab product ie. Avastin is the only product with DCA approved indication for treatment of hepatocellular carcinoma.

Prescribing restriction:
Only for patients with Child-Pugh A","The recommended dosage is 15 mg/kg intravenously after administration of atezolizumab intravenously on the same day, every 3 weeks until disease progression or unacceptable toxicity.",A*,"Pembedahan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi",UBAT PESARA,Avastin,"629.00


62.90
(PaSc)","/


/","vial


vial 
(PaSc: Beli 1 percuma 9)",
L02,Bicalutamide 50 mg Tablet,"Androgen deprivation therapy in advanced prostate cancer in 
combination with luteinising hormone-releasing hormone (LHRH) analogue therapy or surgical castration.","50 mg once daily. (morning or evening), with or without food. 
Take on the same time each day. 
Adult: When used with gonadorelin analogue: Usual dose: 50 mg once daily. 
May be started with or at least 3 days before starting gonadorelin analogue therapy.",A*,Pembedahan,,Bicalox,1.78,/,tab,A*
L01,"Capecitabine 150mg, 500 mg Tablet","1) Metastatic breast cancer; 
2) Treatment of colorectal cancer in adjuvant and metastatic setting; 
3) advanced oesophagogastric cancer in combination with a platinum-based regimen","i. As monotherapy or in combination with docetaxel: 1250 mg/m2 twice daily for 2 weeks followed by a 7-day rest period.
ii. As monotherapy: 1250 mg/m2 twice daily (morning and evening) for 2 weeks, followed by a 7-day rest period. As combination: 1000 mg/m2 twice daily for 2 weeks followed by a 7-day rest period.
iii. In combination with a platinum: 1000 mg/m2 twice daily for 14 days followed by a 7 day rest period

Dosing is individualised and according to product insert/ treatment protocol.",A*,Pembedahan,,Intacape,"2.74, 3.43",/,tab,A*
L01,Carboplatin 450 mg Injection,1) Solid tumours; 2) Salvage therapy for lymphoma,"360 - 400 mg/m2 BSA, by IV infusion over 15 mins to 1 hour on Day 1 every 4 weeks. Alternatively, prescription may be based on Area Under Curve (AUC) calculations. 
CHILD: 500-600 mg/m2 over 1 hour once every 3 weeks. Salvage regimes in lymphomas - refer to specific protocols. Starting dose in renal impairment, please refer to product insert.",A*,,,Kemocarb,80.11,/,vial,A*
L01,Chlorambucil 2 mg Tablet,"Low grade lymphoma, chronic lymphocytic leukaemia. Ovarian cancer","General : Initial :0.1 -0.2 mg/kg body weight daily for 4 - 8 weeks maintanance : given either by reduced daily dosage or intermittent course of treatment. 
Chronic Lymphocytic Leukaemia: initial : 0.15mg/kg/day untill total leukocyte count has fallen to 10,000peruL, then resumed treatment untill 4 weeks after the end of the first course then continued at a dosage 0.1mg/kg/day.",A,Pembedahan,Kuota,Leukeran,5.51,/,tab,A
L04,"Ciclosporin 25 mg, 100 mg Capsule Microemulsion","Only for: 
i) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids 
ii) Follow-up cases of bone marrow transplant 
iii) Patients with severe rheumatoid arthritis not responding to other second line drugs ","i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. 
Maintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation 
iii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months 
iv) ADULT: 5 mg/kg/day in 2 divided doses. 
CHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day 
",A*,Perubatan,,Sandimmun Neoral,"3.74,  15.00",/,cap,
,,"iv) Patients with idiopathic nephrotic syndrome who are steroid toxic or poor response to cyclophosphamide 
v) Severe aplastic anemia, pure red cell aplasia 
vi) Cases of recalcitrant psoriasis and atopic eczema 
vii) Treatment of chronic ocular inflammatory disorders/uveitis","v) 12 mg/kg/day. 
vi) 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day 
vii) 5 mg/kg/day in 2 divided doses, may increase to 7 mg/kg/day in resistant cases. Maintenance: Less than 5 mg/kg/day especially during remission",,,,,,,,A*
L04,Ciclosporin 100mg/ml Drink Solution,"Only for : i) Patients in whom donor specific transplantation cannot be carried out and in young children to minimise side-effects of steroids 
ii) Follow-up cases of bone marrow transplant 
iii) Patients with severe Rheumatoid arthritis not responding to other second line drugs 
iv) Patients with idiopathic nephrotic syndrome who are steroid toxic or poor response to cyclophosphamide 
v) Severe aplastic anaemia, pure red cell aplasia 
vi) Cases of recalcitrant psoriasis and atopic eczema","i & ii) Initially 12.5 - 15 mg/kg/day, beginning on the day before transplant. 
Maintenance approx 12.5 mg/kg/day for 3 - 6 months before being tapered off to zero by 1 year of transplantation 
iii) 3 mg/kg/day in 2 divided doses for first 6 weeks. May increased gradually to maximum 5 mg/kg. Treatment withdrawn if no response after 3 months 
iv) ADULT: 5 mg/kg/day in 2 divided doses. 
CHILD: 6 mg/kg/day in 2 divided doses. Patients with permitted levels of kidney failure, the starting dose must not more than 2.5 mg/kg/day 
v) 12 mg/kg/day 
vi) 2.5 mg/kg/day in 2 divided doses increasing if there is no improvement after 4 weeks by 0.5 -1 mg/kg/month up to maximum 5 mg/kg/day",A*,"Perubatan, Pediatrik",Kuota,Sandimmun Neoral,1195.00,/,bottle,A*
L04,Ciclosporin 50 mg/ml Injection,"i) Post bone marrow transplant 
ii) Solid organ transplant","i) 3 - 5 mg/kg/day until tolerate orally 
ii) 2 - 3 mg/kg/day for recipients who are unable to take orally",A*,,,Sandimmun,19.14,/,amp,A*
L01,Cisplatin (Cis-Platinum) 50 mg Injection,1) Solid tumours; 2) lymphomas,"Germ cell tumours: 20 mg/m2 daily for 5 days every 3 weeks for 3 - 4 courses. 
Ovarian tumours: 75 mg/m2 once every 3 weeks as part of combination therapy with paclitaxel or 50-60mg/m2 IV once every 3 weeks as a single agent. 
Baseline creatinine clearance, pretreatment hydration and forced diuresis are mandatory. CHILD: 100mg/m2 over 6 hours once every 3 weeks. Lymphomas: Refer to protocols CHILD: 100mg/m2 over 6 hours once every 3 weeks. Lymphomas: Refer to protocols",A,,,Platol,28.35,/,vial,A
L01,Cyclophosphamide 50 mg Tablet,"i) Solid tumours, leukaemia, lymphoma, autoimmune disorders, autoimmune bullous diseases, connective tissue disease, pyoderma gangrenosum 
ii) For severe lupus nephritis (Class III & IV), systemic vasculitis and steroid resistant/dependent nephrotic syndrome 
iii) Systemic lupus erythematosus (SLE), rheumatoid arthritis, polyarteritis nodosa, wegener granulomatosis","i) ADULT: 50 - 100 mg/day. Monitor full blood count (FBC), liver function, urine microscopy and renal function. 
CHILD : up to 1 year: 10 - 20 mg daily, 
1 - 5 years: 30 - 50 mg daily, 
6 - 12 years: 50 - 100 mg daily 
ii) 2 mg/kg/day for 3 - 4 months 
iii) 1 - 1.5 mg/kg/day orally in divided doses",A,Perubatan,Import Permit Required for purchase (UKK),Endoxan,0.50,/,tab,A
L01,Cyclophosphamide 1 g Injection,"i) Solid tumours; 
ii) Leukaemia, non-Hodgkin's lymphoma, multiple myeloma; 
iii) Severe lupus nephritis (Class III and IV); 
iv) Other systemic vasculitis; 
v) Systemic lupus erythematosus, rheumatoid arthritis, polyarteritis nodosa, wegener granulomatosis; 
vi) Pemphigus vulgaris.","i) & ii) ADULT: 600 - 750 mg/m2 IV once every 3 weeks as part of combination regime. CHILD: Dose variable depending on disease and protocol. Range 600 mg/m2 to 2 g/m2 infusion over 1 hour to 6 hours (lower doses can be given as bolus). Care with pre and post-hydration. Mesna to be given with doses more than 1 g/m2. Higher doses are used in haematopoetic stem cell transplant-refer to specific protocols 
iii) 750 mg/m2 BSA monthly for 18 months 
iv) 750 mg/m2 BSA monthly for 6 months. 
Dose can be adjusted up to 1,000 mg/m2 BSA to achieve adequate leucocyte suppression ",A,,,Endoxan,39.24,/,vial,
,,,"v) 500 - 1000 mg intravenously (Regime varies according to indication). 
Starting dose may be given fortnightly then at monthly intervals followed by 3 monthly intervals; 
vi) 500 mg infusion on the 2nd day of the dexamethasone-cyclophosphamide pulsed regime, the cycle is repeated every 4 weeks up to 6 cycles or till remission followed by oral cyclophosphamide",,,,,,,,A
L01,Cytarabine 100 mg Injection,"i) Central nervous system lymphoma 
ii) Meningeal leukemia 
iii) Non Hodgkin's Lymphoma 
iv) High dose cytarabine as conditioning to cytoreduce the disease before stem cell transplant for relapsed or refractory leukemia 
v) As salvage for acute lymphocytic leukemia 
vi) As salvage for acute myeloid leukemia 
vii) As palliative chemotherapy in elderly acute myeloid leukemia/ myelodysplastic syndrome","Standard doses 100 - 200 mg/m2 daily over 5 - 10 days. 
Higher doses for intensification/consolidation: 1000 - 3000 mg/m2 daily over 3 - 5 days depending on specific protocols. 
CHILD: Dose variable depending on disease and protocol. Range from 100 mg/m2 to 3 g/m2 twice daily. May be given as SC, IV bolus or infusion. 

Intrathecal dose: Less than 1 year: 15 mg, 1 - 2 years: 20 mg, 2 - 3 years: 25 mg, more than 3 years: 30 mg. (ENSURE THAT PREPARATION IS SUITABLE FOR INTRATHECAL USE)",A,,,Cytarine,7.00,/,amp,A
L01,"Docetaxel 20 mg/0.5 ml, 80 mg /2 ml Injection",For solid tumours such as: Breast Cancer; Non-small cell lung cancer; Prostate cancer; Gastric adenocarcinoma; Head and neck cancer; Ovarian cancer,"Breast cancer: Adult: 60-100 mg/m2 by infusion over 1 hr once every 3 wk. In combination w/ doxorubicin or capecitabine or as adjuvant therapy w/ doxorubicin and cyclophosphamide: 75 mg/m2 once every 3 wk. In combination w/ trastuzumab: 100 mg/m2 once every 3 wk; 

Gastric adenocarcinoma, Head and neck cancer, Non-small cell lung cancer, Prostate cancer: Adult: 75 mg/m2 by infusion over 1 hr once every 3 wk. 
For gastric adenocarcinoma: Dose is given before cisplatin and fluorouracil. 
For head and neck cancer: Given before cisplatin and fluorouracil for 3 cycles followed by chemoradiotherapy or 4 wk followed by radiotherapy alone. 
For prostate cancer: May be given w/ oral prednisolone 5 mg bid continuously during treatment.",A*,,,Daxotel,"23.00, 46.50",/,vial,A*
L01,"Doxorubicin HCl 10 mg, 50 mg Injection","i) Solid tumours, leukaemia, non-Hodgkin's lymphoma 
ii) Leukaemia (ALL induction) 
iii) Multiple myeloma","i) 30 - 75 mg/m2 IV as a single dose at 21 day intervals 
ii) 25 - 45 mg/m2 once a week for the first 4 weeks during induction or re-induction phase (refer to specific protocol. Caution: Total cumulative dose of doxorubicin must not exceed 550 mg/m2 due to risk of cardiotoxicity. 
CHILD: 30 mg/m2/dose over 6 - 24 hours for 1 - 2 days. Need to check cardiac function closely by echocardiography every cumulative dose of 100 mg/m2 to maximum 360 mg/m2 iii) 9 mg/m2 over 24 hours infusion for 4 days at monthly intervals",A,,,Adrim,"11.60, 23.20",/,vial,A
L02,Enzalutamide 40mg Capsule,"i) Metastatic castration-resistant prostate cancer
ii) Non-metastatic castration-resistant prostate cancer
iii) Hormone sensitive metastatic prostate cancer","160mg once daily. 
If greater than or equal to grade 3 toxicity or intolerable side effects occurs, withhold treatment for 1 week or until symptoms improve to less than or equal to grade 2 toxicity, then resume to normal dosing or reduce to 80-120 mg once daily if needed. ",Not in FUKKM,"Pembedahan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi","UBAT PESARA

Special Drugs Approval (UKK) required",Xtandi,,/,cap,
L01,"Epirubicin 10 mg, 50 mg Injection","Solid tumour, Non-Hodgkin's lymphoma, Leukaemia (ALL induction)","75 - 90mg/m2 body area injected IV in 3 - 5 min, repeated at 21 day intervals.
Higher doses up to 135mg/m2 as single agent and 120mg/m2 as combination (effective in treatment of breast cancer) 
CHILD: 50 mg/m2 over 6 hours. Schedule depends on protocol.Refer to specific product for dosing information",A*,,,Anthracin,"33.00, 73.08",/,vial,A*
L04,Etanercept 50mg Inj,"i)Moderately to severe rheumatoid arthritis as monotherapy or in combination with methotrexate in patients with inadequate response to methotrexate alone. 
ii)Active polyarticular-course juvenile idiopathic arthritis in children 2-17 years with inadequate response to, or who have proved intolerant of methotrexate. 
iii)Psoriatic arthritis as monotherapy or in combination with methotrexate in patients inadequate response to methotrexate alone. 
iv)Active ankylosing spondylitis in adults 
v)Moderate to severe plaque psoriasis who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA","Adult & geriatric dose: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis; 50 mg SC once-weekly for once-weekly dosing or 25 mg SC twice weekly (individual doses should be separated by 72 to 96 hours) for twice-weekly dosing. 

Paediatric dose (2 to 17 years): Juvenile idiopathic arthritis; 0.8 mg/kg (max. 25 mg/dose) SC once weekly for once-weekly dosing or 0.4 mg/kg (max. 25 mg/dose) SC twice weekly (individual doses should be separated by 72 to 96 hours) for twice-weekly dosing",A*,Perubatan,Kuota,Enbrel,968.19,/,pen ,A*
L01,Etoposide 100 mg/5 ml Injection,"i) For treatment of children with solid tumours, juvenile myelomonocytic leukemia (JMML) and Langerhan cell histiocytosis 
ii) Leukaemia, lymphoma 
iii) solid tumour","i) CHILD: 60-120 mg/m2/day by IV for 3 - 5 days every 3 - 6 weeks depending on protocols 
ii) Maintenance or palliative chemotherapy for elderly acute myeloid leukemia, consolidation therapy for acute lymphoblastic leukemia, stem cell mobilization (Refer to protocol) 
iii) 100 mg/m2 by IV every other day for 3 doses repeated every 3-4 weeks",A*,,,Fytosid,20.45,/,vial,A*
L04,"Everolimus 0.25mg, 0.75mg Tablet",Indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant in combination with ciclosporin for microemulsion and corticosteroids,"An initial dose regimen of 0.75 mg b.i.d., which is recommended for the general kidney and heart transplant population. The daily dose of everolimus should always be given orally in two divided doses (b.i.d.).",A*,Perubatan,Kuota,"0.25

0.75","7.66

23.12",/,tab,
L02,Exemestane 25 mg Tablet,Treatment of post-menopausal women with advanced breast cancer whose disease has progressed following tamoxifen and non-steroidal aromatase inhibitors,25mg OD,A*,"Pembedahan, Obstetrik",,Aromasin,6.33,/,tab,
L01,Fluorouracil 250 mg/5 ml Injection (20ml),Solid tumours. Ophtalmological indication: trabeculectomy,"Intravenous Infusion: 15 mg/kg bodyweight (to a maximum of 1 g daily) diluted in 300-500mL of 5% glucose given over a period of 4 hours. 12 mg/kg bodyweight daily for 3 consecutive days. Providing there are no signs of toxic effects, the patient may then be given 6mg/kg I.V. on the 5th, 7th and 9th days. If after the 9th day there is still no sign of toxicity, the patient may be placed on maintenance therapy. 
Maintenance Therapy: 5 - 10mg/kg bodyweight by I.V. injection once a week.",A*,,,Intas Flurac,19.14,/,vial,A*
L01,Gefitinib 250mg Tablet,"i) First line treatment of adult patients with locally advanced or metastatic Non Small Cell Lung Cancer (NSCLC) who have activating mutations of the EGFR TK. 

ii) For second line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have previously failed chemotherapy, and who have activating mutation of epidermal growth factor receptor (EGFR).","250mg tablet once a day, taken with or without food

Prescribing restriction:
Indication (i): - Adenocarcinoma histology - Patient's ECOG Performance Status 0-1 - Must be prescribed by an oncologist or oncology-trained respiratory physician. Indication (ii) - Adenocarcinoma histology - Patient's ECOG Performance Status 0-1 - Must be prescribed by an oncologist or oncology-trained respiratory physician. - Must not have received prior TKI for this condition.",A*,Perubatan,Kuota,Intega,16.60,/,tab,
L01,Gemcitabine HCl 1 g Injection,"Solid tumours such as: 
(i) Non-small cell lung cancer
(ii) pancreatic cancer
(iii) ovarian cancer 
(iv) breast cancer","i) Alone or with cisplatin: 1000 mg/m2 day 1 & 8 every 3 weeks or 1000 mg/m2 day 1, day 8, day 15 every 4 weeks 
ii) Initially 1000 mg/m2 weekly for 7 weeks followed by 1 week rest. Subsequent cycles 1000 mg/ m2 weekly for 3 weeks followed by 1 week rest 
iii) Gemcitabine 1000 mg/m2 as 30 minutes IV infusion day 1 & 8 of each 21-day cycle followed by carboplatin on day 1 to attain a target AUC of 4 mg/ml/minute 
iv) 1250 mg/m2 on days 1 and 8 of each 21-day cycle with paclitaxel 175 mg/m2 given as a 3-hour infusion before gemcitabine on day 1 of each 21-day cycle",A*,,,Citabol,41.20,/,vial,A*
L04,"Golimumab 100mg/ml solution
for injection ","i) Rheumatoid arthritis (RA): 
In combination with methotrexate (MTX), is indicated for: 
- The treatment of moderate to severe active rheumatoid arthritis in adult patients when the response to DMARD therapy including MTX has been inadequate. 
- The treatment of active, severe and progressive rheumatoid arthritis in adult patients not previously treated with MTX. 
ii) Psoriatic arthritis (PsA): 
Golimumab alone or in combination with MTX, is indicated for: The treatment of active psoriatic arthritis in adult patients when the response to previous DMARD therapy has been inadequate. 
iii) Ankylosing spondylitis (AS):
Golimumab(used alone) is indicated for: The treatment of active ankylosing spondylitis in adult patients when the response to conventional therapy has been inadequate.","i) Rheumatoid arthritis 50mg given as a subcutaneous injection once a month, on the same date each month. 

ii)Psoriatic arthritis 50mg given as a subcutaneous injection once a month, on the same date each month. 

iii) Ankylosing spondylitis 50mg given as a subcutaneous injection once a month, on the same date each month.",A*,,Kuota,Simponi,3702.00,/,pen,A*
L01,Hydroxyurea 500 mg Capsule,"i) Solid tumours 
ii) Chronic myelocytic leukaemia and myeloproliferative disease ","i) Intermittent therapy: 80 mg/kg orally as a single dose every 3rd day.
Continuous therapy: 20 - 30 mg/kg orally as a single dose dly.
Concomitant therapy with irradiation: 80 mg/kg orally as a single dose every 3rd day (administration of hydroxyurea should be started at least 7 days before initiation of irradiation and continued during radiotherapy as well).

ii) Continuous therapy 20 - 30 mg/kg orally as a single dose daily",A,Perubatan,,DHNP Hydroxyurea,2.53,/,cap,A
L01,Ibrutinib 140mg Capsule,"i) Mantle cell lymphoma

","i) Adult: In patients with relapsed or refractory cases: 560 mg once daily, continue until disease progression or unacceptable toxicity. If toxicity occurs, withhold doses until recovery to baseline or grade 1. Restart treatment at the starting dose for the 1st occurrence, then reduce by 140 mg after the 2nd occurrence, another reduction of 140 mg may be considered if needed. Discontinue following 2 dose reductions if toxicities persist.",Not in FUKKM,"Perubatan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi","UBAT PESARA

Special Drugs Approval (UKK) required",Imbruvica,215.53,/,cap,
,,ii) Chronic lymphocytic leukemia,"ii) Adult: As monotherapy or in combination with bendamustine and rituximab in patients who have received at least 1 prior therapy or as 1st line treatment in patients with 17p deletion: 420 mg once daily, continue until disease progression or unacceptable toxicity. If toxicity occurs, withhold doses until recovery to baseline or grade 1. Restart treatment at the starting dose for the 1st occurrence, then reduce by 140 mg after the 2nd occurrence, another reduction of 140 mg may be considered if needed. Discontinue following 2 dose reductions if toxicities persist.",,,,,,,,
,,iii) Chronic graft versus host disease,"iii) Adult: 420 mg once daily, continue until disease progression or unacceptable toxicity. If toxicity occurs, withhold doses until recovery to baseline or grade 1. Restart treatment at the starting dose for the 1st occurrence, then reduce by 140 mg after the 2nd occurrence, another reduction of 140 mg may be considered if needed. Discontinue following 2 dose reductions if toxicities persist.
",,,,,,,,
L04,Infliximab 100mg Injection ,"i) Rheumatoid arthritis (moderate to severe), in combination with methotrexate 
ii) Ankylosing spondylitis in patients with active disease despite treatment with methotrexate 
iii) Crohn's Disease in patients who have an inadequate response to conventional therapies. 
iv) Fistulizing Crohn's Disease in patients who have an inadequate response to conventional therapies 
v) Ulcerative Colitis in patients who have an inadequate response to conventional therapies","i) Rheumatoid arthritis: ADULT over 18 years old: 3 mg/kg at 0, 2, 6 weeks, then every 8 weeks; May increase to 10 mg/kg or increase dosing frequency to 4 weekly for patients with incomplete response. Discontinue if no response by 12 weeks of initial infusion or after dose adjustment 
ii) Ankylosing spondylitis: ADULT over 18 years: 5 mg/kg IV over 2 hour given at week 0, 2, and 6 then every 6-8 weeks. Discontinue if no response by 6 weeks of initial infusion. 
iii), iv) & v)5 mg/kg given as an intravenous infusion over a 2-hour period followed by additional 5 mg/kg infusion doses at 2 and 6 weeks after the first infusion, then every 8 weeks thereafter",A*,Perubatan,Kuota,Remsima,700.00,/,vial ,A*
L01,Irinotecan HCl Trihydrate 100 mg/5 ml Injection                  ,Metastatic colorectal cancer,In combination therapy (for previously untreated patients): 180 mg/m2 once every 2 weeks as an IV infusion over 90 mins followed by infusion with folinic acid and 5-fluorouracil. In monotherapy (for previously treated patients): 350 mg/m2 administered as an intravenous infusion over 90 minutes period once every 3 weeks,A*,,,Irinol,40.00,/,vial,A*
L04,Ixekizumab 80mg Solution for Injection in Pre-filled Syringe,"Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. Monotherapy or in combination w/ methotrexate for active psoriatic arthritis in adults who have responded inadequately to, or who are intolerant to ≥1 disease-modifying anti-rheumatic drug therapies.
Off-label use: Ankylosing Spondylitis","SC Plaque psoriasis Recommended dose: 2 inj at wk 0, then 1 inj at wk 2, 4, 6, 8, 10 & 12. Maintenance dose: 1 inj every 4 wk. Psoriatic arthritis Recommended dose: 2 inj at wk 0, then 1 inj every 4 wk thereafter.

Ankylosing Spondylitis: 160mg at week 0, then 80mg starting at week 4 every 4 weeks",,Perubatan,"Guna peruntukan JPA, perlu mohon ubat baru jika nak guna peruntukan hosp",Taltz,2568.10,/,PFS,
L01,"L-Asparaginase 10,000 IU Injection","i) Acute lymphoblastic leukemia 
ii) Non-hodgkin's lymphoma","i) 5,000 iu/m2 for 10 days during induction, 10,000 iu/m2 also used with high dose methotrexate rescue in consolidation phase of acute lymphoblastic leukemia 
ii) CHILD: 5,000 - 25,000 iu/m2 per dose depending on protocol",A*,,,Leunase,49.56,/,vial,A*
L01,Lenvatinib 4mg Hard Capsule,Indicated as monotherapy for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have received no prior systemic therapy,"The recommended daily dose of lenvatinib is 8 mg (two 4 mg capsules) once daily for patients with a body weight of < 60 kg and 12 mg (three 4 mg capsules) once daily for patients with a body weight of ≥ 60 kg.

Dose adjustments are based only on toxicities observed and not on body weight changes during treatment (Refer package insert for dosage adjustments)

Treatment should continue as long as clinical benefit is observed or until unacceptable toxicity occurs.

Prescribing restriction: Only for patients with Child-Pugh A
",A*,Pembedahan,Kuota,Lenvima,85.94,/,tab,
L02,Letrozole 2.5 mg Tablet,Hormonal therapy in breast cancer in post-menopausal women if failed /contraindicated to Tamoxifen,2.5 mg once daily,A*,Pembedahan,,Letero,0.52,/,tab,A*
L01,Melphalan 2mg Tablet,"i) Multiple myeloma ii) Neuroblastoma, rhabdomyosarcoma iii) Recurrent neuroblastoma (palliative)","i) 8 - 10 mg/m2 for 4 days every 4 weeks ii) 10 - 35 mg/m2 once every month For dose regimes, refer to protocols",A,Perubatan,,Alkeran,10.13,/,tab,
L01,Mercaptopurine 50mg Tablet,i) Langerhan's cell histocytosis ii) Acute lymphoblastic leukaemia iii) Acute promyelocytic leukaemia APML (maintenance) ,"Leukaemia adults: 2.5mg/kg or 80-00mg/m2 p.o per day, given as a single dose. To be increased at the end of 4 weeks, If necessary, up to 5mg/kg p.o per day. 

Maintainance dosage are 1.5mg/kg -2.5mg/kg p.o per day

Children age 5 and older: Induction: 2.5mg/kg/day p.o once daily. Maintanance dose: 1.5mg/kg -2.5mg.kg p.o once daily or 70-100mg/m2 p.o once daily.",A,Perubatan,,"Averroes 
mercaptopurine",4.01,/,tab,
L01,Methotrexate 50 mg Injection,"i) Solid tumours 
ii) Gestational trophoblastic disease 
iii) Acute leukaemia/lymphomas 
iv) Rheumatoid arthritis, psoriatic arthropathy, severe/erythrodermic psoriasis","i) 50 mg/m2 once every 2 - 3 weeks in combination with other drugs 
ii) 50 mg IV Day 1, 3, 5, 9 every 3 weeks. For high risk gestational trophoblastic disease, use 100 mg/m2 as part of EMA-CO regime 
iii) High dose regimes: 500 - 3000 mg/m2 per dose may be used, employing the 500 mg preparations. 
CHILD: Central nervous system prophylaxis for acute leukaemia 2 gm/m2 over 24 hours with folinic acid rescue, 3 doses for B-cell lineage. 4 doses for T-lineage all every 3 weeks. Relapse acute lymphoblastic leukaemia (ALL): 1 gm/m2 over 36 hours with folinic acid rescue every 3 weeks for 9 doses, maintenance: 50 mg/m2 every 2 weeks. ",A,,,Zexate,10.44,/,vial,
,,,"B-cell lymphoma: 3 gm/m2 over 3 hours with folinic acid rescue for three doses. Methotrexate level monitoring recommended when using high dose regimens. 
The 500 mg strength is not for intrathecal (IT) use. 
Dosage for intrathecal treatment and prophylaxis in leukaemia: less than 1 year: 5 mg, 1 - 2 years: 7.5 mg, 
2 - 3 years: 10 mg, more than 3 years: 12.5 mg. 
IT preparation must be clearly stated/verified. 
ENSURE THAT PREPARATION IS SUITABLE FOR INTRATHECAL USE
 
iv) Dose used by rheumatologist: 10 - 15 mg IM injection or oral weekly. 
Dose used by dermatologist: 10 - 25 mg IM injection weekly",,,,,,,,A
L04,Methotrexate 2.5 mg Tablet,"i. Antineoplastic Chemotherapy
- Treatment of gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole.
- Palliation of acute lymphocytic leukemia
- Treatment and prophylaxis of meningeal leukemia.
- Palliation of acute lymphoblastic (stem-cell) leukemias in children.
- Alone or in combination with other anticancer agents in the management of breast cancer, epidermoid cancers of the head and neck, and lung cancer, particularly squamous cells and small cell types.
- Treatment of the advanced stages (III & IV, Peters Staging System) of lymphosarcoma, particularly in those cases in children; and in advanced cases of mycosis fungoides.

ii. Psoriasis Chemotherapy
Symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation.

iii. Rheumatoid arthritis",Dosing is individualised and according to product insert / protocol,A,Perubatan,,PFZ,0.53,/,tab,A
,,,,,,,,,,,
L01,Mitomycin-C 10 mg Injection,"i) Gastrointestinal, lung, breast, cervical cancers 
ii) Bladder tumours 
iii) Opthalmological conditions: conjunctival squamous neoplasia, squamous cell carcinoma of conjunctiva, trabeculectomy chronic lymphocytic leukaemia, chronic myelogenous leukaemia. Gastric, colorectal, lung cancer","i) 10 - 20 mg/m2 body surface area (BSA) given as a single dose through a running IV infusion repeated every 6 - 8 weeks. The whole schedule may be repeated depending on the bone marrow 
ii) 10 - 40 mg daily or every other day (intravesical) 
iii) 0.4 mg topically as a single application for opthalmological conditions, duration: 1 to 3 minutes",A*,,"No ready stock, will get stock when there is case",Mito-10,205.15,/,vial,A*
L04,"Mycophenolate Mofetil 250 mg capsule, 500 mg tablet   

see notes for which brand to supply                                  "," 
i) Prophylaxis of acute organ rejection in patients receiving allogenic renal, cardiac and hepatic transplant

ii) Used with steroids for induction and maintenance of severe lupus nephritis

Off-label use in HSM: Extra-renal lupus, RA ILD","i) Renal transplant rejection: 
ADULT: 1 g twice daily. 
CHILD (3 months and older): 600 mg/m(2)/dose, twice daily; maximum daily dose, 2 g/10 mL. 
Cardiac transplant rejection: 1.5 g twice daily. 
Hepatic transplant rejection: 1.5 g twice daily 

ii) Induction phase: 2 - 3 g/day for up to 6 months. 
Maintenance phase: dose gradually tapers to 1 g/day

Extra renal lupus & RA ILD: 500mg BD (refer rheumatologist)",A*,"Perubatan
Rheumatology

Special Drugs Approval (UKK) NOT REQUIRED as exemption has been given","Cellcept (for transplant patients & patients intolerant to MYCOFIT);
MYCOFIT (for other patients)"," Cellcept 500,
Mycofit 500 
Mycofit 250   ","4.92
1.42
0.82",/,tab / cap,A*
L04,"Mycophenolate Sodium 180mg, 360mg Tablet","Prophylaxis of acute transplant rejection in adult patients receiving allogenic renal transplant in combination with ciclosporin and corticosteroids

Off-label use in HSM (UKK): Extra-renal lupus, RA ILD","720 mg twice daily


Extra renal lupus & RA ILD: 500mg BD (refer rheumatologist)",A*,"Perubatan
Rheumatology

Special Drugs Approval (UKK) REQUIRED for off-label indication as there is no exemption given for myfortic",,"
Myfortic 180mg

Myfortic 360mg
","3.45


6.74
",/,tab,
L01,Nintedanib 150mg capsule,"i) For the treatment of Idiopathic Pulmonary Fibrosis (IPF) in adults

ii) Indicated in adults for the treatment of other chronic fibrosing lung disease (ILDs) with a progressive phenotype
Restrictions:
• FVC at least 40% of predicted value, and
• DLCO 30% to 89% of predicted value
• To be prescribed by Consultant Respiratory Physician and Rheumatologist only","i) The recommended dose is 150 mg twice daily administered approximately 12 hours apart.
The 100 mg twice daily dose is only recommended to be used in patients who do not tolerate the 150 mg twice daily dose.

ii) 150mg twice a day",A*,"Perubatan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi",UBAT PESARA,OFEV,57.15,/,cap,
L01,Osimertinib 80mg Tablet,"The treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC whose disease has progressed on or after EGFR TKI therapy

Restriction: Second-line therapy, in patients who progressed from first-line EGFR TKI therapy.
To be prescribed by oncologists and oncology-trained respiratory physicians","80 mg once a day until disease progression or unacceptable toxicity, taken with or without food at the same time each day.
If dose reduction is necessary, then the dose should be reduced to 40 mg taken once daily.
",A*,Perubatan, Kuota,Tagrisso,403.60,/,tab,
L01,Oxaliplatin 50 mg/10 ml Injection,Colorectal cancer,85 mg/m2 IV repeated every 2 weeks,A*,,,FK Oxaplin,22.50,/,vial,A*
L01,Paclitaxel 100 mg/16.6 ml Injection,"i) Treatment of recurrent breast cancer, after failure of anthracycline-based chemotherapy 
ii) Primary adjuvant therapy in advanced ovarian cancer in combination with cisplatin 
iii) Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in chemonaive patients in combination with platinum compounds","i) 175 mg/m2 IV over 3 hours every 3 weeks 
ii) 175 mg/m2 IV over 3 hour followed by cisplatin 75 mg/m2 in every 3 weeks or 135 mg/m2 IV over 24 hours followed by cisplatin 75 mg/m2 every 3 weeks 
iii) 135 mg/m2 IV over 24 hours followed by cisplatin 75 mg/m2 every 3 weeks",A*,,,FK Intaxel,60.84,/,vial,A*
L03,Peginterferon Alfa-2b 80 mcg Injection,Treatment of: i) Chronic Hepatitis C ii) Chronic Hepatitis B,"i) Combination therapy with Ribavirin: 
ADULT: SC 1.5 mcg/kg/week 
CHILD and ADOLESCENT (3-17 yr): SC 60 mcg/m2/week for 24-48 weeks 

Monotherapy: ADULT: SC 1 mcg/kg/week for 24 weeks to 1 year 

ii) SC 1.0 - 1.5 mcg/kg once weekly for 52 weeks",A*,,,Peg-Intron,544.00,/,pen,A*
L01,"Palbociclib 75mg, 100mg, 125mg Tablet","Indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.","125 mg capsule taken orally once daily for 21 consecutive days followed by 7 days off treatment to comprise a complete cycle of 28 days.

Palbociclib should be taken with food. For dose modification, refer package insert",A*,Pembedahan,Kuota,Ibrance,110.65,/,tab,
L01,Pazopanib Hydrochloride 400 mg Tablet,"For treatment of advanced and/or metastatic renal cell carcinoma (RCC)

Restriction:
i) KPS ≥ 70% 
ii) Clear cell histology
iii) No brain metastasis
iv) Haemoglobin ≥ 9g/dl 
v) Creatinine ≤2x the ULN
vi) Corrected calcium < 12mg/dl
vii) Platelet count of >100x103/uL viii) Neutrophil count >1,500/mm3",Recommended dose is 800 mg ORALLY once daily. Should be taken without food (at least one hour before or two hours after meal). The dose should not exceed 800 mg.,A*,Pembedahan,Kuota,Votrient,113.30,/,tab,
L01,Pemetrexed Disodium 500mg inj,In combination with Cisplatin for the 2nd line treatment of patients with locally advanced or metastatic non small cell lung cancer (NSCLC) other than predominantly squamous cell histology,"Initial therapy 500 mg/m(2) IV over 10 minutes on day 1, followed 30 minutes later by cisplatin 75 mg/m(2) infused IV over 2 hours; repeat cycle every 21-days. Prior chemotherapy : 500 mg/m(2) IV, as a single-agent, over 10 minutes on day 1 of each 21-day cycle",A*,Perubatan,,Accord,400.53,/,vial,
L01,Pertuzumab 420mg/14ml injection,"Pertuzumab in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory, or early-stage breast cancer (node-positive) as part of a complete treatment regimen for early breast cancer.

Prescribing Restriction:
To be prescribed by Oncologist only","The recommended initial dose of pertuzumab is 840mg administered as a 60-minute intravenous infusion, followed every 3 weeks thereafter by a dose of 420mg administered over a period of 30 to 60 minutes for up to 3 cycles.",A*,"Pembedahan

Menggunakan peruntukan ZAKAT/NGO. Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi",,Perjeta,4998.00,/,vial,
L04,Pirfenidone 267 mg capsule,Idiopathic pulmonary fibrosis,"Adult: Initially, 267 mg tid for 7 days, then increase dose to 534 mg tid for 7 days, then to usual maintenance dose: 801 mg tid. Max: 2403 mg daily. Adjust dosage according to toxicity.

Patient concomitantly using strong CYP1A2 inhibitors (e.g. enoxacin, fluvoxamine): 267 mg tid.
Patient concomitantly using ciprofloxacin at a dosage of 750 mg bid: 534 mg tid.",Not in FUKKM,"Perubatan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi"," UBAT PESARA

Special Drugs Approval (UKK) required",Esbriet,15.47,/,cap,
L04,Rituximab 10mg/ml Injection (500mg/50ml),"i) Treatment of patients with relapsed or chemo-resistant low grade or follicular B-cell Non-Hodgkin's lymphoma 
ii) Adjunctive therapy with combination chemoagents for aggressive Non-Hodgkin Lymphoma 
iii) Severe active rheumatoid arthritis with inadequate response or intolerance to other disease-modifying anti-rheumatic drugs (DMARDs) including one or more tumour necrosis factor (TNF) inhibitor therapies 
iv) Maintenance in relapsed/ refractory follicular lymphoma after response to induction therapy","i) 375 mg/m2 BSA administered as an IV infusion through a dedicated line once weekly for 4 weeks 
ii) Combination with CHOP (cyclophosphamide, doxorubicin, prednisone and vincristine) as 375 mg/m2 BSA on day 1 of each chemotherapy cycle for 8 cycles after IV administration of the glucocorticoid component of CHOP. 
iii) 1000 mg IV infusion followed by a second 1000 mg IV infusion two weeks later 
iv) 375mg/m2 BSA once every 3 months until disease progression or for a maximum period of two years.

",A*,"Perubatan (haematology, rheumatology, neurology, dermatology,  nephrology)

","Kuota

Special Drugs Approval (UKK) required for off-label indication NOT listed

 ",Mabthera,3402.00,/,vial,
,,"Off-label indications 
(UKK exemptions given): 
1) For ITP in patients who failed or unsuitable for first line therapy
2) For acquired haemophilia in patients resistant to first line therapy or whom steroids and/or cytotoxics are best avoided.
3) Non renal manifestation of SLE
4) Active/severe SLE despite conventional immunosuppressants or high dose steroids
5) Active/severe autoimmune systemic vasculitis not responding to conventional immunosuppressants or high dose steroids
6) Multiple sclerosis
7) Refractory Myasthenia Gravis
8) Neuromyelitis optica spectrum disorder- NMOSD
9)Refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
10)Autoimmune encephalitis
11)As 1st line treatment for high risk (Thrombotic thrombocytopenic purpura) TTP patients
12)Pemphigus Vulgaris
13)Pemphigus Foliaceus","1) - 2) & 11) Refer haematologist

3) - 5)  Refer rheumatologist
 
6) - 10) Refer neurologist. 

12) - 13) Refer dermatologist",,,,,,,,
,,,,,,,,,,,
L01,Ribociclib 200mg Tablet,"In combination with: - an aromatase inhibitor for the treatment of postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy.","600 mg daily for 21 consecutive days followed by 7 days off treatment. Can be taken with or without food. For dose modification, refer package insert.",A*,Pembedahan,Kuota,Kryxana,47.59,/,tab,
L01,Ruxolitinib 20mg tablet,"For the treatment of disease-related splenomegaly or symptoms in adult patients with:
i) primary myelofibrosis (also known as chronic idiopathic myelofibrosis); or
ii) post-polycythemia vera myelofibrosis; or
iii) post-essential thrombocythemia myelofibrosis.","The recommended starting dose:
i) Platelet count between 100,000/mm³ and 200,000/mm³: 15 mg twice daily for patients
ii) Platelet count of >200,000/mm³: 20 mg twice daily for patients
iii) Platelet counts between 50,000/mm³ and <100,000/mm³: Limited information to recommend a starting dose for patients.
The maximum recommended starting dose in these patients is 5 mg twice daily and the patients should be titrated cautiously.",A*,"Perubatan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru (borang tambahan kuota untuk kes seterusnya) jika ingin menggunakan peruntukan ubat farmasi", UBAT PESARA,Jakavi,253.57,/,tab,
L04,Secukinumab 150mg/ml solution for injection in a pre-filled pen,"i) Alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.
Restriction: To be prescribed by Rheumatologist only

ii) Indicated for the treatment of active ankylosing spondylitis (AS) in adults who have responded inadequately to conventional therapy.
Restriction: 2nd or 3rd line, after failure of conventional DMARDs or TNF-inhibitors.

iii) Indicated for the treatment of moderate-to-severe plaque psoriasis in patients 6 years and older who are candidates for systemic therapy or phototherapy.","Indication (i)
150 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4.
For patients who are anti-TNFα inadequate responders (IR) or patients with concomitant moderate to severe plaque psoriasis;
300 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4. Each 300 mg dose is given as two subcutaneous injections of 150 mg.

Indication (ii)
150 mg by subcutaneous injection with initial dosing at Weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at Week 4. Based on clinical response, the dose can be increased to 300 mg.

Indication (iii) 
Adult: 300 mg by subcutaneous injection with initial dosing at weeks 0, 1, 2 and 3, followed by monthly maintenance dosing starting at week 4. Each 300 mg dose is given as two subcutaneous injections of 150 mg. For some patients, a dosage of 150 mg may be acceptable.
Child (6 years and older): The recommended dose is based on body weight* and administered by subcutaneous injection with initial dosing at Weeks 0, 1, 2, 3, and 4 followed by monthly maintenance dosing (every 4 weeks).
*<25kg: 75mg; 25-50kg: 75mg; >/=50kg: 150mg (may be increased to 300mg)",A*,Perubatan,Kuota,Fraizeron,930.00,/,vial,
,,,,,,,,,,,A*
L04,Sirolimus 1mg tab,"Prophylaxis of organ rejection in patient receiving renal transplant

Off-label indication: Autoimmune Lymphoproliferative Syndrome (ALPS)","De novo transplant combination therapy: Low to moderate immunologic risk Loading dose: 6 mg as soon as possible after transplant followed by maintenance: 2 mg once daily. High immunologic risk Loading dose: 15 mg on day 1 post-transplant followed by 5 mg on day 2. Adjust dose based on whole blood conc 10-15 ng/mL by obtaining trough levels on days 5-7. Cyclosporine w/drawal Discontinue use over 4-8 wk, 2-4 mth after transplantation. Adjust dose based on whole blood trough conc 16-24 ng/mL (chromatographic method) for 1st yr, thereafter 12-20 ng/mL.

Autoimmune Lymphoproliferative Syndrome (ALPS): 1mg OD to BD depending on TDM levels

",Not in FUKKM,Pediatrik,"Special drugs approval (UKK) required
",Rapamune,31.23,/,tab,
L04,Tacrolimus Ointment 0.1 %,"For short-term and intermittent long-term therapy in the treatment of patients with moderate to severe atopic dermatitis in whom the use of alternative, conventional therapies are deemed inadvisable because of potential risks, or in the treatment of patients who are not adequately responsive to or are intolerant of alternative, conventional therapies","Adult ≥ 16 years: Apply 0.03% or 0.1% to the affected skin twice daily and rub in gently and completely. 
Children ≥ 2 years: Apply 0.03% ointment thinly to the affected skin bd and rub in gently and completely. Treatment should be continued for 1 week after clearing of signs & symptoms of atopic dermatitis.",A*,Perubatan,Kuota,Protopic,134.58,/,tube,A*
L04,"Tacrolimus 1mg, 0.5mg capsule ","i) Primary immunosuppression in liver and kidney allograft recipients. 
ii) Liver and kidney allograft rejection resistant to conventional immunosuppressive agents. It is recommended to be used concomitantly with adrenal corticosteroids. Because of the risk of anaphylaxis. Injection should be reserved for patients unable to take capsules only.

Off-label indication: Lupus nephritis and moderate to severe refractory SLE 
(For patients non-responsive to conventional treatment)","


0.1-0.2 mg/kg/day for liver transplantation and at 0.15-0.3 mg/kg/day for kidney transplantation administered as 2 divided doses.




Lupus nephritis: refer nephrologist. 1mg BD to 2mg BD have been used in this hospital",A*,Perubatan,"Kuota

Special Drugs Approval (UKK) NOT REQUIRED for the mention Off-label indication as exemption has been given ","Prograf 1mg

Prograf 0.5mg","7.3

4.01",/,cap,A*
L04,"Tacrolimus 0.5mg, 1mg, 5mg Prolonged-Release Hard Capsules ","i) Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. 
ii) Treatment of kidney or liver allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult.",i) Prophylaxis of transplant rejection: a) Kidney Transplant: Tacrolimus PR therapy should commence at dose of 0.20-0.30 mg/kg/day administered once daily in the morning. Administration should commence within 24 hours after completion of surgery. b) Liver Transplant Tacrolimus PR therapy should commence at a dose of 0.10-0.20 mg/kg/day administered once daily in the morning. Administration should commence within 12-18 hours after completion of surgery. ii) Treatment of allograft rejection: For conversion: a) From other immunosuppressants to once daily Tacrolimus PR: Treatment should begin with the initial oral dose recommended in kidney and liver transplantation respectively for prophylaxis of transplant rejection. b) From Tacrolimus to Tacrolimus PR: Allograft transplant patients maintained on twice daily Tacrolimus capsules dosing requiring conversion to once daily Tacrolimus PR should be converted on a 1:1 (mg:mg) total daily dose basis. Tacrolimus PR should be administered in the morning.,A*,Perubatan,Kuota,"Advagraf 
0.5mg

Advagraf 1mg

Advagraf 5mg","7.26


3.87


29.04",/,cap,
L02,Tamoxifen Citrate 20 mg Tablet,Breast cancer,20 mg in 1-2 divided doses. Max: 40 mg/day,A,"Pembedahan, Obstetrik",,Nolvadex-D,0.45,/,tab,A
L01,Tegafur 100 mg & uracil 224 mg Capsule,"i) Non small cell lung cancer;
ii) Tegafur Uracil plus folinic acid (leucovorin) combination therapy is indicated for the treatment of colorectal cancer in: a) Metastatic stage; b) Adjuvant setting; c) Concurrent setting.","i) 300-600 mg daily in 2-3 divided doses;
ii) Adjuvant setting - 300mg/m2/day , Day 1-28, rest 7 days; Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles; Concurrent setting - 300mg/m2/day; Leucovorin Calcium 25 mg /day, D8- D36, for 4 weeks; Metastatic stage - 300mg/m2/day , Day 1-28, rest 7 days; Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles.",A*,Pembedahan,Kuota,Ufur,3.89,/,cap,
L04,Thalidomide 50 mg Capsule,"First line induction therapy in newly diagnosed multiple myeloma, salvage therapy in relapsed multiple myeloma and maintenance therapy in multiple myeloma (contraindicated for pregnant women; pregnancy test for females in reproductive age group before starting treatment should be done).",50 mg to 200 mg daily,A*,Pembedahan,Kuota,Domide,4.12,/,tab,A*
L04,"Tocilizumab 162 mg Injection
 in prefilled syringe ","Indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients: 
i) with inadequate respond or intolerance to conventional disease- modifying antirheumatic drugs (DMARDS) 
ii) who has failed antitumour necrosis factors (antiTNFs) 
iii) where TNF is contraindicated (patients with history of pulmonary tuberculosis [PTB]) It also can be used as monotherapy or with combination with methotrexate (MTX) and/ or other DMARDS.","Adult patients: 162mg given once every
 week as a subcutaneous injection.",A*,Perubatan ,Kuota,Actemra,642.57,/,pen ,
L04,"Tocilizumab 400mg/20ml, 80mg/4ml Injection","Indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients: i) with inadequate respond or intolerance to conventional disease- modifying antirheumatic drugs (DMARDS) ii) who has failed antitumour necrosis factors (antiTNFs) iii) where TNF is contraindicated (patients with history of pulmonary tuberculosis [PTB]) It also can be used as monotherapy or with combination with methotrexate (MTX) and/ or other DMARDS.

Off-label indication: Treatment of severe covid-19 infection
","Recommended dose for rheumatoid arthritis of tocilizumab for adult patients is 8mg/kg given once every 4 weeks as a single-drip IV infusion over 1 hour. It should be diluted to 100 ml by a healthcare professional with sterile 0.9% w/v sodium chloride solution over 1 hour. For patients whose body weight is more than 100kg, doses exceeding 800mg per infusion are not recommended

Treatment of severe covid-19 infection: 8mg/kg single dose (not to exceed 800mg)",A*,Perubatan,"Kuota

Special Drugs Approval (UKK) NOT REQUIRED for the mention Off-label indication as exemption has been given ","Actemra 400mg

Actemra 80mg","2560.2


512.05",/,vial,
L04,Tofacitinib citrate 5mg film coated tablet,Indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).,One tablet twice daily,A*,Perubatan,Kuota,Xeljanz,51.41,/,tab,
L01,Trastuzumab 440mg Injection,"i) Used only in adjuvant setting for patients with HER2 over-expressed breast cancer, that is HER2 3+ by immunohistochemistry and over-expressed by FISH (Fluorescence in situ hybridization) and high risk group ii) Restriction: Oncologist only: Treatment of HER2-positive non-metastatic breast cancer in combination with neoadjuvant chemotherapy followed by adjuvant trastuzumab, for locally advanced (including inflammatory) breast cancer or tumours >2cm in diameter.","i) Initial loading dose is 4 mg/kg administered as a 90 minutes IV infusion. Subsequent doses is 2 mg/kg administered as 30 minutes IV infusion weekly for 51 weeks ii) Initial loading dose of 8 mg/kg body weight, followed by 6 mg/kg body weight 3 weeks later and then 6 mg/kg repeated at 3-weekly intervals administered as infusions over approximately 90 minutes. If the prior dose was well tolerated, the dose can be administered as a 30-minute infusion.",A*,Pembedahan,Kuota,Herzuma,812.00,/,vial,
L04,Upadacitinib 15mg tablet,"i) Indicated for the treatment of severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy.
Restriction:
a. As fourth line of treatment in patients who have failed / have contraindications / experienced adverse events to: 
• Intensive and optimized topical treatment 
• Phototherapy 
• At least two immunosuppressants 
b. To be prescribed by Dermatologists only.

ii) Indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. May be used as monotherapy or in combination with methotrexate.
Restriction: To be prescribed by Rheumatologist only

iii) Indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs). Upadacitinib may be used as monotherapy or in combination with methotrexate
Restriction: 
a. To be prescribed after failing/ intolerance/ contraindicated to csDMARDs (as per Malaysian Consensus on Biologic Usage) and one biologic DMARDs.
b. To be prescribed by Rheumatologist only

HSM off label use: 
1. Refractory Ankylosing Spondylitis
2. Ulcerative colitis","Indication i -severe atopic dermatitis:
Adults: The recommended dose of upadacitinib is 15 mg or 30 mg once daily based on individual patient presentation (Refer to package insert). The lowest effective dose for maintenance should be considered.

Adolescents (from 12 to 17 years of age): The recommended dose of upadacitinib is 15 mg once daily for adolescents weighing at least 40 kg.

Upadacitinib can be used with or without concomitant topical therapies (Refer package insert)

Indication ii & iii - active psoriatic arthritis & moderate to severe active rheumatoid arthritis: 15 mg once daily

Off-label use
Ankylosing Spondylitis: 15 mg once daily
Ulcerative colitis: 45mg OD for 8 weeks, then 30mg OD",,"Perubatan (Rheumatology)

","Kuota

Special drugs approval (UKK) required for off- label use
",Rinvoq,96.43,/,tab,
,,,,,,,,,,,
,,,,,,,,,,,
L04,Ustekinumab 45mg/0.5ml injection ,"Treatment of moderate to severe plaque psoriasis in adults who failed to, or who have contraindication to, or are intolerant to conventional systemic therapies including ciclosporin, methotrexate and photochemotherapy (PUVA).","Body weight less than 100kg: Initial dose of 45 mg SC, followed by 45 mg 4 weeks later, then every 12 weeks thereafter. Body weight more than 100 kg: initial dose 90 mg SC, followed by 90 mg 4 weeks later, & then every 12 weeks thereafter.",A*,Perubatan,Kuota,Stelara,7000.00,/,inj,A*
L01,Vinorelbine 10mg/mL Injection,"i) First line treatment in non-small cell lung cancer in combination with cisplatin/ifosfomide
ii) Metastatic breast cancer","i) Single agent: Adult 30mg/m2 IV administered over 6-10 minutes once weekly Combination with cisplatin : 30mg/m2 IV administered over 6-10mintes once weekly combination with cisplatin IV on days and 29 and then every 6 weeks or Vinolrebine administered at a dose of 25mg/m2 IV weekly in combination with cisplatin given every 4 weeks at a dose of 100mg/m2

ii) 25 - 30 mg/m2 diluted in saline solution, infused over 6 - 10 minutes, administered weekly or vinolrebine maybe given as an 8mg/m2 IV BOLUS followed by 8mg/m2 as a 96-hour intravenous infusion.",A*,Pembedahan (Onco),Kuota,Vinelbine,188.00,/,vial,
,,,,,,,,,,,
"7.0 OTHER CHEMOTHERAPEUTICS
7.8 OTHER DRUGS RELATED TO  CANCER",,,,,,,,,,,
L03,Filgrastim (G-CSF) 30 MU/ml (300mcg/ml) Injection,i) Prevention and treatment of febrile neutropenia due to cancer chemotherapy (except chronic myeloid leukaemia and myelodysplastic syndrome) ii) Haemopoeitic stem cell transplantation (HSCT)/stem cell harvesting,"i) Adult: SC or IV 5 mcg/kg/day. Initiation: 24 - 72 hours after chemotherapy. 
Duration: Until a clinically adequate neutrophil recovery is achieved (absolute neutrophil count of at least 1 x 109/L on 2 consecutive days) 
ii) Refer to protocol",A*,,,Neupogen,63.80,/,vial,A*
V03,Leucovorin Calcium (Calcium Folinate) 50 mg /10ml Injection,"(i) Biochemical modulator for 5-Fluorouracil in the treatment of solid tumour;
(ii) As rescue for high dose methotrexate;
(iii) Megaloblastic anaemias due to deficiency of folic acid 
","i) 200mg/m2 by slow IV injection over a minimum 3 minutes, followed by 5-
Fluorouracil or 20mg/m2
IV followed by 5-Fluorouracil. In both cases,
treatment is repeated daily for 5 days; may repeat at 4-week intervals for 2
courses then 4- to 5-week intervals
ii) 15 mg (approximately 10mg/m2
) every 6 hours for 10 doses, starting 24
hours after the beginning of the methotrexate infusion
iii) Up to 1 mg daily
Dosing is individualised and according to product insert/protocol",A,"Pembedahan, Perubatan ",,Pharmaniaga Leucovorin Calcium,4.06,/,vial,A
V03,Leucovorin Calcium (Calcium Folinate) 15mg Tablet,"i) Treatment of folic acid antagonist overdose; 
ii) Leucovorin (folinic acid) plus tegafur-uracil combination therapy is indicated for the treatment of colorectal cancer in: 
a) Metastatic stage, b) Adjuvant setting, c) Concurrent setting.","i) 15 mg every 6 hours for the next 48 - 72 hours; 
ii) Adjuvant setting - Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles; Concurrent setting - Leucovorin Calcium 25 mg /day, D8- D36, for 4 weeks; 
Metastatic stage - Leucovorin Calcium 75 mg/day, Day 1-28, rest 7 days for 5 cycles.",A,,,Folina ,3.45,/,tab,A
V03,Mesna 400mg/4ml Injection,For prevention of urotoxic effects of oxazaphosphorines e.g. ifosfamide and cyclophosphamide,"IV injection at a dosage of 20% of the corresponding oxazaphosphorine dose at the times 0 hour (concurrently with the oxazaphosphorine), 4 hours and 8 hours thereafter. CHILD: Dose given at greater frequency (e.g. 6 times) and a shorter intervals (e.g. 3 hours)",A,,,Uromitexan,11.76,/,amp,
M05,Pamidronate Disodium 30 mg Injection,Hypercalcaemia of malignancy (tumour -induced hypercalcaemia),"Dose depends on the initial serum calcium levels. Doses range from a single infusion of 30 - 90 mg infused over 4 to 6 hours
 (HSM practice: maximum 60mg for renally impaired patients: < 30ml/min)
see notes for restriction of use in HSM",A*,Perubatan,"Kuota bagi CrCL < 30ml/min sahaja. Jika > 30ml/min, guna Zoledronic acid (Zometa)",Biodronate,87.00,/,vial,A*
M05,Zoledronic Acid 4 mg Injection,"i) Treatment of hypercalcaemia of malignancy 
ii) Prevention of skeletal related events (SREs) in patients with multiple myeloma involving multiple bone lesions 
iii) Prevention of skeletal related events (SREs) for metastatic cancers of solid tumours","i) & (ii): 4 mg reconstituted and should be given as a 15 minutes IV infusion every 3-4 weeks 
iii) 4mg reconstituted and should be given as a 15- minute IV infusion every 12 weeks (as advised in MaHTAS 2018 Report)
",A*,,,Oledron,54.00,/,vial,A*
,,,,,,,,,,,
"8.0 GENITOURINARY SYSTEM
8.1 DRUG ACTING ON UTERUS",,,,,,,,,,,
H01,Carbetocin 100 mcg/ml Injection,Prevention of uterine atony and postpartum hemorrhage following elective cesarean section under epidural or spinal anaesthesia,"A single IV dose of 100mcg (1ml) is adminitered by bolus injection, slowly over 1minute, only when delivery of the infant has been completed by caesarean section under epidural or spinal anaesthesia, before or after delivery of the placenta.",A*,O&G,,Pharmidea,56.93,/,vial,A*
G02,Carboprost Tromethamine 250 mcg Injection,"Treatment of refractory postpartum haemorrhage unresponsive to
conventional methods of management.
","Initially 250 mcg deep IM inj. The dose may be repeated at intervals of 15-90
min if necessary. Max total dose: 2000 mcg (8 doses).",A*,O&G,,Hemabate,162.20,/,amp,A*
G02,Dinoprostone (Prostagladine E2) 3 mg Vaginal Tablet,Induction of labour,3 mg vaginal tablet to be inserted high into the posterior formix. A second 3 mg tablet may be inserted after 6-8 hours if labour is not established. Max 6 mg,A,O&G,,Prostin E2,27.22,/,tab,A
G02,Gemeprost (Prostagladin E1 Synthetic Analogue) 1 mg Pessary,"i. Softening and dilatation of the Cervix uteri prior to trans-cervical intrauterine operative procedures in pregnant patients in the first trimester of gestation.

ii. Therapeutic termination of pregnancy in patients in the second trimester of gestation, in licensed institutions.

iii. Induction of abortion of second trimester pregnancies complicated by intrauterine foetal death.
","i. One pessary 3 hours before surgery

ii & iii. One pessary 3-hourly to a maximum of 5 administrations over 24 hours. A second course may be given after 24 hours from the initial commencement of treatment.
",A,O&G,,Cervagem,139.00,/,pessary,A
G02,Misoprostol Tablet 200mcg,Therapeutic termination of pregnancy,"Refer Gynaecologist for dose. 
400mcg (per vaginal route) 3-4 hrs before surgery","Not in FUKKM

(To purchase if Gemeprost discontinue by supplier)",O&G,"Import Permit required for purchase
(UKK)",Tector 200,2.10,/,tab,
H01,Oxytocin 10 units/ml Injection,Induction of labour,IV: 0.5 - 1 milliunits/minute; gradually increase dose in increments of 1 - 2 milliunits/minute until desired contraction pattern is established; dose may be decreased after desired frequency of contractions is reached and labor has progressed to 5 - 6 cm dilation,B,O&G,,Udoxan,1.16,/,amp,B
G02,Oxytocin 5 units & Ergometrine Maleate 0.5 mg/ml Injection,"i)Prevention and treatment of postpartum haemorrhage associated with
uterine atony.
ii)Active management of third stage of labour","i) 1 ml IM, may be repeated after 2 hours. Should not exceed 3 ml within 24 hours 
ii) For routine management of third stage of labour, 1 ml IM following delivery of the anterior shoulder or immediately after delivery of the child",C+,O&G,,Syntometrine,3.39,/,amp,C+
,,,,,,,,,,,
"8.0 GENITOURINARY SYSTEM
8.2 TRICHOMONACIDES, VAGINAL PREPARATIONS",,,,,,,,,,,
G01,Clotrimazole 500 mg Vaginal Tablet,Vaginal candidiasis,500 mg as a single one-time dose,B,,,Candid,3.24,/,pessary,B
G03,Estriol 0.03mg + Lactobacillus acidophillus vaginal tablet,"i)Atrophic vaginitis due to estrogen deficiency during menopause and post-menopause, or as co-medication to systemic hormone replacement therapy 
ii)Restoration of the Lactobacillus flora after local and/or systemic treatment with anti-infective agents or chemotherapeutic agents","Atrophic vaginitis : 1 vaginal tablet daily for 6-12 days followed by a maintenance dose of 1 vaginal tablet for 1-2 days per week.
Restoration therapy: 1-2 vaginal tablet daily for 6-12 days 
Administration: The vaginal tablets should be inserted deeply into the vagina in the evenings before bedtime. 
In cases of a very dry vagina, vaginal tablet can be moistened with 1 or 2 drops of water before insertion into the vagina. 
During menstruation, treatment should be interrupted and resumed afterwards. 
Should not use vaginal douches or rinses during treatment",A/KK,O&G,,Gynoflor,6.78,/,tab,A/KK
G01,"Policresulen Suppository 
90mg","Local treatment of cervical and vaginal inflammation and tissue damage, eg. discharge due to bacterial, trichomonal and fungal infections, protrusions of endocervical mucosa (erosion), haemostasis following biopsy or excision of uterine polyps",1 supp intravag on alternate days.,A,,,Albothyl,2.24,/,supp.,A
,,,,,,,,,,,
"8.0 GENITOURINARY SYSTEM
8.3 URINARY ANTISEPTICS, ANTISPASMODICS",,,,,,,,,,,
J01,Nitrofurantoin 100 mg Tablet,Uncomplicated lower urinary tract infections,"Acute uncomplicated urinary tract infections 
Adult: 50-100 mg 4 times daily for 7 days. 
Dual-release preparation: 100 mg bid. 
Child: >3 mth and older children: 3 mg/kg daily in 4 divided doses. 
Prophylaxis of uncomplicated urinary tract infections 
Adult: 50-100 mg at bedtime. 
Child: >3 mth and older children: 1 mg/kg once daily.",B,,,"Apo-
Nitrofurantoin",0.70,/,tab,B
G04,Oxybutynin Chloride 5 mg Tablet                                           ,"For the relief of symptoms of bladder instability associated with 
voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (ie urgency, frequency, urinary leakage, urge incontinence, dysuria)","ADULT: Initially 5 mg 2 - 3 times daily increased if necessary to maximum 5 mg 4 times daily. 
ELDERLY: Initially 2.5 - 3 mg twice daily, increased to 5 mg twice daily according to response and tolerance. 
CHILD over 5 years, neurogenic bladder instability: 2.5 - 3 mg twice daily increased to 5 mg twice daily to maximum 3 times daily",A*,"Pembedahan, Pediatrik ",Kuota,Ditropan   ,1.63,/,tab,A*
A12,Polycitra Syrup,"For treatment of calcium and uric acid 
stones","The usual dose of potassium citrate is 30 - 60 mEq/day orally in 3 or 4 doses with meals or within 30 minutes after meals. 
ADULT: 15 ml 3 times daily well diluted with water. 
CHILD: 5-15 ml 3 times daily, after meals and at bedtime.",C,,galenical,            -,-,/,bot,C
A12,Potassium Citrate 3 g/10 ml and Citric Acid Mixture 0.5g in 10ml,For systemic or urinary alkalinization,"ADULT: 10-20 ml 3 times daily, well diluted with water.
CHILD up to 1 year: 2.5 ml 3 times daily; 1 - 5 years: 5 ml 3 times daily; 6 - 12
years: 10 ml 3 times daily. To be taken well diluted with water, after meals and at bedtime",C,,,Mist Possit,5.22,/,bot,C
B05,"Sodium Bicarbonate, Citric Acid, Sodium Citrate and Tartaric Acid - 4 g per sachet","For relieving of discomfort in mild urinary tract infection, symptomatic relief of dysuria to enchance the action to certain antibiotics especially some sulphonamides. In gout as urinary alkalinizers to prevent cystallisation of urates",4 - 8 g (1- 2 sachets) dissolved in a glass of cold water 4 times daily as prescribed,B,,,Utix,0.60,/,sac,B
B05,Sodium Citrate 0.3 M Solution 500ml,"Prophylaxis for aspiration pneumonitis
 (use as an oral solution)","Dose depending on clinical cases. Usually, 30 ml given 10- 60 minutes before anaesthesia prior to elective cesarean surgery is an effective antacid",B,,galenical,-,2.00,/,bot,B
,,,,,,,,,,,
"8.0 GENITOURINARY SYSTEM
8.4 OTHERS",,,,,,,,,,,
G04,Alfuzosin HCl 10 mg Tablet,Treatment of functional symptoms related with benign prostatic hypertrophy (BPH),10 mg once a day pre bed,A*,"Pembedahan, Geriatrik",,Ranfuzosin,0.30,/,tab,A*
C02,Doxazosin Mesilate 4 mg CR Tablet,Benign Prostatic Hyperplasia,4 mg once daily to maximum 8mg/day,A*,Pembedahan,,Kamiren XL ,0.32,/,tab,A*
G04,Dutasteride 0.5 mg Capsule,Benign prostatic hyperplasia in men with an enlarged prostate gland,0.5 mg daily,A*,Pembedahan,Kuota,Avodart,"3.44
",/,cap,A*
G04,Dutasteride 0.5 mg & Tamsulosin 0.4 mg Capsule,"Combination therapy for the treatment of moderate to severe symptoms of BPH with: 
i) Large prostate (>30g) 
ii) Poor risk or not fit for surgery 
iii)Those who are awaiting their turn for surgery",One capsule daily,A*,Pembedahan,,Duodart,1.39,/,cap,A*
G04,Finasteride 5 mg Tablet,Treatment and control of benign prostatic hyperplasia,5 mg a day as a single dose. Clinical responses occur within 12 weeks - 6 months of initiation of therapy. Long-term administration is recommended for maximal response,"A*
Consultant/specialists for specific indications only, including Geriatricians","Pembedahan, Geriatrik",,Fincar,0.12,/,tab,A*
G04,Propiverine HCl 15 mg Tablet,"Treatment of urinary incontinence, urgency and frequency in neurogenic detrusor overactivity (detrusor hyperreflexia) and in idiopathic detrusor overactivity (overactive bladder)","ADULT: 15 mg twice daily to 3 times daily, increase to 4 times daily if required. 
Max dose: 60 mg daily. 
CHILD more than 5 years: 0.2 to 0.4 mg/kg per day in 2 divided doses",A*,Pembedahan,,Mictonorm,1.73,/,tab,A*
G04,Mirabegron 50mg Prolonged Release Tablet,"Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome.

Prescribing Restriction:
For patients who are not responsive, intolerant or unsuitable to use other existing agents.","50mg once daily.

Should be taken once daily, with liquid, swallowed whole and is not to be chewed, divided, or crushed",A*,Pembedahan,Kuota,Betmiga,2.61,/,tab,
G04,Solifenacin Succinate 5 mg Tablet                    ,Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.,5mg od. Dose can be increased to 10mg if necessary.,A*,Pembedahan,,Vesicare,"2.69
",/,tab,A*
G04,Tamsulosin HCl 400 mcg Extended Release Tablet,Second line treatment of functional symptoms of benign prostatic hyperplasia (BPH) in patients who do not tolerate first line drugs or when first line drugs are inappropriate or contraindicated,400 mcg once daily,"A*
Consultant/specialists for specific indications only, including Geriatricians","Pembedahan, Geriatrik",Kuota,Harnal Ocas,0.41,/,tab,A*
G04,Terazosin HCl 5 mg Tablet,"i) Treatment of Benign Prostatic Hyperplasia. 
ii)Hypertension","i)Initially 1 mg at night, increased in a stepwise fashion to 2 mg, 5 mg or 10 mg once daily. 
ii)Initial: 1mg once daily at bedtime, Maintenance: 1-5mg once (morning or evening) or twice daily. Max: 20-40mg/day",A/KK,"Perubatan, Pembedahan", ,Terasin,0.27,/,tab,A/KK
G04,Tolterodine Tartrate ER 4 mg Capsule,"Treatment of overactive bladder with symptoms of urinary, frequency or urge incontinence",4 mg once daily. May decrease to 2 mg once daily depending on response and tolerability,A*,Pembedahan,,Detrusitol SR,4.03,/,cap,A*
,,,,,,,,,,,
"9.0 HORMONES
9.1 CORTICOSTEROIDS",,,,,,,,,,,
H02,Dexamethasone Sodium Phosphate 8 mg/2 ml Injection,"i) Prophylaxis and management of nausea and vomiting in cancer chemotherapy, post-operation and palliative care, 
ii) Treatment of adrenocortical function abnormalities, 
iii) Any other treatment requiring corticosteroid therapy.","Initially 0.5 - 9 mg IM, IV or infusion daily, depending upon the disease being treated",B,,,Penatone,"0.81
",/,amp,B
H02,Dexamethasone 0.5 mg Tablet,"i) Prophylaxis and management of nausea and vomiting in cancer chemotherapy, post-operation and palliative care, 
ii) Treatment of adrenocortical function abnormalities, 
iii) Any other treatment requiring corticosteroid therapy.","0.5mg to 10mg daily is given for oral administration, depending upon the disease being treated. Up to 15 mg daily in severe disease.",A,,,Dexasone,"0.06
",/,tab,A
H02,Dexamethasone 4mg tablet,"i) Prophylaxis and management of nausea and vomiting in cancer chemotherapy, post-operation and palliative care, 
ii) Treatment of adrenocortical function abnormalities, 
iii) Any other treatment requiring corticosteroid therapy.","0.5mg to 10mg daily is given for oral administration, depending upon the disease being treated.",A,,,Vextasone,"
0.35
",/,tab,A
H02,Fludrocortisone 0.1 mg Tablet,As an adjunct to glucocorticoids in the management of primary adrenocortical insufficiency in Addison's disease and treatment of salt-losing adrenogenital syndrome,"Adrenocorticoid insufficiency (chronic): ADULT: 1 tablet daily. 
Salt-losing adrenogenital syndrome: ADULT: 1 - 2 tablets daily. 
CHILD and INFANT: 0.5 - 1 tablet daily

Dosing is individualised and according to product insert / protocol.",A,"Perubatan, Pediatrik","Import Permit required for purchase
(UKK)",Floricot,0.85,/,tab,A
H02,Hydrocortisone Sodium Succinate 100 mg Injection,Conditions responsive to systemic or local glucocorticoid injection therapy especially in emergencies,"Initially 100 - 500 mg IV over 30 seconds to more than 10 minutes. Dose may be repeated at intervals of 2, 4 or 6 hours",C,,,Zycort,"2.52
",/,vial,C
H02,Hydrocortisone 10 mg Tablet,"Glucocorticoid replacement therapy in primary or secondary adrenal 
insufficiencies and long term management of congenital adrenal hyperplasia in children","ADULT: 20 - 30 mg daily in divided doses. 
CHILD: 10 - 30 mg daily in divided doses
",B,,,Orion,1.1,/,tab,B
H02,Methylprednisolone Sodium Succinate 0.5 g Injection,"Suppression of inflammatory and allergic disorders, cerebral oedema, immunosuppression treatment of haematological and oncological disorders, treatment of shock states and endocrine disorders",15 - 30 mg/kg daily. Large doses may be repeated 4 - 6 hourly for up to 48 hours,A,,,Solu-Medrol,46.55,/,vial,A
H02,Prednisolone 3mg / 5ml Syrup ,"i) Replacement therapy for primary and secondary adrenocortical insufficiency 
ii) Adrenogenital syndrome 
iii) Other therapy","i) 5 - 25 mg daily in divided doses 
ii) 10 - 20 mg/m2 body surface daily in divided doses 
iii) ADULT: 5 - 60 mg daily. CHILD: 0.5 - 2 mg/kg/day in divided doses every 6 - 8 hours or as a single daily",B,,,Rexolone,2.00,/,bottle,B
H02,Prednisolone 5 mg Tablet,"i) Replacement therapy for primary and secondary adrenocortical insufficiency 
ii) Adrenogenital syndrome 
iii) Other therapy","i) 5 - 25 mg daily in divided doses 
ii) 10 - 20 mg/m2 body surface daily in divided doses 
iii) ADULT: 5 - 60 mg daily. CHILD: 0.5 - 2 mg/kg/day in divided doses every 6 - 8 hours or as a single daily",B,,,Nisolon,"0.11
",/,tab,B
H02,Prednisolone 1mg Tablet,"Indication is as per Prednisolone 5mg Tablet.

HSM: For gradual tapering of steroid dependant rheumatology patients","Dosing is as per Prednisolone 5mg Tablet

Refer rheumatologist for relevant protocols / tapering schedule ",Not ln FUKKM,"Perubatan
Rheumatology",Special drugs approval (UKK) required (by batch basis in HSM),Visolone,0.31,/,tab,
H02,Triamcinolone Acetonide 10 mg/ml Injection,"Inflammation of joints, bursae and tendon sheaths",Smaller joints: 2.5 - 5 mg and larger joints: 5 - 15 mg. Treatment should be limited to 1 mg/injection site to prevent cutaneous atrophy,"A, A/KK",,,Shincort,10.11,/,vial,"A, A/KK"
H02,Triamcinolone Acetonide  40 mg/ml Injection,"Allergies, dermatoses, rheumatoid arthritis and inflammatory opthalmic diseases",40-80 mg deep into the gluteal muscle,"A, A/KK",,,Sivkort,2.73,/,amp,"A, A/KK"
,,,,,,,,,,,
"9.0 HORMONES
9.2 SEX HORMONES",,,,,,,,,,,
G03,Conjugated Oestrogens 0.625 mg/g Cream (14g),"Treatment of atrophic vaginitis, dyspareunia and kraurosis vulvae
","i. Atrophic Vaginitis and Kraurosis Vulvae:
Initial dose: Intravaginal 0.5g daily for 21 days and then off for 7 days
(cyclical regimen). Dose range: 0.5- 2g daily based on individual response.
ii. Dyspareunia:
0.5g intravaginally twice weekly continuous regimen or in a cyclic regimen of
21 days of therapy followed by 7 days off of therapy",A,Obstetrik,,Premarin,45.49,/,tube,A
G03,Conjugated Oestrogens 0.625 mg Tablet,"i. Prevention and management of osteoporosis associated with estrogen
deficiency.
ii. Female hypoestrogenism.
iii. Moderate to severe vasomotor symptoms associated with estrogen
deficiency.
iv. Atrophic vaginitis and atrophic urethritis.","i) 0.3 - 0.625 mg daily
ii) 0.3- 1.25mg daily for 3weeks, then off for 1 week 
iii) & iv) 0.3mg-1.25mg daily",A,Obstetrik,,Premarin,"
1.55
 
",/,tab,A
G03,Conjugated Oestrogens 0.625 mg & Medroxyprogesterone Acetate 2.5 mg Tablet,"Management of moderate to severe vasomotor symptoms associated with menopause, prevention and management of postmenopausal osteoporosis, atropic vaginitis and atropic urethritis in post menopausal woman with intact uterus ","1 tablet daily
",A,,,Premelle 2.5,2.73,/,tab,A
G03,Danazol 100mg Capsule,"i) Endometriosis
ii) Benign breast disorders including gynaecomastia fibrocystic breast disease and pubertal breast hypertrophy
iii) Menorrhagia
iv) Prophylaxis of hereditary angioedema","i. 400mg daily in 2 to 4 divided doses, starting on the 1st day of the menstrual cycle; daily doses of 800mg are also employed.
ii. 100mg to 400mg daily in divided dose.
iii. 200 mg BD iv. 400 mg daily. Reduce to 200 mg daily after 2 months attack free period.

General dosing range: 200-800mg daily in 2 or 4 divided doses.

Dosing is individualised and according to product insert/protocol",A/KK,"Obstetrik, Perubatan",,Nazol,1.51,/,cap,
G03,Dienogest 2 mg Tablet,Treatment of endometriosis,One tablet daily. Treatment can be started on any day of menstrual cycle. Tablets must be taken continously without regard to vaginal bleeding.,A/KK,Obstetrik,Kuota,Visanne,"5.00
",,tab,A/KK
G03,Dydrogesterone 10 mg Tablet,"i) Dysmenorrhoea 
ii) Endometriosis 
iii) Dysfunctional uterine bleeding (to arrest and to prevent bleeding) 
iv) Threatened abortion 
v) Habitual abortion 
vi) Post menopausal complaints (hormone replacement therapy in combination with oestrogen)","i) 10 mg bd from day 5 - 25 of cycle 
ii) 10 mg bd - tds from day 5 - 25 of the cycle or continuously 
iii) To arrest bleeding :10 mg bd with an oestrogen once daily for 5 - 7 days, 
To prevent bleeding : 10 mg bd with an oestrogen once daily from day 11 - 25 of the cycle iv) 40 mg at once, then 10mg 8hrly until symptoms remit 
v) 10 mg bd until 20th week of pregnancy 
vi) 10-20 mg daily during last 12-14 days of each cycle",A/KK,Obstetrik,,Duphaston,2.16,/,tab,A/KK
G03,Estradiol Valerate 1 mg Tablet,"i. Hormone replacement therapy (HRT) for the treatment of signs and
symptoms of estrogen deficiency due to natural menopause or castration.
ii. Prevention of postmenopausal osteoporosis.","1-2 mg daily continuously. Titrate to the minimum effective dose necessary to
control symptoms.",A*,Obstetrik,,Progynova,"0.64
",/,tab,A*
G03,Estradiol 1 mg with Dydrogesterone 5 mg Tablet,"i) Hormone replacement therapy for the relief of symptoms due to oestrogen
deficiency in women with a uterus
ii) Prevention of postmenopausal osteoporosis in women with a uterus",One tablet is to be taken daily for a 28-day cycle,A*,Obstetrik,,Femoston Conti,1.34,/,tab,A*
G03,Estradiol 1 mg (14 tablet) & Estradiol 1 mg with Dydrogesterone 10 mg (14 tablet),Hormone Replacement Therapy for women with disorders due to natural or surgically induced menopause with intact uterus.,"One tablet daily without pill-free interval, starting with 1 mg of Estradiol for first 14 days, followed by 1mg Estradiol with 10 mg Dydrogestrone daily for the next 14 days",A*,Obstetrik,,Femoston 1/10,1.37,/,tab,A*
G03,Estradiol Valerate 2 mg & Norgestrel 500 mcg with Estradiol Valerate 2 mg Tablet,"i. Hormone replacement therapy (HRT) for the treatment of signs and
symptoms of estrogen deficiency due to menopause or hypogonadism,
castration or primary ovarian failure in women with an intact uterus.
ii. Prevention of postmenopausal osteoporosis.
iii. Control of irregular menstrual cycles.
iv. Treatment of primary or secondary amenorrhea.","One white tablet daily for the first 11 days, followed by one light brown tablet
daily for 10 days then stop for a 7- day tablet-free interval before
commencing next pack.",B,Obstetrik,,Progyluton,1.70,/,tab,B
G03,Medroxyprogesterone Acetate 5 mg Tablet,"i) Secondary amenorrhoea 
ii) Abnormal uterine bleeding due to hormonal imbalance","i) 5-10 mg daily for 5-10 days started anytime during cycle 
ii) 5-10 mg daily for 5-10 days on day 16-21 of menstrual cycle. 
Optimum secretory transformation 10 mg daily for 10 days from day 16 of the cycle",B,,,Ravimed,"0.33
",/,tab,B
G03,Progesterone 100 mg capsule,Supplementation of the luteal phase.,"Oral route: On average for progesterone insufficiency, the daily dose of progesterone is 200-300mg per day; one capsule after breakfast and one to two capsules at bedtime. Vaginal route: 4 to 6 capsules (in 2 to 3 divided doses) per day starting from the day of the HCG injection until the 12th week of pregnancy.",A*,Obstetrik,Kuota,Utrogestan,2.17,/,tab,
G03,Testosterone 250 mg/ml Injection,"i. In male:
Testosterone replacement therapy for male hypogonadism, when
testosterone deficiency has been confirmed by clinical features and
biochemical test.
ii. In female:
Additive therapy in cases of advanced breast cancer in postmenopausal
women.",By IM only. Hypogonadism 250 mg every 2-3 weeks. To maintain an adequate androgenic effect 250 mg every 3-6 weeks. Potency disorders 250 mg every 4 weeks. Male climateric disorders: 250 mg every 3-4 weeks. Repeated 6-8 weeks courses at 2-3 months interval,A*,,Kuota,Sustanon,20.80,/,inj,A*
G03,Tibolone 2.5 mg Tablet,"i. Treatment of complaints resulting from the natural or surgical menopause &
in cases at high risk for breast carcinomas where general hormone
replacement therapy is contraindicated
ii. Prevention of osteoporosis in postmenopausal women at high risk of future
fractures who are intolerant of, or contraindicated for, other medicinal
products approved for the prevention of osteoporosis. ",2.5mg daily,A*,"Pembedahan, Obstetrik ",Kuota,Tiboleen,1.60,/,tab,A*
,,,,,,,,,,,
"9.0 HORMONES
9.3 TROPHICS HORMONES & RELATED SYNTHETIC DRUGS",,,,,,,,,,,
G02,Bromocriptine Mesilate 2.5 mg Tablet,"i) Hypogonadism, galactorrhoea, infertility in men and women, cyclical benign
breast and menstrual disorders
ii) Acromegaly
iii) Hyperprolactinaemia, prolactinomas
iv) Parkinson's disease
","i) Initial dose of 1.25-2.5mg once daily at bedtime. Dose may be increased by 2.5mg/day every 3 to 7 days as tolerated to a total of 5 to 7.5mg daily in divided doses
ii) 1.25 - 2.5 mg at bedtime for 3 days and may be increased by 1.25 - 2.5 mg every 3 to 7 days up to 30 mg a day in divided doses 
iii) Initial dose of 1.25mg, two or three times a day. Increase dosage gradually over several weeks to 10 - 20mg a day in divided doses. Higher doses may be required",A/KK,Perubatan. Obstetrik,,"Pharmaniaga
Bromocriptine","0.77
",/,tab,A/KK
,,,"iv) Initial dose of 1.25 mg one or two times a day. Dose may be increased by
2.5mg/day increments in 2 -to 4-week intervals as needed. Maintenance dose
ranges from 10 to 30mg daily in divided doses.
Dosing is individualised and according to product insert/protocol",,,,,,,,
G02,Cabergoline 0.5 mg Tablet,"i) Inhibition of physiological lactation soon after parturition
ii) Suppression of established lactation
iii) Treatment of hyperprolactinaemic disorders","i) 1 mg as a single dose during the first post-partum day
ii) 0.25 mg every 12 hours for 2 days
iii) Initial: 0.5 mg/week given in one or two divided weekly doses. May gradually increase dose by 0.5 mg/week no sooner than every 4 weeks until an optimal therapeutic response is achieved. Usual dose range: 0.25 mg to 2
mg/week (higher doses >1 mg /week may be divided in as many as 3 to 4 divided doses)",A*,Obstetrik,,Dostinex,"21.30
",/,tab,A*
G03,Chorionic Gonadotrophin Human (HCG) 5000 IU Injection,"i. Ovulation induction in subfertility due to anovulation or impaired follicleripening.
ii. Preparation of follicles for puncture in controlled ovarian hyperstimulation
(for assisted reproductive technologies).
iii. Luteal phase support.","i & ii: 5,000-10,000 IU stat once optimal stimulation of follicular growth is achieved.
iii: Up to three repeat injections of 1000 to 3000 IU may be given within 9 days following ovulation or embryo transfer (E.g.: on day 3, 6 and 9 after ovulation induction)
Dosing is individualised and according to product insert/protocol",A*,Obstetrik,,HuCog,33.50,/,vial,A*
G03,"
Clomiphene Citrate 50mg Tablet
",Treatment of ovulatory failure in women desiring pregnancy,"Initial: 50 mg once daily for 5 days.
Increase to 100mg OD for 5 days if there is no response (commence as early as 30 days after the previous course).",A,Obstetrik,,Clomid,0.67,/,tab,A
G03,Cyproterone Acetate 50 mg Tablet,Carcinoma of prostate ,"i) After orchidectomy, 100 mg once daily or twice daily 
ii) If used together with LHRH agonists, the initial dose is 100 mg twice daily for 5 to 7 days before the start of LHRH agonist, then 100 mg twice daily for 3 to 4 weeks together with the LHRH agonist
",A*,"Obstetrik, pembedahan",,Androcur,3.89,/,tab,A*
G03,Danazol 100 mg Capsule,"i)Endometriosis and gynaecomastia 
ii)Menorrhagia 
iii)Prophylaxis of hereditary angioedema ","i)200 - 800 mg daily for max of 9 months 
ii)200 mg daily for 12 weeks 
ii)400 mg daily. Reduce to 200 mg daily after 2 months attack free period
",A/KK,"Obstetrik, perubatan",,Anargil,"
1.55
",/,tab,A/KK
L02,"Goserelin 3.6 mg, 10.8mg Depot Injection","3.6 mg:Androgen deprivation therapy in prostate cancer, endometriosis,leiomyoma uteri and assisted reproduction,breast cancer in premenopausal and perimenopausal women suitable for hormonal manipulation
10.8mg: Androgen deprivation therapy in prostate cancer","One 3.6 mg depot injected subcutaneously into the anterior abdominal wall, every 28 days.

One 10.8mg depot injected S/C into the anterior abdominal wall, every 12 weeks",A,Pembedahan,Kuota: 10.8mg,"Zoladex 3.6
Zoladex 10.8","298.9
812.0",/,PFS,
H01,Lanreotide acetate 120mg prolonged-release solution for injection,"i) Treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumours (GEPNETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease

ii) Treatment of the clinical symptoms of neuroendocrine (particularly carcinoid) tumours","i) 120 mg administered every 28 days
ii) 60 mg to 120 mg administered every 28 days",A*,Perubatan,Kuota,Somatuline Autogel,4949.00,/,vial,
L02,"
Leuprolide Acetate 11.25 mg Injection

","i) Endometriosis 
ii) Hormonal therapy in advanced prostate cancer ","
i) & ii) 11.25mg every 3 months
",A*,"Obstetrik , Pembedahan",Kuota,Lucrin,"
 953.00
",/,PFS,A*
H01,Octreotide 0.1 mg/ml Injection,"i) Acromegaly treatment in patients in whom surgery or radiotherapy is inappropriate or ineffective- based on level of growth hormone and high IGF-1 and residual pituitary tumor
ii) Relief of symptoms associated with functional gastro-entero-pancreatic (GEP) endocrine tumors:
• Carcinoid tumors with features of the carcinoid syndrome.
• VIPomas, Glucagonomas
• Gastrinomas/Zollinger-Ellison syndrome
• Insulinomas
• GRFomas.
iii) Prevention of complications following pancreatic surgery
iv) Emergency management of bleeding gastro-eosophageal varices in patients with cirrhosis","i) Initially 0.05-0.1mg SC every 8 or 12 hours. Optimal daily dose is 0.3mg, not to exceed maximum dose of 1.5mg/day.
ii) Initially 0.05 mg once or twice daily, gradually increase to 0.1-0.2mg 3 times daily. Higher doses may be required in exceptional circumstances.
iii) 0.1 mg 3 times daily for 7 consecutive days, starting on the day of operation, at least 1 hour before laparotomy
iv) ADULT: 50mcg bolus, followed by continuous infusion of 25-50mcg/hour for 2-5 days.
CHILD: IV 1-5 mcg/kg/hour

The dosing is individualized according to product insert / protocol",A,"Pediatrik, Pembedahan",,Sandostatin,41.59,/,amp,A
,,,,,,,,,,,
H01,Somatropin 10mg/1.5 ml Pre-filled Pen ,"To be used in children for: 
i) Growth failure due to inadequate endogenous growth hormone. 
ii) Growth failure in girls due to gonadal dysgenesis (Turner syndrome). iii) Growth failure in short children born small gestational age (SGA) 
To be used in adult for: 
i) Pronounced growth hormone deficiency (GHD) in known hypothalamic-pituitary disease. 
ii) Childhood onset growth hormone insufficiency. ","i) 0.7-1 mg/m2/day or 0.025-0.035 mg/kg/day SC/IM. 
ii) 1.4 mg/m2/day or 0.045-0.05 mg/kg/day SC. 
iii) 0.035 mg/kg/day or 1 mg/m2/day SC 
For adult: a) Replacement therapy: The dosage must be adjusted to the need of the individual patient. b) Childhood-onset GHD: The recommended dose to restart is 0.2-0.5 mg/day with subsequent dose adjustment on the basis of IGF-I concentration determination. c) Adult-onset GHD: It is recommended to start treatment with a low dose 0.1-0.3 mg/day and to increase the dosage gradually at monthly intervals in order to meet the need of the individual patient. 
Serum IGF-I can be used as guidance for the dose titration. Women may require higher doses than men, with men showing an increasing IGF-I sensitivity over time. This means that there is a risk that women, especially those on oral oestrogen replacement, are under-treated while men are over-treated. Dose requirements decline with age. Maintenance dosages vary from person to person, but seldom exceed 1.0 mg/day (equal to 3 IU/day).
",A*,Pediatrik,Kuota,Nordiflex,462.80,/,pen,A*
H01,Synthetic ACTH (Tetracosactrin Acetate) 250 mcg/ml Injection,Diagnostic test to differentiate primary adrenal from secondary (pituitary) adrenocortical insufficiency ,"Diagnostic test for investigation of adrenocortical insufficiency 
Adult: As plain preparation: Measure plasma cortisol concentration immediately before and exactly 30 min after IM/IV inj of 250 mcg. Post-inj rise in plasma cortisol concentration ≥200 nmol/l (70 mcg/l) if normal adrenocortical function. 
As depot preparation (if inconclusive results with plain preparation): Measure plasma cortisol concentration before and exactly 30 min, 1, 2, 3, 4 and 5 hr after an IM inj of 1 mg tetracosactide acetate depot. Adrenocortical function normal if the post-inj rise in plasma cortisol concentration increases 2-fold in 1st hr, and continues to rise steadily. Expected levels in 1st hr: 600-1,250 nmol/l, increasing slowly up to 1000-1800 nmol/l by 5th hr. 
Child: IV 250 mcg/1.73 m2 BSA. Intramuscular
",A,Perubatan,"Kuota

 Import Permit Required for purchase (UKK)",Synacthen,82.00,/,amp,A
H01,Terlipressin 1 mg Injection,"i. Acute oesophageal variceal bleeding

ii. Treatment of type 1 hepatorenal syndrome, characterised by spontaneous acute renal insufficiency, in patients suffering from severe cirrhosis with ascites.","i) 2 mg IV bolus over 1 minute. Maintenance: 1 - 2 mg IV bolus 4 - 6 hourly until bleeding is controlled, up to 24 - 36 hours. The maximum daily dosage is 120-150 mcg/kg body weight.

ii) Terlipressin is usually started at a dose of 1 mg of terlipressin acetate every 4-6 hours. The dose can be increased to a maximum of 12 mg daily, or 2 mg every 4-6 hours, if serum creatinine levels has not decreased by at least 25% after 3 days of treatment.

As an alternative to bolus injection, terlipressin can be administered as a continuous intravenous (IV) infusion with a starting dose of 2 mg of terlipressin acetate/24 hours and increased to a maximum of 12 mg of terlipressin acetate/24 hours.",A*,,,Glypressin,153.60,/,vial,A*
L02,Triptorelin 3.75 mg Injection,"i) Treatment of confirmed central precocious puberty (preterm sexual development) (before 8 years in girls and 10 years in boys)

ii) Genital and extragenital endometriosis (stage I to stage IV). Treatment should not be administered for more than 6 months. It is not recommended to start a second treatment course with triptorelin or another GnRH analogue. ","1 intramuscular injection every 4 weeks. 
The treatment must be started in the first 5 days of the menstrual cycle. The duration of treatment depends on the initial severity of the endometriosis and the changes observed in the clinical features. In principle, the treatment should be administered for at least 4 months and for at most 6 months. It is not recommended to start a second treatment course with triptorelin or another GnRH analogue.
",A,"Obstetrik, 
pembedahan",,Diphereline,252.75,/,vial,A
,,,,,,,,,,,
"9.0 HORMONES
9.4 CONTRACEPTIVES",,,,,,,,,,,
G03,Cyproterone Acetate 2 mg & Ethinyloestradiol 0.035 mg Tablet,Androgen dependent diseases in women,"1 tablet daily for 21 days on the first day of the cycle, followed by 7 tab free days. Starting on day 2 to 5 is allowed, but during the first cycle a barrier method is recommended for the first 7days of tablet taking.",A*,Obstetrik,,Cybelle,0.72,/,tab,A*
G03,Desogestrel 150 mcg & Ethinyloestradiol 30 mcg Tablet,Contraception,"1 tablet daily for 21 days, subsequent courses repeated after 7 day interval (during which withdrawal bleeding occurs)",C+,Obstetrik,,Desolon,"0.11
",/,tab,C+
G03,Ethinylestradiol 20 mcg & Levonorgestrel 100 mcg Tablet,"i) Oral Contraceptive.
ii) Treatment of moderate acne vulgaris not controlled by conventional
therapy (e.g. topical preparations and oral antibiotics) in post-menarchal,
premenopausal women more than or 14 years who accept contraception.
","1 tablet daily for 21 consecutive days, followed by a 7 -day tablet free interval
before the next pack is started",A/KK,Obstetrik,,Minipil 20,"0.40
",/,tab,A/KK
G03,Etonogestrel 68 mg Implant,Contraception,"A single implant inserted subdermally and can be
 left in place for three years. 
The implant can be removed at any time but not later than three years after the date of insertion.",A/KK,,,Implanon NXT,303.48,/,set,A/KK
G03,Levonorgestrel 1.5 mg Tablet                                               ,Emergency contraception within 72 hours of unprotected sexual intercourse for the female victim of sexual violence to prevent unwanted pregnancy,1.5 mg as a single dose as soon as possible after coitus [preferably within 12 hours but no later than after 72 hours],A*,,,Escapelle   ,250.80,/,tab,A*
G02,Levonorgestrel 52mg Releasing Intrauterine System,"i. Contraception.
ii. Idiopathic menorrhagia.
iii. Protection from endometrial hyperplasia during oestrogen replacement
therapy",One unit intrauterine device to be inserted into the uterine cavity within 7 days of the onset of menstruation or immediately after first trimester abortion. Postpartum insertion should be postponed until 6 weeks after delivery.Can be inserted at any time of amenorrheic woman. One unit IUD is effective for 5 years,A*,,,Mirena,638.30,/,set,A*
G03,Medroxyprogesterone Acetate 150 mg/3 ml Injection,Prevention of pregnancy and to provide long term contraception,150mg to be administered once every 3 month,B,,,Condep,3.80,/,vial,B
G02,"Copper 250 mm2
Intrauterine
Device",Intrauterine contraception,"Intrauterine insertion: 1 unit to be replaced within 5 years from the date of
insertion.",REGISTERED WITH MDA AS MEDICAL DEVICE,,,-,23.00,/,set,B
G03,Norethisterone 0.35 mg Tablet,Contraception,1 tablet daily starting on the first day of the menstrual bleeding,C+,Obstetrik,,Noriday,0.29,/,tab,C+
,,,,,,,,,,,
"10.0 METABOLISM
10.1 HYPERLIPIDAEMIC AGENTS",,,,,,,,,,,
C10,"Atorvastatin 20 mg, 40 mg Tablet","Hypercholesterolaemia and coronary heart disease intolerant or 
not responsive to other forms of therapy",10 mg once daily. Maximum: 80 mg daily,A/KK,,,Storvas,"0.12 ,0.14",/,tab,A/KK
C10,Cholestyramine Resin 4G,"i) Hypercholesterolemia 
ii) Familial hypercholesterolemia - heterozygous 
iii) Generalized atherosclerosis 
iv) Diarrhoea due to bile acid malabsorption v) Pruritus of skin associated with partial biliary obstruction","Hypercholesterolemia: Adjunct: initial, 4 g orally 1-2 times 
daily, maintenance, 8 to 16 g in divided doses, 
max 24 g daily CHILD: 50 - 150 mg/ kg 6 - 8 hourly oral

HSM Practice: Adult: initial dose 4g TDS",A,Perubatan,"Kuota

import permit required for purchase (UKK)",Cholestyramine,2.91,/,sachet,
C10,Ezetimibe 10 mg Tablet,"i) Co-administration with statins for patients who have chronic heart disease or are chronic heart disease equivalent or familial hypercholesterolaemia with target LDL-C not achieved by maximum dose of statins
ii) Monotherapy in patients with documented biochemical intolerance to statins",10 mg once daily. Not recommended for children less than 10 years old,A*,Perubatan,Kuota,Accord,0.73,/,tab,A*
C10,Fenofibrate 145 mg Tablet,"1) As second line therapy after failed gemfibrozil in patients:
a) Hypercholesterolemia and hypertriglyceridemia alone or combined [type IIa,IIb,III and V dysplipidemias] in patients unresponsive to dietary and other non-pharmacological measures especially when there is evidence of associated risk factors
b) Treatment of secondary hyperlipoproteinemias if hyperlipoprotenemia persists despite effective treatment of underlying disease
c) Dyslipidemia in Type 2 Diabetes Mellitus

2) Diabetic retinopathy - indicated for the reduction in the progression of diabetic retinopathy in patients with type 2 diabetes and existing diabetic retinopathy.
Prescribing restriction: For mild to moderate non-proliferative diabetic retinopathy only.","145mg once daily, with or without food",A/KK,Perubatan,,Lipanthyl ,1.03,/,tab,A/KK
C10,Gemfibrozil 300 mg Capsule,"Treatment of hyperlipoprotinaemias 
(TYPES IIA, IIB, III, IV, V)","ADULT: 1200 mg/day in 2 divided doses, 30 minutes before breakfast and dinner. 
Dose range from 0.9-1.5 g daily",A/KK,,,Gemfibrozil,0.21,/,cap,A/KK
C10,Inclisiran 284mg/1.5ml Solution for Injection in Pre-filled Syringe,"Treatment of primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet and maximally tolerated statin therapy","284 mg administered as a single subcutaneous injection: initially, again at 3 months, followed by every 6 months.",Not in FUKKM,Perubatan,"Kuota

Special Drugs Approval (UKK)",SYBRAVA,4343.00,/,PFS,
C10,Pravastatin Sodium 20 mg Tablet,"Hypercholesterolaemia and coronary heart disease intolerant or 
not responsive to other forms of therapy. In health clinics, Pravastatin is restricted to HIV patients on HAART.","10 - 20 mg once daily. Maximum: 40 mg daily. In patients concomitantly taking cyclosporine, with or without other immunosuppressive drugs: Initial dose is 10mg/day and titration to higher doses should be performed with caution. Maximum dose 20mg/day.",A/KK,Perubatan,,Pravatas,0.29,/,tab,A/KK
C10,Rosuvastatin 20 mg Tablet,"Dyslipidaemia not responsive to atorvastatin 40 mg 
or equivalent doses of other statins","Initially 5-10 mg once daily (5mg in patients with pre-disposing factors to myopathy), 
increased if necessary at intervals of at least 4 weeks to 20 mg once daily, increased after further 4 weeks to 40 mg daily ONLY in severe hypercholesterolemia with high cardiovascular risk. Patient of Asian origin, patients on concomitant ciclosporin/fibrate and patients with risk factors for myopathy/rhabdomyolysis (including personal/family history of muscular disorders/toxicity), the maximum dose should be 20 mg daily",A*,Perubatan,,Vasticure,0.31,/,tab,A*
C10,"Simvastatin 10 mg, 40 mg Tablet","Hypercholesterolaemia and coronary heart disease intolerant or 
not responsive to other forms of therapy",10 - 20 mg once daily. Maximum: 80 mg daily,B,,,Simvor,"0.04, 0.10",/,tab,B
,,,,,,,,,,,
"10.0 METABOLISM
10.2 ANTITHYROID AND THYROID PREPARATIONS",,,,,,,,,,,
H03,Carbimazole 5 mg Tablet,Hyperthyroidism,"ADULT: Initially, 10-60mg daily in divided doses given 8 hourly. Maintenance: 5 to 20mg daily. 
CHILDREN > 6 years: Initially 15mg daily in divided doses. 
CHILDREN 1-6 years: Initially 7.5mg daily in divided doses",B,,,Camazol,0.04,/,tab,B
H03,Iodine and Potassium Iodide Solution (Lugol's Solution),"i) Pre-operative treatment of thyrotoxicosis 
ii) Thyrotoxicosis crisis 

HSM Off-label indication (O&G): 
For cervical staining during colposcopy procedure,cone biopsy and LLETZ","i) 1 ml daily in divided doses 
ii) 5-10 drops (6.25mg per drop) every 6-8 hourly
",B,Galenical,"Import permit (UKK)
required for purchase",-,-,/,bot,B
H03,"Levothyroxine Sodium 25 mcg, 100mcg Tablet",Hypothyroidism,"Start at low dose and increase at 2-4 weeks interval. 
Usual recommended dose for 
i) Treatment of benign euthyroid goitre: 75-200mcg. 
ii) Prophylaxis of relapse after surgery for euthyroid goitre: 75-200mcg 

",B,Pediatrik ,,Euthyrox. Thyrosit,"0.14, 0.07",/,tab,B
,,,,,,,,,,,
,,,"iii) Substitution therapy in hypothyroidism: 
ADULT Initially, 25-50mcg/day. Maintenance: 100-200mcg/day. 
CHILDREN Initially 12.5-50mcg/day, Maintenance: 100-150mcg/m2 body surface area iv) Concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism: 50-100mcg 
v) Suppression therapy in thyroid cancer: 150-300mcg",,,,,,,,
H03,Levothyroxine 200mcg/ml (1ml) injection,Myxedema crisis,Adult: 100mcg-200mcg OD x 5 days (consult with endocrinologist),,"Perubatan

(JKUT 1/23: ONE-OFF PURCHASE. TO KEEP IN HSM UNTIL NEAR EXP AND OFFER OUT)","Import permit (UKK)
required for purchase",Serb Levothyroxine,283.00,/,amp,
V03,Potassium Iodide Mixture 200 mg/15 ml,Pre-operative management of hyperthyroidism and thyrotoxicosis ,"ADULT and CHILD: 50 - 250 mg 3 times daily
",B,,,-,-,/,bot,B
H03,Propylthiouracil 50 mg Tablet,Hyperthyroidism ,"ADULT 
Initially 300-600mg daily in divided doses, at 8 hourly intervals (can be given up to 600-1,200mg/daily in divided doses).
Maintenance 50-200mg daily when the condition is controlled, probably within 1 to 3 months.

CHILDREN 6-10 years: 50-150mg daily in divided doses.
CHILDREN > 10 years: 150-300mg or 150mg/m2 daily Maintenance 50-100mg daily, according to patient's response. Taken with food.",B,,,Propyl,0.12,/,tab,B
,,,,,,,,,,,
"10.0 METABOLISM
10.3 HYPERGLYCAEMIC AGENTS",,,,,,,,,,,
H04,Glucagon (Lyophilised) 1 mg/ml Injection,Management of hypoglycaemia ,"Adult, children > 20kg: 1mg by SC, IM or IV. 
Children < 20kg : 0.5mg. 
If patient does not respond within 10 minutes, administer IV glucose. Repeat in 20 minutes if necessary.
",B,,,Glucagon,161.24,/,vial,B
,,,,,,,,,,,
"10.0 METABOLISM
10.4 INSULINS",,,,,,,,,,,
A10,"Insulin Aspart 100 IU/ml
Injection",Diabetic Type 1 and 2 in patients that still experienced hypoglycaemia with use of human insulin ,"Dose to be individualised. 
The average daily insulin requirement is between 0.5 to 1.0 units/kg body weight
",A*,"Perubatan, Pediatrik",Kuota,"Novorapid 
Flexpen",18.76,/,vial,A*
A10,Insulin Aspart 30% and Protaminated Insulin Aspart 70% 100 U/ml Injection               ,Diabetic type 1 and 2 in patients that still experienced hypoglycaemia with use of human insulin ,"Dose to be individualised. The average daily insulin requirement is between 0.5 to 1.0 units/kg body weight
",A/KK,Perubatan,Kuota,Novomix 30 Flexpen ,23.14,/,vial,A/KK
A10,Insulin Degludec/ Insulin Aspart 70/30 Solution for Injection in Pre- Filled Pen 100 Units/mL,"Treatment of Type-2 Diabetes Mellitus in adults

Prescribing Restrictions: 
For patients who remained uncontrolled OR experienced recurrent hypoglycaemia with multiple daily dosing of human/analogue basal-bolus/premixed insulin.


HSM off label use: Type 1 DM in pediatric ","Treatment initiation: 10 units with meal(s) followed by individual dosage adjustments. Once or twice daily with the main meal(s)
Treatment switching: Can be administered alone, in combination with oral antidiabetic medicinal products, and in combination with bolus insulin.
• Convert unit-to-unit to once or twice daily Insulin Degludec/Insulin Aspart at the same total insulin dose as the patient’s previous total daily basal or premix insulin dose.
• Patients switching from basal/bolus insulin therapy will need to convert their dose based on individual needs. In general, patients are initiated on the same number of basal units.","A*

 Must be prescribed by Endocrinologist",Pediatrik,"Kuota

Special Drugs Approval (UKK) required for off-label indication",Ryzodeg,45.58,/,pen,
A10,Insulin Detemir 100 IU/ml Injection ,"i)Type 1 Diabetes patients on basal bolus regimen, whom experience hypoglycemia with conventional insulin, to be used in combination with rapid or short-acting insulin. 
ii)Type 2 Diabetes patients on oral anti-diabetics and basal insulin regimen or basal bolus insulin regimen whom experience hypoglycemia with conventional basal insulin. ","Individualized dose given via SC once or twice daily. Initiate at a dose of 10IU or 0.1-0.2IU/kg. For twice daily dosing, the evening dose can be administered either with the evening meal, at bedtime, or 12 hours after the morning dose.
",A/KK,"Perubatan, Pediatrik",Kuota,Levemir Flexpen    ,31.47,/,pen,A/KK
A10,Insulin Glargine 300 IU/3 ml Prefilled Pen for Injection,i) Diabetes mellitus type I in adults and child over 6 years ii) Diabetes mellitus type II in adult ,"ADULT and CHILD over 6 years: individualised dose given by SC, once daily at the same time every day. Adult patients who are insulin naive may be initiated with 10IU daily.
",A/KK,"Perubatan, Pediatrik",Kuota,BASALOG ONE,22.60,/,pen,A/KK
A10,Insulin glargine 300 IU/ml Pre-filled Pen ,"Diabetes mellitus type I and II in adults; 
Prescribing restriction(s): 
i) Patients on insulin not reaching treatment goals defined as high fasting plasma glucose (FPG ≥ 7 mmol/L) and/or HbA1c ≥ 6.5% after 6 months of therapy and/or; 
ii) patients with a high risk of hypoglycaemia as determined by the following risk factors: Advancing age; Severe cognitive impairment; Poor health knowledge; Increased A1c; Hypoglycaemia unawareness; Low standing insulin therapy; Renal impairment; Neuropathy. 
Note: Theu use of this strength can only be prescribed / dispensed to patients in diabetic clinic / registered under DMTAC program ","Initiation: Patient with type 1 diabetes: Once daily with mealtime insulin and requires individual dose adjustments; Patient with type 2 diabetes: 0.2units/kg followed by individual dose adjustment. Please refer to the product information leaflet for details of dosage information (switching, etc).
",A*,,,Toujeo,49.90,/,pen,A*
A10,Insulin Recombinant Neutral Human short-acting 100 IU/ml Injection in 10ml vial / 100IU/ml penfill,Diabetes mellitus ,"Dose to be individualised. The average daily insulin requirement is between 0.3-1.0 units/kg body weight/day. Daily insulin requirement may be higher in patients with insulin resistance, and lower in patients with residual, endogenous insulin production.
",B,,,"
Actrapid vial

Actrapid penfill","16.24

5.6",/,"vial

Penfill",B
A10,"Insulin Recombinant Neutral Human, short-acting 100 IU/ml Penfill and Refill",Diabetes mellitus ,"Dose to be individualised. The average daily insulin requirement is between 0.3-1.0 units/kg body weight/day. Daily insulin requirement may be higher in patients with insulin resistance, and lower in patients with residual, endogenous insulin production.",B,,,Insugen R,6.26,/,vial,B
A10,"Insulin Recombinant Synthetic Human, intermediate-acting 100 IU/ml Injection in 10ml vial / 100 IU/ml penfill",Diabetes mellitus,"Dose to be individualised. The daily insulin requirement is usually between 0.3 and 1.0IU/kg /day
",B,,,"Insulatard vial

Insulatard penfill","16.24


5.6",/,"vial


Penfill",B
A10,"Insulin Recombinant Synthetic Human, intermediate acting 100 IU/ml Penfill and Refill","Insulin dependent diabetes mellitus, non insulin dependent diabetes unresponsive to treatment to diet or oral hypoglycaemics, hyperkalaemia to assure proper utilisation of glucose and reduce glucosuria in non diabetic patients receiving parenteral nutrition ","Dose to be individualised. The daily insulin requirement is usually between 0.3 and 1.0IU/kg /day
",B,,,Insugen N,6.26,/,vial,B
A10,"Insulin Recombinant Synthetic Human, pre-mixed 100 IU/ml Penfill and Refill","Insulin dependent diabetes mellitus, non insulin dependent diabetes unresponsive to treatment to diet or oral hypoglycaemics, hyperkalaemia to assure proper utilisation of glucose and reduce glucosuria in non diabetic patients receiving parenteral nutrition ","Dose to be individualised. The average daily insulin requirement is between 0.5-1.0 units/kg body weight
",B,,,Mixtard,5.60,/,pen,
A10,"Insulin Recombinant Synthetic Human, pre-mixed 100 IU/ml Penfill and Refill","Insulin dependent diabetes mellitus, non insulin dependent diabetes unresponsive to treatment to diet or oral hypoglycaemics, hyperkalaemia to assure proper utilisation of glucose and reduce glucosuria in non diabetic patients receiving parenteral nutrition ","Dose to be individualised. The average daily insulin requirement is between 0.5-1.0 units/kg body weight
",B,,,Insugen 30/70,6.28,/,vial,B
,,,,,,,,,,,
"10.0 METABOLISM
10.5 ORAL ANTIDIABETIC AGENTS",,,,,,,,,,,
A10,Acarbose 50 mg Tablet,"Only for treatment of: i) Non insulin dependent diabetes mellitus (NIDDM) when diet therapy is insufficient ii) Non insulin dependent diabetes mellitus (NIDDM) in combination with existing conventional oral therapy where glycaemic control is inadequate restriction: i) As second/third line treatment of diabetes type 2, with HBA1c < 8%. ii) For patient who have postprandial hyperglycemia when treated with combination of available oral anti-diabetic/insulin. iii) The use of acarbose should be reviewed 6 months after initiation and stopped if HBA1c reduction is less than 0.5%. ","Initially 50 mg daily, increase to 3 times daily up to 100 mg 3 times daily. Maximum dose: 100 mg 3 times daily
",A/KK,,,Garbose,0.16,/,tab,A/KK
A10,Dapagliflozin 10mg Tablet,"Indication 1:
Dapagliflozin is indicated for use as an add-on combination therapy in combination with other glucose-lowering medicinal products including insulin, to improve glycemic control in adult patients with type 2 diabetes mellitus when these, together with diet and exercise, do not provide adequate glycaemic control.

Restriction: Patients with HbA1c between 6.5%-10.0% while on single / combination anti-diabetic therapy.



",10mg OD,A/KK,perubatan,,Novugen,0.78,/,tab,
,,"Indication 2:
Dapagliflozin is indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD).

Restriction: Patients with HbA1c not more than 10.0% while on adequate trial of metformin.",,,,,,,,,
,,"Indication 3:
To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class ll-lV) with reduced ejection fraction.

Restriction: Treatment to be initiated in hospital setting before continuation of treatment for stable patients by Family Medicine Specialist (FMS) in the primary care setting;
All patients must be counselled regarding risk of euglycemic ketoacidosis before initiation of treatment.",,,,,,,,,
,,"Indication 4:
For cardiorenal protection in adult patients with chronic kidney disease, with or without Type 2 Diabetes Mellitus, with eGFR≥25mL/min/1.73m2 and urine albumin creatinine ratio (UACR) ≥200-5,000mg/m2 (or the equivalent in uPRC/u-dipstick) receiving stable treatment with ACEi or ARB (unless they are contraindicated or not tolerated).

Restriction: In adult patients with underlying Type 2 Diabetes Mellitus, to be used only if HbA1c level <10%.
All patients must be counselled regarding risk of euglycemic ketoacidosis before initiation of treatment.",,,,,,,,,
A10,Empagliflozin 25mg Tablet,"Indication 1:
Indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults as: Add-on combination therapy: In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.

Restriction: Indication 1: Patients with HbA1c between 6.5%-10.0% while on single / combination anti-diabetic therapy.","Starting dose is 10 mg empagliflozin once daily for monotherapy and add-on combination therapy with other glucose-lowering medicinal products including insulin. In patients tolerating empagliflozin 10 mg once daily and need tighter glycaemic control, the dose can be increased to 25 mg once daily. The maximum daily dose is 25 mg
","A/KK

Consultant/specialists for specific indications only, including Geriatricians","

perubatan

",Kuota,Jardiance ,1.66,/,tab,A*
,,"Indication 2:
Indicated in patients with type 2 diabetes mellitus (T2DM) and established cardiovascular disease (CVD) to reduce the risk of cardiovascular (CV) death: As an adjunct to diet, exercise and standard of care, to reduce the risk of cardiovascular (CV) death.

Restriction: Indication 2: Patients with HbA1c not more than 10.0% while on adequate trial of metformin.",,,,,,,,,
,,"Indication 3:
Indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV).

Restriction: Indication 3:
i. Treatment to be initiated in hospital setting before continuation of treatment for stable patients by Family Medicine Specialist (FMS) in the primary care setting.
ii. All patients must be counselled regarding risk of euglycemic ketoacidosis before initiation of treatment",10mg once daily,,,,,,,,
A10,Gliclazide 80 mg Tablet,Diabetes mellitus type 2 ,"Initially 40-80mg daily. A single dose should not exceed 160mg and when higher doses are required, a twice daily split dosage is advised and should be divided. Maximum daily dose: 320mg. For elderly, starting dose should be 40mg twice daily.
",B,,,Pharmaniaga Gliclazide,0.16,/,tab,B
A10,"Gliclazide 30mg, 60 mg Modified Release Tablet",Diabetes mellitus type 2 ,"Initially, 30mg daily at breakfast time, may increase in successive steps to 60, 90 or 120mg daily at 1 month intervals (except in patients whose blood glucose level was not reduced after 2 weeks of treatment). Max daily dose: 120mg
",B,,,"
Remicron MR
Oziclide MR
","0.08
0.32",/,tab,B
A10,Metformin HCl 500 mg Tablet,Diabetes mellitus ,"Initial: 500mg orally twice daily with food. Maintenance: Titrate in 500mg increments weekly, doses up to 2000 mg daily may be divided into 2 equal doses.
",B,,,Glucoxit,0.08,/,tab,B
A10,Metformin HCl 500 mg Extended Release Tablet,Diabetes mellitus who experienced gastrointestinal side effects with normal metformin ,"500 mg once daily. Maximum dose 2000 mg once daily with evening meal
",B,,,Diabetmin,0.08,/,tab,A/KK
A10,Saxagliptin 5 mg Tablet ,"FUKKM restriction: As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea. 

i) As add on therapy in type 2 diabetes patients inadequately controlled on metformin monotherapy and high risk of hypoglycaemia, especially elderly patients with co-morbidities. 
ii) As add on therapy in type 2 diabetes patients inadequately controlled with a sulphonylure and intolerant/contraindicated for metformin therapy 
","2.5-5mg once daily. Patients with CrCl < 50ml/min, and when coadministered with strong CYP450 3A4/5 inhibitors: 2.5mg OD
",A/KK,Perubatan,kuota,Onglyza FC,0.97,/,tab,A/KK
,,"iii) As add on therapy in type 2 diabetes patients inadequately controlled on metformin and sulphonylurea combination therapy 
iv) In patients with renal failure where metformin contraindicated Not to be used in patients with HbA1c > 8% on single/combination OAD, as insulin initiation is preferred. ",,,,,,,,,
A10,Vildagliptin 50 mg Tablet,"FUKKM restriction: As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea. 
i) As second line therapy in type 2 diabetes patients inadequately controlled on maximal tolerated dose of metformin monotherapy and high risk of hypoglycaemia. 
ii) As second line therapy in type 2 diabetes patients inadequately controlled on maximal tolerated dose of sulphonylurea and intolerant/contraindicated for metformin therapy. ","ADULT over 18 years: 50mg bd when combine with metformin, 50 mg od when combine with sulphonylurea
",A/KK,Perubatan,kuota,Galvus ,0.42,/,tab,
,,"iii) As third line therapy in type 2 diabetes patients inadequately controlled with dual OAD combination therapy with sulphonylurea and metformin 
iv) As a monotherapy in type 2 diabetes mellitus patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. 
v) An adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus: As a dual therapy in combination with insulin in patients with insufficient glycaemic control. Insulin dose and regimen should be optimized before addition of vildagliptin. ",,,,,,,,,A/KK
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.1 ANTIINFECTIVES",,,,,,,,,,,
S01,Chloramphenicol 0.5% Eye Drops,Ophthalmic infections,"Instil 1 drop of a 0.5% solution every 2 hr. Increase dosage interval upon
improvement.",C,,,Nicol,1.75,/,bot,C
S01,Chloramphenicol 1% Eye Ointment,Treatment of ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol susceptible organisms ,"ADULT and CHILD : Apply to the conjunctiva, a thin strip (approximately 1 cm) of ointment every 3 hours or more frequently
",C,,,Chlorop,1.40,/,tube,C
S01,Ciprofloxacin HCl 0.3% Ophthalmic Solution,"Treatment of bacterial infections caused by susceptible strains in 
i) corneal ulcers 
ii) bacterial conjunctivitis ","i) 2 drops every 15 minutes for the first 6 hours, then 2 drops every 30 minutes for the rest of the first day. Second day : 2 drops every hour. Subsequent days (3rd - 14th day) : 2 drops every 4 hours. Treatment may be continued after 14 days if corneal re-epithelialization has not occured 
ii) 1 - 2 drops every 2 hours into the conjunctival sac while awake for 2 days and 1-2 drops every 4 hours while awake for the next 5 days
",A*,Oftalmologi,,Cipmax,3.50,/,bot,A*
S01,Fusidic Acid 1% Eye Drops,Bacterial eye infections caused by susceptible organisms,"1 drop in conjunctival sac 12 hourly. To be continued for 2 days after the eye appears normal. On the first day of treatment, may be applied more frequently : 1 drop 4 hourly. Surgical prophylaxis : 1 drop every 12 hours, 24 - 48 hours before operation
",A,Oftalmologi,,Fucithalmic,17.55,/,bot,A
S01,Gentamicin 0.3% Eye Drops ,Bacterial eye infections caused by susceptible organisms,"1 drops every 4 hours, in severe infection dosage may be increased up to 1
drops every hour
Dosing is individualised and according to product insert/protocol",A/KK,,,Bactigen,2.90,/,bot,A/KK
S01,Gentamicin 0.3% Eye Ointment,"Conjunctivitis, blepharitis, blepharo-conjunctivitis, keratitis, keratoconjunctivitis, episcleritis, dacrocystitis, corneal ulcers, styes and infected eye socket ","Apply into the conjunctival sac 3 - 4 times daily
",A/KK,,,Gentamicin,4.32,/,tube,A/KK
S01,"Moxifloxacin 0.5% 
Ophthalmic Solution","Treatment of conjunctivitis caused by 
susceptible organism ","CHILD more than 1 year and ADULT: 1 drop to affected eye(s) 3 times daily for 7 days
",A*,Oftalmologi,,Zanaflox,11.11,/,bot,A*
S01,"Natamycin 5% Opthalmic 
Suspension",Treatment of fungal keratitis,1 drop in affected eyes every 1 to 2 hours. reduce to 1 drop 6-8 times daily after 3-4 days.  Duration of treatment: 2-3 weeks. Gradually reduce dose at 4-7 day intervals.,Not in FUKKM,Oftalmologi,"Kuota

Special Drugs Approval (UKK)",Natacyn,513.00,/,bot,
S01,Oxytetracycline with Polymyxin B Sulphate Eye Ointment,"Treatment of superficial ocular infections involving the conjunctiva and/or
cornea due to susceptible microorganisms","Apply into the conjunctival sac 4 times daily
",B,Oftalmologi,,Terramycin,3.04,/,tube,B
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.2 ANTISEPTICS WITH CORTICOSTEROIDS",,,,,,,,,,,
S01,Dexamethasone 0.1% and Neomycin Sulphate 3500 mcg/g and Polymyxin B 6000 iu/g Sulphate Ophthalmic Suspension,Treatment of ocular inflammation when concurrent use of an antimicrobial is judged necessary ,"1 - 2 drops hourly for severe cases and 4 - 6 hourly for mild infection
",A,,,Maxitrol,7.26,/,bot,A
S01,Dexamethasone 0.1% and Neomycin Sulphate 3500 mcg/g and Polymyxin B 6000 iu/g Eye Ointment,Treatment of ocular inflammation when concurrent use of an antimicrobial is judged necessary ,"Apply 1 - 1.5 cm 3 - 4 times daily, may be used adjunctively with drops at bedtime
",A,,,Maxitrol,9.40,/,tube,A
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.3 ANTIVIRALS",,,,,,,,,,,
S01,Acyclovir 3% Eye Ointment,Only for the treatment of herpes simplex keratitis ,"Apply 1 cm 5 times daily. Continue for at least 3 days after healing
",A*,Oftalmologi,Import Permit required for purchase (UKK),Acivir,18.47,/,tube,A*
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.4 CORTICOSTEROIDS",,,,,,,,,,,
S01,Dexamethasone Sodium Phosphate 0.1% Eye Drops,Acute steroid responsive inflammatory and allergic conditions ,"1 - 2 drops 4 - 6 times a day
",A,Oftalmologi,,Maxidex,6.18,/,bot,A
S01,Fluorometholone 0.1% Ophthalmic Suspension,Treatment of steroid responsive ocular inflammation ,"1-2 drops qds. During the initial 24-48 hr, dose may be increased to 2 drops 2 hrly.
",A*,Oftalmologi,,FML-fluorone,5.05,/,bot,A*
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.5 MIOTICS",,,,,,,,,,,
S01,Pilocarpine 2% Eye Drops,Miotics in chronic open-angle glaucoma ,1 drop 1 - 4 times a day,B,Oftalmologi,,Isopto-Carpine,7.90,/,bot,B
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.6 MYDRIATICS",,,,,,,,,,,
S01,Atropine Sulphate 1% Eye Drops,"Determination of refraction, strabismus, iritis and iridocyclitis, after extra or intracapsular extraction of lens ","PREOPERATIVE MYDRIASIS : one drop of a 1% solution supplemented with one drop of 2.5 or 10% phenylephrine prior to surgery. 
ANTERIOR UVEITIS or POSTOPERATIVE MYDRIASIS : one drop of a 1% or 2% solution up to 3 times a day
",B,Oftalmologi,,Isopto-Atropine,10.12,/,bot,B
S01,Cyclopentolate 1% Eye Drops,Mydriasis and cycloplegia ,"ADULT : 1 drop of solution in eye(s); may repeat after 5-10 minutes if needed. CHILD : 1 drop of solution in eye(s); may repeat after 5-10 minutes if needed. Pre-treatment on the day prior to examination is usually not necessary. If desirable, 1 or 2 drops may be instilled the evening prior to examination.
",A,,,Cyclogyl,26.32,/,bot,A
S01,Cyclopentolate 0.2% with Phenylephrine 1% Eye Drops,Dilating agent for premature babies ,"1 drop every 5 - 10 minutes; not exceeding three times to produce rapid mydriasis. Observe infants closely for at least 30 minutes
",A,,,Cyclomydril,13.20,/,bot,A
S01,Homatropine 2% Eye Drops,i) Mydriasis and cycloplegia for refraction ii) Treatment of anterior segment inflammation ,"i) Adult: Instill 1 or 2 drops of 2% solution immediately before the procedure, repeat at 5-10-minute intervals if necessary. Child: Instill 1 drop of 2% soln immediately before the procedure, repeat at 10-min intervals if necessary. 
ii) Adult: Instill 1-2 drops of 2% bd-tds up to every 3-4 hr as needed. Child: 3 mth- 2 yr: instill 1 drop of 0.5% soln once daily or on alternate days. >2 yr: instill 1 drop of 1% or 2% soln bd.
",B,Oftalmologi,"Import Permit required for purchase
(UKK)",Aurohom,10.00,/,bot,B
S01,Phenylephrine HCI 2.5% Eye Drops,"For pupillary dilation in uveitis, for refraction without cyclopegic. For fundoscopy and other diagnostic procedures ","Mydriasis and vasoconstriction: 1 drop of 2.5% or 10% solution, repeated in one hour if necessary. Chronic mydriasis: 1 drop of a 2.5% or 10% solution 2 - 3 times a day. Uveitis with posterior synechiae (treatment) or synechiae, posterior (prophylaxis): 1 drop of a 2.5% or 10% solution, repeated in one hour if necessary, not to exceed three times a day. Treatment may be continued the following day, if necessary
",B,Oftalmologi,,Mydfrin,13.14,/,bot,B
S01,Tropicamide 1% Eye Drops,Topical use to produce cycloplegic refraction for diagnostic purposes ,1 - 2 drops several times a day,A/KK,Oftalmologi,,Mydriacyl,27.27,/,bot,A/KK
,,,,,,,,,,,
"11.0 EYE PREPARATIONS
11.7 OTHERS",,,,,,,,,,,
S01,Acetazolamide 500 mg Injection,"Reduction of intra-ocular pressure in open-angle glaucoma, 
secondary glaucoma and peri-operatively in angle-closure glaucoma","Adult : 250-1000mg per 24hours, usually in divided doses for amounts over 250mg daily",B,,,Diamox,202.80,/,vial,B
S01,Acetazolamide 250 mg Tablet,"Reduction of intraocular pressure in open-angle glaucoma, 
secondary glaucoma and peri-operatively in angle-closure glaucoma","250mg 1-4 times a day, the dosage being titrated according to patient response",B,,,Apo - acetazolamide,0.45,/,tab,B
S01,Artificial tear/ ophthalmic GEL 0.2% 10g  (Polyacrylic acid/ carbomer),"Symptomatic relief of severe dry eye 
conditions and as lens lubricant during ophthalmic diagnostic procedures ","Instill 1-2 drops in affected eye(s) as needed. Refer to product information leaflet.
",,Oftalmologi,Same role as Genteal,Siccapos,12.58,/,tube,
S01,Betaxolol 0.25% Eye Suspension,"Ocular hypertension, Open-angle glaucoma",Adult: As 0.25% drops: Instill 1 drop bid.,A,Oftalmologi,,Betoptic S,25.00,/,bot,A
S01,Bimatoprost 0.03% Ophthalmic Solution,Bimatoprost 0.01% ophthalmic solution is indicated for the reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension in adults (as monotherapy or as adjunctive therapy to beta blockers). (for 2nd line) ,"One drop in the affected eye(s) once daily, administered in the evening. The dose should not exceed once daily, as more frequent administration may lessen the intraocular pressure lowering effect.
",A*,Oftalmologi,,Lumigan,.39.25,/,bot,A*
S01,Brimonidine Tartrate 0.15% Ophthalmic,Lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension ,"1 drop in the affected eye(s) 3 times daily
",A*,Oftalmologi,,Alphagan P,41.90,/,bot,A*
S01,Brinzolamide 1% and Brimonidine tartrate 0.2% ophthalmic suspension,Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction,1 drop in the affected eye(s) 2 times daily.,A*,Oftalmologi,,Simbrinza,44.32,/,bot,
S01,Carbachol 0.01% Intraocular Solution,For intraocular use for miosis during surgery ,"Instill no more than 0.5 ml gently into the anterior chamber
",A,Oftalmologi,,Miostat,33.92,/,vial,A
S01,"Ciclosporin 0.5%, 0.05% Eye Drops",To increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking anti inflammatory drugs or using punctal plugs. ,"0.05%:1 drop twice a day in each eye approximately 12 hours apart.
0.5%: refer ophtalmologist .(1 drop OD to QID (severe) to affected eye(s) is the recommended dose using the 1% strength-MIMS Malaysia)
",A*,Oftalmologi,Not commercially available-Please refer CDR unit for aseptic preparation,  -,"(0.5%)32.5
(0.05%)10.0",/,bot,A*
S01,Dorzolamide HCl 2% Ophthalmic Solution,All glaucoma patients where beta-blockers are contraindicated and when intraocular pressure is not well controlled by other drugs ,"Monotherapy : 1 drop 3 times daily. Adjunctive therapy with an ophthalmic beta-blocker : 1 drop 2 times daily. When substituting for another ophthalmic antiglaucoma agent with this product, discontinue the other agent after proper dosing on one day and start Trusopt on the next day. If more than 1 topical ophthalmic drug is used, the drugs should be administered at least 10 mins apart
",A*,Oftalmologi,,Ocudor,10.70,/,bot,A*
S01,Fluorescein 1 mg Ophthalmic Strip,Used in diagnostic examinations,"Moisten tip with tear fluid from lower fornix, sterile water or ophthalmic solution and gently stroke across the conjunctiva",B,,,Fluoro Touch,0.29,/,strip,B
S01,Hypromellose 0.3% Eye Drops/ Artificial Tears/Opthalmic solution,Dry eye,Adult: As 0.3-2.5% soln/gel: Instill 1-2 drops into affected eye(s) tid or as needed.,B,,,Eye Glo Moist,2.05,/,bot,B
S01,"Hypromellose 0.3%, Carbomer 980 Ophthalmic Gel",Symptomatic relief of severe dry eye conditions and as lens lubricant during ophthalmic diagnostic procedures ,"Instill 1-2 drops in affected eye(s) as needed. Refer to product information leaflet.
",B,Oftalmologi,,Genteal,18.83,/,bot,B
S01,Latanoprost 0.005% Eye Drops,Reduction of elevated intraocular pressure in patients with open-angle glaucoma ,"The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart
",A*,Oftalmologi,,Xalatan,4.14,/,bot,A*
S01,Latanoprost 0.005% +Timolol Maleate 0.5% Eye Drops,For reduction of Intraocular Pressure (IOP) in patients with Open-angle Glaucoma (OAG) and Ocular Hypertension (OH) who are insufficiently responsive to topical beta-blocker. ,"1 drop in the affected eye(s) once daily
",A*,Oftalmologi,,Xalacom,26.28,/,bot,A*
S01,Nepafenec 0.1% Ophthalmic Solution,Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients. ,"One drop 3 times/day beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 60 days of the postoperative period as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery.
",A*,Oftalmologi,,Nevanac,15.67,/,bot,A*
S01,Olopatadine HCl 0.2% Opthalmic Solution,Temporary prevention of ocular itching due to allergic conjunctivitis ,"One drop in each affected eye once a day
",A*,Oftalmologi,,Pataday,30.24,/,bot,A*
S01,Prednisolone Acetate 1% Ophthalmic Suspension ,"For steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. ","1 to 2 drops to be instilled into the conjunctival sac 2 to 4 times daily. During the initial 24 to 48 hours the dosage may be safely increased to 2 drops every hour. Care should be taken not to discontinue therapy prematurely.
",A,Oftalmologi,,Pred,5.59,/,bot,A
S01,Proparacaine HCI 0.5% Ophthalmic Drops,Topical anaesthesia in ophthalmic procedures ,Deep anaesthesia:1 or 2 drops in the (eyes) every 5 to 10 minutes for 3 to 5 doses. For minor surgical procedures: instill 1 to 2 drops every 5 to 10 minutes for 1 to 3 doses. Tonometry and/or tonography procedure: 1 to 2 drops in each eye before procedure.,B,Oftalmologi,,Alcaine,11.15,/,bot,B
S01,Sodium Chloride 0.9% eye drop,Irrigation of conjunctival sac ,1 - 2 drops every 3 - 4 hours,C,,,Normal Saline,2.87,/,bot,C
S01,Sodium Hyaluronate 0.1% eye drops (preservative- free),For lubricating surface of eyes in moderate to severe dry eyes post op,"refer eye clinic: 1 drop TDS, QID, PRN",Bukan ubat (medical device),Oftalmologi,,Hylo Comod,33.00,/,bot,
S01,Sodium Cromoglycate 2% Eye Drops,Prevention and treatment of allergic conjunctivitis including seasonal and perennial allergic conjunctivitis and vernal keratoconjunctivitis ,"1 or 2 drops 4 times daily
",A/KK,Oftalmologi,,Allergo-Comod,14.04,/,bot,A/KK
S01,Timolol Maleate 0.5% Eye Drops (with preservative),"Elevated intraocular pressure, chronic open angle glaucoma ",1 drop for once daily or 2 times daily depending on manufacturer's recommendation.,A,Oftalmologi,,Iotim,4.06,/,bot,A
S01,Timolol Maleate 0.5% Eye Drops (without preservative),"Elevated intraocular pressure, chronic open angle glaucoma ",1 drop for once daily or 2 times daily depending on manufacturer's recommendation.,A,Oftalmologi,,Timo-comod,20.97,/,bot,A
S01,Timolol Maleate 0.5% Ophthalmic Gel Forming Solution ,treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.,1 drop daily in affected eye(s),A,Oftalmologi,,TIMOLAST,12.97,/,bot,A
S01,Travoprost 0.004% & Timolol 0.5% Eye Drops,To decrease intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to other topical anti glaucomas ,"1 drop in the affected eye(s) once daily
",A*,Oftalmologi,,Duotrav,51.26,/,bot,A*
S01,White petroleum mineral oil eye ointment 3.5g tube,Ocular lubricant. Prevent corneal abrasions or ocular complications during general anesth.,1-1.5 cm ribbon of oint under lower lid.,,Oftalmologi,,Duratears,9.09,/,tube,
,,,,,,,,,,,
"12.0 EAR AND NOSE
12.1 EAR",,,,,,,,,,,
S03,Chloramphenicol 5% w/v Ear Drops,"Acute otitis media, otitis externa with perforation ",Apply 2 - 3 drops into the ear 2 - 3 times daily. Not to be used for long term,C,,,Enclor,5.36,/,bot,C
S03,Hydrogen Peroxide 1.5% Ear Drops,To soften impacted ear wax ,"Instill 1 - 2 drops into the ear as required (leave for a few minutess)
",C,,,   -,-,/,bot,C
S02,Ear Wax Softener,Occlusion or partial occlusion of the external auditory meatus by soft wax or wax plug,Instill 5 drops into the ears. Refer product information leaflet,B,,,,9.85,/,bot,
S02,Ofloxacin 0.3% Otic Solution,"i. Acute otitis media with tympanostomy tubes 
ii. Chronic suppurative otitis media with perforated tympanic membranes and 
iii. Otitis externa ","CHILD: 1 - 12 years: 5 drops twice daily for 10 days. 
ADULT and CHILD over 12 years: 6 - 10 drops twice daily and remain in the ear about 10 minutes
",A/KK,"Perubatan, ENT ",,Effexin,13.57,/,bot,A/KK
S02,Sodium Bicarbonate 5% w/v Ear Drops,To soften the impacted ear wax ,"2-3 drops 3-4 times daily
",C,To remove from formulary after finish stock,galenical,   -,-,/,bot,C
,,,,,,,,,,,
"12.0 EAR AND NOSE
12.2 NOSE",,,,,,,,,,,
R01,Alkaline Nasal Douche,To remove nasal plug ,"To be diluted with an equal volume of warm water before use
",B,,galenical,  -,-,/,bot,B
R01,Beclomethasone Dipropionate 50 mcg/dose Nasal Spray (200 doses),the treatment of seasonal allergic rhinitis (hayfever) in patients 6 years of age and over.,two sprays into each nostril twice a day. The maximum daily dose is a total of eight sprays.,A/KK,,,Aqua BECLOMET Nasal,10.74,/,unit,A/KK
H05,Calcitonin (Synthetic Salmon) 200 IU Nasal Spray,treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause when alternative treatments are not suitable,"For intranasal use only: one spray (200 International Units) per day, alternating nostrils daily",A*,,,Tendolon,143.20,/,unit,A*
R01,Ephedrine 0.5% w/v Nasal Drops,relieves nasal congestion in adults and children over 12 years old.,Use one or two drops in each nostril as required not more than 4 times a day. Do not use for longer than 7 days,A/KK,,galenical,  -,-,/,bot,A/KK
R01,Fluticasone Furoate 27.5 mcg/dose Nasal Spray,"Treatment of nasal symptoms (rhinorrhea, nasal congestion, nasal itching and sneezing) and ocular symptoms (itching/burning, tearing/watering, and redness of the eye) of seasonal and perennial allergic rhinitis. ","Adults/Adolescents (≥12 years) : 1-2 sprays (27.5 mcg/spray) in each nostril once daily. Children (2-11 years) : 1-2 sprays (27.5 mcg/spray) in each nostril once daily
",A*,Pediatrik,Kuota,Avamys,24.51,/,bot,A*
R02,Menthol 1% Inhalation,"For relief of the symptoms of coughs, colds and blocked noses","Inhaled via the mouth and nasal passages.

Adults, children over 3 months of age and the elderly:

Add one 5ml spoonful to a pint of hot, but not boiling water.

The dose may be repeated after 4 hours if required.",C,,galenical,  -,-,/,bot,C
R01,Normal Saline Nasal Drops,to treat dry or irritated nose passages. to thin fluid in the nose passages.,1 to 2 drops in each nostril as required,-,,,  -,-,/,bot,-
,,,,,,,,,,,
"12.0 EAR AND NOSE
12.3 DECONGESTANTS",,,,,,,,,,,
R01,Budesonide 64mcg Nasal Spray (120 doses),"Seasonal allergic, perennial rhinitis and nasal polyposis ","ADULT and CHILD 6 years and older. 
Rhinitis : 2 spray into each nostril once daily in the morning or 1 spray into each nostril twice daily. 
Nasal polyps : 2 spray twice daily
",A,,,Budenase,6.50,/,unit,A
R01,Mometasone Furoate 50 mcg Aqueous Nasal Spray (140 doses),Allergic rhinitis. For the treatment of nasal polyps in patients 18 years of age and older. ,"ALLERGIC RHINITIS: ADULT and CHILD, 12 years and above: 100 mcg/day (2 sprays) to each nostril once daily. Maximum 200 mcg (4 sprays) once daily. Reduce to 50 mcg (1 spray) once daily when control achieved. CHILD 3 - 11 years old: 50 mcg (1 spray) to each nostril once daily. 
TREATMENT OF NASAL POLYPS: Two sprays (50 micrograms/spray) in each nostril twice daily (total daily dose of 400 mcg). Once symptoms are adequately controlled, dose reduction to two sprays in each nostril once daily (total daily dose 200 mcg) is recommended.
",A*,ENT,,Elonide,7.90,/,unit,A*
R01,Oxymetazoline HCl 0.05% (Adult) Nasal Spray,"Acute colds, paranasal sinusitis and otitis media ","2 - 3 sprays into each nostril twice daily, maximum 6 sprays per nostril/day",A,ENT,,Oxynase,11.10,/,unit,A
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.1 ANTIINFECTIVES",,,,,,,,,,,
D06,Fusidic Acid 2% Cream,"Skin infections caused by staphylococci, streptococci, corynebacterium minutissumun and other sodium fusidate-sensitive organisms ","Apply to affected area 2 - 3 times daily
",A,,,Disuf,3.44,/,tube,A
D06,Gentamicin 0.1% Cream,For localised infections ,Apply 2 - 3 times daily,A*,,,Gentacin,4.10,/,tube,A*
D06,Mupirocin 2% Cream,"Skin infection by Staphylococcus aureus (including MRSA), Staphylococcus epidermidis and beta-haemolytic streptococcus ","Adults and child over 1 year, apply up to 3 times daily for up to 10 days
",A,Perubatan,,Bactroban,19.00,/,tube,A
D06,Mupirocin 2% Ointment,For MRSA infections only ,"ADULT and CHILD: Apply up to three times daily for up to 10 days
",A,Perubatan,,Bactopic,8.40,/,tube,A
D06,Neomycin 0.5% Cream,Infections of the skin due to susceptible organisms ,"Apply sparingly to affected area up to 3 times daily (For short term use, 1 - 2 weeks)
",B,,,Rexom,3.36,/,tube,B
D06,Silver Sulfadiazine 1% Cream,"Prevention and treatment of infections in severe burns, leg ulcers where infections may prevent healing and for the prophylaxis of infections in skin grafting ","Burns: Apply 3 mm thick layer twice daily with sterile applicator. 
Leg ulcer: apply at least 3 times a week
",B,,,Silfazine,64.95,/,kg,B
D06,Sodium Fusidate 2% Ointment,"Skin infections caused by staphylococci, streptococci, corynebacterium minutissumun and other sodium fusidate-sensitive organisms ","Apply to affected area 2 - 3 times daily
",A,Perubatan,,FOBAN,7.18,/,tube,A
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.2 ANTIINFECTIVES WITH CORTICOSTEROIDS",,,,,,,,,,,
D07,Fusidic Acid 2% in Betamethasone Valerate 0.1% Cream,"Inflammatory dermatosis where bacterial infection is likely to occur eg atopic eczema, discoid eczema, stasis eczema, seborrhoic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus ","Uncovered lesion- Apply 2 to 3 times daily. Covered lesions- Less frequent applications may be adequate
",A/KK,,,Disuf-B,3.95,/,tube,A/KK
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.3 TOPICAL CORTICOSTEROIDS",,,,,,,,,,,
D07,Betamethasone 17-Valerate 0.1% Cream,"Potent topical corticosteroid indicated for adults, elderly and child over 1 year for relief of inflammatory and pruritic manifestation of steroid responsive dermatoses.",Apply sparingly to affected area 2 times daily then reduced to once daily when improvement occurs,A/KK,,,Betaval,5.45,/,tube,A
D07,"Betamethasone 17-Valerate
 0.1% Ointment","Potent topical corticosteroid indicated for adults, elderly and child over 1 year for relief of inflammatory and pruritic manifestation of steroid responsive dermatoses.",Apply sparingly to affected area 2 times daily then reduced to once daily when improvement occurs,A/KK,,,Xorsoint,4.64,/,tube,A
D07,"Betamethasone 17-Valerate 0.01% (i.e. 1: 10), 0.025% (i.e. 1: 4), 0.05% (i.e. 1: 2) Cream","Eczemas, prurigo nodularis, limited psoriasis in appropriate in sites ","Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs
",B,,galenical,-,-,/,container,B
D07,"Betamethasone 17-Valerate 0.01% (i.e. 1: 10), 0.025% (i.e. 1: 4), 0.05% (i.e. 1: 2) Ointment","Eczema, prurigo nodularis, limited psoriasis in appropriate in sites ","Apply sparingly to affected area 2 - 3 times daily then reduced to once daily when improvement occurs
",B,,galenical,-,-,/,container,B
D07,Clobetasol Propionate 0.05% Cream,"Short term treatment only of more resistant dermatoses eg. psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus and other conditions which do not respond satisfactorily to less potent steroids ","Apply sparingly once or twice daily, changing to lower potency therapy as soon as condition is controlled. For mild to moderate use maximum for 2 weeks. For moderate to severe maximum duration 4 consecutive weeks. Max: 50 g/week
",A,Perubatan,,Dermosol,2.00,/,tube,A
D07,Clobetasol Propionate 0.05% Ointment,"Short term treatment only of more resistant dermatoses eg. psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus and other conditions which do not respond satisfactorily to less potent steroids ","Apply sparingly once or twice daily, changing to lower potency therapy as soon as condition is controlled. For mild to moderate use maximum for 2 weeks. For moderate to severe maximum duration 4 consecutive weeks. Max:50 g/week
",A,Perubatan,,Cloderm,2.64,/,tube,A
D07,Clobetasone Butyrate 0.05% Cream,Eczema and dermatitis of all types ,"Apply up to four times daily until condition improves, then reduce frequency
",A/KK,Perubatan,,U-Closone,4.40,/,tube,A/KK
D07,Clobetasone Butyrate 0.05% Ointment,Eczema and dermatitis of all types ,"Apply up to four times daily until condition improves, then reduce frequency
",A,Perubatan,,U-Closone,3.35,/,tube,A
D07,Hydrocortisone 1% Cream,Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses ,"Apply sparingly to affected area 2 - 3 times daily until condition improve, then reduce frequency
",B,,,Np Hydrocortisone ,46.40,/,jar,B
D07,Hydrocortisone 1% Ointment,Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses ,"Apply sparingly to affected area 2 - 3 times daily until condition improve, then reduce frequency
",B,,,H - cort,5.57,/,tube,B
D07,Mometasone Furoate 0.1% Cream,For the relief of the inflammatory and pruritic manifestations of the corticosteroid responsive dermatoses,"Apply thin layer to the affected skin areas once daily until the lesion heals or for a duration of 3 weeks whichever is sooner.Massage gently and thoroughly until the medication disappears.
",A*,Perubatan,,Elosone,3.04,/,tube,A*
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.4 ACNE AND DANDRUFF PREPARATIONS",,,,,,,,,,,
D08,Cetrimide 1% Lotion,As shampoo and cleansing agent ,"Apply to affected area
",C+,,,Xortim,3.75,/,bot,C+
D04,Calamine with 2% Precipitated Sulphur Lotion,Acne vulgaris ,"Apply to the skin as required and allow to dry, 1 - 3 times daily
",C,,galenical,-,-,/,bot,C
D05,"Salicylic acid, Sulphur and Liquid Coal Tar Ointment (Cocois Co. Ointment)",Scalp psoriasis and severe seborrhoeic dermatitis ,"Rub a small amount into the scalp gently
",B,,galenical,-,-,/,container,B
D01,Ketoconazole 2% Shampoo,Resistant dandruff only ,"Apply twice weekly for 2 - 4 weeks. Prophylaxis: Once every 1 - 2 weeks
",A/KK,Perubatan,,Ketazone,7.88,/,bot,A/KK
D05,"Coal Tar Solution 1% w/w, Salicylic Acid 2% w/w Shampoo","Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis ","Apply to the affected areas or as in product leaflet
",A/KK,Perubatan,,Sebitar,29.92,/,bot,A/KK
D11,Selenium Sulphide 2.5% Shampoo,"Dandruff, seborrheic dermatitis of scalp ","Dandruff: apply 5-10 mL topically twice weekly for 2 weeks, then 1-4 times per month, as needed, leave on for 2-3 min, then rinse thoroughly. Seborrheic dermatitis of scalp: apply 5-10 mL topically twice weekly for 2 weeks, then 1-4 times per month, as needed, leave on for 2-3 min, then rinse thoroughly
",A/KK,Perubatan,,Selfide,19.50,/,bot,A/KK
D10,Benzoyl Peroxide 5% Gel,Mild to moderate acne vulgaris ,"Apply 1-2 times daily preferably after washing with soap and water
",B,Perubatan,,Benzac AC,7.60,/,bot,B
D10,Sulphur 2% & Salicylic Acid 2% Cream,Acne vulgaris and seborrhoeic dermatitis ,"When used in scalp disorders, a small amount of cream should be rubbed gently into the roots of the hair. When used in skin disorders, the cream should be applied sparingly to the affected area. Apply once daily or until noticeable improvement, then once or twice a week
",C,,galenical,   -,-,/,container,C
D10,Tretinoin 0.05% Cream,Acne vulgaris and recalcitrant cases of acne (comedonal type) ,"Apply thinly to the affected area once daily or twice daily. Avoid exposure to sunlight. Duration of treatment: 8 - 12 weeks is required before any noticeable response
",A/KK,Perubatan,,Retin-A,5.30,/,tube,A/KK
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.5 ANTISEPTICS AND DISINFECTANTS",,,,,,,,,,,
D08,Acriflavine 0.1% Lotion,"Infected skin, lesions, cuts, abrasions, wounds and burns. ","Apply undiluted three times daily to the affected part .
",C+,,,NW Acriflavine,2.46,/,bot,C+
D08,Alcohol 70% Solution,Use as antiseptic and disinfectant ,"Apply to the skin undiluted or when needed
",C+,,galenical, -,-,/,bot,C+
D08,Chlorhexidine Gluconate 2% in Alcohol 70% solution,Use as disinfectant in central venous catheter care bundle ,"Skin Preparation:Use Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70% and allow to dry. Catheter acces:Apply to catheter ports or hubs prior to accessing the line for administering fluids or injections
",C,,,-,-,/,bot,C
D08,Chlorhexidine 2% in alcohol 70% solution (500ml),Use as disinfectant in central venous catheter care bundle ,"Skin Preparation:Use Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70% and allow to dry. Catheter acces:Apply to catheter ports or hubs prior to accessing the line for administering fluids or injections
",C,,,Steriprep,11.70,/,bot,C
D08,Chlorhexidine Gluconate 0.2% w/v Hand Disinfectant 1L,Alcohol-based disinfectant for hand hygiene and surgical disinfection,The solution is to be rubbed into the skin and keep the skin moistened for 30 secs (hand disinfectant) or 3 minutes (surgical hand disinfectant),,Unit Kawalan Infeksi,,Alsoft,42.00,/,bot,
R02,Chlorhexidine Gluconate 0.2% Mouthwash,As a gargle ,"Rinse mouth with 10 ml for about 1 minute twice daily
",C,,galenical, -,-,/,bot,C
D08,Chlorhexidine Gluconate 5% Solution (1L),"i) Preoperative skin disinfection 
ii) Wounds or burns 
iii) Emergency disinfection of instruments ","i) & iii) 1 : 10 in 70 % Alcohol 
ii) 1 : 100
",C+,,,Chlorhexida 5,46.40,/,bot,C+
D08,Chlorinated Lime Solution 2.5% & Buffered Sodium Acetate Solution 0.68%,Wound or ulcer ,"Apply to affected areas undiluted as a cleansing agent
",C,,,"Eusol I, Eusol II",21.20,/,bot,C
D08,Hydrogen Peroxide 20 volume Solution,"Skin disinfection, particularly cleansing and deodorising wounds and ulcers ","Hydrogen Peroxide 6% (=approx. 20 vol) shall be dispensed. 
For cleansing wounds: 1.5% to 6% solution apply 2-3 times daily or when nescessary. As a mouthwash: rinse the mouth for 2-3 minutes with 15ml of hydrogen peroxide 6% diluted in half a tumblerful of warm water 2-3 times daily. 
Disinfecting cleaned equipment: immersion for 30 minutes in 6% solution. As ear drop for removal of wax: hydrogen peroxide 6% diluted with 3 parts of water preferably just before use
",C,,galenical,   -,-,/,bot,C
V07,Peracetic Acid < 7% and Hydrogen Peroxide < 5% (5L),High level disinfectant or sterilant for heat labile endoscopes ,"Immersion time based on manufacturer recommendation
",A,,,Endopa,150.00,/,bot,A
D08,Povidone Iodine 10% (equivalent to 1% iodine) Solution (1L/ 500ml),"Skin operation prior to surgery, in cleansing open wounds, as an antiseptic for operative wounds infections ","To be applied undiluted in pre-operative skin disinfection and general antisepsis.
",B,,,"
U-Iodine

Septidine

Betadine (500ml)","28.84

18.80

10.00",/,bot,B
D08,Povidone-Iodine 5% w/w antiseptic cream (Betadine) 15gm,"Bacterial and mycotic (fungal) skin infections;Bed sore and leg ulcer; Minor burns, cuts and abrasions;Herpes genitalis.",To be applied topically once or twice daily ,Not in FUKKM,wound care,"Special Drugs Approval (KPK) required
-TIDAK LULUS-",Betadine,7.85,/,tube,
D08,Povidone-Iodine 2.5% w/v spray (Betadine) 55gm ,"Treatment and prevention of skin infections in wounds including ulcers, burns, cuts, abrasions and other minor injuries.",To be sprayed several times a day (every 3 to 4 hours) ,Not in FUKKM,wound care,Special Drugs Approval (UKK) (secara pukal) required,Betadine,16.83,/,bot,
V07,Sodium Dichloroisocyanurate 2.5 g Tablet (100 tabs),Low and medium level disinfectant ,"50 - 10,000 ppm av chlorine
",C,,,DKLOR-TAB,33.00,/,bot,C
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.6 ASTRINGENTS",,,,,,,,,,,
ATC,NAMA GENERIK UBAT & KEKUATAN,INDIKASI,DOS,KATEGORI PRESKRIBER,JABATAN,CATATAN,BRAND NAME*,PRICE/UNIT (RM),,,CAT.
,,,,,,,,,,,-
,,,,,,,,,,,C+
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.7 FUNGISIDE & ANTIVIRAL",,,,,,,,,,,
D06,Acyclovir 5% Cream 10g,"Herpes simplex infections of the skin, including initial and recurrent labial and genital herpes simplex infections ","Apply every 4 hours for 5 - 10 days
",A*,,,Vicide,3.25,/,tube,A*
D01,Benzoic Acid 6% + Salicylic Acid 3% Ointment,Topical Antifungal & AntiParasite,Apply to affected areas two times a day,C,,,Whitefield's Ointment,28.98,/,jar,C
D01,Clotrimazole 1% Solution,"Cutaneous candidiasis, tinea orporis, tinea cruris, tinea pedis and tinea versicolor ",Apply gently onto affected and surrounding skin area 2 or 3 times daily continuing for 2-4 weeks,A,Perubatan,,Candid,6.58,/,bot,A
D01,Miconazole 2% Cream 15g,"i) Fungal infections: Tinea pedis, Tinea corporis, Tinea capitis and other dermatophyte infections caused by Trichophyton and Epidermophyton species; 
ii) Antifungal agent that has been in various candida infections including vaginal candidiasis. 
Prescribing restriction(s): To be used as 2nd line treatment at health facilities without medical officer. ","Apply sparingly and rub gently onto affected area 1-2 times daily continuing for 14 days after lesions have healed
",B,,,Mico,1.12,/,tube,B
D01,"Nystatin 100,000 units/g Cream",Prevention and treatment of cutaneous infections caused by Candida albicans ,"Apply liberally to affected area twice daily or as required. After lesion has disappeared continue treatment for 10 days to prevent relapses. Nail infection: Cut nails as short as possible. Apply cream once daily until growth of new nail has set in
",C,,,Tystatin,7.42,/,tube,C
D01,"Salicylic Acid 2 % Lotion 
(Tinea Lotion)","Seborrhoeic dermatitis, scalp, 
psoriasis and hyperkeratotic skin conditions ","Apply sparingly to the affected area 2-3 times daily. 
Wash with cleanser 2 - 3 times per day",B,,galenical,-,-,/,bot,B
D01,Sodium Thiosulphate 20% Solution,Fungicides. For the treatment of pityriasis versicolor ,"Apply to all affected parts of the body and face with a brush after a bath once daily or twice daily or 3 times daily
",C,,,-,-,/,bot,C
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.8 KERATOLYTICS",,,,,,,,,,,
D05,"Coal Tar 1%, 2%, 3%, 6%, 9% Ointment (Liquor Picis Carbonis in Ung. Emulsificant)","Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis. Used as a mild astringent for the skin, as a soothing and protective application in eczema and as a protective to slight excoriation ","Apply sparingly to the affected area 1-3 times daily starting with low strength preparations
",B,,galenical,-,-,/,container,B
D05,"Coal Tar (LPC) 1% + 2% Salicylic Acid, Coal Tar (LPC) 3% + 2% Salicylic Acid, Coal Tar (LPC) 6% + 3% Salicylic Acid Ointment","Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis ","Apply to the affected areas
",B,,galenical,-,-,/,container,B
D01,"Salicylic Acid 2%, 4%, 10% Cream","Seborrhoeic dermatitis, scalp psoriasis and hyperkeratotic skin conditions ","Apply sparingly to the affected area 2-3 times daily
",C,,galenical,-,-,/,container,C
D01,"Salicylic Acid 2%, 4%, 10% Ointment","Seborrhoeic dermatitis, scalp, psoriasis and hyperkeratotic skin disorders ","Apply sparingly to the affected area 2-3 times daily
",C,,galenical,-,-,/,container,C
D01,Salicylic Acid 20% Ointment,Plantar warts ,"Apply daily and protect surrounding skin (eg with soft paraffin or specially designed plaster) ,may need to continue up to 3 months",C,,galenical,-,-,/,container,C
D07,"Salicylic Acid 2% in Hydrocortisone 1% Ointment, Cream",Seborrhoeic capitis ,Apply sparingly to affected areas 1-2 times daily,B,,galenical,-,-,/,container,B
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.9 PIGMENTS AND SKIN PROTECTIVES",,,,,,,,,,,
D02,Aqueous Cream 500g,Dry skin ,"As a soap or apply to the skin as an emollient cream
",C+,,,Xorquas,11.37,/,jar,C+
D04,Calamine Cream 30g,"Soothes and relieves nappy rashes, prickly heat, minor skin irritations, insect bites and sunburn, Pruritic skin conditions. ","Apply to the affected area as required, 1-3 times daily
",C+,,,Idaman Calamine Cream,5.80,/,tube,C+
D02,Carbamide (Urea) 10 % Cream 20g,"Contact irritant dermatitis, infantile eczemas, acute and chronic allergic eczemas, icthyosis, hyperkeratotic ","Apply sparingly and rub into affected area 2 - 3 times daily and when required after cleansing skin
",B,Perubatan,,UO,4.43,/,tube,B
D04,"Calamine 8%, Zinc Oxide 8% with Menthol 0.035% Lotion 120ml","Soothes and relieves nappy rashes, prickly heat, minor skin irritations, insect bites and sunburn, Pruritic skin conditions. ","Apply to the skin as required and allow to dry, 1 - 3 times daily
",C+,,,"Idaman
Calamine Lotion",6.38,/,bot,C+
D02,Emulsificants Ointment 450g,Xerosis and ichthyosis ,Use as a soap and emollient,C,,,Hovid Emulsificant Ointment,30.00,/,jar,C
D02,"Paraffin, Yellow Soft (Vaseline)",Xerosis and ichthyosis ,"Apply to the affected area
",C,,,-,17.20,/,kg,
D02,Sunscreen SPF 50+ Lotion 100ml,To prevent sunburn,Apply as required,A ,Perubatan ,"Skin 
Clinic",SUNSENSE,40.34,/,bot,
D02,Zinc Oxide 555.7mg plus calamine 164.5mg in 3.5g sachet ,As a skin barrier to prevent wound maceration during dressing,apply 2-4 times daily or as required,C,Wound Care,Buy when needed,Calmoseptine Ointment,3.00,/,sachet,
D02,Zinc Oxide Cream 500gm,"Skin protective in various skin conditions such as nappy rash, eczema and problem skin ","Apply 3 times daily or as required
",C+,,,Zorbyx,87.00,/,jar,C
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.10 SCABICIDES AND PEDICULOCIDES",,,,,,,,,,,
P03,Benzyl Benzoate 12.5% Emulsion,Scabies - for child 2-12 years old ,"After bath, apply over the whole body, neck down and leave on for 24 hours then wash off. Reapply for another 24 hours, the first repeat application should be within 5 days of the initial application, a third application may be required in some cases
",C+,,Prepared by diluting Benzyl Benzoate 25% emulsion,Scabitone,3.31,/,bot,C+
P03,Benzyl Benzoate 25% Emulsion 120ml,Scabies for adult and children more than 12 years old. ,"After bath, apply over the whole body, neck down and leave on for 24 hours then wash off. Reapply for another 24 hours, the first repeat application should be within 5 days of the initial application, a third application may be required in some cases.
",C+,,,Scabitone,3.31,/,bot,C+
P03,Crotamiton 10 % Cream 15g,"i) Pruritus
ii) Scabies 
iii) Insect bite reactions ","i) and iii) Massage into affected area until the medication is completely absorbed. Repeat as needed. Apply 2 or 3 times daily 
ii) Apply to the whole body from below the chin. 2nd application is applied 24 hr later. May need to use once daily for up to 5 days.
",B,,,A-bite,6.79,/,tube,B
P03,Gamma Benzene Hexachloride 1 % Lotion,For treatment of head lice ,Leave lotion on hair for exactly 4 minutes. Then wash off of the hair and skin with warm water.,B,To remove from formulary after finish stock,galenical,-,-,/,bot,B
P03,Permetrin 1% w/v lotion,For topical treatment of head lice,Apply lotion onto clean towel dried hair ensuring every strand comes in contact with lotion for at least 10 minutes. Rinse completely. Re-apply after 10 days to ensure total recovery,B,,,,11.21,/,bot,
P03,Permethrin 5% w/v Lotion,Treatment of scabies ,Two applications needed one week apart. Apply thoroughly to all body parts from neck down. Leave overnight for 8 - 14 hours. Washed off. Reapply after one week. Not recommended for children less than 2 months of age.,A/KK,,,A-scabs,9.46,/,bot,A/KK
,,,,,,,,,,,
"13.0 DERMATOLOGICAL
13.11 OTHER DERMATOLOGICAL PREPARATIONS (INC. ORAL FORM FOR DERMATOLOGICAL PROBLEM)",,,,,,,,,,,
D05,"Acitretin 10 mg, 25 mg Capsule","i) Severe form of psoriasis including erythrodermic psoriasis and local or generalized pustular psoriasis. 
ii) Severe disorders of keratinization, such as:
-congenital ichthyosis -pityriasis rubra pilaris 
-Darier's disease 
-other disorders of keratinization which may be resistant to other therapies ","ADULT: initially 25-30 mg daily for 2-4 weeks, then adjusted according to response, usually within range 25-50 mg daily for further 6-8 weeks (max: 75 mg daily). In disorders of keratinization, maintenance therapy of less than 20mg/day and should not exceed 50mg/day 
CHILD: 0.5mg/kg daily occasionally up to 1 mg/kg daily to a max. 35 mg daily for limited periods
",A*,Perubatan,,Novatretin,"3.10, 5.57",/,cap,A*
D05,Calcipotriol Hydrate 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Ointment (30g),Resistant plaque psoriasis ,"Apply once daily up to 4 weeks with maximum weekly dose of 100g and maximum treatment area 30% of body surface
",A*,Perubatan,Kuota,Daivobet,137.00,/,tube,A*
D05,Calcipotriol Hydrate 50 mcg/g & Betamethasone Dipropionate 0.5 mg/g Gel (30g),Topical treatment of scalp and non-scalp plaque psoriasis vulgaris in adults,Should be applied to affected areas once daily. The recommended treatment period is 4 weeks for scalp areas and 8 weeks for non-scalp areas. The body surface area treated with calcipotriol containing products should not exceed 30% and maximum dose should not exceed 15g or 100g/ week,A*,Perubatan,Kuota,Xamiol,135.35,/,tube,
D05,Coal Tar 20% Solution,"Dandruff, seborrhoeic dermatitis, atopic dermatitis, eczema and psoriasis ","Use 100 ml in a bath
",B,,galenical,  -,1.37,/,bot,B
D08,Copper Sulphate Crystal 1kg,Wounds,"The tip of the crystal should be moistened by dipping in water and applied carefully to the lesion
",C,,,Cu sulphate crystal,56.65,/,bot,C
D05,"Dithranol 0.5%, 1%, 2% Ointment",Short contact treatment for plaque psoriasis and alopecia areata ,"For application to skin or scalp. 0.1-0.5% suitable for overnight treatment. 1-2% for max 1 hour.
",A,,,  -,-,/,container,A
D11,Dupilumab 300mg Solution for Injection in Pre-filled Syringe,"(i) Indicated for the treatment of adult patients with severe atopic dermatitis (AD) whose disease is not adequately controlled with systemic immunosuppressants and / or phototherapy or when those therapies are not advisable. Dupilumab can be used with or without topical corticosteroids.
Restriction: 
As fourth line of treatment in patients who have failed / have contraindications / experienced adverse events to:
- Intensive and optimized topical treatment
- Phototherapy
- At least two immunosuppressants
(To be prescribed by Dermatologists only)","Indication (i):
The recommended dose is an initial dose of 600 mg (two 300 mg injections), followed by 300 mg given every other week.",A*,Perubatan,"Kuota

",Dupixent,2404.00,/,PFS,
,,"(ii) Dupilumab is indicated in adults and adolescents 12 years and older as an add on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (FeNO). Dupilumab is indicated as maintenance therapy for oral corticosteroid-dependent asthma.
Restriction:
i.Raised blood eosinophils (150 cells/microlitre or more) and/or raised (25 parts per billion or more) fraction of exhaled nitric oxide (FeNO).
ii.To be prescribed by Respiratory Physician (Pulmonologist) only","Indication (ii):
• An initial dose of 400 mg (two 200 mg injections) followed by 200 mg given every other week as subcutaneous injection

• For patients with severe asthma and who are on oral corticosteroids or for patients with severe asthma and co-morbid moderate-to-severe atopic dermatitis or adults witsh co-morbid severe chronic rhinosinusitis with nasal polyposis, an initial dose of 600 mg (two 300 mg injections), followed by 300 mg every other week as subcutaneous injection",,,,,,,,
D10,"Isotretinoin 10 mg, 20 mg Capsule","Only for treatment of 
i) Severe nodulo-cystic acne 
ii) Acne conglobata 
iii) Acne fulminans 
iv) Severe acne vulgaris failing conventional treatment. ","0.5-1 mg/kg of body weight per day (in two divided doses) for 15 to 20 weeks; the maximum recommended dose is 2mg/kg of body weight per day. After about 4 weeks, therefore, dosage for the maintenance treatment should be adjusted within the range 0f 0.1-1mg/kg daily to meet individual need. Treatment usually lasts a total of 16 weeks. There should be an interval of at least 8 weeks before re-starting treatment.",A*,Perubatan,,"Acnotin 10

Acnotin 20","1.40

2.20",/,cap,A*
D11,Magnesium Sulphate Paste,Inflammatory skin conditions such as boils and carbuncles ,"Apply under dressing
",C,,galenical,-,-,/,container,C
D05,Methoxsalen 1% Lotion,Repigmenting agent in vitiligo in conjuction with controlled doses of UVA or sunlight ,"Apply 0.1% lotion to area to be exposed to the UVA light ( need to dilute the 1% lotion to 0.1% lotion, otherwise the skin will burn)
",A,,import permit required for purchase (KPK),-,115.80,/,bot,A
D08,"Potassium Permanganate Solution 1: 1,000 (0.1%)",Cleansing and deodorising suppurative eczematous reactions and wounds ,"As soaks or wet dressing 1 - 3 times daily or as required
For soaks/ wet dressing (cuci): 10ml dilute to 100ml water
For baths (mandi): 10ml dilute to 5L water",C+,,galenical,-,-,/,bot,C+
,,,,,,,,,,,
"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS
14.1 ANTIANAEMIC DRUGS",,,,,,,,,,,
B03,Cyanocobalamin 1 mg/ ml Injection,"i) Prophylaxis of anaemia associated with Vitamin B12 deficiency 
ii) Uncomplicated pernicious anaemia or Vitamin B12 malabsorption ","i) Prophylaxis of anaemia: 250-1000 mcg IM every month 
ii) Uncomplicated pernicious anaemia or Vitamin B12 malabsorption: Initial 100 mcg daily for 5-10 days followed by 100-200 mcg monthly until complete remission is achieved. Maintenance: up to 1000 mcg monthly. 
CHILD: 30-50 mcg daily for 2 or more weeks (to a total dose of 1-5mg). OR AS PRESCRIBED.",B,,,Cyanocobalamine,1.81,/,amp,B
B03,Cyanocobalamin 50 mcg Tablet,Vitamin B12 deficiency of dietary origin ,ADULT: 50-150 mcg daily. CHILD: 50-105 mcg daily in 1-3 divided doses,B,,,Sunward,0.06,/,tab,B
B03,Darbepoetin alfa 0.2mcg/0.5ml injection,"i. Treatment of anaemia associated with chronic renal failure, including patients on dialysis and patients not on dialysis. ii. Anemia with myelodysplastic syndrome

restriction For indication (i): Patients who require higher doses of erythropoietin if it is more cost saving to use a long-acting agent instead of short-acting agents","Indication (i): Haemodialysis patients: Initial dose: 20mcg IV once weekly Initial dose for switched ESA-treated patient: 15 – 60mcg IV once weekly Maintenance dose: 15 – 60mcg IV once weekly, then 30 – 120mcg IV biweekly. Peritoneal dialysis patients and patients with chronic kidney disease not on dialysis: Initial dose: 30mcg IV or SC biweekly Initial dose for switched ESA-treated patient: 30 – 120mcg IV or SC biweekly Maintenance dose: 30 – 120mcg IV or SC biweekly, then 60 – 180mcg IV or SC once every four weeks. Indication (ii): Adults: 240mcg administered as a single subcutaneous injection once weekly. The dose should be decreased in view of the degree of anemic symptoms and the patient’s age.",A*,Perubatan,Kuota,NESP,47.58,/,PFS,
B03,Erythropoietin Human Recombinant 2000 IU/0.5ml Injection (Epoetin Alfa),"i) Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases 
ii) Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy ","i) ADULT by IV injection over 1-5 minutes, initially 50 units/kg 3 times weekly adjusted according to response in step of 25 units/kg 3 times weekly at interval of at least 4 weeks. CHILD initially as for adult. Maintenance: bodyweight under 10 kg usually 75-150 units/kg 3 times weekly, bodyweight 10-30 kg usually 60-150 units/kg 3 times weekly, bodyweight over 30 kg usually 30-100 units/kg 3 times weekly 

ii) ADULT by SC injection (max. 1 ml per injection site), initially 150 units/kg 3 times weekly, increased if appropriate rise in haemoglobin not achieved after 4 weeks to 300 units/kg 3 times weekly. Discontinue if inadequate response after 4 weeks at higher dose
",A*,Perubatan,"Kuota jika pesakit dialisis dari luar HSM / indikasi hematologi

Erysaa NOT APPROVE for S/C route",Erysaa (contract KKM),14.80,/,PFS,A*
B03,Erythropoietin Human Recombinant 4000 IU/0.4ml Injection (Epoetin Alfa),"i) Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases 
ii) Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy ","
i) ADULT by IV injection over 1-5 minutes, initially 50 units/kg 3 times weekly adjusted according to response in step of 25 units/kg 3 times weekly at interval of at least 4 weeks. CHILD initially as for adult. Maintenance: bodyweight under 10 kg usually 75-150 units/kg 3 times weekly, bodyweight 10-30 kg usually 60-150 units/kg 3 times weekly, bodyweight over 30 kg usually 30-100 units/kg 3 times weekly 

ii) ADULT by SC injection (max. 1 ml per injection site), initially 150 units/kg 3 times weekly, increased if appropriate rise in haemoglobin not achieved after 4 weeks to 300 units/kg 3 times weekly. Discontinue if inadequate response after 4 weeks at higher dose
",A*,Perubatan,"Kuota

Binocrit APPROVE for S/C route",Binocrit,52.26,/,PFS,
B03,"Erythropoietin Human Recombinant 2000 IU/0.3ml, 4000 IU/0.3ml Injection (Epoetin Beta)","i) Treatment of anaemia associated with chronic renal failure. Dialysis patients who have haemoglobin less than 10 g/dL or are exhibiting symptoms of anaemia although haemoglobin more than 10 g/dL and pre-transplant cases 
ii) Anaemia in cancer (non-myeloid malignancies) with concomitant chemotherapy ","i) ADULT by IV injection over 1-5 minutes, initially 50 units/kg 3 times weekly adjusted according to response in step of 25 units/kg 3 times weekly at interval of at least 4 weeks. CHILD initially as for adult. Maintenance, bodyweight under 10 kg usually 75-150 units/kg 3 times weekly, bodyweight 10-30 kg usually 60-150 units/kg 3 times weekly, bodyweight over 30 kg usually 30-100 units/kg 3 times weekly 
ii) ADULT by SC injection (max. 1 ml per injection site), initially 150 units/kg 3 times weekly, increased if appropriate rise in haemoglobin not achieved after 4 weeks to 300 units/kg 3 times weekly. Discontinue if inadequate response after 4 weeks at higher dose
",A,Perubatan,"2000 iu: Open Quota for Nephrologist & Haematologist

4000iu: Kuota","Recormon 2000
Recormon 4000","16.25 

32.96",/,inj,A
B03,Ferric derisomaltose [formerly known as Fe (III) isomaltoside 1000] 100mg/ml (10ml),"Indicated for the treatment of iron deficiency in the following conditions:
- when oral iron preparations are ineffective or cannot be used
- where there is a clinical need to deliver iron rapidly

The diagnosis must be based on laboratory tests.

Restriction: For cases where less number of administration and fewer medical visits or quick achievement of Hb target are imperative / crucial","Intravenous bolus injection:
Up to 500 mg up to three times a week at an administration rate of up to 250 mg iron/minute.

Intravenous drip infusion:
Up to 20 mg iron/kg body weight or as weekly infusions until the cumulative iron dose has been administered.
If the cumulative iron dose exceeds 20 mg iron/kg body weight, the dose must be split in two administrations with an interval of at least one week.",A*,"Unit Transfusi Darah, Perubatan
",Kuota,Monofer ,531.00,/,vial,
B03,Ferrous Fumarate 200 mg Tablet,Prevention and treatment of iron-deficiency anaemias ,"
Adult: Usual dose range: Up to 600 mg daily. May increase up to 1.2 g daily if necessary. 
Child: As syrup containing 140 mg(45 mg iron)/5ml. 
Preterm neonate: 0.6-2.4 ml/kg daily; up to 6 years old: 2.5-5ml twice daily
",C+,,,Idaman Iron Tablets,0.21,/,tab,C+
B03,"Ferrous Controlled Release 500 mg, Vitamin B1, B2, B6, B12, Vitamin C 500mg, Niacinamide, Calcium Panthothenate and Folic Acid 800 mcg Tablet","Anemia due to iron deficiency, megaloblastic anemia where there is an associated deficiency of Vitamin C and Vitamin B-complex particularly in pregnancy. In primary health clinic, the indication is restricted to anemia due to iron deficiency in pregnant women ONLY. ","One tablet daily
",A/KK,Obstetrik,,Iberet Folic,0.60,/,tab,A/KK
B03,Folic Acid 5 mg Tablet,"i) For the prevention and treatment of folate deficiency states 
ii) For the prevention of neural tube defect in the foetus ","i) ADULT initially 10-20mg mg daily for 14 days or until haematopoietic response obtained. Daily maintenance: 2.5 mg-10mg .
CHILD up to 1 year:250 mcg/kg daily; 1 to 5 years:2.5mg/day;6-12 years: 5mg/day 
ii) 5 mg daily starting before pregnancy and continued through the first trimester
",C+,,,Royce Folic Acid,0.02,/,tab,C+
B03,Iron (III) Polymaltose Complex 10mg iron/ml syrup,"Treatment of latent iron deficiency and iron deficiency anaemia (manifest iron deficiency).

Restriction:
In primary care setting, for pediatrics use only","Infants (up to 1 year): 2.5-5ml daily (25-50mg iron)
Children (1-12 years old): 5-10ml daily (50-100mg iron)
Children (>12 years), adults: 10-30 ml daily (100-300mg iron)
Pregnant woman 20-30ml daily (200-300mg iron)",A/KK,Pediatrik,,Maltofer,18.35,/,bot,
B03,Iron Sucrose 100 mg/5 ml Injection,"Treatment of iron deficiency anaemia: 
a) where there is a clinical need for rapid iron supply 
b) in patients who cannot tolerate oral iron therapy or who are non-compliant 
c) in active inflammatory bowel disease where oral iron preparations are ineffective ","Individualised dosage. ADULT and ELDERLY: Cumulative dose is to be administered in single doses of 100 - 200 mg of iron 2 - 3 times weekly depending on Hb level. By IV drip infusion, slow IV injection or directly into the venous limb of the dialyser. Total cumulative dose: 1000 mg
",A/KK,Perubatan,,Ranofer,10.00,/,amp,
B03,"Methoxy Polyethylene Glycol-epoetin Beta 100 mcg/0.3 ml, 120 mcg/0.3ml, 150mcg/0.3ml Injection in Prefilled Syringe",Treatment of anaemia associated with chronic renal failure. Prescribing restriction: Patients who require higher doses of erythropoietin if it is more cost saving to use a long-acting agent instead of short-acting agents.,"Non Erythropoiesis Stimulating Agent (ESA)-treated patients : 0.6 mcg/kg, once every two weeks (IV or SC). When the Hb is >11g/dl, administration can be reduced to once monthly using the dose equal to twice the previous two weekly dose. ESA-treated patients : 120-360 mcg once monthly or 60-180 mcg every two weeks",A*,Perubatan,Kuota,"Mircera 100
Mircera 120
Mircera 150","191.10
229.32
286.65",/,PFS,
,,,,,,,,,,,
"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS
14.2 CHOLAGOGUES, CHOLELITHOLYTICS AND HEPATIC PROTECTORS",,,,,,,,,,,
A11,"Essential Phospholipids,
Nicotinamide,
Cyanocobalamine, Tocopheryl,
Pyridoxine, Thiamine,
Riboflavine Capsule","Nutritional support in the management of damaged liver (due to chronic liver disease, liver cirrhosis, fatty liver & intoxication by hepatotoxic substances).","
1-2 capsules 3 times a day
",A/KK,Perubatan,,Livovid,0.25,/,cap,A/KK
,,,,,,,,,,,
"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS
14.3 DIGESTIVE ENZYMES",,,,,,,,,,,
A05,Ursodeoxycholic Acid 250 mg Capsule,"Cholestatic liver diseases (eg. primary biliary cholangitis, primary cholangitis
etc.)","10-15 mg/kg daily in 2 to 3 divided doses
Dosing is individualised based on body weight and according to product
insert/protocol
",A,"Pembedahan, Pediatrik",Kuota,Ursofalk,2.63,/,tab,A
,,,,,,,,,,,
"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS
14.4 ENTERAL AND PARENTERAL NUTRITION",,,,,,,,,,,
B05,Amino Acids 6.53%  Injection 500ml,Source of amino acids in patients needing IV nutrition ,"Dose to be individualised. ADULT usually 500-2000 ml by IV. ADULT usual requirement for amino acid: 1-2 g/kg/day
",A,,,Vaminolact,197.14,/,bot,A
B05,Amino Acids N(2)-L-alanyl-L-glutamine 20% Injection 100ml,"indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen in patients with severe catabolic illness-burns, sepsis, trauma, BMT, radiation & chemotherapy, other critical illness.",1.5-2 ml/kg body-wt/day equivalent to 0.3-0.4g L-alanyl L-glutamine/kg body-wt.,A,,,Dipeptivan,166.60,/,vial,A
B05,Amino Acids with Glucose with Electrolytes Injection,"Source of amino acids, carbohydrate and electrolytes in patients needing IV nutrition ","Dose to be individualised. ADULT usual requirement for amino acid 1-2 g/kg/day, carbohydrate 4-6 g/kg/day
",A,,,Vamin Glucose,63.25,/,bot,A
B05,"Amino Acids, Glucose and Lipid with Electrolytes (Peripheral) 1000 kcal/day","Parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.",Adult Individualised dosage. Range: 20-40 mL/kg body wt/day. Max dose: 40 mL/kg body wt/day. Administer by IV infusion into peripheral or central vein over 14-24 hr. Max infusion rate: 3 mL/kg body wt/hr.,A,Pembedahan,,Smof Kabiven Peripheral,140.14,/,"bag of 
1.5L",A
B05,"Amino Acid, Glucose and Lipid Electrolyte Free Injection EF 1000ml, 1100kcal","Parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.",Adult Individualised dosage. Range: 25-30 kcal/kg/day,A,Pembedahan,,"SMOF Kabiven EF 1000ml, 1100kcal",126.38,/,"bag of
 1.0L",
B05,"Amino Acids, Glucose and Lipid with Electrolytes Injection (Central) 1600 kcal/day        ","Parenteral nutrition for adults when oral or enteral nutrition is impossible, insufficient or contraindicated.",Adult Individualized dosage. Range: 13-31 mL/kg body wt/day. Max dose: 35 mL/kg body wt/day. Administer via central IV infusion over 14-24 hr. Max infusion rate: 0.25 g/kg body wt/hr for glucose,A,Pembedahan,,Smof Kabiven Central  ,180.76,/,"bag of 
1.5L",A
A11,Multivitamin Injection- Cernevit lyophilisate for reconstitution 5ml,"for adults and children over 11 years of age. When the daily requirements
of vitamins are required to be given to the patient by the parenteral route because oral
administration is either contraindicated, impossible or insufficient (eg due to malnutrition,
gastrointestinal malabsorption, etc).",Adults and children aged 11 years and older: 1 vial per day,B,Pembedahan,,Cernevit,45.00,/,vial,
B05,Dextrose 50% Injection (10 ml amp),For parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient  ,"According to the needs of the patient
",B,,,Infusol D50,0.94,/,amp,B
B05,"Dextrose 5%,10%, 50% Injection 500 ml",For parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient ,"According to the needs of the patient
",B,,,"Infusol D5,  Infusol D10, Infusol D50","2.53, 2.71 8.00",/,drip,B
V04,Dextrose Powder 75g,Use as a diagnostic agent for diabetes ,75 g stat,B,,,Dextrose Monohydrate,1.40,/,pack,B
B05,Fat Emulsion 20% for IV Infusion 100ml,Source of lipid in patients needing IV nutrition ,Dose to be individualised. ADULT usual lipid requirement 2-3 g/kg/day. INFANT 0.5-1 g/kg/day,A,,,Smof Lipid 20%,48.52,/,bot,A
A11,"Multivitamin Injection - Lipid Soluble Vitamins (Vitamin A, D, E, K)","Vitalipid N Infant is indicated as a supplement in complete intravenous nutrition to meet
the daily requirements of the fat-soluble vitamins A, D2, E and K1  in paediatric patients up to 11 years of age.","Must be diluted before use: Infants and children under 11 years.
Vitalipid N Infant in a dosage of 1 mL per kg bodyweight per day is added to Intralipid
10% or 20%. The daily dose must not exceed 10 mL. After mixing by gentle agitation
the emulsion is infused as described for Intralipid.
Vitalipid N Infant should be added aseptically within one hour of the commencement of
the infusion and should be used within 24 hours.",B,,,  Vitalipid N Infant,34.54,/,amp,
A11,"Multivitamin Injection - Lipid Soluble Vitamins (Vitamin A, D, E, K)","Vitalipid N Adult is indicated as a supplement in complete intravenous nutrition to meet
the daily requirements of the fat-soluble vitamins A, D2, E and K1.","Must be diluted before use: Adults and children aged 11 years and above.
One ampoule (10 mL) of Vitalipid N Adult is added to 500 mL Intralipid 10% or 20%.
After mixing by gentle agitation, the emulsion is infused as described for Intralipid",B,,,  Vitalipid N Adult,34.54,/,amp,
V06,Starter PN Standard,Parenteral nutrition for neonates,Dose to be individualized,A,Pediatrik,Outsource from HRPB,-,148.70,/,100ml,
V06,Preterm PN Normal Sodium,,,,,,,144.34,/,400ml,
V06,Preterm PN High Sodium,,,,,,,185.61,/,300ml,
V06,Standard Lipid 3.2g in 18ml,,,,,,,30.07,/,18ml,
V06,Term PN High Sodium,,,,,,,193.51,/,500ml,
B05,Sodium Glycerophosphate 20ml Injection ,Indicated in adult patients and infants as a supplement in intravenous nutrition to meet the requirement of phosphate. ,"Adults: The recommended dosage is individual. The recommended daily dosage of phosphate during intravenous nutrition would normally be 10-20mmol. This can be met by using 10-20ml of sodium glycerophosphate to the infusion solution or to the admixture for which compatibility has been proved. Infants: The recommended dosage is individual. The recommended dose for infants and neonates is 1.0-1.5 mmol/kg bodyweight/day.
",A,,,Glycophos ,14.76,/,amp,
B05,Multivitamin Injection - Water Soluble Vitamins,"Soluvit N is intended as a supplement in intravenous nutrition in order to meet the daily requirements of
the water-soluble vitamins in adults, children, infants and neonates.","Adults and children weighing 10kg or more
The recommended daily dosage is the content of one vial.

Children, infants and neonates weighing less than 10kg
Children weighing less than 10kg should be given 1/10 of the content of one vial per kg body weight per
day",B,,,Soluvit N,34.70,/,vial,
B05,Trace Elements and Electrolytes (Adult) Solution 10ml,Only to be used to cover daily loss of electrolyte and trace elements for patient on parenteral nutrition ,"10 ml added to 500-1000 ml solution, given by IV infusion
",A*,,,  Addaven,38.38,/,amp,
B05,Trace Elements and Electrolytes (Paediatric) Solution 10ml,Only to be used to cover daily loss of electrolyte and trace elements for patient on parenteral nutrition ,"According to the needs of the patient. INFANT and CHILD weighing 15 kg or less: Basal requirements of the included trace elements are covered by 1 ml/kg/day to a maximum dose of 15 ml. CHILD weighing 15 kg or more, a daily dose of 15 ml, should meet basic trace element requirements. However, for patients weighing more than 40 kg the adult preparation trace element should be used
",A*,,,Peditrace,38.41,/,amp,A
,,,,,,,,,,,
"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS
14.5 VITAMINS AND MINERAL SUPPLEMENT",,,,,,,,,,,
A11,Alfacalcidol 0.25 mcg Capsule,"i) Chronic kidney disease mineral bone disorder
ii) Osteoporosis
iii) Hypoparathyroidism and pseudohypoparathyroidism
iv) Rickets and osteomalacia","Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily;
CHILD under 20kg body weight : 0.05 mcg/kg/day.
Maintenance dose : 0.25 mcg to 2 mcg daily

Dosing is individualised based on serum calcium level and according to product insert/protocol",A/KK,,,One-alpha,0.22,/,cap,A/KK
A11,Alfacalcidol 1 mcg Capsule,,,,,,Alfacip,0.29,/,cap,
A11,Alfacalcidol 2 mcg/ml Drops (0.1mcg/drop) 20ml,"i) Neonatal hypocalcemia
ii) Osteoporosis
iii) Hypoparathyroidism and pseudohypoparathyroidism
iv) Rickets and osteomalacia","NEONATES : 0.1 mcg/kg/day

Dosing is individualised based on serum calcium level and according to
product insert/protocol",A*,Pediatrik,,One-alpha,234.45,/,bot,A*
A11,Alfacalcidol 2mcg/ml Injection (1mcg/0.5ml),"i) Chronic kidney disease mineral bone disorder
ii) Osteoporosis
iii) Hypoparathyroidism and pseudohypoparathyroidism
iv) Rickets and osteomalacia"," Initial dose ADULT and CHILD above 20kg body weight : 1 mcg daily;
CHILD under 20kg body weight : 0.05 mcg/kg/day.
Maintenance dose : 0.25 mcg to 2 mcg daily

Dosing is individualised based on serum calcium level and according to product insert/protocol",A*,,,One-alpha,13.45,/,amp,A*
A11,"Ascorbic Acid 100 mg, 500 mg Tablet",Vitamin C deficiency ,"ADULT: 100-250 mg once or twice daily 
CHILD: 100 mg three times daily for one week followed by 100mg daily until symptoms abate.",C+,,,"Chewette-C
Dyna","0.06
0.14",/,tab,C+
A11,Calcitriol 0.25 mcg Capsule,"i) Osteoporosis
ii) Chronic kidney disease-mineral bone disorder
iii) Hypoparathyroidism and pseudohypoparathyroidism
iv) Rickets and osteomalacia","i) 0.25 mcg 2 times daily
ii) ADULT and CHILD 3 years and older:
Initial dose: 0.25 mcg.
In patients with normal or only slightly reduced serum calcium levels, doses of 0.25 mcg every other day is sufficient. Dosage may be increased if necessary to 0.5 mcg/day. Maintenance dose: 0.5-1mcg daily
CHILD less than 3 years: 10 to 15 ng/kg/day
iii) and iv) 0.25 mcg/day given in the morning",A/KK,,,Osteocap,0.26,/,cap,A/KK
A12,"Calcium Carbonate 500 mg Tablet, 500mg capsule","i) Hyperphosphatemia (phosphate binder) in chronic kidney disease patients
ii) Calcium supplementation","i) Total dose of elemental calcium from calcium-based phosphate binder not to exceed 1,500 mg/day.
Dosing is individualised based on serum phosphate level and according to product insert/protocol

ii) 500 mg to 4g per day as calcium carbonate in 1-3 divided doses (500mg capsule contains 200mg elemental calcium)
Dosing is individualised based on serum calcium level and according to product insert/protocol
",B,,,"Malaysian Pharmaceutical Calcium Carbonate

Duopharma Calsonate","0.03



0.09",/,"tab



cap",B
A12,Calcium Gluconate 10% Injection (1 g /10 ml),"i)Acute hypocalcaemia 
ii)Hypocalcaemic tetany 
iii)Cardiac resuscitation ","i) 1-2 g (2.25-4.5 mmol). CHILD: 50 mg/kg 
ii) ADULT: 1g (2.2 mmol) by slow IV injection followed by continuous infusion of 4 g (8.8 mmol) daily 
iii) IV or intracardiac injection, 10 ml",B,,,B Braun,4.60,/,amp,B
A12,Calcium Lactate 300 mg Tablet,For prophylaxis of calcium deficiency and treatment of chronic hypocalcaemia ,ADULT: 1-5 g daily in divided doses,C,,,"Idaman
Calcium Lactate",0.17,/,tab,C
A11,"Cholecalciferol 25,000 IU Oral Solution ",Prevention & treatment of vit D deficiency. Adjunctive therapy to osteoporosis in patients w/ vit D deficiency or at risk of vit D insufficiency.,"Prevention of vit D deficiency Adult 25,000 IU mthly as single dose. Childn 1-18 yr 25,000 IU as single dose every 6 wk, 0-1 yr 25,000 IU as single dose every 8 wk. Treatment of vit D deficiency (<25 ng/mL) Adult 50,000 IU wkly as 2-single dose for 6-8 wk, followed by maintenance therapy: 1,400-2,000 IU daily. Childn 0-18 yr 25,000 IU as single dose once every 2 wk for 6 wk, followed by maintenance therapy: 400-1,000 IU daily.",Not in FUKKM,Perubatan,Special drugs approval (UKK) required,D-Cure,7.60,/,amp,
H05,Cinacalcet Hydrochloride 25mg Tablet,"Secondary hyperparathyroidism in patients undergoing maintenance dialysis with hypercalcaemia. restriction:For treatment of refractory secondary hyperparathyroidism in patients with end-stage renal disease (including those with calciphylaxis) only in those: i) who have 'very uncontrolled' plasma levels of intact parathyroid hormone (defined as greater than 85pmol/L [800 pg/mL] that are refractory to standard therapy, and an adjusted serum calcium level at upper limit of normal or high, despite appropriate adjustment of phosphate binders including non-calcium based phosphate binders. ","The starting dose for adults is 25mg once daily to be administered orally. Depending on the serum parathyroid hormone (PTH) and calcium levels, the dose may be adjusted within a range of 25-75mg once daily. If no improvement in PTH, the dose may be increased up to 100 mg once daily. Dose can be increased by 25mg at a time at intervals of at least 3 weeks.",A*,Perubatan,Kuota,Regpara,14.25,/,tab,
,,"ii) in whom surgical parathyroidectomy is contraindicated in that the risks of surgery are considered to outweigh the benefits, or if there is likely to be a significant delay for surgery.",,,,,,,,,
B05,Magnesium Sulphate crystal/powder 1 kg,"HSM practice:
Magnesium deficiency due to pseudohypoparathyroidism",PO: 4 g OD,,Perubatan,,Magnesium Sulphate Crystal BP,22.00,/,pack of 1 kg,
B05,Magnesium Sulphate 50% Injection,"i)Treatment and prophylaxis of acute hypomagnesaemia 
ii) Prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia) ","i) Mild hypomagnesemia (ADULT): 1gm magnesium sulphate (8mEq) IM every 6 hours for 4 doses. 
Severe hypomagnesemia (ADULT): 0.25 g/kg IM over 4 hours. Alternative dose of 5g may be given by slow intravenous infusion over 3 hours 
ii) Toxemia of pregnancy: An initial intravenous dose of 4gm of magnesium sulphate is recommended. Followed by an intramuscular dose of 4-5gm into each buttock. This may be followed by a dose of 4-5gm into alternate buttocks every 4 hours as needed. Alternatively, the initial dose IV dose may be followed by an infusion of 1-2gm/hr",C,,,Injecsol MgSO4,10.35,/,amp,C
B03,Mecobalamin 500 mcg Tablet,Peripheral neuropathies ,1 tablet 3 times daily. The dosage should be adjusted according to age of patient and severity of symptoms,B,,,Mecovit,0.09,/,tab,B
A11,Multivitamin Drops,For prevention and treatment of vitamin deficiencies ,"INFANT less than 1 year: 1 ml daily
",B,,,Appeton,19.25,/,bot,B
A11,Multivitamin Injection,For prevention and treatment of vitamin deficiencies ,"Initially 2 - 4 pairs IV 4 - 8 hourly, reducing to 1 pair IV daily. For less serious cases, 1 pair IV 1 - 2 times daily or based on individual requirements
",B,,,Parentrovite,-,/,pair,B
A07,Oral Rehydration Salts,Replacement of fluid and electrolytes loss in diarrhoea ,"Dissolve 1 sachet in 200 or 250mL of water according to product insert.
The amount to give depends on hydration status.
ADULT: 200-400mL (1 - 2 sachets) for every loose motion/ diarrhoea/ vomiting
CHILD (2 yrs & above): 100-200mL (1 sachet) for every loose motion/ diarrhoea/ vomiting. In severe dehydration 100ml/kg for 3-4 hours.
INFANT (up to 2 yrs): 1 - 1.5 times their usual feed volume (50-100mL) each diarrhoea/vomiting

Dose is according to product insert and dependent on the product/ brand used as well as patient comorbidities e.g. heart failure and chronic kidney disease.",C,,,ORS Plus,0.01,/,sac,C
B05,Potassium Chloride 1 g/10 ml Injection,For the correction of severe hypokalaemia and when sufficient potassium cannot be taken by mouth ,"By slow IV infusion depending on the deficit or the daily maintenance requirements. 1 g diluted in 500 ml normal saline or glucose and given slowly over 2 - 3 hours
",B,,,Injecsol K10,0.67,/,amp,B
A12,Potassium Chloride 1g/10 ml Mixture,Potassium depletion ,"1 g once or twice daily until serum potassium is restored
",C,,"To freshly prepare from powder.
Reserve for Ryle's tube & Peadiatric pateint only",  -,-,/,bot,C
A12,Potassium Chloride 600 mg SR Tablet,For the treatment and specific prevention of hypokalaemia ,"ADULT: 2 - 3 tablets daily. Severe deficiency: 9 - 12 tablets daily or according to the needs of the patient
",B,,,Protrelease TR,0.03,/,tab,B
B05,Potassium Dihydrogen Phosphate Injection,For treatment of hypophosphataemia ,"Up to 10mmol phosphate administered over 12 hours
",A,,,DBL KH2PO4 Concentrated,16.25,/,amp,A
A11,Pre/Post Natal Vitamin & Mineral Tablet,Vitamin and mineral supplement for use during pregnancy and lactation ,"1 tablet daily or based on individual requirements
",C+,,, Zincofer ,0.13,/,tab,C+
A11,Pyridoxine HCl 10 mg Tablet,"i)Pyridoxine-dependent convulsions in infant 
ii)Sideroblastic anaemia 
iii)B6-deficient anaemia in adult 
iv) Prophylaxis to peripheral neuritis in isoniazid therapy 
v) Nausea and vomiting of pregnancy and irradiation sickness ","i) INFANT 4 mg/kg daily for short periods 
ii) 100 - 400 mg daily in divided doses 
iii) ADULT 20 - 50 mg up to 3 times daily 
iv) Prophylaxis 10 mg daily, therapeutic 50 mg 3 times daily 
v) 20 - 100 mg daily
",C+,,,Malaysian Pharmaceutical Pyridoxine,0.07,/,tab,C+
A11,Riboflavine 3 mg Tablet,For prevention and treatment of riboflavine deficiency ,"CHILD: 2.5-10 mg/day in divided doses. ADULT: 5-30 mg/day in divided doses
",C,,,Riboflavine,0.02,/,tab,C
B05,"Sodium Bicarbonate 8.4% 
(1 mmol/ml) Injection",For acceleration of excretion in drug intoxication (where excretion of the drug into the urine is accelerated by elevated urine pH) and for acidosis ,"According to the needs of the patient. 
In severe shock due to cardiac arrest: 50 ml by IV
",B,,,DB Sodium Bicarbonate,1.42,/,amp,B
B05,"Sodium Bicarbonate Powder 5 g, 2 g, 1.5 g, 1 g, 0.5 g","1. For the relief of the symptoms of dyspepsia, heartburn and indigestion.

2. As an external lotion for relief of the symptoms of insect bites and sunburn.","1. For relief of the symptoms of dyspepsia, heartburn and indigestion:

Adults and children over 12 years: one level 5ml spoonful dissolved in warm water, to be taken up to 4 times a day.

Not to be taken by children under 12 years old.

2. As an external lotion:

Dissolve one 5ml spoonful in a pint of warm water. Apply with lint or cotton wool.",-,,galenical,-,-,/,packet,-
A12,Sodium Chloride Powder 1 g,,,-,,,-,-,/,packet,-
RAW,Sodium Dihydrogen Phosphate Powder,To treat hypophosphatemia,10-20 mmol when required phosphate,-,,Galenikal,,50.40,/,500g,
B05,"Sodium Phosphate Monobasic 500 mg (16.1mmol)Effervescent Tablet /
Phosphorus 500mg (1.936g sodium acid phosphate) Effervescent Tablet",Phosphate supplement for premature baby with risk of osteopenia,"Phosphate-Sandoz® effervescent tablets should be dissolved in ⅓ to ½ glass of water and taken orally. 
Hypercalcaemia: up to 3 tablets daily (adjustment being made according to requirements).
Vitamin D-resistant rickets: 2-3 tablets daily

Phosphate supplement for premature babies: 1 mmol/kg/day in 1 or 2 divided doses",A,Pediatrik,"Import Permit required for purchase
(UKK)",Phosphate- Sandoz,3.99,/,tab,-
A11,Thiamine HCl 100 mg/ml Injection,"i) For the prevention or treatment of Vitamin B1 deficiency syndromes including beri-beri and peripheral neuritis associated with pellagra 
ii) Wernicke-Korsakoff Syndrome ","i) Mild to chronic deficiency: 10-25 mg daily. Severe deficiency: 200- 300 mg daily 
ii) 500 mg every 8 hours for 2 days, followed by 100 mg 2 times daily until patient can take oral dose
",B,"Perubatan, Pembedahan","Import Permit required for purchase
(UKK)",Exeltis Thiamin,3.20,/,amp,B
A11,Thiamine Mononitrate 10 mg Tablet,Prevention and treatment of thiamine deficiency state,"Mild chronic deficiency: 5mg to 30mg daily
Severe deficiency: up to 300mg daily",C,,,Aneurine,0.07,/,tab,C
A11,"Vitamin B1, B6, B12 Tablet","For deficiency or raised requirement of Vitamin B1, B6, B12 ","1 - 3 tablets 3 times daily swallowed unchewed.
",B,,,VITBION FORTE ,0.12,/,tab,B
A11,Vitamin B Complex Tablet,Prophylaxis and treatment of vitamin B deficiency ,"1-2 tablets daily
",C+,,,duobion,0.01,/,tab,C+
,,,,,,,,,,,
"14.0 NUTRITION, VITAMINS AND MINERAL SUPPLEMENTS
14.6 DRUGS AFFECTING BONE METABOLISM",,,,,,,,,,,
M05,Alendronate Sodium 70 mg Tablet,"Kategori preskriber A*:
Osteoporosis (Male)

Kategori preskriber A/KK:
Indicated for the treatment of osteoporosis in high-risk postmenopausal women","70 mg once weekly. Swallow the tablet whole with a full glass of plain water only on an empty stomach at least 30 minutes before breakfast (and any other oral medication); stand or sit upright for at least 30 minutes and do not lie down until after eating breakfast
","A*, A/KK",Ortopedik,,Hovid Alendronate,1.13,/,tab,A*
M05,Alendronate Sodium 70 mg and Cholecalciferol 5600 IU Tablet,"Osteoporosis in postmenopausal women with a history of vertebral fracture and whom oestrogen replacement therapy is contraindicated. Review treatment after 2 years and if there is positive response, treatment may be continued up to 5 years and then re-evaluate. Treatment should be stopped if there is no positive response after 5 years. Otherwise, patient needs to be given drug holiday for 1 to 2 years and then continue treatment shall the benefit outweigh the risk. ","1 tablet once weekly [70mg/5600 IU]. Patient should receive supplemental calcium or vitamin D, if dietary vitamin D inadequate. The tablet should be taken at least half and hour before the first food, beverage, or medication of the day with plain water only. To facilitate delivery to stomach and thus reduce the potential for esophageal irritation, it should only be swallowed upon arising for the day with a full glass of water and patient should not lie down for at least 30 minutes and until after their first food of the day.
",A*,Ortopedik,Kuota, Fosamax Plus ,18.17,/,tab,A*
M05,Denosumab in 1.0 mL solution (60 mg/mL) Pre‐filled syringe (subcutaneous injection),"Post-Menopausal Osteoporosis.

PRESCRIBING RESTRICTIONS
To be used by Orthopaedic Specialist, Rheumatologist, Endocrinologist and Geriatricians",A single subcutaneous injection of 60 mg administered once every 6 months. Patients should receive calcium and vitamin D supplements whilst undergoing treatment.,A*,"Ortopedik, Perubatan",Kuota,Prolia,650.00,/,PFS,
M05,Ibandronic Acid 150 mg Tablet,"Treatment of postmenopausal osteoporosis to reduce the risk of fracture. Review treatment after 2 years and if there is positive response, treatment may be continued up to 5 years and then re-evaluate. Treatment should be stopped if there is no positive response after 5 years. Otherwise, patient needs to be given drug holiday for 1 to 2 years and then continue treatment shall the benefit outweigh the risk. ","150 mg once monthly
",A*,Ortopedik,Kuota,Bonviva,86.00,/,tab,A*
H05,Teriparatide 20mcg/80mcl Injection in Prefilled-Pen (250mcg/ml),"Osteoporosis in postmenopausal women, Primary or hypogonadal osteoporosis in men, Corticosteroid-induced osteoporosis. In patients at high risk of fracture, or who have failed or are intolerant to other available osteoporosis therapies","20 mcg once daily by SC inj in thigh or abdomen. 
Max duration of treatment: 24 months (a treatment course must not to be repeated over a patient's lifetime).  ",Not in FUKKM,"Ortopedik

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru jika ingin menggunakan peruntukan ubat farmasi"," Ubat PESARA

Special Drugs Approval (UKK) required",Forteo,875.00,/,prefilled-pen,A*
,,,,,,,,,,,
"15.0 SOLUTIONS CORRECTING WATER, ELECTROLYTES AND ACID DISTURBANCES",,,,,,,,,,,
B05,"Calcium Chloride Dihydrate, Sodium Chloride, Magnesium Chloride Hexahydrate, Sodium Acetate Trihydrate,Potassium Chloride, and Malic Acid Solution","Replacement of extracellular fluid losses in the case of isotonic dehydration, where acidosis is present or imminent.","The maximum infusion rate depends on the needs of the patient in fluid replacement and electrolytes, patient's weight, clinical condition, and biological status. Adults, elderly, adolescents:500ml-3L/24hr. Babies, children: 20ml to 100ml/kg/24 hr.",A,,,Sterofundin ISO,11.00,/,drip,
B05,"Mannitol 10%, 20% Injection 500 ml",Cerebral oedema ,"0.25- 2 g/kg IV of a 15% to 25% solution over 30-60 minutes. Safety and efficacy not established in children under 12 years of age
",A,,,Infusol M10 Infusol M20,"5.44, 5.37",/,drip,A
B05,"Sodium Chloride 0.9% Injection 100 ml, 500 ml",For replenishing fluid and for restoring/maintaining the concentration of sodium and chloride ions ,100 - 1000 ml by IV or according to the needs of the patient,C+,,,Infusol NS,"1.42, 2.42",/,drip,C+
B05,Sodium Chloride 3% Injection 500 ml,Acute dilutional hyponatraemia ,refer protocols,B,,,Infusol S3,6.80,/,drip,B
B05,Sodium Chloride 20% Injection,"Addition of sodium electrolyte in parenteral nutrition bags especially in paediatrics or neonates with restricted fluid allowance

HSM off label use (Pediatrik):
As hypertonic saline nebulisation for chronic suppurative lung disease ","refer protocols

HSM off label use:
To dilute into 5% NaCl (1ml NaCl 20% + 3ml water for injection) 4 - 12 hourly",B,Pediatrik,Special Drugs Approval (UKK) required for off-label indication  (by batch basis in HSM),,0.85,/,amp,
B05,Sodium Chloride 0.9% with Dextrose 5% Injection 500 ml,For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions ,refer protocols,C+,,,Infusol NSD5,2.80,/,drip,C+
B05,Sodium Chloride 0.45% with Dextrose 5% Injection 500 ml,For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions ,refer protocols,B,,,Infusol HSD5,2.37,/,drip,B
B05,Sodium Chloride 0.45% Injection 500 ml,For replenishing fluid and for restoring / maintaining the concentration of sodium and chloride ions ,"100 - 1000 ml by IV or according to the needs of the patient
",B,,,Infusol HS,2.42,/,drip,B
B05,Sodium Chloride 0.45% with Dextrose 10% Injection 500 ml,For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions ,refer protocols,B,,,Infusol HSD10,2.50,/,drip,B
B05,Sodium Chloride 0.18% with Dextrose 4.23% Injection 500 ml,For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions ,refer protocols,B,,,Infusol QSD1,1.87,/,drip,B
B05,Sodium Chloride 0.18% with Dextrose 10% Injection 500 ml,For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions ,refer protocols,B,,,Infusol QSDIO,2.50,/,drip,B
B05,Sodium Citrate 3.8% Solution 500 ml,Sterile solution for irrigation or washout of infected bladder ,refer protocols,B,,galenical,-,6.10,/,drip,B
B05,Sodium Lactate Compound (Hartmanns Solution/Ringer-lactate],"Replacement of extracellular losses of fluid and electrolytes, as an alkaliniser agent ","100-1000 ml by IV or according to the needs of the patient
",C,,,Infusol HM,2.21,/,drip,C
V07,"Water for Injection 10 ml, 500 ml",As a diluent and vehicle for the administration of medications ,refer protocols,C+,,,Infusol W,"0.31, 2.55",/,"amp, drip",C+
,,,,,,,,,,,
16.0 RADIOCONTRAST MEDIA,,,,,,,,,,,
V08,Barium Sulphate Powder for Suspension 96% w/w,"For x-ray examination of the alimentary tract: 
i) Oesophagus 
ii) Stomach and duodenum 
iii) Colon ","i) Up to 150 ml of a 50% - 200% suspension orally 
ii) Up to 300 ml of a 30% - 200% suspension orally 
iii) Up to 2 litre of a 30% - 200% suspension orally
",B,Radiologi,"Import Permit required for purchase
(UKK)",E-Z Paque,62.50,/,botol,B
V08,Diatrizoate Meglumine and Sodium Amidotrizoate Solution,"i) Contrast medium for the radiological examination of the gastrointestinal tract (primarily in cases in which barium sulphate is contraindicated) 
ii) Computerised tomography in abdominal region 
iii) Treatment of Mecolinium ileus ","i) ADULT and CHILD more than 10 year, ORALLY: 60 -100 ml RECTALLY, contrast medium should be diluted with 3-4 times its volume of water. 
ORALLY: CHILD less than 10 years,: 15- 30 ml 
NEWBORN, INFANT contrast medium should be diluted with 3 times its volume of water. 
RECTALLY: CHILD more than 5 years, contrast medium should be diluted with 4-5 times its volume of water. Younger patients a dilution with 5 times its volume is recommended 
ii) Adult, orally, 25-77 mL in 1000 mL tap water 15-30 minutes prior to imaging
",A,,,Gastrografin,63.00,/,100ml vial,A
V08,Gadobutrol 1 mmol/ml injection,"In adults, adolescents and children aged 2 years and older with diagnostic difficulty especially in patients with renal impairment for: i) Contrast enhancement in cranial and spinal magnetic resonance imaging (MRI). ii) Contrast enhanced MRI of liver or kidneys in patients with high suspicion or evidence of having focal lesion to classify these lesions as benign or malignant. iii)Contrast enhancement in Magnetic Resonance Angiography (CE-MRA).",A single intravenous injection of 0.1 mmol/kg (equivalent to 0.1 ml/kg body weight). Max: 0.3 mmol/kg (equivalent to 0.3 ml/kg body weight),A*,,,Gadovist,117.60,/,PFS,
V08,Gadoxetic acid disodium 0.25 mmol/ml solution for injection (10ml pre-filled syringe),For use in adults for the enhancement of magnetic resonance imaging (MRI) of focal liver lesions,0.1ml/kg body weight (equivalent to 25 µmol per kg body weight). Not recommended for patients younger than 18 years,A*,,,Primovist,808.50,/,PFS,
V08,Iohexol 300mg iodine/ml  Injection (50ml),"X-ray contrast medium for use in adults and children for cardioangiography, arteriography, urography, phlebography and CT-enhancement. Lumbar, thoracic, cervical myelography and computed tomography of the basal cisterns, following subarachnoid injection. Arthrography, endoscopic retrograde pancreatography (ERCP), herniography, hysterosalpingography, sialography and studies of the gastrointestinal tract ","Dose will vary depending on the route and procedure
Refer to MIMS Gateway Malaysia for more info",A,"Pembedahan, Ortopedik",Kuota,Omnipaque,30.37,/,50ml vial,A
,,,,,,,,,,,
17.0 ANTIDOTES AND DETOXIFYING AGENTS,,,,,,,,,,,
-,"Anti-Hyperammonemic drugs cocktail (mixture of IV Sodium Benzoate 2g in 10ml, IV Sodium Phenylbutyrate 2g in 10ml, IV L-Arginince 5g in 10ml)","Hyperammonemia due to urea cycle 
defects","Loading dose: 
i) IV Sodium Benzoate 250mg/kg
ii)IV Sodium Phenylbutyrate 250mg/kg
iii) IV L-Arginine 250mg/kg 
(mix all 3 in D10% to a total volume of 50mls, infuse over 90 mins)

Maintenance dose
Same dilution as above but infuse over 24 hours",-,Paediatrik,HSM keeps 1 vial each as buffer. Additional stock to be taken from Genetics Pharmacy HKL when required. Purchasing the replacement stock will require application of import permit via special drugs approval request (UKK),,"61.7

128.2

68.3",/,"vial of i)

vial of ii)

vial of iii)",
V03,Acetylcysteine 5000 mg/25ml Injection,Antidote for paracetamol poisoning ,"Diluted with dextrose 5% and infused IV. Initial, 150 mg/kg IV in 200 ml over 60 minutes, then 50 mg/kg IV in 500 ml over 4 hours, followed by 100 mg/kg IV in 1000 ml over 16 hours. Total dose: 300mg/kg in 20 hour
",A*,,,Infusol NAC,90.00,/,vial,A*
A07,"Charcoal, activated granules",Emergency treatment of acute oral poisoning and drug overdose,ADULT:Acute poisoning: 50 - 100g in suspension. Severe poisoning: 50 - 100g as an initial dose followed by 20-25g every 4 - 6 hours. CHILDREN: 1g/kg/dose,A,,repacked to 25g,-,18.54,/,500g,
V03,Calcium Polystyrene Sulphonate Powder 5g/sachet,Hyperkalemia resulting from acute or chronic renal failure ,15 - 30g daily in 2-3 divided doses. Each dose should be suspended in 30 - 50ml of water and administered orally,A/KK,,,Resin Calcio,0.81,/,sac,A
V03,Deferiprone 500 mg Tablet,Treatment of iron overload in patients with thalassemia major for whom desferrioxamine therapy is contraindicated or inadequate. Add on therapy to desferrioxamine for thalassemia patients with cardiac complication ,"25 mg/kg 3 times a day for total daily dose of 75 mg/kg. Doses greater 100 mg/kg are not recommended
",A*,Perubatan,,Ferriprox,3.92,/,tab,A*
V03,Desferrioxamine B Methanesulphonate 0.5 g Injection,"i) Acute iron poisoning in children 
ii) Investigation and treatment of haemochromatosis 
iii) Diagnosis and treatment of aluminium toxicity in patients with renal failure and dialysis 
iv) Chronic iron toxicity or overload ","i) 2 g by IM immediately and 5 g by mouth after gastric lavage 
ii) 0.5 - 1.5 g by IM injection daily 
iii) Diagnosis: 5 mg per kg by slow intravenous infusion during the last hour of haemodialysis. Treatment: 5 mg per kg once a week by slow intravenous infusion during the last hour of dialysis 
iv) 30 - 50 mg/kg
",A,,,Desferal,26.50,/,vial,A
V03,"Deferasirox 90 mg, 180mg, 360 mg Film-Coated Tablets",Treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and paediatric patients aged 2 years and above. ,"• Recommended initial dose is 14mg/kg body weight. 
• An initial dose of 21mg/kg may be considered for patients receiving more than 14ml/kg/month of packed red blood cells, and for whom the objective is reduction of iron overload. 
• An initial dose of 7mg/kg may be considered for patients receiving less than 7ml/kg/month of packed red blood cells, and for whom the objective is reduction of iron overload. 
• For patients already well-managed on treatment with Deferoxamine, a starting dose of Deferasirox film- coated tablets that is numerically one third of the Deferoxamine dose could be considered.",A*,"Pediatrik, Perubatan",Kuota,"Exjade - FCT 90mg

Exajde-FCT 360mg

Irosix 180mg","3.74


14.83


29.77",/,tab,A*
V03,Flumazenil 0.5 mg/5 ml Injection,"i) Diagnosis and/or management of benzodiazepine overdose due to self-poisoning or accidental overdose 

ii) Reversal of sedation following anaesthesia with benzodiazepine ","i) Initial, 0.2 mg IV over 30 seconds; if desired level of consciousness not obtained after an additional 30 seconds, give dose of 0.3 mg IV over 30 seconds; further doses of 0.5 mg IV over 30 seconds may be given at 1-minutes intervals if needed to maximum total dose of 3 mg; patients with only partial response to 3 mg may require additional slow titration to a total dose of 5 mg; if no response 5 minutes after receiving total dose of 5 mg, overdose is unlikely to be benzodiazepine and further treatment with flumazenil will not help ",B,,,"Pharmaniaga
Fulmazenil",7.80,/,amp,
,,,"ii) 0.2 mg IV over 15 seconds; if desired level of consciousness is not obtained after waiting 45 seconds, a second dose of 0.2 mg IV may be given and repeated at 60-seconds intervals as needed (up to a maximum of 4 additional times) to a maximum total dose of 1 mg; most patients respond to doses of 0.6 to 1 mg; in the event of resedation, repeated doses may be given at 20-minutes intervals if needed; for repeat treatment, no more than 1 mg (given as 0.5 mg/minute) should be given at any one time and no more than 3 mg should be given in any one hour
",,,,,,,,B
V03,Fuller’s Earth powder 60g,Adsorbent in pesticide poisoning ,"Adult: 100-150g every 2-4 hours. Child: 1-2g/kg. (100g of Fuller's Earth is mixed with 200ml water. Repeat until Fuller's Earth is seen in stool (normally between 4-6 hours)
",C,,,Fuller's Earth,4.15,/,pack,C
V03,Idarucizumab 2.5g/50ml inj,"Idarucizumab is a specific reversal agent for dabigatran and is indicated in patients treated with dabigatran when rapid reversal of the anticoagulant effects of dabigatran is required:
i. For emergency surgery/urgent procedures
ii. In life-threatening or uncontrolled bleeding

Prescribing Restrictions:
To be prescribed by cardiologist, haematologist, general medicine physician, anaesthesiologist and emergency physician only","The recommended dose of Idarucizumab is 5 g (2 x 2.5 g/50 ml) to be administered intravenously, as two consecutive infusions over 5 to 10 minutes each or as a bolus injection.",A*,"Perubatan

(Not kept in HSM, to get stock from HRPB when there is a case and purchase afterwards)",,Praxbind,3309.50,/,vial,
V03,Naloxone HCl 0.4 mg/ml Injection,For the complete/partial reversal of narcotic depression including respiratory depression induced by opioids such as natural and synthetic narcotics. Diagnosis of suspected acute opioids overdosage ,"Initially 0.4 - 2 mg IV repeated at intervals of 2 - 3 minutes according to patient's needs
",B,,,Mapin,5.68,/,amp,B
V03,Pralidoxime 0.5 g/20 ml Injection,Antidote in the treatment of organophosphorus insecticide poisoning and in the control of overdosage by anticholinergic drugs used in the treatment of myasthenia gravis ,"Adult: Used in combination with atropine. Admin atropine via IM/IV inj and repeat as needed until patient shows signs of atropine toxicity. Maintain atropinisation for at least 48 hr. As soon as the effects of atropine are observed, 1-2 g of pralidoxime (chloride, iodide or mesilate) may be given via IM/IV inj. Repeat dose after 1 hr, then every 8-12 hr, if necessary. In severe poisoning, continuous infusion of 200-500 mg/hr may be given, titrated according to response. Alternatively, pralidoxime chloride may be given at an initial dose of 30 mg/kg via IV infusion over 20 minutes or IV inj over 5 minutes, followed by IV infusion at 8 mg/kg/hr. Max: 12 g/24 hr. 
Child: As mesilate: 20-60 mg/kg. Renal impairment: Dose adjustment may be required.
",B,,,Pampara,92.13,/,amp,B
V03,Protamine Sulphate 50 mg/5 ml Injection,Heparin overdose and following cardiac or arterial surgery or dialysis procedures when required to neutralize the effects of heparin administered during extracorporeal circulation ,"5 ml slow IV injected over 10 minutes. If administered within 15 minutes of heparin dose, 1 mg will neutralise approximately 100 units of heparin. If longer time has elapsed, less protamine is required. Not more than 50 mg should be injected at any one time. The dose is dependent on the amount and type of heparin to be neutralised, its route of administration and the time elapsed since it was last given and blood coagulation studies.
",B,,,Protamine,374.00,/,vial,B
V03,Sevelamer 800mg Tablet,"Control of hyperphosphatemia in adult patients receiving haemodialysis and peritoneal dialysis. 
restriction: Sevelamer carbonate 800mg tablet should be used in context of multiple therapeutic approach which include calcium supplement, 1, 25-hydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.",Starting dose is one or two 800mg tablets three times per day with meals. Adjust by one tablet per meal in two weeks interval as needed to obtain serum phosphorus target (1.13 to 1.78mmol/L).,A*,Perubatan,Kuota,Renvela,3.16,/,tab,
V03,Sucroferric Oxyhydroxide 500mg Chewable Tablet,"Control of hyperphosphataemia in chronic kidney disease, as potent non calcium based phosphate binder","For patients requiring haemodialysis or peritoneal dialysis: Initially, 1,500 mg (3 tabs) daily in 3 divided doses with meals. Titrate the dose in increments or decrements of 500 mg daily at intervals of at least 1 week or every 2-4 weeks as needed until acceptable serum phosphorus levels are achieved and with regular monitoring thereafter. 
Usual maintenance dose: 1,500-2,000 mg (3-4 tabs) daily in divided doses.
Max: 3,000 mg (6 tabs) daily.",Not in FUKKM,"Perubatan

Menggunakan peruntukan PESARA Mohon hantar borang ubat baru jika ingin menggunakan peruntukan ubat farmasi","UBAT PESARA

Special Drugs Approval (UKK) required",Velphoro,6.48,/,tab,
V03,Sugammadex 100 mg/ml Injection,"Indicated for reversal of neuromuscular blockade induced by 
rocuronium and vecuronium in selective patient group: obese, elderly, underlying cardiovascular disease. For pediatric population, sugammadex is recommended for routine reversal ","2 mg/kg sugammadex is recommended, if spontaneous recovery has occurred up to at least the reappearance of second twitch tension of the train-of-four (T2). 4 mg/kg sugammadex is recommended if recovery has reached at least 1- 2 post-tetanic counts (PTC). For immediate reversal following administration of rocuronium a dose of 16 mg/kg sugammadex is recommended
",A*,,,Bridion,257.90,/,vial,A*
,,,,,,,,,,,
"18.0 ANAESTHETICS
18.1 GENERAL ANAESTHETICS",,,,,,,,,,,
N01,Desflurane Liquid                        ,"i) Induction and maintenance of anaesthesia in adult 
ii) Maintenance of anaesthesia in infants & children ","ADULT: Induction , initially 3% in oxygen or nitrous oxide/oxygen and increased by 0.5%-1% every 2-3 breaths or as tolerated (up to 11%), until loss of consciousness. Maintenance: 2.5%-8.5% with or without concomitant nitrous oxide 
CHILD: maintenance, inhaled in concentrations of 5.2%-10% with or without concomitant nitrous oxide
",A,,,Supane          ,510.00,/,bot,A
N01,Etomidate 20 mg Injection,Induction of general anaesthesia for haemodynamically unstable patients ,"Adult: 300 mcg/kg given slowly over 30-60 seconds into a large vein in the arm. Child: Up to 30% more than the standard adult dose. Elderly: 150-200 mcg/kg, subsequently adjusted according to effects.
",A*,,"Import Permit required for purchase
(UKK)",Etomidate-Lipuro,26.12,/,amp,A*
N01,Isoflurane Liquid,"i) Induction 
ii) Maintenance of anaesthesia ","i) Induction- Initiate at a concentration of 0.5 % 
ii) Maintenance- 1 - 2.5 % in oxygen or nitrous oxide mixture. 0.5 - 0.75 % with oxygen and nitrous oxide for Caesarian section
",B,,,Forane,177.90,/,bot,B
N01,Ketamine 50 mg/ml Injection,Sole anaesthetic for short procedures or induction of anaesthesia in certain types of patients (e.g in shock states) ,"IV Initially, 1-4.5 mg/kg IV, a dose of 2 mg/kg produces anesthesia for 5-10 mins. IM Initially, 6.5-13 mg/kg IM, a dose of 10 mg/kg produces anesthesia for 12-25 mins.
",B,,,Kanox,25.88,/,vial,B
N01,Propofol 1 % Injection (200mg/20ml),"i) Induction & maintenance of general anaesthesia

ii) Sedation of ventilated patients in intensive care","Adult: 
Induction: 20- 40 mg by injection or infusion every 10 sec. Usual dose: 1.5-2.5 mg/kg. 
Maintenance: 4-12 mg/kg/hr or intermittent bolus inj of 20-50 mg. 
Child: >8 yr: 
Induction dose: of 2.5 mg/kg. Maintenance dose: 9-15 mg/kg/hr by IV infusion or intermittent bolus inj. 
Elderly: Including neurosurgical and debilitated patients: Infuse at a rate of 20 mg every 10 sec. Maintenance: 3-6 mg/kg/hr. Usual dose needed: 1-1.5 mg/kg. 
Duration of use : Can be administered for a maximum period of 7 days. Sedation: 0.3 - 4 mg/kg/hour up to 3 days
",A*,,,Troypofol,6.58,/,vial,A*
N01,Sevoflurane Liquid 250ml,To be used only for i) induction and ii) maintenance of anaesthesia ,"i) Adult: Given via a calibrated vaporiser: Up to 5% v/v with oxygen or a mixture of oxygen and nitrous oxide. Child: Given via a calibrated vaporiser: Up to 7% v/v. 
ii) Adult: 0.5-3% v/v with or without nitrous oxide. Child: 0.5-3% v/v with or without nitrous oxide.
",A*,,,Sevoflurane inhalation anesthetic liquid,242.44,/,bot,A*
N01,Thiopental Sodium 500 mg Injection,"i) General anaesthesia, induction 
ii) Anticonvulsant for cases resistant to conventional anticonvulsants in the ICU ","i) ADULT : For induction 200 - 400 mg. For repeat injection 3 - 5 mg/kg over 10 - 15 seconds until desired depth of anaesthesia is obtained. Not FDA approved for use in pediatric patients 
ii) 75 - 125 mg IV single dose; 
for local-anaesthetic induced convulsion: 125 - 250 mg IV over 10 minutes
",B,,,Pentotex,13.78,/,vial,B
,,,,,,,,,,,
"18.0 ANAESTHETICS
18.2 REGIONAL ANAESTHETICS",,,,,,,,,,,
N01,Bupivacaine 0.5 % Injection,For peripheral sympathetic nerve and epidural (excluding caudal) anaesthesia and obstetrics anaesthesia ,"Regional nerve block or epidural block: 15 - 30 ml. Nerve block of finger or toe: 2 - 6 ml. Maximum: 2 mg/kg body weight in any 4 hours period, equivalent to 25 - 30 ml in adults of average weight
",B,,,Pivakan,5.75,/,vial,B
N01,"Bupivacaine 0.5 % with Adrenaline 1:200,000 Injection",Regional nerve block or epidural block. ,"10 - 40 ml (0.25 %) or maximum : 2 mg/kg body weight in any 4 hours period, equivalent to 25 - 30 ml of 0.5% solution
",B,,,Marcain 0.5% with Adrenaline,23.73,/,vial,B
N01,Bupivacaine 0.5 % Heavy Injection,Used for spinal anaesthesia ,ADULT: 2 - 4 ml. Not to exceed 2 mg/kg in a single dose,A,,,Marcaine Spinal 0.5% Heavy,12.79,/,vial,A
N01,Ethyl Chloride Spray,"For minor surgical procedures including lancing boils, incision and drainage of small abscesses, pain due to athletic injuries and pain due to injection administration ","Spray to affected area at a distance of about 30cm until a fine white film is produced
",C,,,Wari Ethyl Chloride Spray,23.20,/,bot,C
N01,Levobupivacaine 5mg/ml Injection,"Production of local or regional anesthesia for surgery and obstetrics, and for postoperative pain management ","Surgical anesthesia : Lumber epidural : 10 - 20 ml (50 - 150 mg) , caesarean section : 15 - 30 ml (75 - 150 mg), intrathecal: 3 ml (15 mg), peripheral nerve block : 1 - 40 ml, ilioinguinal/iliohypogastric block. CHILD : 0.25 - 0.5 ml/kg (1.25-2.5 mg/kg)
",A,,Kuota,Chirocaine,15.26,/,amp,A
N01,Lidocaine 25mg and Prilocaine 25mg Cream,"Used for painless venepunctures, radial artery cannulations before extradural/spinal and other regional blocks in children above 1 year old and adults. Also used in chronic renal failure patients for insertion of A-V fistulas and shunts for haemodialysis. ","Apply a thick layer under occlusive dressing at least 1 hour before the procedure
",A,"Perubatan, Pediatrik ",,RACSER,8.13,/,tube,A
N01,Lignocaine HCl (Lidocaine) 2% Injection,For local or regional anaesthesia and nerve block. Not for IV use. ,Local anesthesia: ADULT Maximum: 100 mg; CHILD Maximum: 3 mg/kg,B,,7/25: To remove from formulary after finish stock,Pharmaniaga Lidocaine,1.38,/,vial,B
N01,Lignocaine 2% Jelly,"Use for endotracheal tubes and instruments, painful procedures in the ear, nose and throat, burns, wounds, abrasions, lacerations; catheterisation of the male and female urethra and for symptomatic treatment of cystitis and urethritis ","Apply to affected area 10 mins before catheterization, etc
",B,,,"Axcel 
Lignocaine",7.54,/,tube,B
N01,Lignocaine 2% Viscous Solution (100ml),"i) To relief pain associated with irritated or inflamed mucous membranes of the:
a) mouth;
b) pharynx (post-tonsillectomy)
c) upper gastrointestinal tract (e.g esophagitis).

ii) Use for instrumentation of the respiratory and digestive tracts (e.g. bronchoscopy, oesophagoscopy).
","i) a) For anaesthesia of the mouth: Rinse the mouth with 5-15 ml (100- 300 mg lignocaine), then the solution is spat out. In dental practice, 10 ml solution (200 mg lidocaine) are used. The solution should be spat out when adequate anaesthesia has been achieved (after approx. 1 minute).
b) For anaesthesia of the pharynx: Gargle with 5-10 ml (100-200 mg lignocaine), after which the solution is slowly swallowed.
c) Painful conditions in the upper GI tract: 5-15 ml (100-300 mg lignocaine) are rapidly swallowed all at once.
*Daily dose should not exceed 1200 mg (Total of 60 ml)

ii) Instrumentations into the stomach: 10-15 ml (200-300 mg lignocaine) are swallowed.
",A,,,Vignocaine,58.88,/,bot,A
,,,"Indications (i) & (ii):
The daily dose should not exceed 1200mg (60mL)
If combined with other lignocaine products, the total dose of lignocaine on one dosing occasion should not exceed 400mg.",,,,,,,,
N01,Lignocaine 10 % w/w Spray,"For surface anaesthesia in dental practice, in otorhinolaryngology and 
paracentesis ","Spray to affected part
",B,,,Lox 10%,92.70,/,bot,B
N01,Lignocaine (Lidocaine) 5% and Phenylephrine HCl 0.5% Nasal Spray,"Preparation of nasal mucosa for surgery (eg. Cautery to Little's area), aid the treatment of acute nose bleeds and removal of foreign bodies from the nose, topical anaesthesia of the pharynx prior to direct or indirect laryngoscopy, topical anaesthesia and local vasoconstriction prior to endoscopy of the upper airways","Adults and children over 12 years : 5 squirts per nostril. Children: 8 to 12 years 3 squirts per nostril, 
4 to 8 years 2 squirts per nostril, 
2 to 4 years 1 squirt per nostril. 

Doses are to be administered once only.",A*,ENT,,Co-Phenylcine Forte ,314.75,/,bot,
N01,Ropivacaine HCl 7.5 mg/ml (=0.75%) Injection,"i) Surgical anaesthaesia including obstetrics 
ii) Acute pain management ","Dose adjusted according to patient physical status and nature of procedure. 
i) Lumbar epidural: 15-25 ml of 7.5 mg/ml solution; Caesarean section, 15-20 ml of 7.5 mg/ml solution in incremental doses ( max . total dose 150 mg). 
ii) lumbar epidural: 10-20 ml of 2mg/ml solution followed by 10-15 ml of 2 mg/ml solution at interval at of least 30 minutes. Labour pain 6-10 ml/hour of 2mg/ml solution
",A*,,,Naropin,32.80,/,amp,A*
,,,,,,,,,,,
"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS
19.1 VACCINES",,,,,,,,,,,
J07,Haemophillus Influenza Type B (HiB) Conjugate Vaccine Injection,Immunisation of infants against Haemophilus Influenzae Type B,"0.5ml by IM. In patients with thrombocytopenia or bleeding disorders, vaccine can be administered by SC.",C+,,,Hiberix,57.42,/,vial,C
J07,Hepatitis B Vaccine Injection,Immunisation against infections caused by Hepatitis B virus ,"Dose depends on the products used. Please refer to package insert. 
Example: 1. Euvax-B Adult (from 16 years old) - 20mcg/dose 
Neonates, infants & children up to and including 15 years - 10mcg/dose 
2. Engerix-B Adult (from 20 years old) - 20mcg/dose 
Neonates, infants & children up to and including 19 years - 10mcg/dose 
Second dose to be given after 1 month and booster dose after 6 months
",C+,,,Euvax-B,"6.84  (adult), 4.29 (paed)",/,vial,C+
J07,Influenza Vaccine,"i) Prophylaxis of influenza for frontliners (KKM staff and essential services personnel). 
ii) Prophylaxis of influenza in high risk groups, particularly individuals who have chronic cardiovascular, pulmonary, metabolic or renal disease, or who are immunocompromised and elderly patients. Refer to current recommendation by WHO for selection of product of inactivated influenza vaccines. ","CHILD 6-35 months: Single dose of 0.5 ml IM or deep SC; 3-8 years: 1-2 doses of 0.5 ml IM 
ADULT & CHILD more than 9 years: Single dose of 0.5 ml IM
",B,,,Vaxigrip,24.83,/,vial,B
J07,"Meningococcal A, C, Y, W 135 Vaccine Injection","Immunisation against meningococcal diseases caused by Neisseria meningitis Group A, Group C, Group Y or Group W-135 ","Prophylaxis: 0.5 ml intramuscular injection.
",B,,,Menactra,97.21,/,vial,B
J06,Palivizumab 100 mg Injection,For the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in paediatric patients at high risk of RSV disease ,"15 mg/kg IM once a month during season of RSV risk
",A*,,Kuota,Synagis,3488.00,/,vial,A*
J07,Pneumococcal Vaccine (Polyvalent),Prevention of pneumococcal infections in high risk subjects from the age of 2 years including patient with a history of splenectomy or scheduled splenectomy ,"Primary injection: 1 single injection (0.5 ml) only. Booster: Must not be given within 5 years except in very high risk patient who received the vaccine while under immunosuppressive treatment
",A,,,PneumoVax,101.90,/,vial,A
J07,Rabies Human Diploid Cell Vaccine (Lyophilised) Injection,Pre-exposure and post-exposure vaccination against rabies ,"Pre-exposure (prophylaxis): 3 doses scheduled on D0, D7 and D28. Booster dose after every 6 months to 5 years (refer to manufacturer's recommendations). Post-exposure prophylaxis: use after attack of a potential rabid animal: 1 dose on D0, D3, D7, D14 and D28. In previously vaccinated individuals 2 doses on D0 and D3.
",B,,,Verorab,78.00,/,vial,B
J07,Tetanus Toxoid Vaccine  Injection,Immunization against tetanus infection ,"2 doses of 0.5 mL IM at an interval of 4-8 wk, followed by the 3rd dose 6-12 mth later. Booster: 0.5 mL IM every 10 yr.",C+,,,Vaksin TT,10.15,/,vial,C+
,,,,,,,,,,,
"19.0 VACCINES, ANTISERA AND IMMUNOLOGICALS
19.2 ANTISERA AND IMMUNOLOGICALS",,,,,,,,,,,
J06,Anti RhD Gamma Globulin 300 mcg/2 ml Injection ,"Prevention of Rh(D) sensitisation to Rh(D)-negative woman: 
i) Pregnancy/delivery of Rh(D)-positive infant 
ii) Abortion/threatened abortion, ectopic pregnancy or hydatidiform mole iii) Transplacental haemorrhage resulting from antepartum haemorrhage, amniocentesis, chorionic biopsy or obstetric manipulative procedures e.g. external version or abdominal trauma ","i) Antenatal prophylaxis: According to general recommendations, currently administered doses range from 50 – 330 micrograms or 250 - 1650 IU. For specific details, please refer to product's package insert. 
ii) Postnatal prophylaxis: According to general recommendations, currently administered doses range from 100 – 300 micrograms or 500 – 1500 IU. For specific details, please refer to product's package insert.
",B,,,Rhophylac (150mcg = 750IU),464.00,/,vial,B
J06,Antivenene Green Pit Viper Injection ,Green pit viper snake bite,"initial dose 3 vials, subsequent doses can be given every 6 hours according to clinical symptoms. 
Total dose for adults to be further diluted in 250ml-500ml NS% or D5%. 
Total dose for children to be further diluted in 5-10ml/kg of NS or D5%

to run at initial rate of 1ml/min for 10 minutes, then 2ml/min for 10 minutes, if no anapylactic reaction, increase to 5-10ml/min to complete the infusion within 1 hour
As product may differ from batches and manufacturer, it is strongly recommended to refer to the product insert on dosing recommendation.",-,,Import Permit Required for purchase (UKK),Green Pit Viper Snake Antivenin,351.90,/,vial ,-
J06,Antivenene Malayan Pit Viper Injection,Treatment of patients who exhibit manifestations of systemic envenoming following a bite by Malayan Pit Viper (Calloselasma rhodostoma). ,"Initial dose of 30ml of reconstituted antivenene given by slow intravenous infusion (2ml/min). Subsequent dose can be given every 6 hours according to the clinical symptoms. As product may differ from batches and manufacturer, it is strongly recommended to refer to the product insert on dosing recommendation.
",B,,,Malayan Pit Viper Antivenin,452.40,/,vial,B
J06,Antivenene Serum (Cobra) Injection,Treatment of patients who exhibit manifestations of systemic envenoming following a bite by Cobra (Naja kaouthia). ,"Initial dose of 100ml of reconstituted antivenene given by slow intravenous infusion (2ml/min). Subsequent dose can be given every 12 hours according to the clinical symptoms. As product may differ from batches and manufacturer, it is strongly recommended to refer to the product insert on dosing recommendation.",B,,,Cobra Antivenin,754.00,/,vial,B
J06,Antivenom Serum Snake Polyvalent Injection (Hemato Polyvalent),"Passive immunisation against poisonous of a range of haematotoxic snakebites or neurotoxic snakebites, based on the type of snake identified. ","For initial does, at least 20mL of reconstituted serum should be given by slow intravenous infusion (not more than 1mL/minute). If symptoms still persist, the second dose should be repeated 2 hours or even earlier after the initial dose. The further dose should be repeated every 6 hours according to the clinical symptoms. Administration: Draw 10mL of the sterile water for injection to the freeze-dried antivenin, shake well to dissolve the contents until the serum became clear colourless or pale yellow liquid, ready for administration.",-,,,Hemato Polyvalent Snake Antivenin,507.96,/,vial,-
J06,Antivenom Serum Snake Polyvalent Injection (Neuro Polyvalent),"Passive immunisation against poisonous of a range of haematotoxic snakebites neurotoxic snakebites, based on the type of snake identified. ","For initial dose, at least 20mL of reconstituted serum should be given by slow intravenous infusion (not more than 1mL/minute). If symptoms still persist, the second dose should be repeated 2 hours or even earlier after the initial dose. The further dose should be repeated every 6 hours according to the clinical symptoms. Administration: Draw 10mL of the sterile water for injection to the freeze-dried antivenin, shake well to dissolve the contents until the serum became clear colourless or pale yellow liquid, ready for administration.
",-,,,Neuro Polyvalent Snake Antivenin,507.96,/,vial,-
J06,Antivenene Serum (Sea snake) 1000 IU,Treatment of patients who exhibit manifestations of systemic envenoming following a bite by sea snake. ,"1000 units by IV infusion over 1/2 to 1 hour. In severe cases 3000 -10000 units may be required
",B,,,CSL Sea Snake Antivenom,20752.40,/,vial,B
J06,Hepatitis B Immunoglobulin (Human) Injection 100U/0.5ml,"i) For post-exposure prophylaxis of hepatitis B 
ii) Prophylaxis against recurrence of hepatitis B infection in chronic hepatitis B post liver transplantation ","i) Adults: Recommended Dose: 1000-2000 IU IM and if necessary, the dose should be increased or repeated. 
Children: Inject 32-48 IU/kg of body weight, should be administered within 7 days after exposure to HBsAg (preferably within 48 hrs). 
Neonates: Recommended Initial Dose: 100-200 IU. The 1st dose should be administered within 5 days after birth (preferably within 48 hrs) and booster dose should be 32-48 IU/kg body weight. The booster dose should be administered between 2 and 3 months after the 1st administration. 
ii) Different regimens depending on hepatitis B virus (HBV) DNA positivity
",A,,,Hepabig,211.30,/,vial,A
J06,Hyperimmune Gamma Globulin IM/IV Inj.,,,-,,,Gamma-16,556.80,/,vial,-
J06,Human Normal Immunoglobulin Injection 3g/50ml (6%),"i. Replacement therapy such as:
a) Primary immunodeficiency syndromes
b) Severe secondary hypogammabulinaemia and
recurrent infections
c) Congenital or acquired immune deficiency syndrome
with recurrent infections
d) Allogeneic haematopoietic stem cell transplantation
(HSCT)
","0.2-2g/kg as required

Dosing and frequency of administration are according to product insert and protocol.",A,,,Flebogamma 5% DIF,517.36,/,vial,
,,"ii. Immunomodulation such as:
a) Immune thrombocytopenic purpura (ITP) in children
or adults at high risk of bleeding or prior to surgical
interventions to correct the platelet count
b) Guillain-Barre syndrome
c) Kawasaki disease",,,,,,,,,
J06,Immunoglobulin Tetanus Human 250 Units/Vial Injection,Passive immunization against tetanus,"Prophylaxis of tetanus: IM 250 units. 
Treatment of tetanus: IM 30 - 300 units/kg",B,,,Sero-Tet,120.00,/,vial,
L03,Interferon Beta-1a 44mcg /0.5mlInjection,Multiple sclerosis of the relapsing remitting type with 2 or more relapses within the last 2 years,44 mcg 3 times weekly,A*,,,Rebif,297.00,/,PFS,
J06,Palivizumab 100mg injection,For the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in paediatric patients at high risk of RSV disease,"15 mg/kg IM once a month during season of RSV risk
",A*,,,Synagis,3676.00,/,vial,
J06,Varicella-Zoster Immunoglobulin,To provide passive immunity to babies born to mothers with active varicella infection within 5 days before or 48 hours after delivery ,IM 125 unit ( for baby weighing 0-10 kg),Not in FUKKM,Pediatrik,Import Permit Required for purchase (UKK),Varitect CP ,1015.00,/,Inj,-
,,,,,,,,,,,
20.0 PLASMA SUBSTITUTE,,,,,,,,,,,
B05,Human Albumin 20% Injection 50ml,"i) Acute hypovolemic shock 
ii) Hypoproteinaemia 
iii) Neonatal hyperbilirubinaemia ","i) ADULT 25 g. CHILD 0.6 g/kg body weight 
ii) Maximum daily dose is 2g 
ii) 1 g/kg before exchange transfusion. Dose is given at rate of 1 ml of 25% solution per minute
",B,,,Albapure,123.70,/,vial,B
B05,Hydroxyethyl Starch 6% Injection (6% hydroxyethyl starch 130/0.4 in an isotonic electrolyte injection),"Therapy and prophylaxis of hypovolaemia and shock in connection with surgery trauma, infections and burns ","ADULT daily dose up to 20 ml/kg/day. Normally 500-1500 ml. The rate of infusion may approach 20 ml/kg/hour in acute haemorrhagic shock, slower rates in burns and septic shock. CHILD under 10 years do not exceed 15 ml /kg/hour.
",B,,,Voluven,45.63,/,drip,B
B05,Modified Fluid Gelatin 4% Injection,"For primary volume replacement in hypovolaemia, peri-operative stabilization of the circulation, haemodilution, extracorporeal circulation (haemodialysis and heart-lung machine) ","ADULT 500 - 1500 ml given as IV infusion
",B,,,Infusol SG,13.57,/,drip,B
,,,,,,,,,,,
21.0 MISCELLANEOUS,,,,,,,,,,,
B05,Balanced Salt Solution,For irrigation during ocular surgery ,Irrigate as directed,A,,,BSS®,18.27,/,drip,A
R07,Beractant Intratracheal Suspension (200 mg phospholipids in 8 ml vial),"Treatment of newborn baby with birth weight of 700 g or greater undergoing mechanical ventilation for respiratory distress syndrome, whose heart rate and arterial oxygenation are continuously monitored ","100 mg/kg (4 ml/kg) body weight intratracheally up to 4 doses in 1st 48 hr. Doses should not be given more frequently than 6 hrly. To be administered as soon as possible.
",A*,Pediatrik,,Survanta,"1,503",/,vial,A*
R07,Calfactant 35mg/ml intratracheal suspension,"For the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS and for the treatment (“rescue”) of premature infants who develop RDS. Prophylaxis: Indicated for premature infants <29 weeks of gestational age at significant risk for RDS. Should be administered as soon as possible, preferably within 30 minutes after birth. Treatment: Indicated for infants ≤72 hours of age with RDS (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.",3mL/kg body weight at birth to be administered every 12 hours for total up to 3 doses.,A*,Pediatrik,,Intrasurf,"1,400",/,vial,
N01,Ether Solvent 1 L,To remove adhesive plaster from the skin ,"Dose depending on the route and procedure
",C,,,Ether,210.00,/,bot,C
B05,Haemodialysis Concentrate with Acetate,"For acute renal failure, chronic renal failure, overhydration, intoxication, adjustment of acid-base and electrolyte balance ","Dose depending on clinical cases
",A,,,Renacid,16.40,/,10L bag,A
B05,Haemodialysis Concentrate with Bicarbonate,"For acute renal failure, chronic renal failure, overhydration, intoxication, adjustment of acid-base and electrolyte balance ","Dose depending on clinical cases
",A,,,Renacarb K2,33.92,/,20L bag,A
B05,Haemodialysis Concentrate Acidic Component,"For acute renal failure, chronic renal failure, overhydration, intoxication, adjustment of acid-base and electrolyte balance ","Dose depending on clinical cases
",A,,,Renacid K5,33.92,/,20L bag,
V07,Hydroxyethyl Cellulose Jelly,For lubricating purpose ,"Apply sufficiently for lubricating purpose
",B,,,QC Lubricating Jelly,8.00,/,tube,B
N07,Methadone 5 mg/ml Syrup 1L,"Detoxification treatment or maintenance treatment of narcotic addiction. 
Off-label use: Pain control in cancer","Initial 10-20mg per day, increasing by 10-20mg per day until there are no signs of withdrawal or intoxication. Usual dose 40-60mg/day
cancer pain: refer pain specialist. Doses of 2.5mg OD to 5mg BD have been used in HSM. WHO: titrated up to 20mg BD",A/KK,"Psikiatrik
Perubatan
Pembedahan","Special
 drugs
 approval (UKK) 
(by bulk) required for off label use","Sunward 
Methadone",22.51,/,bot,A/KK
V03,"Methylene Blue 0.5%, 1% Injection","i) For treatment of idiopathic and drug-induced methaemoglobinemia 
ii) As dye in diagnostic procedures
HSM: Surgical markings in OT","i) Adult and children: 1 to 2 mg/kg IV over 5 minutes.
This dosage can be repeated if necessary after one hour.

ii) A dose of 5 mg/kg diluted in 500 mL of glucose 5% infused over 1 hour has been used successfully to stain and identify the parathyroid glands.

Dosing is individualised and according to product insert/protocol.",B,Pembedahan,"Currently using 0.5%

1% no longer a registered product in M'sia",Proveblue,63.01,/,vial,B
N07,"Nicotine 2 mg, 4mg Gum","For the treatment of tobacco dependence by relieving nicotine withdrawal symptoms, thereby facilitating smoking cessation in smokers motivated to quit. ","Smokes ≤ 20 sticks/day, chew 2mg gum. Smokes ≥ 20 sticks/day,chew 4 mg gum. (MAX 24 pieces /day for up to 12 week.)
",A/KK,,,"Nicorette 2mg

Nicorette 4 mg","0.79 

1.18",/,each,A/KK
B05,Peritoneal Dialysis with 1.5% Glucose Solution 2 L,For chronic renal disease requiring dialysis and for acute renal failure ,"Dose depending on clinical cases
",B,,,Peritonil H1,12.23,/,drip,B
B05,Peritoneal Dialysis with 4.25% Glucose Solution 2 L,For chronic renal disease requiring dialysis and for acute renal failure ,"Dose depending on clinical cases
",B,,,Peritonil H2,12.55,/,drip,B
D03,Protein Free Haemodialysate 10% Jelly,"Trophic lesions in patients with arterial occlusive disease and with chronic venous insufficiency, burn injuries, impaired wound healing, decubitus ulcers and skin ulcer caused by irradiation ","Apply 3 - 5 times daily
",A,,product discont,Solcoseryl,25.00,/,tube,A
N07,Varenicline Tartrate 0.5 mg + 1 mg Tablet Starter Pack,Smoking cessation treatment ,"0.5 mg once daily for Day 1-3, then 0.5 mg twice daily for Day 4-7, then 1 mg twice daily; duration of treatment is 12 weeks
",A/KK,Perubatan,,Champix,103.22,/,pack of 25,A/KK
N07,Varenicline Tartrate 1 mg Tablet,Smoking cessation treatment ,"0.5 mg once daily for Day 1-3, then 0.5 mg twice daily for Day 4-7, then 1 mg twice daily; duration of treatment is 12 weeks
",A/KK,Perubatan,,Champix,103.22,/,pack of 28,A/KK